<html xmlns:ecco="http://owl.cs.manchester.ac.uk/diff">
   <head>
      <meta http-equiv="Content-Type" content="text/html; charset=UTF-8">
      <title>ecco</title>
      <meta charset="utf-8">
      <link rel="stylesheet" href="css/style.css">
      <link rel="stylesheet" href="css/reveal.css"><script type="text/javascript" src="js/jquery-1.4.4.js"></script><script type="text/javascript" src="js/jquery-ui-1.8.12.custom.min.js"></script><script type="text/javascript" src="js/script.js"></script><script type="text/javascript" src="js/jquery.checkboxtree.js"></script><script type="text/javascript" src="js/jquery.reveal.js"></script><script type="text/javascript" src="js/jscript.js"></script></head>
   <body>
      <h1><br></h1>
      				[<a href="index.jsp">Back Home</a>]
      				
      <form action="getXml" method="post" class="inl">
         						[<a id="top3" target="_blank" href="EccoChangeSet_labels.xml">Source XML</a>]
         					
      </form><br><br><h2 style="display:inline;">Change Summary</h2>&nbsp;
      				[<a id="top1" href="javascript:;" onClick="showAll();$('#tree1').checkboxTree('expandAll');$('#tree2').checkboxTree('expandAll')">Show All</a> | 
      				<a id="top2" href="javascript:;" onClick="hideAll();$('#tree1').checkboxTree('collapseAll');$('#tree2').checkboxTree('collapseAll');">Hide All</a>] 
      				[<a id="genViewPerml" href="#" onclick="setPermalink();">Generate View Permalink</a>]
      				
      <div id="view-plink-modal" class="reveal-modal">
         <h3>view-permalink</h3><textarea id="view-plink" rows="3" cols="60" readonly="true" style="resize: none;"></textarea><br>
         					[<a href="javascript:;" onclick="select_all('view-plink');">Select all</a>]
         					<a class="close-reveal-modal">x</a></div><br><br><form action="output" method="post" name="GenSymTrigger"><input type="hidden" name="uuid" value="0a910852-6451-4588-8721-e1279b453d58-lbl"><input type="button" name="gensyms" onClick="parent.location='index_labels.html'" value="Use Labels"> <input type="button" name="gensyms" onClick="parent.location='index_names.html'" value="Use Term Names"> <input type="button" name="gensyms" onClick="parent.location='index_gensyms.html'" value="Use GenSyms"></form>
      <table width="70%" style="table-layout:fixed;">
         <tr>
            <th class="topright"><input type="checkbox" name="removals" onClick="toggleGroup('removals')">  
               <h3 style="display:inline;">Removals (230)</h3>
            </th>
            <th class="topleft"><input type="checkbox" name="additions" onClick="toggleGroup('additions')">  
               <h3 style="display:inline;">Additions (1455)</h3>
            </th>
         </tr>
         <tr>
            <td class="topright">
               <ul id="tree1">
                  <li>  <input type="checkbox" name="effRemsTrigger" onClick="toggleChanges('effRems','effRemsTrigger')">  
                     <h4 style="display:inline;">Effectual (212)</h4>  <img src="images/info_bubble.png" alt="" align="right" width="14" height="14" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Axioms that are in Ontology 1, not in Ontology 2, and are not entailed by Ontology 2');"><ul>
                        <li>  Weakenings (0)</li>
                        <li>  <input type="checkbox" name="effRems" onClick="toggleDiv('wkequiv','wkequivrt');">  <b>Modified Definitions (54)</b>  <img src="images/info_bubble.png" alt="" align="right" width="14" height="14" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Equivalence axioms that have been extended; if split into subsumptions then one was strengthened and the other weakened');"><ul style="display:none">
                              <li id="wkequivtrig"><img src="images/blank.png" alt="">  <input type="checkbox" name="effAdds" onClick="toggleDiv('wkequiv');">  <a href="#wkequiv">With Shared Terms (54)</a></li>
                              <li><img src="images/blank.png" alt="">&nbsp;&nbsp;With Retired Terms (0)
                              </li>
                           </ul>
                        </li>
                        <li><img src="images/blank.png" alt="">&nbsp;&nbsp;Retired Descriptions (0)
                        </li>
                        <li>  <input type="checkbox" name="effRems" onClick="toggleDiv('rem','remrt');">  <b>Pure Removals (158)</b>  <img src="images/info_bubble.png" alt="" align="right" width="14" height="14" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Axioms with no co-relation with axioms in Ontology 2; typically related to hierachy changes');"><ul style="display:none">
                              <li id="remtrig"><img src="images/blank.png" alt="">  <input type="checkbox" name="effAdds" onClick="toggleDiv('rem');">  <a href="#rem">With Shared Terms (158)</a></li>
                              <li><img src="images/blank.png" alt="">&nbsp;&nbsp;With Retired Terms (0)
                              </li>
                           </ul>
                        </li><br></ul>
                  </li><br><li>  <input type="checkbox" name="ineffRemsTrigger" onClick="toggleChanges('ineffRems','ineffRemsTrigger')">  
                     <h4 style="display:inline;">Ineffectual (18)</h4>  <img src="images/info_bubble.png" alt="" align="right" width="14" height="14" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Axioms that are in Ontology 1, not in Ontology 2, but are entailed by Ontology 2, i.e., that have been removed but are still entailed');"><ul>
                        <li>  <input type="checkbox" name="ineffRems" onClick="toggleDiv('ravred','rst','rpsnovred');">  <b>Prospective Redundancy (18)</b>  <img src="images/info_bubble.png" alt="" align="right" width="14" height="14" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Axioms in Ontology 1 for which there are more constraining related axioms in Ontology 2');"><ul style="display:none">
                              <li><img src="images/blank.png" alt="">&nbsp;&nbsp;Reshuffle (0)
                              </li>
                              <li>  <input type="checkbox" name="ineffRems" onClick="toggleDiv('rst','rpsnovred');">  <b>Retired Prospective Redundancy (18)</b><b id="t1"></b>  
                                 <ul style="display:none">
                                    <li id="rsttrig"><img src="images/blank.png" alt="">  <input type="checkbox" name="ineffRems" onClick="toggleDiv('rst');">  <a href="#rst">Novel (15)</a></li>
                                    <li id="rpsnovredtrig"><img src="images/blank.png" alt="">  <input type="checkbox" name="ineffRems" onClick="toggleDiv('rpsnovred');">  <a href="#rpsnovred">Pseudo Novel (3)</a></li>
                                 </ul>
                              </li>
                           </ul>
                        </li>
                        <li><img src="images/blank.png" alt="">&nbsp;&nbsp;Rewritten (0)
                        </li>
                        <li><img src="images/blank.png" alt="">&nbsp;&nbsp;Redundant (0)
                        </li>
                     </ul>
                  </li>
               </ul>
            </td>
            <td class="topleft" style="vertical-align:top">
               <ul id="tree2">
                  <li>  <input type="checkbox" name="effAddsTrigger" onClick="toggleChanges('effAdds','effAddsTrigger')">  
                     <h4 style="display:inline;">Effectual (1445)</h4>  <img src="images/info_bubble.png" alt="" align="right" width="14" height="14" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Axioms that are in Ontology 2, not in Ontology 1, and are not entailed by Ontology 1');"><ul>
                        <li>  <input type="checkbox" name="effAdds" onClick="toggleDiv('st','stnt');">  <b>Strengthenings (1)</b>  <img src="images/info_bubble.png" alt="" align="right" width="14" height="14" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Axioms that are more constraining than existing axioms in Ontology 1');"><ul style="display:none">
                              <li id="sttrig"><img src="images/blank.png" alt="">  <input type="checkbox" name="effAdds" onClick="toggleDiv('st');">  <a href="#st">With Shared Terms (1)</a></li>
                              <li><img src="images/blank.png" alt="">&nbsp;&nbsp;With New Terms (0)
                              </li>
                           </ul>
                        </li>
                        <li>  <input type="checkbox" name="effAdds" onClick="toggleDiv('stequiv','stequivnt');">  <b>Modified Definitions (53)</b>  <img src="images/info_bubble.png" alt="" align="right" width="14" height="14" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Equivalence axioms that have been extended; if split into subsumptions then one was strengthened and the other weakened');"><ul style="display:none">
                              <li id="stequivtrig"><img src="images/blank.png" alt="">  <input type="checkbox" name="effAdds" onClick="toggleDiv('stequiv');">  <a href="#aed">With Shared Terms (43)</a></li>
                              <li id="stequivnttrig"><img src="images/blank.png" alt="">  <input type="checkbox" name="effAdds" onClick="toggleDiv('stequivnt');">  <a href="#aednt">With New Terms (10)</a></li>
                           </ul>
                        </li>
                        <li id="newdesctrig"><img src="images/blank.png" alt="">  <input type="checkbox" name="effAdds" onClick="toggleDiv('newdesc');">  <a href="#newdesc">New Descriptions (1153)</a>  <img src="images/info_bubble.png" alt="" align="right" width="14" height="14" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Axioms describing newly created terms, i.e., terms that did not exist in Ontology 1');"></li>
                        <li>  <input type="checkbox" name="effAdds" onClick="toggleDiv('add','addnt');">  <b>Pure Additions (238)</b>  <img src="images/info_bubble.png" alt="" align="right" width="14" height="14" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Axioms with no co-relation with axioms in Ontology 1; typically related to hierachy changes');"><ul style="display:none">
                              <li id="addtrig"><img src="images/blank.png" alt="">  <input type="checkbox" name="effAdds" onClick="toggleDiv('add');">  <a href="#add">With Shared Terms (225)</a></li>
                              <li id="addnttrig"><img src="images/blank.png" alt="">  <input type="checkbox" name="effAdds" onClick="toggleDiv('addnt');">  <a href="#addnt">With New Terms (13)</a></li>
                           </ul>
                        </li>
                     </ul>
                  </li><br><li>  <input type="checkbox" name="ineffAddsTrigger" onClick="toggleChanges('ineffAdds','ineffAddsTrigger')">  
                     <h4 style="display:inline;">Ineffectual (10)</h4>  <img src="images/info_bubble.png" alt="" align="right" width="14" height="14" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Axioms that are in Ontology 2, not in Ontology 1, but are entailed by Ontology 1, i.e., that have been added but were already entailed');"><ul>
                        <li>  <input type="checkbox" name="ineffAdds" onClick="toggleDiv('aavred','apseudopred','aweak');">  <b>Retrospective Redundancy (9)</b>  <img src="images/info_bubble.png" alt="" align="right" width="14" height="14" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Axioms in Ontology 2 for which there are more constraining related axioms in Ontology 1');"><ul style="display:none">
                              <li><img src="images/blank.png" alt="">&nbsp;&nbsp;Reshuffle (0)
                              </li>
                              <li>  <input type="checkbox" name="ineffAdds" onClick="toggleDiv('aweak','apseudopred');">  <b>New Retrospective Redundancy (9)</b>  
                                 <ul style="display:none">
                                    <li id="aweaktrig"><img src="images/blank.png" alt="">  <input type="checkbox" name="ineffAdds" onClick="toggleDiv('aweak');">  <a href="#aweak">Novel (9)</a></li>
                                    <li><img src="images/blank.png" alt="">&nbsp;&nbsp;Pseudo Novel (0)
                                    </li>
                                 </ul>
                              </li>
                           </ul>
                        </li>
                        <li><img src="images/blank.png" alt="">&nbsp;&nbsp;Rewritten (0)
                        </li>
                        <li id="aredtrig"><img src="images/blank.png" alt="">  <input type="checkbox" name="ineffAdds" onClick="toggleDiv('ared')">  <a href="#ared">Redundant (1)</a>  <img src="images/info_bubble.png" alt="" align="right" width="14" height="14" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Axioms in Ontology 2 that are entailed by at least one shared axiom between Ontology 1 and 2');"></li>
                     </ul>
                  </li>
               </ul>
            </td>
         </tr>
         <tr>
            <td class="topright">[<a href="javascript:void(0);" id="tree1-expandAll">Expand All</a> | <a href="javascript:void(0);" id="tree1-collapseAll">Collapse All</a>]
            </td>
            <td class="topleft">[<a href="javascript:void(0);" id="tree2-expandAll">Expand All</a> | <a href="javascript:void(0);" id="tree2-collapseAll">Collapse All</a>]
            </td>
         </tr>
      </table>
      <table width="100%" style="table-layout:fixed;">
         <colgroup>
            <col>
            <col width="47.5%">
            <col width="47.5%">
         </colgroup>
         <tbody id="st" style="display:none">
            <tr class="withoutstyle">
               <td colspan="3">
                  <h4 style="display: inline-block;">Strengthenings with Shared Terms (1)</h4> [<a href="#">back to top</a>]
               </td>
            </tr>
            <tr>
               <th class="addition">ID</th>
               <th class="normaladd">Weaker Axiom in Ontology 1</th>
               <th class="addition">Strengthened Axiom in Ontology 2</th>
            </tr>
            <tr class="addition">
               <td>1</td>
               <td>CLCF1 wt Allele<span class="subclass"> SubClassOf </span>Gene_Found_In_Organism<span class="some"> some </span>Human. 
               </td>
               <td>CLCF1 wt Allele<span class="subclass"> EquivalentTo </span>CLCF1 Gene<br><span class="keyword"> and </span>(Gene_Found_In_Organism<span class="some"> some </span>Human)<br><span class="keyword"> and </span>(Gene_In_Chromosomal_Location<span class="some"> some </span>11q13.3)<br><span class="keyword"> and </span>(Gene_Is_Element_In_Pathway<span class="some"> some </span>Cytokine-Cytokine Receptor Signaling Pathway)<br><span class="keyword"> and </span>(Gene_Is_Element_In_Pathway<span class="some"> some </span>Jak-STAT Signaling Pathway).<br></td>
            </tr>
         </tbody>
         <tbody id="newdesc" style="display:none">
            <tr class="withoutstyle">
               <td colspan="3">
                  <h4 style="display: inline-block;">New Descriptions (1153)</h4> [<a href="#">back to top</a>]
               </td>
            </tr>
            <tr>
               <th class="addition">ID</th>
               <th class="addition" colspan="2">New Description Axiom in Ontology 2</th>
            </tr>
            <tr class="addition">
               <td>1152</td>
               <td colspan="2">14-3-3 Protein Epsilon<span class="subclass"> EquivalentTo </span>Signaling Protein<br><span class="keyword"> and </span>(Gene_Product_Encoded_By_Gene<span class="some"> some </span>YWHAE Gene)<br><span class="keyword"> and </span>(Gene_Product_Has_Associated_Anatomy<span class="some"> some </span>Cytosol)<br><span class="keyword"> and </span>(Gene_Product_Has_Biochemical_Function<span class="some"> some </span>Signaling Protein)<br><span class="keyword"> and </span>(Gene_Product_Has_Chemical_Classification<span class="some"> some </span>14-3-3 Family)<br><span class="keyword"> and </span>(Gene_Product_Is_Element_In_Pathway<span class="some"> some </span>Cell Cycle Pathway)<br><span class="keyword"> and </span>(Gene_Product_Is_Element_In_Pathway<span class="some"> some </span>HDAC Class II Signaling Pathway)<br><span class="keyword"> and </span>(Gene_Product_Is_Element_In_Pathway<span class="some"> some </span>IGF1 Pathway)<br><span class="keyword"> and </span>(Gene_Product_Is_Element_In_Pathway<span class="some"> some </span>Lissencephaly-1 Gene in Neuronal Migration<br><span class="keyword"> and </span>Development)<br><span class="keyword"> and </span>(Gene_Product_Is_Element_In_Pathway<span class="some"> some </span>Nerve Growth Factor Receptor Signaling Pathway)<br><span class="keyword"> and </span>(Gene_Product_Is_Element_In_Pathway<span class="some"> some </span>Neurotrophin Signaling Pathway)<br><span class="keyword"> and </span>(Gene_Product_Is_Element_In_Pathway<span class="some"> some </span>Oocyte Meiosis Pathway)<br><span class="keyword"> and </span>(Gene_Product_Is_Element_In_Pathway<span class="some"> some </span>TGF-Beta Receptor Signaling Pathway)<br><span class="keyword"> and </span>(Gene_Product_Is_Element_In_Pathway<span class="some"> some </span>Telomerase Regulation Pathway)<br><span class="keyword"> and </span>(Gene_Product_Plays_Role_In_Biological_Process<span class="some"> some </span>Intracellular Signaling Process)<br><span class="keyword"> and </span>(Gene_Product_Plays_Role_In_Biological_Process<span class="some"> some </span>G2 to M Transition Process)<br><span class="keyword"> and </span>(Gene_Product_Plays_Role_In_Biological_Process<span class="some"> some </span>Positive Regulation of Apoptosis)<br><span class="keyword"> and </span>(Gene_Product_Plays_Role_In_Biological_Process<span class="some"> some </span>Signal Transduction). <br><i>New Terms: YWHAE Gene, 14-3-3 Protein Epsilon</i></td>
            </tr>
            <tr class="addition">
               <td>1153</td>
               <td colspan="2">3,4-Dihydroxyphenylglycol Measurement<span class="subclass"> SubClassOf </span>Chemistry Test. <br><i>New Terms: 3,4-Dihydroxyphenylglycol Measurement</i></td>
            </tr>
            <tr class="addition">
               <td>2</td>
               <td colspan="2">ADAS-Cog CDISC Version Questionnaire Question<span class="subclass"> SubClassOf </span>Clinical<br><span class="keyword"> or </span>Research Assessment Question. <br><i>New Terms: ADAS-Cog CDISC Version Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>3</td>
               <td colspan="2">ARID2 Gene<span class="subclass"> SubClassOf </span>Gene_Plays_Role_In_Process<span class="some"> some </span>Chromatin Remodeling. <br><i>New Terms: ARID2 Gene</i></td>
            </tr>
            <tr class="addition">
               <td>4</td>
               <td colspan="2">ARID2 Gene<span class="subclass"> SubClassOf </span>Gene_Plays_Role_In_Process<span class="some"> some </span>Transcriptional Regulation. <br><i>New Terms: ARID2 Gene</i></td>
            </tr>
            <tr class="addition">
               <td>5</td>
               <td colspan="2">ARID2 Gene<span class="subclass"> SubClassOf </span>Transcription Regulation Gene. <br><i>New Terms: ARID2 Gene</i></td>
            </tr>
            <tr class="addition">
               <td>6</td>
               <td colspan="2">ARID2 wt Allele<span class="subclass"> SubClassOf </span>ARID2 Gene. <br><i>New Terms: ARID2 wt Allele, ARID2 Gene</i></td>
            </tr>
            <tr class="addition">
               <td>7</td>
               <td colspan="2">ARID2 wt Allele<span class="subclass"> SubClassOf </span>Gene_In_Chromosomal_Location<span class="some"> some </span>12q12. <br><i>New Terms: ARID2 wt Allele</i></td>
            </tr>
            <tr class="addition">
               <td>8</td>
               <td colspan="2">AT-Rich Interactive Domain-Containing Protein 2<span class="subclass"> EquivalentTo </span>Transcription Regulatory Protein<br><span class="keyword"> and </span>(Gene_Product_Encoded_By_Gene<span class="some"> some </span>ARID2 Gene)<br><span class="keyword"> and </span>(Gene_Product_Expressed_In_Tissue<span class="some"> some </span>Heart)<br><span class="keyword"> and </span>(Gene_Product_Expressed_In_Tissue<span class="some"> some </span>Testis)<br><span class="keyword"> and </span>(Gene_Product_Has_Associated_Anatomy<span class="some"> some </span>Nucleus)<br><span class="keyword"> and </span>(Gene_Product_Has_Biochemical_Function<span class="some"> some </span>Chromatin Remodeling Factor)<br><span class="keyword"> and </span>(Gene_Product_Has_Biochemical_Function<span class="some"> some </span>DNA Binding Protein)<br><span class="keyword"> and </span>(Gene_Product_Has_Structural_Domain_Or_Motif<span class="some"> some </span>ARID Domain)<br><span class="keyword"> and </span>(Gene_Product_Has_Structural_Domain_Or_Motif<span class="some"> some </span>C2H2 Zinc Finger)<br><span class="keyword"> and </span>(Gene_Product_Plays_Role_In_Biological_Process<span class="some"> some </span>Chromatin Remodeling)<br><span class="keyword"> and </span>(Gene_Product_Plays_Role_In_Biological_Process<span class="some"> some </span>Transcriptional Regulation). <br><i>New Terms: ARID2 Gene, AT-Rich Interactive Domain-Containing Protein 2</i></td>
            </tr>
            <tr class="addition">
               <td>9</td>
               <td colspan="2">ATIC/ALK Fusion Gene<span class="subclass"> SubClassOf </span>Fusion Gene. <br><i>New Terms: ATIC/ALK Fusion Gene</i></td>
            </tr>
            <tr class="addition">
               <td>10</td>
               <td colspan="2">ATIC/ALK Fusion Gene<span class="subclass"> SubClassOf </span>Gene_Involved_In_Pathogenesis_Of_Disease<span class="some"> some </span>Anaplastic Large Cell Lymphoma, ALK-Positive. <br><i>New Terms: ATIC/ALK Fusion Gene</i></td>
            </tr>
            <tr class="addition">
               <td>11</td>
               <td colspan="2">ATIC/ALK Fusion Protein<span class="subclass"> SubClassOf </span>Fusion Protein. <br><i>New Terms: ATIC/ALK Fusion Protein</i></td>
            </tr>
            <tr class="addition">
               <td>12</td>
               <td colspan="2">ATIC/ALK Fusion Protein<span class="subclass"> SubClassOf </span>Gene_Product_Encoded_By_Gene<span class="some"> some </span>ATIC/ALK Fusion Gene. <br><i>New Terms: ATIC/ALK Fusion Gene, ATIC/ALK Fusion Protein</i></td>
            </tr>
            <tr class="addition">
               <td>13</td>
               <td colspan="2">Activated PTT to Standard PTT Ratio Measurement<span class="subclass"> SubClassOf </span>Coagulation Study. <br><i>New Terms: Activated PTT to Standard PTT Ratio Measurement</i></td>
            </tr>
            <tr class="addition">
               <td>14</td>
               <td colspan="2">Activated Protein C Resistance Measurement<span class="subclass"> SubClassOf </span>Protein<br><span class="keyword"> or </span>Enzyme<span class="subclass"> Type </span>Measurement. <br><i>New Terms: Activated Protein C Resistance Measurement</i></td>
            </tr>
            <tr class="addition">
               <td>15</td>
               <td colspan="2">Ademetionine<span class="subclass"> SubClassOf </span>Antioxidant. <br><i>New Terms: Ademetionine</i></td>
            </tr>
            <tr class="addition">
               <td>16</td>
               <td colspan="2">Adenovirus/Cytomegalovirus/Epstein-Barr Virus-specific Allogeneic Cytotoxic T Lymphocytes<span class="subclass"> SubClassOf </span>Therapeutic Allogeneic Lymphocytes. <br><i>New Terms: Adenovirus/Cytomegalovirus/Epstein-Barr Virus-specific Allogeneic Cytotoxic T Lymphocytes</i></td>
            </tr>
            <tr class="addition">
               <td>17</td>
               <td colspan="2">Alanine Aminopeptidase Measurement<span class="subclass"> SubClassOf </span>Protein<br><span class="keyword"> or </span>Enzyme<span class="subclass"> Type </span>Measurement. <br><i>New Terms: Alanine Aminopeptidase Measurement</i></td>
            </tr>
            <tr class="addition">
               <td>21</td>
               <td colspan="2">Alpha 1 Microglobulin Measurement<span class="subclass"> SubClassOf </span>Retired Concept Current Year. <br><i>New Terms: Alpha 1 Microglobulin Measurement</i></td>
            </tr>
            <tr class="addition">
               <td>18</td>
               <td colspan="2">Alpha-1 Acid Glycoprotein Measurement<span class="subclass"> SubClassOf </span>Protein<br><span class="keyword"> or </span>Enzyme<span class="subclass"> Type </span>Measurement. <br><i>New Terms: Alpha-1 Acid Glycoprotein Measurement</i></td>
            </tr>
            <tr class="addition">
               <td>19</td>
               <td colspan="2">Alpha-1 Microglobulin Measurement<span class="subclass"> SubClassOf </span>Immunology Test. <br><i>New Terms: Alpha-1 Microglobulin Measurement</i></td>
            </tr>
            <tr class="addition">
               <td>20</td>
               <td colspan="2">Alpha-1 Microglobulin to Creatinine Ratio Measurement<span class="subclass"> SubClassOf </span>Immunology Test. <br><i>New Terms: Alpha-1 Microglobulin to Creatinine Ratio Measurement</i></td>
            </tr>
            <tr class="addition">
               <td>22</td>
               <td colspan="2">Alzheimer's Disease Assessment Scale-Cognitive CDISC Version Questionnaire<span class="subclass"> SubClassOf </span>Clinical<br><span class="keyword"> or </span>Research Assessment Questionnaire. <br><i>New Terms: Alzheimer's Disease Assessment Scale-Cognitive CDISC Version Questionnaire</i></td>
            </tr>
            <tr class="addition">
               <td>23</td>
               <td colspan="2">Annotation Collection<span class="subclass"> SubClassOf </span>Item Collection. <br><i>New Terms: Annotation Collection</i></td>
            </tr>
            <tr class="addition">
               <td>24</td>
               <td colspan="2">Anti-CD37 Antibody-Drug Conjugate IMGN529<span class="subclass"> SubClassOf </span>Immunoconjugate. <br><i>New Terms: Anti-CD37 Antibody-Drug Conjugate IMGN529</i></td>
            </tr>
            <tr class="addition">
               <td>25</td>
               <td colspan="2">Apolipoprotein C2 Measurement<span class="subclass"> SubClassOf </span>Protein<br><span class="keyword"> or </span>Enzyme<span class="subclass"> Type </span>Measurement. <br><i>New Terms: Apolipoprotein C2 Measurement</i></td>
            </tr>
            <tr class="addition">
               <td>26</td>
               <td colspan="2">Apolipoprotein J Measurement<span class="subclass"> SubClassOf </span>Protein<br><span class="keyword"> or </span>Enzyme<span class="subclass"> Type </span>Measurement. <br><i>New Terms: Apolipoprotein J Measurement</i></td>
            </tr>
            <tr class="addition">
               <td>31</td>
               <td colspan="2">Atrioventricular Septal Defect<span class="subclass"> SubClassOf </span>Congenital Septal Defect. <br><i>New Terms: Atrioventricular Septal Defect</i></td>
            </tr>
            <tr class="addition">
               <td>32</td>
               <td colspan="2">BCL-6 Corepressor<span class="subclass"> EquivalentTo </span>Transcription Regulatory Protein<br><span class="keyword"> and </span>(Gene_Product_Encoded_By_Gene<span class="some"> some </span>BCOR Gene)<br><span class="keyword"> and </span>(Gene_Product_Has_Associated_Anatomy<span class="some"> some </span>Nucleus)<br><span class="keyword"> and </span>(Gene_Product_Has_Biochemical_Function<span class="some"> some </span>Transcription Repressor/Corepressor)<br><span class="keyword"> and </span>(Gene_Product_Has_Structural_Domain_Or_Motif<span class="some"> some </span>Ankyrin Repeat)<br><span class="keyword"> and </span>(Gene_Product_Is_Element_In_Pathway<span class="some"> some </span>HDAC Class II Signaling Pathway)<br><span class="keyword"> and </span>(Gene_Product_Plays_Role_In_Biological_Process<span class="some"> some </span>Odontogenesis)<br><span class="keyword"> and </span>(Gene_Product_Plays_Role_In_Biological_Process<span class="some"> some </span>Pattern Formation)<br><span class="keyword"> and </span>(Gene_Product_Plays_Role_In_Biological_Process<span class="some"> some </span>Transcriptional Repression). <br><i>New Terms: BCL-6 Corepressor, BCOR Gene</i></td>
            </tr>
            <tr class="addition">
               <td>33</td>
               <td colspan="2">BCOR Gene<span class="subclass"> SubClassOf </span>Gene_Plays_Role_In_Process<span class="some"> some </span>Odontogenesis. <br><i>New Terms: BCOR Gene</i></td>
            </tr>
            <tr class="addition">
               <td>34</td>
               <td colspan="2">BCOR Gene<span class="subclass"> SubClassOf </span>Gene_Plays_Role_In_Process<span class="some"> some </span>Pattern Formation. <br><i>New Terms: BCOR Gene</i></td>
            </tr>
            <tr class="addition">
               <td>35</td>
               <td colspan="2">BCOR Gene<span class="subclass"> SubClassOf </span>Gene_Plays_Role_In_Process<span class="some"> some </span>Transcriptional Repression. <br><i>New Terms: BCOR Gene</i></td>
            </tr>
            <tr class="addition">
               <td>36</td>
               <td colspan="2">BCOR Gene<span class="subclass"> SubClassOf </span>Transcription Repressor/Corepressor Gene. <br><i>New Terms: BCOR Gene</i></td>
            </tr>
            <tr class="addition">
               <td>37</td>
               <td colspan="2">BCOR wt Allele<span class="subclass"> SubClassOf </span>BCOR Gene. <br><i>New Terms: BCOR wt Allele, BCOR Gene</i></td>
            </tr>
            <tr class="addition">
               <td>38</td>
               <td colspan="2">BCOR wt Allele<span class="subclass"> SubClassOf </span>Gene_Is_Element_In_Pathway<span class="some"> some </span>HDAC Class II Signaling Pathway. <br><i>New Terms: BCOR wt Allele</i></td>
            </tr>
            <tr class="addition">
               <td>39</td>
               <td colspan="2">BCR/JAK2 Fusion Gene<span class="subclass"> SubClassOf </span>Fusion Gene. <br><i>New Terms: BCR/JAK2 Fusion Gene</i></td>
            </tr>
            <tr class="addition">
               <td>40</td>
               <td colspan="2">BCR/JAK2 Fusion Gene<span class="subclass"> SubClassOf </span>Gene_Plays_Role_In_Process<span class="some"> some </span>Tyrosine Phosphorylation. <br><i>New Terms: BCR/JAK2 Fusion Gene</i></td>
            </tr>
            <tr class="addition">
               <td>41</td>
               <td colspan="2">BCR/JAK2 Fusion Protein<span class="subclass"> SubClassOf </span>Fusion Protein. <br><i>New Terms: BCR/JAK2 Fusion Protein</i></td>
            </tr>
            <tr class="addition">
               <td>42</td>
               <td colspan="2">BCR/JAK2 Fusion Protein<span class="subclass"> SubClassOf </span>Gene_Product_Encoded_By_Gene<span class="some"> some </span>BCR/JAK2 Fusion Gene. <br><i>New Terms: BCR/JAK2 Fusion Gene, BCR/JAK2 Fusion Protein</i></td>
            </tr>
            <tr class="addition">
               <td>43</td>
               <td colspan="2">BCR/JAK2 Fusion Protein<span class="subclass"> SubClassOf </span>Gene_Product_Plays_Role_In_Biological_Process<span class="some"> some </span>Tyrosine Phosphorylation. <br><i>New Terms: BCR/JAK2 Fusion Protein</i></td>
            </tr>
            <tr class="addition">
               <td>44</td>
               <td colspan="2">BPI - Aching<span class="subclass"> SubClassOf </span>BPI Questionnaire Question. <br><i>New Terms: BPI Questionnaire Question, BPI - Aching</i></td>
            </tr>
            <tr class="addition">
               <td>45</td>
               <td colspan="2">BPI - Area Hurts Most<span class="subclass"> SubClassOf </span>BPI Questionnaire Question. <br><i>New Terms: BPI - Area Hurts Most, BPI Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>46</td>
               <td colspan="2">BPI - Areas of Pain<span class="subclass"> SubClassOf </span>BPI Questionnaire Question. <br><i>New Terms: BPI Questionnaire Question, BPI - Areas of Pain</i></td>
            </tr>
            <tr class="addition">
               <td>47</td>
               <td colspan="2">BPI - Biofeedback to Relieve Pain<span class="subclass"> SubClassOf </span>BPI Questionnaire Question. <br><i>New Terms: BPI - Biofeedback to Relieve Pain, BPI Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>48</td>
               <td colspan="2">BPI - Burning<span class="subclass"> SubClassOf </span>BPI Questionnaire Question. <br><i>New Terms: BPI - Burning, BPI Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>49</td>
               <td colspan="2">BPI - Cold Compresses to Relieve Pain<span class="subclass"> SubClassOf </span>BPI Questionnaire Question. <br><i>New Terms: BPI Questionnaire Question, BPI - Cold Compresses to Relieve Pain</i></td>
            </tr>
            <tr class="addition">
               <td>50</td>
               <td colspan="2">BPI - Concerned with Too Much Pain Medication Use<span class="subclass"> SubClassOf </span>BPI Questionnaire Question. <br><i>New Terms: BPI Questionnaire Question, BPI - Concerned with Too Much Pain Medication Use</i></td>
            </tr>
            <tr class="addition">
               <td>51</td>
               <td colspan="2">BPI - Current Job Status<span class="subclass"> SubClassOf </span>BPI Questionnaire Question. <br><i>New Terms: BPI - Current Job Status, BPI Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>52</td>
               <td colspan="2">BPI - Current Occupation<span class="subclass"> SubClassOf </span>BPI Questionnaire Question. <br><i>New Terms: BPI Questionnaire Question, BPI - Current Occupation</i></td>
            </tr>
            <tr class="addition">
               <td>53</td>
               <td colspan="2">BPI - Describe Unrelated Medical Condition<span class="subclass"> SubClassOf </span>BPI Questionnaire Question. <br><i>New Terms: BPI Questionnaire Question, BPI - Describe Unrelated Medical Condition</i></td>
            </tr>
            <tr class="addition">
               <td>54</td>
               <td colspan="2">BPI - Distraction to Relieve Pain<span class="subclass"> SubClassOf </span>BPI Questionnaire Question. <br><i>New Terms: BPI Questionnaire Question, BPI - Distraction to Relieve Pain</i></td>
            </tr>
            <tr class="addition">
               <td>55</td>
               <td colspan="2">BPI - Education<span class="subclass"> SubClassOf </span>BPI Questionnaire Question. <br><i>New Terms: BPI - Education, BPI Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>56</td>
               <td colspan="2">BPI - Exhausting<span class="subclass"> SubClassOf </span>BPI Questionnaire Question. <br><i>New Terms: BPI - Exhausting, BPI Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>57</td>
               <td colspan="2">BPI - Gnawing<span class="subclass"> SubClassOf </span>BPI Questionnaire Question. <br><i>New Terms: BPI - Gnawing, BPI Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>58</td>
               <td colspan="2">BPI - Hours before Pain Returns<span class="subclass"> SubClassOf </span>BPI Questionnaire Question. <br><i>New Terms: BPI - Hours before Pain Returns, BPI Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>59</td>
               <td colspan="2">BPI - How Long Since Diagnosis<span class="subclass"> SubClassOf </span>BPI Questionnaire Question. <br><i>New Terms: BPI - How Long Since Diagnosis, BPI Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>60</td>
               <td colspan="2">BPI - Hypnosis to Relieve Pain<span class="subclass"> SubClassOf </span>BPI Questionnaire Question. <br><i>New Terms: BPI - Hypnosis to Relieve Pain, BPI Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>61</td>
               <td colspan="2">BPI - Kind of Surgery in Past Month<span class="subclass"> SubClassOf </span>BPI Questionnaire Question. <br><i>New Terms: BPI - Kind of Surgery in Past Month, BPI Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>62</td>
               <td colspan="2">BPI - Marital Status<span class="subclass"> SubClassOf </span>BPI Questionnaire Question. <br><i>New Terms: BPI Questionnaire Question, BPI - Marital Status</i></td>
            </tr>
            <tr class="addition">
               <td>63</td>
               <td colspan="2">BPI - Medications <span class="keyword">not </span>Prescribed Taken for Pain<span class="subclass"> SubClassOf </span>BPI Questionnaire Question. <br><i>New Terms: BPI Questionnaire Question, BPI - Medications not Prescribed Taken for Pain</i></td>
            </tr>
            <tr class="addition">
               <td>64</td>
               <td colspan="2">BPI - Miserable<span class="subclass"> SubClassOf </span>BPI Questionnaire Question. <br><i>New Terms: BPI - Miserable, BPI Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>65</td>
               <td colspan="2">BPI - Nagging<span class="subclass"> SubClassOf </span>BPI Questionnaire Question. <br><i>New Terms: BPI - Nagging, BPI Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>66</td>
               <td colspan="2">BPI - Need Further Information about Pain Medication<span class="subclass"> SubClassOf </span>BPI Questionnaire Question. <br><i>New Terms: BPI - Need Further Information about Pain Medication, BPI Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>67</td>
               <td colspan="2">BPI - Need Stronger<span class="subclass"> Type </span>of Pain Medication<span class="subclass"> SubClassOf </span>BPI Questionnaire Question. <br><i>New Terms: BPI - Need Stronger Type of Pain Medication, BPI Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>68</td>
               <td colspan="2">BPI - Need more Pain Medication than Prescribed<span class="subclass"> SubClassOf </span>BPI Questionnaire Question. <br><i>New Terms: BPI - Need more Pain Medication than Prescribed, BPI Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>69</td>
               <td colspan="2">BPI - Numb<span class="subclass"> SubClassOf </span>BPI Questionnaire Question. <br><i>New Terms: BPI Questionnaire Question, BPI - Numb</i></td>
            </tr>
            <tr class="addition">
               <td>70</td>
               <td colspan="2">BPI - Other Methods to Relieve Pain<span class="subclass"> SubClassOf </span>BPI Questionnaire Question. <br><i>New Terms: BPI Questionnaire Question, BPI - Other Methods to Relieve Pain</i></td>
            </tr>
            <tr class="addition">
               <td>71</td>
               <td colspan="2">BPI - Pain Due to Effects of Treatment<span class="subclass"> SubClassOf </span>BPI Questionnaire Question. <br><i>New Terms: BPI - Pain Due to Effects of Treatment, BPI Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>72</td>
               <td colspan="2">BPI - Pain Due to Present Disease<span class="subclass"> SubClassOf </span>BPI Questionnaire Question. <br><i>New Terms: BPI - Pain Due to Present Disease, BPI Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>73</td>
               <td colspan="2">BPI - Pain Due to Primary Disease<span class="subclass"> SubClassOf </span>BPI Questionnaire Question. <br><i>New Terms: BPI Questionnaire Question, BPI - Pain Due to Primary Disease</i></td>
            </tr>
            <tr class="addition">
               <td>74</td>
               <td colspan="2">BPI - Pain Due to Unrelated Medical Condition<span class="subclass"> SubClassOf </span>BPI Questionnaire Question. <br><i>New Terms: BPI Questionnaire Question, BPI - Pain Due to Unrelated Medical Condition</i></td>
            </tr>
            <tr class="addition">
               <td>75</td>
               <td colspan="2">BPI - Pain Interfered with Enjoyment of Life<span class="subclass"> SubClassOf </span>BPI Questionnaire Question. <br><i>New Terms: BPI - Pain Interfered with Enjoyment of Life, BPI Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>76</td>
               <td colspan="2">BPI - Pain Interfered with General Activity<span class="subclass"> SubClassOf </span>BPI Questionnaire Question. <br><i>New Terms: BPI Questionnaire Question, BPI - Pain Interfered with General Activity</i></td>
            </tr>
            <tr class="addition">
               <td>77</td>
               <td colspan="2">BPI - Pain Interfered with Mood<span class="subclass"> SubClassOf </span>BPI Questionnaire Question. <br><i>New Terms: BPI Questionnaire Question, BPI - Pain Interfered with Mood</i></td>
            </tr>
            <tr class="addition">
               <td>78</td>
               <td colspan="2">BPI - Pain Interfered with Normal Work<span class="subclass"> SubClassOf </span>BPI Questionnaire Question. <br><i>New Terms: BPI - Pain Interfered with Normal Work, BPI Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>79</td>
               <td colspan="2">BPI - Pain Interfered with Relations<span class="subclass"> SubClassOf </span>BPI Questionnaire Question. <br><i>New Terms: BPI Questionnaire Question, BPI - Pain Interfered with Relations</i></td>
            </tr>
            <tr class="addition">
               <td>80</td>
               <td colspan="2">BPI - Pain Interfered with Sleep<span class="subclass"> SubClassOf </span>BPI Questionnaire Question. <br><i>New Terms: BPI - Pain Interfered with Sleep, BPI Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>81</td>
               <td colspan="2">BPI - Pain Interfered with Walking Ability<span class="subclass"> SubClassOf </span>BPI Questionnaire Question. <br><i>New Terms: BPI Questionnaire Question, BPI - Pain Interfered with Walking Ability</i></td>
            </tr>
            <tr class="addition">
               <td>82</td>
               <td colspan="2">BPI - Pain Medications in the Last 7 Days<span class="subclass"> SubClassOf </span>BPI Questionnaire Question. <br><i>New Terms: BPI - Pain Medications in the Last 7 Days, BPI Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>83</td>
               <td colspan="2">BPI - Pain Other than Everyday Kinds<span class="subclass"> SubClassOf </span>BPI Questionnaire Question. <br><i>New Terms: BPI - Pain Other than Everyday Kinds, BPI Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>84</td>
               <td colspan="2">BPI - Pain Requires Medication Daily<span class="subclass"> SubClassOf </span>BPI Questionnaire Question. <br><i>New Terms: BPI - Pain Requires Medication Daily, BPI Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>85</td>
               <td colspan="2">BPI - Pain Right Now<span class="subclass"> SubClassOf </span>BPI Questionnaire Question. <br><i>New Terms: BPI Questionnaire Question, BPI - Pain Right Now</i></td>
            </tr>
            <tr class="addition">
               <td>86</td>
               <td colspan="2">BPI - Pain as a Symptom<span class="subclass"> SubClassOf </span>BPI Questionnaire Question. <br><i>New Terms: BPI - Pain as a Symptom, BPI Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>87</td>
               <td colspan="2">BPI - Pain at its Least in Last Week<span class="subclass"> SubClassOf </span>BPI Questionnaire Question. <br><i>New Terms: BPI Questionnaire Question, BPI - Pain at its Least in Last Week</i></td>
            </tr>
            <tr class="addition">
               <td>88</td>
               <td colspan="2">BPI - Pain at its Worst in Last Week<span class="subclass"> SubClassOf </span>BPI Questionnaire Question. <br><i>New Terms: BPI Questionnaire Question, BPI - Pain at its Worst in Last Week</i></td>
            </tr>
            <tr class="addition">
               <td>89</td>
               <td colspan="2">BPI - Pain on the Average<span class="subclass"> SubClassOf </span>BPI Questionnaire Question. <br><i>New Terms: BPI - Pain on the Average, BPI Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>90</td>
               <td colspan="2">BPI - Penetrating<span class="subclass"> SubClassOf </span>BPI Questionnaire Question. <br><i>New Terms: BPI Questionnaire Question, BPI - Penetrating</i></td>
            </tr>
            <tr class="addition">
               <td>91</td>
               <td colspan="2">BPI - Prefer to Take Pain Medicine<span class="subclass"> SubClassOf </span>BPI Questionnaire Question. <br><i>New Terms: BPI - Prefer to Take Pain Medicine, BPI Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>92</td>
               <td colspan="2">BPI - Problems with Side Effects Pain Medication<span class="subclass"> SubClassOf </span>BPI Questionnaire Question. <br><i>New Terms: BPI Questionnaire Question, BPI - Problems with Side Effects Pain Medication</i></td>
            </tr>
            <tr class="addition">
               <td>93</td>
               <td colspan="2">BPI - Professional Degree<span class="subclass"> SubClassOf </span>BPI Questionnaire Question. <br><i>New Terms: BPI - Professional Degree, BPI Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>94</td>
               <td colspan="2">BPI - Relaxation Techniques Relieve Pain<span class="subclass"> SubClassOf </span>BPI Questionnaire Question. <br><i>New Terms: BPI - Relaxation Techniques Relieve Pain, BPI Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>95</td>
               <td colspan="2">BPI - Relief Pain Treatments Provided<span class="subclass"> SubClassOf </span>BPI Questionnaire Question. <br><i>New Terms: BPI - Relief Pain Treatments Provided, BPI Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>96</td>
               <td colspan="2">BPI - Sharp<span class="subclass"> SubClassOf </span>BPI Questionnaire Question. <br><i>New Terms: BPI Questionnaire Question, BPI - Sharp</i></td>
            </tr>
            <tr class="addition">
               <td>97</td>
               <td colspan="2">BPI - Shooting<span class="subclass"> SubClassOf </span>BPI Questionnaire Question. <br><i>New Terms: BPI - Shooting, BPI Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>98</td>
               <td colspan="2">BPI - Specified Other Method to Relieve Pain<span class="subclass"> SubClassOf </span>BPI Questionnaire Question. <br><i>New Terms: BPI Questionnaire Question, BPI - Specified Other Method to Relieve Pain</i></td>
            </tr>
            <tr class="addition">
               <td>99</td>
               <td colspan="2">BPI - Spouse's Occupation<span class="subclass"> SubClassOf </span>BPI Questionnaire Question. <br><i>New Terms: BPI - Spouse's Occupation, BPI Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>100</td>
               <td colspan="2">BPI - Stabbing<span class="subclass"> SubClassOf </span>BPI Questionnaire Question. <br><i>New Terms: BPI Questionnaire Question, BPI - Stabbing</i></td>
            </tr>
            <tr class="addition">
               <td>101</td>
               <td colspan="2">BPI - Surgery in Past Month<span class="subclass"> SubClassOf </span>BPI Questionnaire Question. <br><i>New Terms: BPI Questionnaire Question, BPI - Surgery in Past Month</i></td>
            </tr>
            <tr class="addition">
               <td>102</td>
               <td colspan="2">BPI - Take my Pain Medicine<span class="subclass"> SubClassOf </span>BPI Questionnaire Question. <br><i>New Terms: BPI Questionnaire Question, BPI - Take my Pain Medicine</i></td>
            </tr>
            <tr class="addition">
               <td>103</td>
               <td colspan="2">BPI - Tender<span class="subclass"> SubClassOf </span>BPI Questionnaire Question. <br><i>New Terms: BPI - Tender, BPI Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>104</td>
               <td colspan="2">BPI - Things that Make Pain Feel Better<span class="subclass"> SubClassOf </span>BPI Questionnaire Question. <br><i>New Terms: BPI Questionnaire Question, BPI - Things that Make Pain Feel Better</i></td>
            </tr>
            <tr class="addition">
               <td>105</td>
               <td colspan="2">BPI - Things that Make your Pain Worse<span class="subclass"> SubClassOf </span>BPI Questionnaire Question. <br><i>New Terms: BPI - Things that Make your Pain Worse, BPI Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>106</td>
               <td colspan="2">BPI - Throbbing<span class="subclass"> SubClassOf </span>BPI Questionnaire Question. <br><i>New Terms: BPI - Throbbing, BPI Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>107</td>
               <td colspan="2">BPI - Tiring<span class="subclass"> SubClassOf </span>BPI Questionnaire Question. <br><i>New Terms: BPI - Tiring, BPI Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>108</td>
               <td colspan="2">BPI - Treatments Receiving for Pain<span class="subclass"> SubClassOf </span>BPI Questionnaire Question. <br><i>New Terms: BPI - Treatments Receiving for Pain, BPI Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>109</td>
               <td colspan="2">BPI - Unbearable<span class="subclass"> SubClassOf </span>BPI Questionnaire Question. <br><i>New Terms: BPI Questionnaire Question, BPI - Unbearable</i></td>
            </tr>
            <tr class="addition">
               <td>110</td>
               <td colspan="2">BPI - Warm Compresses to Relieve Pain<span class="subclass"> SubClassOf </span>BPI Questionnaire Question. <br><i>New Terms: BPI Questionnaire Question, BPI - Warm Compresses to Relieve Pain</i></td>
            </tr>
            <tr class="addition">
               <td>111</td>
               <td colspan="2">BPI - What Side Effects from Pain Medication<span class="subclass"> SubClassOf </span>BPI Questionnaire Question. <br><i>New Terms: BPI - What Side Effects from Pain Medication, BPI Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>112</td>
               <td colspan="2">BPI - Why Concerned with Too Much Pain Medication Use<span class="subclass"> SubClassOf </span>BPI Questionnaire Question. <br><i>New Terms: BPI - Why Concerned with Too Much Pain Medication Use, BPI Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>113</td>
               <td colspan="2">BPI Questionnaire Question<span class="subclass"> SubClassOf </span>Clinical<br><span class="keyword"> or </span>Research Assessment Question. <br><i>New Terms: BPI Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>114</td>
               <td colspan="2">BPI Short Form - Area that Hurts Most<span class="subclass"> SubClassOf </span>BPI Short Form Questionnaire Question. <br><i>New Terms: BPI Short Form Questionnaire Question, BPI Short Form - Area that Hurts Most</i></td>
            </tr>
            <tr class="addition">
               <td>115</td>
               <td colspan="2">BPI Short Form - Areas of Pain<span class="subclass"> SubClassOf </span>BPI Short Form Questionnaire Question. <br><i>New Terms: BPI Short Form Questionnaire Question, BPI Short Form - Areas of Pain</i></td>
            </tr>
            <tr class="addition">
               <td>116</td>
               <td colspan="2">BPI Short Form - Pain Interfered with Enjoyment of Life<span class="subclass"> SubClassOf </span>BPI Short Form Questionnaire Question. <br><i>New Terms: BPI Short Form - Pain Interfered with Enjoyment of Life, BPI Short Form Questionnaire
                     Question</i></td>
            </tr>
            <tr class="addition">
               <td>117</td>
               <td colspan="2">BPI Short Form - Pain Interfered with General Activity<span class="subclass"> SubClassOf </span>BPI Short Form Questionnaire Question. <br><i>New Terms: BPI Short Form Questionnaire Question, BPI Short Form - Pain Interfered with General
                     Activity</i></td>
            </tr>
            <tr class="addition">
               <td>118</td>
               <td colspan="2">BPI Short Form - Pain Interfered with Mood<span class="subclass"> SubClassOf </span>BPI Short Form Questionnaire Question. <br><i>New Terms: BPI Short Form Questionnaire Question, BPI Short Form - Pain Interfered with Mood</i></td>
            </tr>
            <tr class="addition">
               <td>119</td>
               <td colspan="2">BPI Short Form - Pain Interfered with Normal Work<span class="subclass"> SubClassOf </span>BPI Short Form Questionnaire Question. <br><i>New Terms: BPI Short Form Questionnaire Question, BPI Short Form - Pain Interfered with Normal
                     Work</i></td>
            </tr>
            <tr class="addition">
               <td>120</td>
               <td colspan="2">BPI Short Form - Pain Interfered with Relations<span class="subclass"> SubClassOf </span>BPI Short Form Questionnaire Question. <br><i>New Terms: BPI Short Form Questionnaire Question, BPI Short Form - Pain Interfered with Relations</i></td>
            </tr>
            <tr class="addition">
               <td>121</td>
               <td colspan="2">BPI Short Form - Pain Interfered with Sleep<span class="subclass"> SubClassOf </span>BPI Short Form Questionnaire Question. <br><i>New Terms: BPI Short Form Questionnaire Question, BPI Short Form - Pain Interfered with Sleep</i></td>
            </tr>
            <tr class="addition">
               <td>122</td>
               <td colspan="2">BPI Short Form - Pain Interfered with Walking Ability<span class="subclass"> SubClassOf </span>BPI Short Form Questionnaire Question. <br><i>New Terms: BPI Short Form - Pain Interfered with Walking Ability, BPI Short Form Questionnaire
                     Question</i></td>
            </tr>
            <tr class="addition">
               <td>123</td>
               <td colspan="2">BPI Short Form - Pain Other Than Everyday Kinds<span class="subclass"> SubClassOf </span>BPI Short Form Questionnaire Question. <br><i>New Terms: BPI Short Form Questionnaire Question, BPI Short Form - Pain Other Than Everyday Kinds</i></td>
            </tr>
            <tr class="addition">
               <td>124</td>
               <td colspan="2">BPI Short Form - Pain Right Now<span class="subclass"> SubClassOf </span>BPI Short Form Questionnaire Question. <br><i>New Terms: BPI Short Form Questionnaire Question, BPI Short Form - Pain Right Now</i></td>
            </tr>
            <tr class="addition">
               <td>125</td>
               <td colspan="2">BPI Short Form - Pain at its Least in Last 24 Hours<span class="subclass"> SubClassOf </span>BPI Short Form Questionnaire Question. <br><i>New Terms: BPI Short Form Questionnaire Question, BPI Short Form - Pain at its Least in Last
                     24 Hours</i></td>
            </tr>
            <tr class="addition">
               <td>126</td>
               <td colspan="2">BPI Short Form - Pain at its Worst in Last 24 Hours<span class="subclass"> SubClassOf </span>BPI Short Form Questionnaire Question. <br><i>New Terms: BPI Short Form Questionnaire Question, BPI Short Form - Pain at its Worst in Last
                     24 Hours</i></td>
            </tr>
            <tr class="addition">
               <td>127</td>
               <td colspan="2">BPI Short Form - Pain on the Average<span class="subclass"> SubClassOf </span>BPI Short Form Questionnaire Question. <br><i>New Terms: BPI Short Form Questionnaire Question, BPI Short Form - Pain on the Average</i></td>
            </tr>
            <tr class="addition">
               <td>128</td>
               <td colspan="2">BPI Short Form - Relief from Pain Treatments Provided<span class="subclass"> SubClassOf </span>BPI Short Form Questionnaire Question. <br><i>New Terms: BPI Short Form Questionnaire Question, BPI Short Form - Relief from Pain Treatments
                     Provided</i></td>
            </tr>
            <tr class="addition">
               <td>129</td>
               <td colspan="2">BPI Short Form - Treatments<br><span class="keyword"> or </span>Medications Receiving for Pain<span class="subclass"> SubClassOf </span>BPI Short Form Questionnaire Question. <br><i>New Terms: BPI Short Form Questionnaire Question, BPI Short Form - Treatments or Medications
                     Receiving for Pain</i></td>
            </tr>
            <tr class="addition">
               <td>130</td>
               <td colspan="2">BPI Short Form Questionnaire Question<span class="subclass"> SubClassOf </span>Clinical<br><span class="keyword"> or </span>Research Assessment Question. <br><i>New Terms: BPI Short Form Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>131</td>
               <td colspan="2">BPRS-A - Anxiety<span class="subclass"> SubClassOf </span>BPRS-A Questionnaire Question. <br><i>New Terms: BPRS-A Questionnaire Question, BPRS-A - Anxiety</i></td>
            </tr>
            <tr class="addition">
               <td>132</td>
               <td colspan="2">BPRS-A - Blunted Affect<span class="subclass"> SubClassOf </span>BPRS-A Questionnaire Question. <br><i>New Terms: BPRS-A Questionnaire Question, BPRS-A - Blunted Affect</i></td>
            </tr>
            <tr class="addition">
               <td>133</td>
               <td colspan="2">BPRS-A - Conceptual Disorganization<span class="subclass"> SubClassOf </span>BPRS-A Questionnaire Question. <br><i>New Terms: BPRS-A Questionnaire Question, BPRS-A - Conceptual Disorganization</i></td>
            </tr>
            <tr class="addition">
               <td>134</td>
               <td colspan="2">BPRS-A - Depressive Mood<span class="subclass"> SubClassOf </span>BPRS-A Questionnaire Question. <br><i>New Terms: BPRS-A Questionnaire Question, BPRS-A - Depressive Mood</i></td>
            </tr>
            <tr class="addition">
               <td>135</td>
               <td colspan="2">BPRS-A - Disorientation<span class="subclass"> SubClassOf </span>BPRS-A Questionnaire Question. <br><i>New Terms: BPRS-A Questionnaire Question, BPRS-A - Disorientation</i></td>
            </tr>
            <tr class="addition">
               <td>136</td>
               <td colspan="2">BPRS-A - Emotional Withdrawal<span class="subclass"> SubClassOf </span>BPRS-A Questionnaire Question. <br><i>New Terms: BPRS-A Questionnaire Question, BPRS-A - Emotional Withdrawal</i></td>
            </tr>
            <tr class="addition">
               <td>137</td>
               <td colspan="2">BPRS-A - Excitement<span class="subclass"> SubClassOf </span>BPRS-A Questionnaire Question. <br><i>New Terms: BPRS-A - Excitement, BPRS-A Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>138</td>
               <td colspan="2">BPRS-A - Grandiosity<span class="subclass"> SubClassOf </span>BPRS-A Questionnaire Question. <br><i>New Terms: BPRS-A Questionnaire Question, BPRS-A - Grandiosity</i></td>
            </tr>
            <tr class="addition">
               <td>139</td>
               <td colspan="2">BPRS-A - Guilt Feelings<span class="subclass"> SubClassOf </span>BPRS-A Questionnaire Question. <br><i>New Terms: BPRS-A Questionnaire Question, BPRS-A - Guilt Feelings</i></td>
            </tr>
            <tr class="addition">
               <td>140</td>
               <td colspan="2">BPRS-A - Hallucinatory Behavior<span class="subclass"> SubClassOf </span>BPRS-A Questionnaire Question. <br><i>New Terms: BPRS-A Questionnaire Question, BPRS-A - Hallucinatory Behavior</i></td>
            </tr>
            <tr class="addition">
               <td>141</td>
               <td colspan="2">BPRS-A - Hostility<span class="subclass"> SubClassOf </span>BPRS-A Questionnaire Question. <br><i>New Terms: BPRS-A - Hostility, BPRS-A Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>142</td>
               <td colspan="2">BPRS-A - Mannerisms<br><span class="keyword"> and </span>Posturing<span class="subclass"> SubClassOf </span>BPRS-A Questionnaire Question. <br><i>New Terms: BPRS-A Questionnaire Question, BPRS-A - Mannerisms and Posturing</i></td>
            </tr>
            <tr class="addition">
               <td>143</td>
               <td colspan="2">BPRS-A - Motor Retardation<span class="subclass"> SubClassOf </span>BPRS-A Questionnaire Question. <br><i>New Terms: BPRS-A - Motor Retardation, BPRS-A Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>144</td>
               <td colspan="2">BPRS-A - Somatic Concern<span class="subclass"> SubClassOf </span>BPRS-A Questionnaire Question. <br><i>New Terms: BPRS-A - Somatic Concern, BPRS-A Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>145</td>
               <td colspan="2">BPRS-A - Suspiciousness<span class="subclass"> SubClassOf </span>BPRS-A Questionnaire Question. <br><i>New Terms: BPRS-A - Suspiciousness, BPRS-A Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>146</td>
               <td colspan="2">BPRS-A - Tension<span class="subclass"> SubClassOf </span>BPRS-A Questionnaire Question. <br><i>New Terms: BPRS-A Questionnaire Question, BPRS-A - Tension</i></td>
            </tr>
            <tr class="addition">
               <td>147</td>
               <td colspan="2">BPRS-A - Uncooperativeness<span class="subclass"> SubClassOf </span>BPRS-A Questionnaire Question. <br><i>New Terms: BPRS-A Questionnaire Question, BPRS-A - Uncooperativeness</i></td>
            </tr>
            <tr class="addition">
               <td>148</td>
               <td colspan="2">BPRS-A - Unusual Thought Content<span class="subclass"> SubClassOf </span>BPRS-A Questionnaire Question. <br><i>New Terms: BPRS-A - Unusual Thought Content, BPRS-A Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>149</td>
               <td colspan="2">BPRS-A Questionnaire Question<span class="subclass"> SubClassOf </span>Clinical<br><span class="keyword"> or </span>Research Assessment Question. <br><i>New Terms: BPRS-A Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>151</td>
               <td colspan="2">Beta Carotene Measurement<span class="subclass"> SubClassOf </span>Protein<br><span class="keyword"> or </span>Enzyme<span class="subclass"> Type </span>Measurement. <br><i>New Terms: Beta Carotene Measurement</i></td>
            </tr>
            <tr class="addition">
               <td>150</td>
               <td colspan="2">Beta-Trace Protein Measurement<span class="subclass"> SubClassOf </span>Protein<br><span class="keyword"> or </span>Enzyme<span class="subclass"> Type </span>Measurement. <br><i>New Terms: Beta-Trace Protein Measurement</i></td>
            </tr>
            <tr class="addition">
               <td>152</td>
               <td colspan="2">Bifocal<span class="subclass"> SubClassOf </span>Focality. <br><i>New Terms: Bifocal</i></td>
            </tr>
            <tr class="addition">
               <td>153</td>
               <td colspan="2">Biological Child<span class="subclass"> SubClassOf </span>Offspring. <br><i>New Terms: Biological Child</i></td>
            </tr>
            <tr class="addition">
               <td>154</td>
               <td colspan="2">Biological Grandchild<span class="subclass"> SubClassOf </span>Grandchild. <br><i>New Terms: Biological Grandchild</i></td>
            </tr>
            <tr class="addition">
               <td>155</td>
               <td colspan="2">Biological Grandparent<span class="subclass"> SubClassOf </span>Grandparent. <br><i>New Terms: Biological Grandparent</i></td>
            </tr>
            <tr class="addition">
               <td>156</td>
               <td colspan="2">Biological Sibling<span class="subclass"> SubClassOf </span>Sibling. <br><i>New Terms: Biological Sibling</i></td>
            </tr>
            <tr class="addition">
               <td>157</td>
               <td colspan="2">Brief Pain Inventory Questionnaire<span class="subclass"> SubClassOf </span>Clinical<br><span class="keyword"> or </span>Research Assessment Questionnaire. <br><i>New Terms: Brief Pain Inventory Questionnaire</i></td>
            </tr>
            <tr class="addition">
               <td>158</td>
               <td colspan="2">Brief Pain Inventory Short Form Questionnaire<span class="subclass"> SubClassOf </span>Clinical<br><span class="keyword"> or </span>Research Assessment Questionnaire. <br><i>New Terms: Brief Pain Inventory Short Form Questionnaire</i></td>
            </tr>
            <tr class="addition">
               <td>159</td>
               <td colspan="2">Brief Psychiatric Rating Scale A Questionnaire<span class="subclass"> SubClassOf </span>Clinical<br><span class="keyword"> or </span>Research Assessment Questionnaire. <br><i>New Terms: Brief Psychiatric Rating Scale A Questionnaire</i></td>
            </tr>
            <tr class="addition">
               <td>160</td>
               <td colspan="2">C-SSRS Baseline - Aborted Suicide Attempt<span class="subclass"> SubClassOf </span>C-SSRS Baseline Questionnaire Question. <br><i>New Terms: C-SSRS Baseline Questionnaire Question, C-SSRS Baseline - Aborted Suicide Attempt</i></td>
            </tr>
            <tr class="addition">
               <td>161</td>
               <td colspan="2">C-SSRS Baseline - Actual Suicide Attempt<span class="subclass"> SubClassOf </span>C-SSRS Baseline Questionnaire Question. <br><i>New Terms: C-SSRS Baseline - Actual Suicide Attempt, C-SSRS Baseline Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>162</td>
               <td colspan="2">C-SSRS Baseline - Control over Most Severe Ideation<span class="subclass"> SubClassOf </span>C-SSRS Baseline Questionnaire Question. <br><i>New Terms: C-SSRS Baseline - Control over Most Severe Ideation, C-SSRS Baseline Questionnaire
                     Question</i></td>
            </tr>
            <tr class="addition">
               <td>163</td>
               <td colspan="2">C-SSRS Baseline - Describe Most Severe Ideation<span class="subclass"> SubClassOf </span>C-SSRS Baseline Questionnaire Question. <br><i>New Terms: C-SSRS Baseline Questionnaire Question, C-SSRS Baseline - Describe Most Severe Ideation</i></td>
            </tr>
            <tr class="addition">
               <td>164</td>
               <td colspan="2">C-SSRS Baseline - Description of Aborted Suicide Attempt<span class="subclass"> SubClassOf </span>C-SSRS Baseline Questionnaire Question. <br><i>New Terms: C-SSRS Baseline Questionnaire Question, C-SSRS Baseline - Description of Aborted Suicide
                     Attempt</i></td>
            </tr>
            <tr class="addition">
               <td>165</td>
               <td colspan="2">C-SSRS Baseline - Description of Actual Suicide Attempts<span class="subclass"> SubClassOf </span>C-SSRS Baseline Questionnaire Question. <br><i>New Terms: C-SSRS Baseline Questionnaire Question, C-SSRS Baseline - Description of Actual Suicide
                     Attempts</i></td>
            </tr>
            <tr class="addition">
               <td>166</td>
               <td colspan="2">C-SSRS Baseline - Description of Ideation With Intent, No Plan<span class="subclass"> SubClassOf </span>C-SSRS Baseline Questionnaire Question. <br><i>New Terms: C-SSRS Baseline Questionnaire Question, C-SSRS Baseline - Description of Ideation
                     With Intent, No Plan</i></td>
            </tr>
            <tr class="addition">
               <td>167</td>
               <td colspan="2">C-SSRS Baseline - Description of Ideation With Plan<br><span class="keyword"> and </span>Intent<span class="subclass"> SubClassOf </span>C-SSRS Baseline Questionnaire Question. <br><i>New Terms: C-SSRS Baseline Questionnaire Question, C-SSRS Baseline - Description of Ideation
                     With Plan and Intent</i></td>
            </tr>
            <tr class="addition">
               <td>168</td>
               <td colspan="2">C-SSRS Baseline - Description of Interrupted Suicide Attempt<span class="subclass"> SubClassOf </span>C-SSRS Baseline Questionnaire Question. <br><i>New Terms: C-SSRS Baseline - Description of Interrupted Suicide Attempt, C-SSRS Baseline Questionnaire
                     Question</i></td>
            </tr>
            <tr class="addition">
               <td>169</td>
               <td colspan="2">C-SSRS Baseline - Description of Non-Specific Suicide Thought<span class="subclass"> SubClassOf </span>C-SSRS Baseline Questionnaire Question. <br><i>New Terms: C-SSRS Baseline - Description of Non-Specific Suicide Thought, C-SSRS Baseline Questionnaire
                     Question</i></td>
            </tr>
            <tr class="addition">
               <td>170</td>
               <td colspan="2">C-SSRS Baseline - Description of Preparatory Acts<br><span class="keyword"> or </span>Behaviors Toward Suicide Attempt<span class="subclass"> SubClassOf </span>C-SSRS Baseline Questionnaire Question. <br><i>New Terms: C-SSRS Baseline Questionnaire Question, C-SSRS Baseline - Description of Preparatory
                     Acts or Behaviors Toward Suicide Attempt</i></td>
            </tr>
            <tr class="addition">
               <td>171</td>
               <td colspan="2">C-SSRS Baseline - Description of Suicidal Ideation-No Intent<span class="subclass"> SubClassOf </span>C-SSRS Baseline Questionnaire Question. <br><i>New Terms: C-SSRS Baseline - Description of Suicidal Ideation-No Intent, C-SSRS Baseline Questionnaire
                     Question</i></td>
            </tr>
            <tr class="addition">
               <td>172</td>
               <td colspan="2">C-SSRS Baseline - Description of Wish to be Dead<span class="subclass"> SubClassOf </span>C-SSRS Baseline Questionnaire Question. <br><i>New Terms: C-SSRS Baseline - Description of Wish to be Dead, C-SSRS Baseline Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>173</td>
               <td colspan="2">C-SSRS Baseline - Deterrents to Most Severe Ideation<span class="subclass"> SubClassOf </span>C-SSRS Baseline Questionnaire Question. <br><i>New Terms: C-SSRS Baseline - Deterrents to Most Severe Ideation, C-SSRS Baseline Questionnaire
                     Question</i></td>
            </tr>
            <tr class="addition">
               <td>174</td>
               <td colspan="2">C-SSRS Baseline - Duration of Most Severe Ideation<span class="subclass"> SubClassOf </span>C-SSRS Baseline Questionnaire Question. <br><i>New Terms: C-SSRS Baseline Questionnaire Question, C-SSRS Baseline - Duration of Most Severe
                     Ideation</i></td>
            </tr>
            <tr class="addition">
               <td>175</td>
               <td colspan="2">C-SSRS Baseline - First Suicide Attempt Damage<span class="subclass"> SubClassOf </span>C-SSRS Baseline Questionnaire Question. <br><i>New Terms: C-SSRS Baseline Questionnaire Question, C-SSRS Baseline - First Suicide Attempt Damage</i></td>
            </tr>
            <tr class="addition">
               <td>176</td>
               <td colspan="2">C-SSRS Baseline - First Suicide Attempt Date<span class="subclass"> SubClassOf </span>C-SSRS Baseline Questionnaire Question. <br><i>New Terms: C-SSRS Baseline Questionnaire Question, C-SSRS Baseline - First Suicide Attempt Date</i></td>
            </tr>
            <tr class="addition">
               <td>177</td>
               <td colspan="2">C-SSRS Baseline - First Suicide Attempt Potential<span class="subclass"> SubClassOf </span>C-SSRS Baseline Questionnaire Question. <br><i>New Terms: C-SSRS Baseline - First Suicide Attempt Potential, C-SSRS Baseline Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>178</td>
               <td colspan="2">C-SSRS Baseline - Frequency of Most Severe Ideation<span class="subclass"> SubClassOf </span>C-SSRS Baseline Questionnaire Question. <br><i>New Terms: C-SSRS Baseline - Frequency of Most Severe Ideation, C-SSRS Baseline Questionnaire
                     Question</i></td>
            </tr>
            <tr class="addition">
               <td>179</td>
               <td colspan="2">C-SSRS Baseline - Ideation With Intent, No Plan<span class="subclass"> SubClassOf </span>C-SSRS Baseline Questionnaire Question. <br><i>New Terms: C-SSRS Baseline Questionnaire Question, C-SSRS Baseline - Ideation With Intent, No
                     Plan</i></td>
            </tr>
            <tr class="addition">
               <td>180</td>
               <td colspan="2">C-SSRS Baseline - Ideation With Plan/Intent<span class="subclass"> SubClassOf </span>C-SSRS Baseline Questionnaire Question. <br><i>New Terms: C-SSRS Baseline - Ideation With Plan/Intent, C-SSRS Baseline Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>181</td>
               <td colspan="2">C-SSRS Baseline - Interrupted Suicide Attempt<span class="subclass"> SubClassOf </span>C-SSRS Baseline Questionnaire Question. <br><i>New Terms: C-SSRS Baseline Questionnaire Question, C-SSRS Baseline - Interrupted Suicide Attempt</i></td>
            </tr>
            <tr class="addition">
               <td>182</td>
               <td colspan="2">C-SSRS Baseline - Most Lethal Suicide Attempt Damage<span class="subclass"> SubClassOf </span>C-SSRS Baseline Questionnaire Question. <br><i>New Terms: C-SSRS Baseline - Most Lethal Suicide Attempt Damage, C-SSRS Baseline Questionnaire
                     Question</i></td>
            </tr>
            <tr class="addition">
               <td>183</td>
               <td colspan="2">C-SSRS Baseline - Most Lethal Suicide Attempt Date<span class="subclass"> SubClassOf </span>C-SSRS Baseline Questionnaire Question. <br><i>New Terms: C-SSRS Baseline Questionnaire Question, C-SSRS Baseline - Most Lethal Suicide Attempt
                     Date</i></td>
            </tr>
            <tr class="addition">
               <td>184</td>
               <td colspan="2">C-SSRS Baseline - Most Lethal Suicide Attempt Potential<span class="subclass"> SubClassOf </span>C-SSRS Baseline Questionnaire Question. <br><i>New Terms: C-SSRS Baseline Questionnaire Question, C-SSRS Baseline - Most Lethal Suicide Attempt
                     Potential</i></td>
            </tr>
            <tr class="addition">
               <td>185</td>
               <td colspan="2">C-SSRS Baseline - Most Recent Suicide Attempt Damage<span class="subclass"> SubClassOf </span>C-SSRS Baseline Questionnaire Question. <br><i>New Terms: C-SSRS Baseline Questionnaire Question, C-SSRS Baseline - Most Recent Suicide Attempt
                     Damage</i></td>
            </tr>
            <tr class="addition">
               <td>186</td>
               <td colspan="2">C-SSRS Baseline - Most Recent Suicide Attempt Date<span class="subclass"> SubClassOf </span>C-SSRS Baseline Questionnaire Question. <br><i>New Terms: C-SSRS Baseline Questionnaire Question, C-SSRS Baseline - Most Recent Suicide Attempt
                     Date</i></td>
            </tr>
            <tr class="addition">
               <td>187</td>
               <td colspan="2">C-SSRS Baseline - Most Recent Suicide Attempt Potential<span class="subclass"> SubClassOf </span>C-SSRS Baseline Questionnaire Question. <br><i>New Terms: C-SSRS Baseline Questionnaire Question, C-SSRS Baseline - Most Recent Suicide Attempt
                     Potential</i></td>
            </tr>
            <tr class="addition">
               <td>188</td>
               <td colspan="2">C-SSRS Baseline - Most Severe Ideation<span class="subclass"> SubClassOf </span>C-SSRS Baseline Questionnaire Question. <br><i>New Terms: C-SSRS Baseline Questionnaire Question, C-SSRS Baseline - Most Severe Ideation</i></td>
            </tr>
            <tr class="addition">
               <td>189</td>
               <td colspan="2">C-SSRS Baseline - Non-Specific Suicidal Thought<span class="subclass"> SubClassOf </span>C-SSRS Baseline Questionnaire Question. <br><i>New Terms: C-SSRS Baseline Questionnaire Question, C-SSRS Baseline - Non-Specific Suicidal Thought</i></td>
            </tr>
            <tr class="addition">
               <td>190</td>
               <td colspan="2">C-SSRS Baseline - Non-suicidal Self-injurious Behavior<span class="subclass"> SubClassOf </span>C-SSRS Baseline Questionnaire Question. <br><i>New Terms: C-SSRS Baseline - Non-suicidal Self-injurious Behavior, C-SSRS Baseline Questionnaire
                     Question</i></td>
            </tr>
            <tr class="addition">
               <td>191</td>
               <td colspan="2">C-SSRS Baseline - Number of Aborted Suicide Attempts<span class="subclass"> SubClassOf </span>C-SSRS Baseline Questionnaire Question. <br><i>New Terms: C-SSRS Baseline - Number of Aborted Suicide Attempts, C-SSRS Baseline Questionnaire
                     Question</i></td>
            </tr>
            <tr class="addition">
               <td>192</td>
               <td colspan="2">C-SSRS Baseline - Number of Actual Suicide Attempts<span class="subclass"> SubClassOf </span>C-SSRS Baseline Questionnaire Question. <br><i>New Terms: C-SSRS Baseline Questionnaire Question, C-SSRS Baseline - Number of Actual Suicide
                     Attempts</i></td>
            </tr>
            <tr class="addition">
               <td>193</td>
               <td colspan="2">C-SSRS Baseline - Number of Interrupted Suicide Attempts<span class="subclass"> SubClassOf </span>C-SSRS Baseline Questionnaire Question. <br><i>New Terms: C-SSRS Baseline Questionnaire Question, C-SSRS Baseline - Number of Interrupted Suicide
                     Attempts</i></td>
            </tr>
            <tr class="addition">
               <td>194</td>
               <td colspan="2">C-SSRS Baseline - Preparatory Acts<br><span class="keyword"> or </span>Behaviors Toward Suicide Attempt<span class="subclass"> SubClassOf </span>C-SSRS Baseline Questionnaire Question. <br><i>New Terms: C-SSRS Baseline - Preparatory Acts or Behaviors Toward Suicide Attempt, C-SSRS Baseline
                     Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>195</td>
               <td colspan="2">C-SSRS Baseline - Reasons for Most Severe Ideation<span class="subclass"> SubClassOf </span>C-SSRS Baseline Questionnaire Question. <br><i>New Terms: C-SSRS Baseline - Reasons for Most Severe Ideation, C-SSRS Baseline Questionnaire
                     Question</i></td>
            </tr>
            <tr class="addition">
               <td>196</td>
               <td colspan="2">C-SSRS Baseline - Suicidal Behavior<span class="subclass"> SubClassOf </span>C-SSRS Baseline Questionnaire Question. <br><i>New Terms: C-SSRS Baseline - Suicidal Behavior, C-SSRS Baseline Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>197</td>
               <td colspan="2">C-SSRS Baseline - Suicidal Ideation-No Intent<span class="subclass"> SubClassOf </span>C-SSRS Baseline Questionnaire Question. <br><i>New Terms: C-SSRS Baseline Questionnaire Question, C-SSRS Baseline - Suicidal Ideation-No Intent</i></td>
            </tr>
            <tr class="addition">
               <td>198</td>
               <td colspan="2">C-SSRS Baseline - Wish to be Dead<br><span class="keyword"> or </span>go to Sleep<br><span class="keyword"> and </span><span class="keyword">not </span>Wake Up<span class="subclass"> SubClassOf </span>C-SSRS Baseline Questionnaire Question. <br><i>New Terms: C-SSRS Baseline - Wish to be Dead or go to Sleep and not Wake Up, C-SSRS Baseline
                     Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>199</td>
               <td colspan="2">C-SSRS Baseline Questionnaire Question<span class="subclass"> SubClassOf </span>Clinical<br><span class="keyword"> or </span>Research Assessment Question. <br><i>New Terms: C-SSRS Baseline Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>200</td>
               <td colspan="2">CBFB/MYH11 Fusion Gene<span class="subclass"> SubClassOf </span>Fusion Gene. <br><i>New Terms: CBFB/MYH11 Fusion Gene</i></td>
            </tr>
            <tr class="addition">
               <td>201</td>
               <td colspan="2">CBFB/MYH11 Fusion Gene<span class="subclass"> SubClassOf </span>Gene_Involved_In_Pathogenesis_Of_Disease<span class="some"> some </span>Acute Myeloid Leukemia with inv(16)(p13.1q22)<br><span class="keyword"> or </span>t(16;16)(p13.1;q22); CBFB-MYH11. <br><i>New Terms: CBFB/MYH11 Fusion Gene</i></td>
            </tr>
            <tr class="addition">
               <td>202</td>
               <td colspan="2">CBFB/MYH11 Fusion Gene<span class="subclass"> SubClassOf </span>Gene_Plays_Role_In_Process<span class="some"> some </span>Transcriptional Repression. <br><i>New Terms: CBFB/MYH11 Fusion Gene</i></td>
            </tr>
            <tr class="addition">
               <td>203</td>
               <td colspan="2">CBFB/MYH11 Fusion Protein<span class="subclass"> SubClassOf </span>Fusion Protein. <br><i>New Terms: CBFB/MYH11 Fusion Protein</i></td>
            </tr>
            <tr class="addition">
               <td>204</td>
               <td colspan="2">CBFB/MYH11 Fusion Protein<span class="subclass"> SubClassOf </span>Gene_Product_Encoded_By_Gene<span class="some"> some </span>CBFB/MYH11 Fusion Gene. <br><i>New Terms: CBFB/MYH11 Fusion Gene, CBFB/MYH11 Fusion Protein</i></td>
            </tr>
            <tr class="addition">
               <td>205</td>
               <td colspan="2">CBFB/MYH11 Fusion Protein<span class="subclass"> SubClassOf </span>Gene_Product_Plays_Role_In_Biological_Process<span class="some"> some </span>Transcriptional Repression. <br><i>New Terms: CBFB/MYH11 Fusion Protein</i></td>
            </tr>
            <tr class="addition">
               <td>206</td>
               <td colspan="2">CDISC ADAS-Cog - Attempt to Draw<span class="subclass"> SubClassOf </span>ADAS-Cog CDISC Version Questionnaire Question. <br><i>New Terms: CDISC ADAS-Cog - Attempt to Draw, ADAS-Cog CDISC Version Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>212</td>
               <td colspan="2">CDISC ADAS-Cog - Commands Summary Score<span class="subclass"> SubClassOf </span>ADAS-Cog CDISC Version Questionnaire Question. <br><i>New Terms: ADAS-Cog CDISC Version Questionnaire Question, CDISC ADAS-Cog - Commands Summary Score</i></td>
            </tr>
            <tr class="addition">
               <td>208</td>
               <td colspan="2">CDISC ADAS-Cog - Commands: Ceiling<span class="subclass"> SubClassOf </span>ADAS-Cog CDISC Version Questionnaire Question. <br><i>New Terms: CDISC ADAS-Cog - Commands: Ceiling, ADAS-Cog CDISC Version Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>209</td>
               <td colspan="2">CDISC ADAS-Cog - Commands: Fist<span class="subclass"> SubClassOf </span>ADAS-Cog CDISC Version Questionnaire Question. <br><i>New Terms: ADAS-Cog CDISC Version Questionnaire Question, CDISC ADAS-Cog - Commands: Fist</i></td>
            </tr>
            <tr class="addition">
               <td>210</td>
               <td colspan="2">CDISC ADAS-Cog - Commands: Pencil<span class="subclass"> SubClassOf </span>ADAS-Cog CDISC Version Questionnaire Question. <br><i>New Terms: ADAS-Cog CDISC Version Questionnaire Question, CDISC ADAS-Cog - Commands: Pencil</i></td>
            </tr>
            <tr class="addition">
               <td>211</td>
               <td colspan="2">CDISC ADAS-Cog - Commands: Shoulder<span class="subclass"> SubClassOf </span>ADAS-Cog CDISC Version Questionnaire Question. <br><i>New Terms: CDISC ADAS-Cog - Commands: Shoulder, ADAS-Cog CDISC Version Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>213</td>
               <td colspan="2">CDISC ADAS-Cog - Commands: Watch<span class="subclass"> SubClassOf </span>ADAS-Cog CDISC Version Questionnaire Question. <br><i>New Terms: CDISC ADAS-Cog - Commands: Watch, ADAS-Cog CDISC Version Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>214</td>
               <td colspan="2">CDISC ADAS-Cog - Comprehension<span class="subclass"> SubClassOf </span>ADAS-Cog CDISC Version Questionnaire Question. <br><i>New Terms: CDISC ADAS-Cog - Comprehension, ADAS-Cog CDISC Version Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>215</td>
               <td colspan="2">CDISC ADAS-Cog - Concentration/Distractibility<span class="subclass"> SubClassOf </span>ADAS-Cog CDISC Version Questionnaire Question. <br><i>New Terms: CDISC ADAS-Cog - Concentration/Distractibility, ADAS-Cog CDISC Version Questionnaire
                     Question</i></td>
            </tr>
            <tr class="addition">
               <td>220</td>
               <td colspan="2">CDISC ADAS-Cog - Constructional Praxis Summary Score<span class="subclass"> SubClassOf </span>ADAS-Cog CDISC Version Questionnaire Question. <br><i>New Terms: CDISC ADAS-Cog - Constructional Praxis Summary Score, ADAS-Cog CDISC Version Questionnaire
                     Question</i></td>
            </tr>
            <tr class="addition">
               <td>216</td>
               <td colspan="2">CDISC ADAS-Cog - Constructional Praxis: 2 Rectangles<span class="subclass"> SubClassOf </span>ADAS-Cog CDISC Version Questionnaire Question. <br><i>New Terms: CDISC ADAS-Cog - Constructional Praxis: 2 Rectangles, ADAS-Cog CDISC Version Questionnaire
                     Question</i></td>
            </tr>
            <tr class="addition">
               <td>217</td>
               <td colspan="2">CDISC ADAS-Cog - Constructional Praxis: Circle<span class="subclass"> SubClassOf </span>ADAS-Cog CDISC Version Questionnaire Question. <br><i>New Terms: ADAS-Cog CDISC Version Questionnaire Question, CDISC ADAS-Cog - Constructional Praxis:
                     Circle</i></td>
            </tr>
            <tr class="addition">
               <td>218</td>
               <td colspan="2">CDISC ADAS-Cog - Constructional Praxis: Cube<span class="subclass"> SubClassOf </span>ADAS-Cog CDISC Version Questionnaire Question. <br><i>New Terms: CDISC ADAS-Cog - Constructional Praxis: Cube, ADAS-Cog CDISC Version Questionnaire
                     Question</i></td>
            </tr>
            <tr class="addition">
               <td>219</td>
               <td colspan="2">CDISC ADAS-Cog - Constructional Praxis: Diamond<span class="subclass"> SubClassOf </span>ADAS-Cog CDISC Version Questionnaire Question. <br><i>New Terms: ADAS-Cog CDISC Version Questionnaire Question, CDISC ADAS-Cog - Constructional Praxis:
                     Diamond</i></td>
            </tr>
            <tr class="addition">
               <td>221</td>
               <td colspan="2">CDISC ADAS-Cog - Delayed Word Recall Summary Score<span class="subclass"> SubClassOf </span>ADAS-Cog CDISC Version Questionnaire Question. <br><i>New Terms: CDISC ADAS-Cog - Delayed Word Recall Summary Score, ADAS-Cog CDISC Version Questionnaire
                     Question</i></td>
            </tr>
            <tr class="addition">
               <td>222</td>
               <td colspan="2">CDISC ADAS-Cog - Delayed Word Recall: Word 1<span class="subclass"> SubClassOf </span>ADAS-Cog CDISC Version Questionnaire Question. <br><i>New Terms: ADAS-Cog CDISC Version Questionnaire Question, CDISC ADAS-Cog - Delayed Word Recall:
                     Word 1</i></td>
            </tr>
            <tr class="addition">
               <td>223</td>
               <td colspan="2">CDISC ADAS-Cog - Delayed Word Recall: Word 10<span class="subclass"> SubClassOf </span>ADAS-Cog CDISC Version Questionnaire Question. <br><i>New Terms: ADAS-Cog CDISC Version Questionnaire Question, CDISC ADAS-Cog - Delayed Word Recall:
                     Word 10</i></td>
            </tr>
            <tr class="addition">
               <td>224</td>
               <td colspan="2">CDISC ADAS-Cog - Delayed Word Recall: Word 2<span class="subclass"> SubClassOf </span>ADAS-Cog CDISC Version Questionnaire Question. <br><i>New Terms: ADAS-Cog CDISC Version Questionnaire Question, CDISC ADAS-Cog - Delayed Word Recall:
                     Word 2</i></td>
            </tr>
            <tr class="addition">
               <td>225</td>
               <td colspan="2">CDISC ADAS-Cog - Delayed Word Recall: Word 3<span class="subclass"> SubClassOf </span>ADAS-Cog CDISC Version Questionnaire Question. <br><i>New Terms: CDISC ADAS-Cog - Delayed Word Recall: Word 3, ADAS-Cog CDISC Version Questionnaire
                     Question</i></td>
            </tr>
            <tr class="addition">
               <td>226</td>
               <td colspan="2">CDISC ADAS-Cog - Delayed Word Recall: Word 4<span class="subclass"> SubClassOf </span>ADAS-Cog CDISC Version Questionnaire Question. <br><i>New Terms: CDISC ADAS-Cog - Delayed Word Recall: Word 4, ADAS-Cog CDISC Version Questionnaire
                     Question</i></td>
            </tr>
            <tr class="addition">
               <td>227</td>
               <td colspan="2">CDISC ADAS-Cog - Delayed Word Recall: Word 5<span class="subclass"> SubClassOf </span>ADAS-Cog CDISC Version Questionnaire Question. <br><i>New Terms: CDISC ADAS-Cog - Delayed Word Recall: Word 5, ADAS-Cog CDISC Version Questionnaire
                     Question</i></td>
            </tr>
            <tr class="addition">
               <td>228</td>
               <td colspan="2">CDISC ADAS-Cog - Delayed Word Recall: Word 6<span class="subclass"> SubClassOf </span>ADAS-Cog CDISC Version Questionnaire Question. <br><i>New Terms: CDISC ADAS-Cog - Delayed Word Recall: Word 6, ADAS-Cog CDISC Version Questionnaire
                     Question</i></td>
            </tr>
            <tr class="addition">
               <td>229</td>
               <td colspan="2">CDISC ADAS-Cog - Delayed Word Recall: Word 7<span class="subclass"> SubClassOf </span>ADAS-Cog CDISC Version Questionnaire Question. <br><i>New Terms: CDISC ADAS-Cog - Delayed Word Recall: Word 7, ADAS-Cog CDISC Version Questionnaire
                     Question</i></td>
            </tr>
            <tr class="addition">
               <td>230</td>
               <td colspan="2">CDISC ADAS-Cog - Delayed Word Recall: Word 8<span class="subclass"> SubClassOf </span>ADAS-Cog CDISC Version Questionnaire Question. <br><i>New Terms: CDISC ADAS-Cog - Delayed Word Recall: Word 8, ADAS-Cog CDISC Version Questionnaire
                     Question</i></td>
            </tr>
            <tr class="addition">
               <td>231</td>
               <td colspan="2">CDISC ADAS-Cog - Delayed Word Recall: Word 9<span class="subclass"> SubClassOf </span>ADAS-Cog CDISC Version Questionnaire Question. <br><i>New Terms: CDISC ADAS-Cog - Delayed Word Recall: Word 9, ADAS-Cog CDISC Version Questionnaire
                     Question</i></td>
            </tr>
            <tr class="addition">
               <td>233</td>
               <td colspan="2">CDISC ADAS-Cog - Executive Function Maze Summary Score<span class="subclass"> SubClassOf </span>ADAS-Cog CDISC Version Questionnaire Question. <br><i>New Terms: ADAS-Cog CDISC Version Questionnaire Question, CDISC ADAS-Cog - Executive Function
                     Maze Summary Score</i></td>
            </tr>
            <tr class="addition">
               <td>232</td>
               <td colspan="2">CDISC ADAS-Cog - Executive Function Maze: Errors<span class="subclass"> SubClassOf </span>ADAS-Cog CDISC Version Questionnaire Question. <br><i>New Terms: CDISC ADAS-Cog - Executive Function Maze: Errors, ADAS-Cog CDISC Version Questionnaire
                     Question</i></td>
            </tr>
            <tr class="addition">
               <td>234</td>
               <td colspan="2">CDISC ADAS-Cog - Executive Function Maze: Time<span class="subclass"> SubClassOf </span>ADAS-Cog CDISC Version Questionnaire Question. <br><i>New Terms: CDISC ADAS-Cog - Executive Function Maze: Time, ADAS-Cog CDISC Version Questionnaire
                     Question</i></td>
            </tr>
            <tr class="addition">
               <td>240</td>
               <td colspan="2">CDISC ADAS-Cog - Ideational Praxis Summary Score<span class="subclass"> SubClassOf </span>ADAS-Cog CDISC Version Questionnaire Question. <br><i>New Terms: CDISC ADAS-Cog - Ideational Praxis Summary Score, ADAS-Cog CDISC Version Questionnaire
                     Question</i></td>
            </tr>
            <tr class="addition">
               <td>235</td>
               <td colspan="2">CDISC ADAS-Cog - Ideational Praxis: Address<span class="subclass"> SubClassOf </span>ADAS-Cog CDISC Version Questionnaire Question. <br><i>New Terms: CDISC ADAS-Cog - Ideational Praxis: Address, ADAS-Cog CDISC Version Questionnaire
                     Question</i></td>
            </tr>
            <tr class="addition">
               <td>236</td>
               <td colspan="2">CDISC ADAS-Cog - Ideational Praxis: Fold<span class="subclass"> SubClassOf </span>ADAS-Cog CDISC Version Questionnaire Question. <br><i>New Terms: CDISC ADAS-Cog - Ideational Praxis: Fold, ADAS-Cog CDISC Version Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>237</td>
               <td colspan="2">CDISC ADAS-Cog - Ideational Praxis: Insert<span class="subclass"> SubClassOf </span>ADAS-Cog CDISC Version Questionnaire Question. <br><i>New Terms: CDISC ADAS-Cog - Ideational Praxis: Insert, ADAS-Cog CDISC Version Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>238</td>
               <td colspan="2">CDISC ADAS-Cog - Ideational Praxis: Seal<span class="subclass"> SubClassOf </span>ADAS-Cog CDISC Version Questionnaire Question. <br><i>New Terms: CDISC ADAS-Cog - Ideational Praxis: Seal, ADAS-Cog CDISC Version Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>239</td>
               <td colspan="2">CDISC ADAS-Cog - Ideational Praxis: Stamp<span class="subclass"> SubClassOf </span>ADAS-Cog CDISC Version Questionnaire Question. <br><i>New Terms: CDISC ADAS-Cog - Ideational Praxis: Stamp, ADAS-Cog CDISC Version Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>256</td>
               <td colspan="2">CDISC ADAS-Cog - Naming Objects<br><span class="keyword"> and </span>Fingers Summary Score<span class="subclass"> SubClassOf </span>ADAS-Cog CDISC Version Questionnaire Question. <br><i>New Terms: ADAS-Cog CDISC Version Questionnaire Question, CDISC ADAS-Cog - Naming Objects and
                     Fingers Summary Score</i></td>
            </tr>
            <tr class="addition">
               <td>241</td>
               <td colspan="2">CDISC ADAS-Cog - Naming Objects<br><span class="keyword"> and </span>Fingers: 1<span class="subclass"> SubClassOf </span>ADAS-Cog CDISC Version Questionnaire Question. <br><i>New Terms: CDISC ADAS-Cog - Naming Objects and Fingers: 1, ADAS-Cog CDISC Version Questionnaire
                     Question</i></td>
            </tr>
            <tr class="addition">
               <td>242</td>
               <td colspan="2">CDISC ADAS-Cog - Naming Objects<br><span class="keyword"> and </span>Fingers: 10<span class="subclass"> SubClassOf </span>ADAS-Cog CDISC Version Questionnaire Question. <br><i>New Terms: CDISC ADAS-Cog - Naming Objects and Fingers: 10, ADAS-Cog CDISC Version Questionnaire
                     Question</i></td>
            </tr>
            <tr class="addition">
               <td>243</td>
               <td colspan="2">CDISC ADAS-Cog - Naming Objects<br><span class="keyword"> and </span>Fingers: 11<span class="subclass"> SubClassOf </span>ADAS-Cog CDISC Version Questionnaire Question. <br><i>New Terms: CDISC ADAS-Cog - Naming Objects and Fingers: 11, ADAS-Cog CDISC Version Questionnaire
                     Question</i></td>
            </tr>
            <tr class="addition">
               <td>244</td>
               <td colspan="2">CDISC ADAS-Cog - Naming Objects<br><span class="keyword"> and </span>Fingers: 12<span class="subclass"> SubClassOf </span>ADAS-Cog CDISC Version Questionnaire Question. <br><i>New Terms: CDISC ADAS-Cog - Naming Objects and Fingers: 12, ADAS-Cog CDISC Version Questionnaire
                     Question</i></td>
            </tr>
            <tr class="addition">
               <td>245</td>
               <td colspan="2">CDISC ADAS-Cog - Naming Objects<br><span class="keyword"> and </span>Fingers: 2<span class="subclass"> SubClassOf </span>ADAS-Cog CDISC Version Questionnaire Question. <br><i>New Terms: CDISC ADAS-Cog - Naming Objects and Fingers: 2, ADAS-Cog CDISC Version Questionnaire
                     Question</i></td>
            </tr>
            <tr class="addition">
               <td>246</td>
               <td colspan="2">CDISC ADAS-Cog - Naming Objects<br><span class="keyword"> and </span>Fingers: 3<span class="subclass"> SubClassOf </span>ADAS-Cog CDISC Version Questionnaire Question. <br><i>New Terms: CDISC ADAS-Cog - Naming Objects and Fingers: 3, ADAS-Cog CDISC Version Questionnaire
                     Question</i></td>
            </tr>
            <tr class="addition">
               <td>247</td>
               <td colspan="2">CDISC ADAS-Cog - Naming Objects<br><span class="keyword"> and </span>Fingers: 4<span class="subclass"> SubClassOf </span>ADAS-Cog CDISC Version Questionnaire Question. <br><i>New Terms: CDISC ADAS-Cog - Naming Objects and Fingers: 4, ADAS-Cog CDISC Version Questionnaire
                     Question</i></td>
            </tr>
            <tr class="addition">
               <td>248</td>
               <td colspan="2">CDISC ADAS-Cog - Naming Objects<br><span class="keyword"> and </span>Fingers: 5<span class="subclass"> SubClassOf </span>ADAS-Cog CDISC Version Questionnaire Question. <br><i>New Terms: ADAS-Cog CDISC Version Questionnaire Question, CDISC ADAS-Cog - Naming Objects and
                     Fingers: 5</i></td>
            </tr>
            <tr class="addition">
               <td>249</td>
               <td colspan="2">CDISC ADAS-Cog - Naming Objects<br><span class="keyword"> and </span>Fingers: 6<span class="subclass"> SubClassOf </span>ADAS-Cog CDISC Version Questionnaire Question. <br><i>New Terms: ADAS-Cog CDISC Version Questionnaire Question, CDISC ADAS-Cog - Naming Objects and
                     Fingers: 6</i></td>
            </tr>
            <tr class="addition">
               <td>250</td>
               <td colspan="2">CDISC ADAS-Cog - Naming Objects<br><span class="keyword"> and </span>Fingers: 7<span class="subclass"> SubClassOf </span>ADAS-Cog CDISC Version Questionnaire Question. <br><i>New Terms: ADAS-Cog CDISC Version Questionnaire Question, CDISC ADAS-Cog - Naming Objects and
                     Fingers: 7</i></td>
            </tr>
            <tr class="addition">
               <td>251</td>
               <td colspan="2">CDISC ADAS-Cog - Naming Objects<br><span class="keyword"> and </span>Fingers: 8<span class="subclass"> SubClassOf </span>ADAS-Cog CDISC Version Questionnaire Question. <br><i>New Terms: ADAS-Cog CDISC Version Questionnaire Question, CDISC ADAS-Cog - Naming Objects and
                     Fingers: 8</i></td>
            </tr>
            <tr class="addition">
               <td>252</td>
               <td colspan="2">CDISC ADAS-Cog - Naming Objects<br><span class="keyword"> and </span>Fingers: 9<span class="subclass"> SubClassOf </span>ADAS-Cog CDISC Version Questionnaire Question. <br><i>New Terms: ADAS-Cog CDISC Version Questionnaire Question, CDISC ADAS-Cog - Naming Objects and
                     Fingers: 9</i></td>
            </tr>
            <tr class="addition">
               <td>253</td>
               <td colspan="2">CDISC ADAS-Cog - Naming Objects<br><span class="keyword"> and </span>Fingers: Middle<span class="subclass"> SubClassOf </span>ADAS-Cog CDISC Version Questionnaire Question. <br><i>New Terms: ADAS-Cog CDISC Version Questionnaire Question, CDISC ADAS-Cog - Naming Objects and
                     Fingers: Middle</i></td>
            </tr>
            <tr class="addition">
               <td>818</td>
               <td colspan="2">CDISC ADAS-Cog - Naming Objects<br><span class="keyword"> and </span>Fingers: Pinky<span class="subclass"> SubClassOf </span>ADAS-Cog CDISC Version Questionnaire Question. <br><i>New Terms: ADAS-Cog CDISC Version Questionnaire Question, CDISC ADAS-Cog - Naming Objects and
                     Fingers: Pinky</i></td>
            </tr>
            <tr class="addition">
               <td>254</td>
               <td colspan="2">CDISC ADAS-Cog - Naming Objects<br><span class="keyword"> and </span>Fingers: Pointer<span class="subclass"> SubClassOf </span>ADAS-Cog CDISC Version Questionnaire Question. <br><i>New Terms: CDISC ADAS-Cog - Naming Objects and Fingers: Pointer, ADAS-Cog CDISC Version Questionnaire
                     Question</i></td>
            </tr>
            <tr class="addition">
               <td>255</td>
               <td colspan="2">CDISC ADAS-Cog - Naming Objects<br><span class="keyword"> and </span>Fingers: Ring<span class="subclass"> SubClassOf </span>ADAS-Cog CDISC Version Questionnaire Question. <br><i>New Terms: ADAS-Cog CDISC Version Questionnaire Question, CDISC ADAS-Cog - Naming Objects and
                     Fingers: Ring</i></td>
            </tr>
            <tr class="addition">
               <td>257</td>
               <td colspan="2">CDISC ADAS-Cog - Naming Objects<br><span class="keyword"> and </span>Fingers: Thumb<span class="subclass"> SubClassOf </span>ADAS-Cog CDISC Version Questionnaire Question. <br><i>New Terms: CDISC ADAS-Cog - Naming Objects and Fingers: Thumb, ADAS-Cog CDISC Version Questionnaire
                     Question</i></td>
            </tr>
            <tr class="addition">
               <td>261</td>
               <td colspan="2">CDISC ADAS-Cog - Number Cancellation Summary Score<span class="subclass"> SubClassOf </span>ADAS-Cog CDISC Version Questionnaire Question. <br><i>New Terms: ADAS-Cog CDISC Version Questionnaire Question, CDISC ADAS-Cog - Number Cancellation
                     Summary Score</i></td>
            </tr>
            <tr class="addition">
               <td>258</td>
               <td colspan="2">CDISC ADAS-Cog - Number Cancellation: Correct<span class="subclass"> SubClassOf </span>ADAS-Cog CDISC Version Questionnaire Question. <br><i>New Terms: CDISC ADAS-Cog - Number Cancellation: Correct, ADAS-Cog CDISC Version Questionnaire
                     Question</i></td>
            </tr>
            <tr class="addition">
               <td>259</td>
               <td colspan="2">CDISC ADAS-Cog - Number Cancellation: Errors<span class="subclass"> SubClassOf </span>ADAS-Cog CDISC Version Questionnaire Question. <br><i>New Terms: CDISC ADAS-Cog - Number Cancellation: Errors, ADAS-Cog CDISC Version Questionnaire
                     Question</i></td>
            </tr>
            <tr class="addition">
               <td>260</td>
               <td colspan="2">CDISC ADAS-Cog - Number Cancellation: Remind<span class="subclass"> SubClassOf </span>ADAS-Cog CDISC Version Questionnaire Question. <br><i>New Terms: CDISC ADAS-Cog - Number Cancellation: Remind, ADAS-Cog CDISC Version Questionnaire
                     Question</i></td>
            </tr>
            <tr class="addition">
               <td>268</td>
               <td colspan="2">CDISC ADAS-Cog - Orientation Summary Score<span class="subclass"> SubClassOf </span>ADAS-Cog CDISC Version Questionnaire Question. <br><i>New Terms: CDISC ADAS-Cog - Orientation Summary Score, ADAS-Cog CDISC Version Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>262</td>
               <td colspan="2">CDISC ADAS-Cog - Orientation: Date<span class="subclass"> SubClassOf </span>ADAS-Cog CDISC Version Questionnaire Question. <br><i>New Terms: CDISC ADAS-Cog - Orientation: Date, ADAS-Cog CDISC Version Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>263</td>
               <td colspan="2">CDISC ADAS-Cog - Orientation: Day of Week<span class="subclass"> SubClassOf </span>ADAS-Cog CDISC Version Questionnaire Question. <br><i>New Terms: CDISC ADAS-Cog - Orientation: Day of Week, ADAS-Cog CDISC Version Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>264</td>
               <td colspan="2">CDISC ADAS-Cog - Orientation: Full Name<span class="subclass"> SubClassOf </span>ADAS-Cog CDISC Version Questionnaire Question. <br><i>New Terms: ADAS-Cog CDISC Version Questionnaire Question, CDISC ADAS-Cog - Orientation: Full
                     Name</i></td>
            </tr>
            <tr class="addition">
               <td>265</td>
               <td colspan="2">CDISC ADAS-Cog - Orientation: Month<span class="subclass"> SubClassOf </span>ADAS-Cog CDISC Version Questionnaire Question. <br><i>New Terms: CDISC ADAS-Cog - Orientation: Month, ADAS-Cog CDISC Version Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>266</td>
               <td colspan="2">CDISC ADAS-Cog - Orientation: Place<span class="subclass"> SubClassOf </span>ADAS-Cog CDISC Version Questionnaire Question. <br><i>New Terms: ADAS-Cog CDISC Version Questionnaire Question, CDISC ADAS-Cog - Orientation: Place</i></td>
            </tr>
            <tr class="addition">
               <td>267</td>
               <td colspan="2">CDISC ADAS-Cog - Orientation: Season<span class="subclass"> SubClassOf </span>ADAS-Cog CDISC Version Questionnaire Question. <br><i>New Terms: ADAS-Cog CDISC Version Questionnaire Question, CDISC ADAS-Cog - Orientation: Season</i></td>
            </tr>
            <tr class="addition">
               <td>269</td>
               <td colspan="2">CDISC ADAS-Cog - Orientation: Time<span class="subclass"> SubClassOf </span>ADAS-Cog CDISC Version Questionnaire Question. <br><i>New Terms: CDISC ADAS-Cog - Orientation: Time, ADAS-Cog CDISC Version Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>270</td>
               <td colspan="2">CDISC ADAS-Cog - Orientation: Year<span class="subclass"> SubClassOf </span>ADAS-Cog CDISC Version Questionnaire Question. <br><i>New Terms: ADAS-Cog CDISC Version Questionnaire Question, CDISC ADAS-Cog - Orientation: Year</i></td>
            </tr>
            <tr class="addition">
               <td>271</td>
               <td colspan="2">CDISC ADAS-Cog - Remembering Test Instructions<span class="subclass"> SubClassOf </span>ADAS-Cog CDISC Version Questionnaire Question. <br><i>New Terms: CDISC ADAS-Cog - Remembering Test Instructions, ADAS-Cog CDISC Version Questionnaire
                     Question</i></td>
            </tr>
            <tr class="addition">
               <td>272</td>
               <td colspan="2">CDISC ADAS-Cog - Spoken Language Ability<span class="subclass"> SubClassOf </span>ADAS-Cog CDISC Version Questionnaire Question. <br><i>New Terms: CDISC ADAS-Cog - Spoken Language Ability, ADAS-Cog CDISC Version Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>273</td>
               <td colspan="2">CDISC ADAS-Cog - Word Difficulty in Spontaneous Speech<span class="subclass"> SubClassOf </span>ADAS-Cog CDISC Version Questionnaire Question. <br><i>New Terms: CDISC ADAS-Cog - Word Difficulty in Spontaneous Speech, ADAS-Cog CDISC Version Questionnaire
                     Question</i></td>
            </tr>
            <tr class="addition">
               <td>274</td>
               <td colspan="2">CDISC ADAS-Cog - Word Recall Average Score<span class="subclass"> SubClassOf </span>ADAS-Cog CDISC Version Questionnaire Question. <br><i>New Terms: CDISC ADAS-Cog - Word Recall Average Score, ADAS-Cog CDISC Version Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>275</td>
               <td colspan="2">CDISC ADAS-Cog - Word Recall Trial 1 Subscore<span class="subclass"> SubClassOf </span>ADAS-Cog CDISC Version Questionnaire Question. <br><i>New Terms: CDISC ADAS-Cog - Word Recall Trial 1 Subscore, ADAS-Cog CDISC Version Questionnaire
                     Question</i></td>
            </tr>
            <tr class="addition">
               <td>276</td>
               <td colspan="2">CDISC ADAS-Cog - Word Recall Trial 2 Subscore<span class="subclass"> SubClassOf </span>ADAS-Cog CDISC Version Questionnaire Question. <br><i>New Terms: ADAS-Cog CDISC Version Questionnaire Question, CDISC ADAS-Cog - Word Recall Trial
                     2 Subscore</i></td>
            </tr>
            <tr class="addition">
               <td>277</td>
               <td colspan="2">CDISC ADAS-Cog - Word Recall Trial 3 Subscore<span class="subclass"> SubClassOf </span>ADAS-Cog CDISC Version Questionnaire Question. <br><i>New Terms: CDISC ADAS-Cog - Word Recall Trial 3 Subscore, ADAS-Cog CDISC Version Questionnaire
                     Question</i></td>
            </tr>
            <tr class="addition">
               <td>278</td>
               <td colspan="2">CDISC ADAS-Cog - Word Recall: Word 1<span class="subclass"> SubClassOf </span>ADAS-Cog CDISC Version Questionnaire Question. <br><i>New Terms: ADAS-Cog CDISC Version Questionnaire Question, CDISC ADAS-Cog - Word Recall: Word
                     1</i></td>
            </tr>
            <tr class="addition">
               <td>279</td>
               <td colspan="2">CDISC ADAS-Cog - Word Recall: Word 10<span class="subclass"> SubClassOf </span>ADAS-Cog CDISC Version Questionnaire Question. <br><i>New Terms: ADAS-Cog CDISC Version Questionnaire Question, CDISC ADAS-Cog - Word Recall: Word
                     10</i></td>
            </tr>
            <tr class="addition">
               <td>280</td>
               <td colspan="2">CDISC ADAS-Cog - Word Recall: Word 2<span class="subclass"> SubClassOf </span>ADAS-Cog CDISC Version Questionnaire Question. <br><i>New Terms: CDISC ADAS-Cog - Word Recall: Word 2, ADAS-Cog CDISC Version Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>281</td>
               <td colspan="2">CDISC ADAS-Cog - Word Recall: Word 3<span class="subclass"> SubClassOf </span>ADAS-Cog CDISC Version Questionnaire Question. <br><i>New Terms: CDISC ADAS-Cog - Word Recall: Word 3, ADAS-Cog CDISC Version Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>282</td>
               <td colspan="2">CDISC ADAS-Cog - Word Recall: Word 4<span class="subclass"> SubClassOf </span>ADAS-Cog CDISC Version Questionnaire Question. <br><i>New Terms: ADAS-Cog CDISC Version Questionnaire Question, CDISC ADAS-Cog - Word Recall: Word
                     4</i></td>
            </tr>
            <tr class="addition">
               <td>283</td>
               <td colspan="2">CDISC ADAS-Cog - Word Recall: Word 5<span class="subclass"> SubClassOf </span>ADAS-Cog CDISC Version Questionnaire Question. <br><i>New Terms: ADAS-Cog CDISC Version Questionnaire Question, CDISC ADAS-Cog - Word Recall: Word
                     5</i></td>
            </tr>
            <tr class="addition">
               <td>284</td>
               <td colspan="2">CDISC ADAS-Cog - Word Recall: Word 6<span class="subclass"> SubClassOf </span>ADAS-Cog CDISC Version Questionnaire Question. <br><i>New Terms: ADAS-Cog CDISC Version Questionnaire Question, CDISC ADAS-Cog - Word Recall: Word
                     6</i></td>
            </tr>
            <tr class="addition">
               <td>285</td>
               <td colspan="2">CDISC ADAS-Cog - Word Recall: Word 7<span class="subclass"> SubClassOf </span>ADAS-Cog CDISC Version Questionnaire Question. <br><i>New Terms: ADAS-Cog CDISC Version Questionnaire Question, CDISC ADAS-Cog - Word Recall: Word
                     7</i></td>
            </tr>
            <tr class="addition">
               <td>286</td>
               <td colspan="2">CDISC ADAS-Cog - Word Recall: Word 8<span class="subclass"> SubClassOf </span>ADAS-Cog CDISC Version Questionnaire Question. <br><i>New Terms: ADAS-Cog CDISC Version Questionnaire Question, CDISC ADAS-Cog - Word Recall: Word
                     8</i></td>
            </tr>
            <tr class="addition">
               <td>287</td>
               <td colspan="2">CDISC ADAS-Cog - Word Recall: Word 9<span class="subclass"> SubClassOf </span>ADAS-Cog CDISC Version Questionnaire Question. <br><i>New Terms: ADAS-Cog CDISC Version Questionnaire Question, CDISC ADAS-Cog - Word Recall: Word
                     9</i></td>
            </tr>
            <tr class="addition">
               <td>288</td>
               <td colspan="2">CDISC ADAS-Cog - Word Recognition Summary Score<span class="subclass"> SubClassOf </span>ADAS-Cog CDISC Version Questionnaire Question. <br><i>New Terms: CDISC ADAS-Cog - Word Recognition Summary Score, ADAS-Cog CDISC Version Questionnaire
                     Question</i></td>
            </tr>
            <tr class="addition">
               <td>289</td>
               <td colspan="2">CDISC ADAS-Cog - Word Recognition Trial 1 Summary Score<span class="subclass"> SubClassOf </span>ADAS-Cog CDISC Version Questionnaire Question. <br><i>New Terms: ADAS-Cog CDISC Version Questionnaire Question, CDISC ADAS-Cog - Word Recognition Trial
                     1 Summary Score</i></td>
            </tr>
            <tr class="addition">
               <td>290</td>
               <td colspan="2">CDISC ADAS-Cog - Word Recognition Trial 2 Summary Score<span class="subclass"> SubClassOf </span>ADAS-Cog CDISC Version Questionnaire Question. <br><i>New Terms: ADAS-Cog CDISC Version Questionnaire Question, CDISC ADAS-Cog - Word Recognition Trial
                     2 Summary Score</i></td>
            </tr>
            <tr class="addition">
               <td>291</td>
               <td colspan="2">CDISC ADAS-Cog - Word Recognition Trial 3 Summary Score<span class="subclass"> SubClassOf </span>ADAS-Cog CDISC Version Questionnaire Question. <br><i>New Terms: CDISC ADAS-Cog - Word Recognition Trial 3 Summary Score, ADAS-Cog CDISC Version Questionnaire
                     Question</i></td>
            </tr>
            <tr class="addition">
               <td>292</td>
               <td colspan="2">CDISC ADAS-Cog - Word Recognition: Word 1<span class="subclass"> SubClassOf </span>ADAS-Cog CDISC Version Questionnaire Question. <br><i>New Terms: ADAS-Cog CDISC Version Questionnaire Question, CDISC ADAS-Cog - Word Recognition:
                     Word 1</i></td>
            </tr>
            <tr class="addition">
               <td>293</td>
               <td colspan="2">CDISC ADAS-Cog - Word Recognition: Word 10<span class="subclass"> SubClassOf </span>ADAS-Cog CDISC Version Questionnaire Question. <br><i>New Terms: CDISC ADAS-Cog - Word Recognition: Word 10, ADAS-Cog CDISC Version Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>294</td>
               <td colspan="2">CDISC ADAS-Cog - Word Recognition: Word 11<span class="subclass"> SubClassOf </span>ADAS-Cog CDISC Version Questionnaire Question. <br><i>New Terms: CDISC ADAS-Cog - Word Recognition: Word 11, ADAS-Cog CDISC Version Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>295</td>
               <td colspan="2">CDISC ADAS-Cog - Word Recognition: Word 12<span class="subclass"> SubClassOf </span>ADAS-Cog CDISC Version Questionnaire Question. <br><i>New Terms: CDISC ADAS-Cog - Word Recognition: Word 12, ADAS-Cog CDISC Version Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>207</td>
               <td colspan="2">CDISC ADAS-Cog - Word Recognition: Word 13<span class="subclass"> SubClassOf </span>ADAS-Cog CDISC Version Questionnaire Question. <br><i>New Terms: ADAS-Cog CDISC Version Questionnaire Question, CDISC ADAS-Cog - Word Recognition:
                     Word 13</i></td>
            </tr>
            <tr class="addition">
               <td>296</td>
               <td colspan="2">CDISC ADAS-Cog - Word Recognition: Word 14<span class="subclass"> SubClassOf </span>ADAS-Cog CDISC Version Questionnaire Question. <br><i>New Terms: CDISC ADAS-Cog - Word Recognition: Word 14, ADAS-Cog CDISC Version Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>297</td>
               <td colspan="2">CDISC ADAS-Cog - Word Recognition: Word 15<span class="subclass"> SubClassOf </span>ADAS-Cog CDISC Version Questionnaire Question. <br><i>New Terms: CDISC ADAS-Cog - Word Recognition: Word 15, ADAS-Cog CDISC Version Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>298</td>
               <td colspan="2">CDISC ADAS-Cog - Word Recognition: Word 16<span class="subclass"> SubClassOf </span>ADAS-Cog CDISC Version Questionnaire Question. <br><i>New Terms: CDISC ADAS-Cog - Word Recognition: Word 16, ADAS-Cog CDISC Version Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>299</td>
               <td colspan="2">CDISC ADAS-Cog - Word Recognition: Word 17<span class="subclass"> SubClassOf </span>ADAS-Cog CDISC Version Questionnaire Question. <br><i>New Terms: CDISC ADAS-Cog - Word Recognition: Word 17, ADAS-Cog CDISC Version Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>300</td>
               <td colspan="2">CDISC ADAS-Cog - Word Recognition: Word 18<span class="subclass"> SubClassOf </span>ADAS-Cog CDISC Version Questionnaire Question. <br><i>New Terms: CDISC ADAS-Cog - Word Recognition: Word 18, ADAS-Cog CDISC Version Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>301</td>
               <td colspan="2">CDISC ADAS-Cog - Word Recognition: Word 19<span class="subclass"> SubClassOf </span>ADAS-Cog CDISC Version Questionnaire Question. <br><i>New Terms: CDISC ADAS-Cog - Word Recognition: Word 19, ADAS-Cog CDISC Version Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>302</td>
               <td colspan="2">CDISC ADAS-Cog - Word Recognition: Word 2<span class="subclass"> SubClassOf </span>ADAS-Cog CDISC Version Questionnaire Question. <br><i>New Terms: CDISC ADAS-Cog - Word Recognition: Word 2, ADAS-Cog CDISC Version Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>303</td>
               <td colspan="2">CDISC ADAS-Cog - Word Recognition: Word 20<span class="subclass"> SubClassOf </span>ADAS-Cog CDISC Version Questionnaire Question. <br><i>New Terms: ADAS-Cog CDISC Version Questionnaire Question, CDISC ADAS-Cog - Word Recognition:
                     Word 20</i></td>
            </tr>
            <tr class="addition">
               <td>304</td>
               <td colspan="2">CDISC ADAS-Cog - Word Recognition: Word 21<span class="subclass"> SubClassOf </span>ADAS-Cog CDISC Version Questionnaire Question. <br><i>New Terms: ADAS-Cog CDISC Version Questionnaire Question, CDISC ADAS-Cog - Word Recognition:
                     Word 21</i></td>
            </tr>
            <tr class="addition">
               <td>305</td>
               <td colspan="2">CDISC ADAS-Cog - Word Recognition: Word 22<span class="subclass"> SubClassOf </span>ADAS-Cog CDISC Version Questionnaire Question. <br><i>New Terms: ADAS-Cog CDISC Version Questionnaire Question, CDISC ADAS-Cog - Word Recognition:
                     Word 22</i></td>
            </tr>
            <tr class="addition">
               <td>306</td>
               <td colspan="2">CDISC ADAS-Cog - Word Recognition: Word 23<span class="subclass"> SubClassOf </span>ADAS-Cog CDISC Version Questionnaire Question. <br><i>New Terms: ADAS-Cog CDISC Version Questionnaire Question, CDISC ADAS-Cog - Word Recognition:
                     Word 23</i></td>
            </tr>
            <tr class="addition">
               <td>307</td>
               <td colspan="2">CDISC ADAS-Cog - Word Recognition: Word 24<span class="subclass"> SubClassOf </span>ADAS-Cog CDISC Version Questionnaire Question. <br><i>New Terms: ADAS-Cog CDISC Version Questionnaire Question, CDISC ADAS-Cog - Word Recognition:
                     Word 24</i></td>
            </tr>
            <tr class="addition">
               <td>308</td>
               <td colspan="2">CDISC ADAS-Cog - Word Recognition: Word 3<span class="subclass"> SubClassOf </span>ADAS-Cog CDISC Version Questionnaire Question. <br><i>New Terms: CDISC ADAS-Cog - Word Recognition: Word 3, ADAS-Cog CDISC Version Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>309</td>
               <td colspan="2">CDISC ADAS-Cog - Word Recognition: Word 4<span class="subclass"> SubClassOf </span>ADAS-Cog CDISC Version Questionnaire Question. <br><i>New Terms: CDISC ADAS-Cog - Word Recognition: Word 4, ADAS-Cog CDISC Version Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>310</td>
               <td colspan="2">CDISC ADAS-Cog - Word Recognition: Word 5<span class="subclass"> SubClassOf </span>ADAS-Cog CDISC Version Questionnaire Question. <br><i>New Terms: CDISC ADAS-Cog - Word Recognition: Word 5, ADAS-Cog CDISC Version Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>311</td>
               <td colspan="2">CDISC ADAS-Cog - Word Recognition: Word 6<span class="subclass"> SubClassOf </span>ADAS-Cog CDISC Version Questionnaire Question. <br><i>New Terms: CDISC ADAS-Cog - Word Recognition: Word 6, ADAS-Cog CDISC Version Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>312</td>
               <td colspan="2">CDISC ADAS-Cog - Word Recognition: Word 7<span class="subclass"> SubClassOf </span>ADAS-Cog CDISC Version Questionnaire Question. <br><i>New Terms: CDISC ADAS-Cog - Word Recognition: Word 7, ADAS-Cog CDISC Version Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>313</td>
               <td colspan="2">CDISC ADAS-Cog - Word Recognition: Word 8<span class="subclass"> SubClassOf </span>ADAS-Cog CDISC Version Questionnaire Question. <br><i>New Terms: CDISC ADAS-Cog - Word Recognition: Word 8, ADAS-Cog CDISC Version Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>314</td>
               <td colspan="2">CDISC ADAS-Cog - Word Recognition: Word 9<span class="subclass"> SubClassOf </span>ADAS-Cog CDISC Version Questionnaire Question. <br><i>New Terms: CDISC ADAS-Cog - Word Recognition: Word 9, ADAS-Cog CDISC Version Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>315</td>
               <td colspan="2">CDISC Questionnaire ADAS-Cog CDISC Version Test Code Terminology<span class="subclass"> SubClassOf </span>CDISC Questionnaire Terminology. <br><i>New Terms: CDISC Questionnaire Terminology, CDISC Questionnaire ADAS-Cog CDISC Version Test Code
                     Terminology</i></td>
            </tr>
            <tr class="addition">
               <td>316</td>
               <td colspan="2">CDISC Questionnaire ADAS-Cog CDISC Version Test Name Terminology<span class="subclass"> SubClassOf </span>CDISC Questionnaire Terminology. <br><i>New Terms: CDISC Questionnaire Terminology, CDISC Questionnaire ADAS-Cog CDISC Version Test Name
                     Terminology</i></td>
            </tr>
            <tr class="addition">
               <td>317</td>
               <td colspan="2">CDISC Questionnaire BPI Short Form Test Code Terminology<span class="subclass"> SubClassOf </span>CDISC Questionnaire Terminology. <br><i>New Terms: CDISC Questionnaire Terminology, CDISC Questionnaire BPI Short Form Test Code Terminology</i></td>
            </tr>
            <tr class="addition">
               <td>318</td>
               <td colspan="2">CDISC Questionnaire BPI Short Form Test Name Terminology<span class="subclass"> SubClassOf </span>CDISC Questionnaire Terminology. <br><i>New Terms: CDISC Questionnaire Terminology, CDISC Questionnaire BPI Short Form Test Name Terminology</i></td>
            </tr>
            <tr class="addition">
               <td>319</td>
               <td colspan="2">CDISC Questionnaire BPI Test Code Terminology<span class="subclass"> SubClassOf </span>CDISC Questionnaire Terminology. <br><i>New Terms: CDISC Questionnaire Terminology, CDISC Questionnaire BPI Test Code Terminology</i></td>
            </tr>
            <tr class="addition">
               <td>320</td>
               <td colspan="2">CDISC Questionnaire BPI Test Name Terminology<span class="subclass"> SubClassOf </span>CDISC Questionnaire Terminology. <br><i>New Terms: CDISC Questionnaire BPI Test Name Terminology, CDISC Questionnaire Terminology</i></td>
            </tr>
            <tr class="addition">
               <td>321</td>
               <td colspan="2">CDISC Questionnaire BPRS-A Test Code Terminology<span class="subclass"> SubClassOf </span>CDISC Questionnaire Terminology. <br><i>New Terms: CDISC Questionnaire BPRS-A Test Code Terminology, CDISC Questionnaire Terminology</i></td>
            </tr>
            <tr class="addition">
               <td>322</td>
               <td colspan="2">CDISC Questionnaire BPRS-A Test Name Terminology<span class="subclass"> SubClassOf </span>CDISC Questionnaire Terminology. <br><i>New Terms: CDISC Questionnaire Terminology, CDISC Questionnaire BPRS-A Test Name Terminology</i></td>
            </tr>
            <tr class="addition">
               <td>323</td>
               <td colspan="2">CDISC Questionnaire C-SSRS Baseline Test Code Terminology<span class="subclass"> SubClassOf </span>CDISC Questionnaire Terminology. <br><i>New Terms: CDISC Questionnaire Terminology, CDISC Questionnaire C-SSRS Baseline Test Code Terminology</i></td>
            </tr>
            <tr class="addition">
               <td>324</td>
               <td colspan="2">CDISC Questionnaire C-SSRS Baseline Test Name Terminology<span class="subclass"> SubClassOf </span>CDISC Questionnaire Terminology. <br><i>New Terms: CDISC Questionnaire Terminology, CDISC Questionnaire C-SSRS Baseline Test Name Terminology</i></td>
            </tr>
            <tr class="addition">
               <td>325</td>
               <td colspan="2">CDISC Questionnaire CGI Test Code Terminology<span class="subclass"> SubClassOf </span>CDISC Questionnaire Terminology. <br><i>New Terms: CDISC Questionnaire Terminology, CDISC Questionnaire CGI Test Code Terminology</i></td>
            </tr>
            <tr class="addition">
               <td>326</td>
               <td colspan="2">CDISC Questionnaire CGI Test Name Terminology<span class="subclass"> SubClassOf </span>CDISC Questionnaire Terminology. <br><i>New Terms: CDISC Questionnaire CGI Test Name Terminology, CDISC Questionnaire Terminology</i></td>
            </tr>
            <tr class="addition">
               <td>327</td>
               <td colspan="2">CDISC Questionnaire COMM Test Code Terminology<span class="subclass"> SubClassOf </span>CDISC Questionnaire Terminology. <br><i>New Terms: CDISC Questionnaire COMM Test Code Terminology, CDISC Questionnaire Terminology</i></td>
            </tr>
            <tr class="addition">
               <td>328</td>
               <td colspan="2">CDISC Questionnaire COMM Test Name Terminology<span class="subclass"> SubClassOf </span>CDISC Questionnaire Terminology. <br><i>New Terms: CDISC Questionnaire Terminology, CDISC Questionnaire COMM Test Name Terminology</i></td>
            </tr>
            <tr class="addition">
               <td>329</td>
               <td colspan="2">CDISC Questionnaire Category Terminology<span class="subclass"> SubClassOf </span>CDISC Questionnaire Terminology. <br><i>New Terms: CDISC Questionnaire Terminology, CDISC Questionnaire Category Terminology</i></td>
            </tr>
            <tr class="addition">
               <td>330</td>
               <td colspan="2">CDISC Questionnaire EQ-5D-3L Test Code Terminology<span class="subclass"> SubClassOf </span>CDISC Questionnaire Terminology. <br><i>New Terms: CDISC Questionnaire Terminology, CDISC Questionnaire EQ-5D-3L Test Code Terminology</i></td>
            </tr>
            <tr class="addition">
               <td>331</td>
               <td colspan="2">CDISC Questionnaire EQ-5D-3L Test Name Terminology<span class="subclass"> SubClassOf </span>CDISC Questionnaire Terminology. <br><i>New Terms: CDISC Questionnaire Terminology, CDISC Questionnaire EQ-5D-3L Test Name Terminology</i></td>
            </tr>
            <tr class="addition">
               <td>332</td>
               <td colspan="2">CDISC Questionnaire FPSR Test Code Terminology<span class="subclass"> SubClassOf </span>CDISC Questionnaire Terminology. <br><i>New Terms: CDISC Questionnaire Terminology, CDISC Questionnaire FPSR Test Code Terminology</i></td>
            </tr>
            <tr class="addition">
               <td>333</td>
               <td colspan="2">CDISC Questionnaire FPSR Test Name Terminology<span class="subclass"> SubClassOf </span>CDISC Questionnaire Terminology. <br><i>New Terms: CDISC Questionnaire FPSR Test Name Terminology, CDISC Questionnaire Terminology</i></td>
            </tr>
            <tr class="addition">
               <td>334</td>
               <td colspan="2">CDISC Questionnaire HAMD 17 Test Code Terminology<span class="subclass"> SubClassOf </span>CDISC Questionnaire Terminology. <br><i>New Terms: CDISC Questionnaire Terminology, CDISC Questionnaire HAMD 17 Test Code Terminology</i></td>
            </tr>
            <tr class="addition">
               <td>335</td>
               <td colspan="2">CDISC Questionnaire HAMD 17 Test Name Terminology<span class="subclass"> SubClassOf </span>CDISC Questionnaire Terminology. <br><i>New Terms: CDISC Questionnaire Terminology, CDISC Questionnaire HAMD 17 Test Name Terminology</i></td>
            </tr>
            <tr class="addition">
               <td>336</td>
               <td colspan="2">CDISC Questionnaire KPS Scale Test Code Terminology<span class="subclass"> SubClassOf </span>CDISC Questionnaire Terminology. <br><i>New Terms: CDISC Questionnaire Terminology, CDISC Questionnaire KPS Scale Test Code Terminology</i></td>
            </tr>
            <tr class="addition">
               <td>337</td>
               <td colspan="2">CDISC Questionnaire KPS Scale Test Name Terminology<span class="subclass"> SubClassOf </span>CDISC Questionnaire Terminology. <br><i>New Terms: CDISC Questionnaire KPS Scale Test Name Terminology, CDISC Questionnaire Terminology</i></td>
            </tr>
            <tr class="addition">
               <td>338</td>
               <td colspan="2">CDISC Questionnaire MDS-UPDRS Test Code Terminology<span class="subclass"> SubClassOf </span>CDISC Questionnaire Terminology. <br><i>New Terms: CDISC Questionnaire MDS-UPDRS Test Code Terminology, CDISC Questionnaire Terminology</i></td>
            </tr>
            <tr class="addition">
               <td>339</td>
               <td colspan="2">CDISC Questionnaire MDS-UPDRS Test Name Terminology<span class="subclass"> SubClassOf </span>CDISC Questionnaire Terminology. <br><i>New Terms: CDISC Questionnaire MDS-UPDRS Test Name Terminology, CDISC Questionnaire Terminology</i></td>
            </tr>
            <tr class="addition">
               <td>340</td>
               <td colspan="2">CDISC Questionnaire MMSE Test Code Terminology<span class="subclass"> SubClassOf </span>CDISC Questionnaire Terminology. <br><i>New Terms: CDISC Questionnaire Terminology, CDISC Questionnaire MMSE Test Code Terminology</i></td>
            </tr>
            <tr class="addition">
               <td>341</td>
               <td colspan="2">CDISC Questionnaire MMSE Test Name Terminology<span class="subclass"> SubClassOf </span>CDISC Questionnaire Terminology. <br><i>New Terms: CDISC Questionnaire MMSE Test Name Terminology, CDISC Questionnaire Terminology</i></td>
            </tr>
            <tr class="addition">
               <td>342</td>
               <td colspan="2">CDISC Questionnaire MNSI Test Code Terminology<span class="subclass"> SubClassOf </span>CDISC Questionnaire Terminology. <br><i>New Terms: CDISC Questionnaire MNSI Test Code Terminology, CDISC Questionnaire Terminology</i></td>
            </tr>
            <tr class="addition">
               <td>343</td>
               <td colspan="2">CDISC Questionnaire MNSI Test Name Terminology<span class="subclass"> SubClassOf </span>CDISC Questionnaire Terminology. <br><i>New Terms: CDISC Questionnaire Terminology, CDISC Questionnaire MNSI Test Name Terminology</i></td>
            </tr>
            <tr class="addition">
               <td>344</td>
               <td colspan="2">CDISC Questionnaire NPI Test Code Terminology<span class="subclass"> SubClassOf </span>CDISC Questionnaire Terminology. <br><i>New Terms: CDISC Questionnaire Terminology, CDISC Questionnaire NPI Test Code Terminology</i></td>
            </tr>
            <tr class="addition">
               <td>345</td>
               <td colspan="2">CDISC Questionnaire NPI Test Name Terminology<span class="subclass"> SubClassOf </span>CDISC Questionnaire Terminology. <br><i>New Terms: CDISC Questionnaire Terminology, CDISC Questionnaire NPI Test Name Terminology</i></td>
            </tr>
            <tr class="addition">
               <td>346</td>
               <td colspan="2">CDISC Questionnaire PDQUALIF Test Code Terminology<span class="subclass"> SubClassOf </span>CDISC Questionnaire Terminology. <br><i>New Terms: CDISC Questionnaire PDQUALIF Test Code Terminology, CDISC Questionnaire Terminology</i></td>
            </tr>
            <tr class="addition">
               <td>347</td>
               <td colspan="2">CDISC Questionnaire PDQUALIF Test Name Terminology<span class="subclass"> SubClassOf </span>CDISC Questionnaire Terminology. <br><i>New Terms: CDISC Questionnaire PDQUALIF Test Name Terminology, CDISC Questionnaire Terminology</i></td>
            </tr>
            <tr class="addition">
               <td>348</td>
               <td colspan="2">CDISC Questionnaire RDQ Test Code Terminology<span class="subclass"> SubClassOf </span>CDISC Questionnaire Terminology. <br><i>New Terms: CDISC Questionnaire RDQ Test Code Terminology, CDISC Questionnaire Terminology</i></td>
            </tr>
            <tr class="addition">
               <td>349</td>
               <td colspan="2">CDISC Questionnaire RDQ Test Name Terminology<span class="subclass"> SubClassOf </span>CDISC Questionnaire Terminology. <br><i>New Terms: CDISC Questionnaire RDQ Test Name Terminology, CDISC Questionnaire Terminology</i></td>
            </tr>
            <tr class="addition">
               <td>350</td>
               <td colspan="2">CDISC Questionnaire SF36 v1.0 Standard Test Code Terminology<span class="subclass"> SubClassOf </span>CDISC Questionnaire Terminology. <br><i>New Terms: CDISC Questionnaire Terminology, CDISC Questionnaire SF36 v1.0 Standard Test Code
                     Terminology</i></td>
            </tr>
            <tr class="addition">
               <td>351</td>
               <td colspan="2">CDISC Questionnaire SF36 v1.0 Standard Test Name Terminology<span class="subclass"> SubClassOf </span>CDISC Questionnaire Terminology. <br><i>New Terms: CDISC Questionnaire Terminology, CDISC Questionnaire SF36 v1.0 Standard Test Name
                     Terminology</i></td>
            </tr>
            <tr class="addition">
               <td>352</td>
               <td colspan="2">CDISC Questionnaire SOAPP-R Test Code Terminology<span class="subclass"> SubClassOf </span>CDISC Questionnaire Terminology. <br><i>New Terms: CDISC Questionnaire SOAPP-R Test Code Terminology, CDISC Questionnaire Terminology</i></td>
            </tr>
            <tr class="addition">
               <td>353</td>
               <td colspan="2">CDISC Questionnaire SOAPP-R Test Name Terminology<span class="subclass"> SubClassOf </span>CDISC Questionnaire Terminology. <br><i>New Terms: CDISC Questionnaire Terminology, CDISC Questionnaire SOAPP-R Test Name Terminology</i></td>
            </tr>
            <tr class="addition">
               <td>354</td>
               <td colspan="2">CDISC Questionnaire Short-Form MPQ-2 Test Code Terminology<span class="subclass"> SubClassOf </span>CDISC Questionnaire Terminology. <br><i>New Terms: CDISC Questionnaire Terminology, CDISC Questionnaire Short-Form MPQ-2 Test Code Terminology</i></td>
            </tr>
            <tr class="addition">
               <td>355</td>
               <td colspan="2">CDISC Questionnaire Short-Form MPQ-2 Test Name Terminology<span class="subclass"> SubClassOf </span>CDISC Questionnaire Terminology. <br><i>New Terms: CDISC Questionnaire Terminology, CDISC Questionnaire Short-Form MPQ-2 Test Name Terminology</i></td>
            </tr>
            <tr class="addition">
               <td>356</td>
               <td colspan="2">CDISC Questionnaire Terminology<span class="subclass"> SubClassOf </span>Clinical Data Interchange Standards Consortium Terminology. <br><i>New Terms: CDISC Questionnaire Terminology</i></td>
            </tr>
            <tr class="addition">
               <td>357</td>
               <td colspan="2">CDISC Questionnaire UPDRS Test Code Terminology<span class="subclass"> SubClassOf </span>CDISC Questionnaire Terminology. <br><i>New Terms: CDISC Questionnaire Terminology, CDISC Questionnaire UPDRS Test Code Terminology</i></td>
            </tr>
            <tr class="addition">
               <td>358</td>
               <td colspan="2">CDISC Questionnaire UPDRS Test Name Terminology<span class="subclass"> SubClassOf </span>CDISC Questionnaire Terminology. <br><i>New Terms: CDISC Questionnaire Terminology, CDISC Questionnaire UPDRS Test Name Terminology</i></td>
            </tr>
            <tr class="addition">
               <td>359</td>
               <td colspan="2">CDISC Questionnaire WPAI:SHP v2.0 Test Code Terminology<span class="subclass"> SubClassOf </span>CDISC Questionnaire Terminology. <br><i>New Terms: CDISC Questionnaire Terminology, CDISC Questionnaire WPAI:SHP v2.0 Test Code Terminology</i></td>
            </tr>
            <tr class="addition">
               <td>360</td>
               <td colspan="2">CDISC Questionnaire WPAI:SHP v2.0 Test Name Terminology<span class="subclass"> SubClassOf </span>CDISC Questionnaire Terminology. <br><i>New Terms: CDISC Questionnaire Terminology, CDISC Questionnaire WPAI:SHP v2.0 Test Name Terminology</i></td>
            </tr>
            <tr class="addition">
               <td>361</td>
               <td colspan="2">CDISC SDTM Relationship to Subject Terminology<span class="subclass"> SubClassOf </span>CDISC SDTM Terminology. <br><i>New Terms: CDISC SDTM Relationship to Subject Terminology</i></td>
            </tr>
            <tr class="addition">
               <td>362</td>
               <td colspan="2">CDK12 Gene<span class="subclass"> SubClassOf </span>Cyclin-Dependent Kinase Gene. <br><i>New Terms: CDK12 Gene</i></td>
            </tr>
            <tr class="addition">
               <td>363</td>
               <td colspan="2">CDK12 Gene<span class="subclass"> SubClassOf </span>Gene_Plays_Role_In_Process<span class="some"> some </span>RNA Splicing. <br><i>New Terms: CDK12 Gene</i></td>
            </tr>
            <tr class="addition">
               <td>364</td>
               <td colspan="2">CDK12 Gene<span class="subclass"> SubClassOf </span>Gene_Plays_Role_In_Process<span class="some"> some </span>Serine/Threonine Phosphorylation. <br><i>New Terms: CDK12 Gene</i></td>
            </tr>
            <tr class="addition">
               <td>365</td>
               <td colspan="2">CDK12 wt Allele<span class="subclass"> SubClassOf </span>CDK12 Gene. <br><i>New Terms: CDK12 Gene, CDK12 wt Allele</i></td>
            </tr>
            <tr class="addition">
               <td>366</td>
               <td colspan="2">CDK12 wt Allele<span class="subclass"> SubClassOf </span>Gene_In_Chromosomal_Location<span class="some"> some </span>17q12. <br><i>New Terms: CDK12 wt Allele</i></td>
            </tr>
            <tr class="addition">
               <td>367</td>
               <td colspan="2">CGI - Efficacy Index<span class="subclass"> SubClassOf </span>CGI Questionnaire Question. <br><i>New Terms: CGI Questionnaire Question, CGI - Efficacy Index</i></td>
            </tr>
            <tr class="addition">
               <td>368</td>
               <td colspan="2">CGI - Global Improvement<span class="subclass"> SubClassOf </span>CGI Questionnaire Question. <br><i>New Terms: CGI Questionnaire Question, CGI - Global Improvement</i></td>
            </tr>
            <tr class="addition">
               <td>369</td>
               <td colspan="2">CGI - Severity of Illness<span class="subclass"> SubClassOf </span>CGI Questionnaire Question. <br><i>New Terms: CGI Questionnaire Question, CGI - Severity of Illness</i></td>
            </tr>
            <tr class="addition">
               <td>370</td>
               <td colspan="2">CGI Questionnaire Question<span class="subclass"> SubClassOf </span>Clinical<br><span class="keyword"> or </span>Research Assessment Question. <br><i>New Terms: CGI Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>371</td>
               <td colspan="2">CH50 Measurement<span class="subclass"> SubClassOf </span>Complement Measurement. <br><i>New Terms: CH50 Measurement</i></td>
            </tr>
            <tr class="addition">
               <td>372</td>
               <td colspan="2">COL1A2/PLAG1 Fusion Gene<span class="subclass"> SubClassOf </span>Fusion Gene. <br><i>New Terms: COL1A2/PLAG1 Fusion Gene</i></td>
            </tr>
            <tr class="addition">
               <td>373</td>
               <td colspan="2">COL1A2/PLAG1 Fusion Gene<span class="subclass"> SubClassOf </span>Gene_Involved_In_Pathogenesis_Of_Disease<span class="some"> some </span>Lipoblastoma. <br><i>New Terms: COL1A2/PLAG1 Fusion Gene</i></td>
            </tr>
            <tr class="addition">
               <td>374</td>
               <td colspan="2">COL1A2/PLAG1 Fusion Gene<span class="subclass"> SubClassOf </span>Gene_Involved_In_Pathogenesis_Of_Disease<span class="some"> some </span>Lipoblastomatosis. <br><i>New Terms: COL1A2/PLAG1 Fusion Gene</i></td>
            </tr>
            <tr class="addition">
               <td>375</td>
               <td colspan="2">COMM - Been in an Argument<span class="subclass"> SubClassOf </span>COMM Questionnaire Question. <br><i>New Terms: COMM Questionnaire Question, COMM - Been in an Argument</i></td>
            </tr>
            <tr class="addition">
               <td>376</td>
               <td colspan="2">COMM - Borrowed Medication From Others<span class="subclass"> SubClassOf </span>COMM Questionnaire Question. <br><i>New Terms: COMM Questionnaire Question, COMM - Borrowed Medication From Others</i></td>
            </tr>
            <tr class="addition">
               <td>377</td>
               <td colspan="2">COMM - Complaints Not Completing Tasks<span class="subclass"> SubClassOf </span>COMM Questionnaire Question. <br><i>New Terms: COMM Questionnaire Question, COMM - Complaints Not Completing Tasks</i></td>
            </tr>
            <tr class="addition">
               <td>378</td>
               <td colspan="2">COMM - Emergency Phone Call<br><span class="keyword"> or </span>Clinic Visit<span class="subclass"> SubClassOf </span>COMM Questionnaire Question. <br><i>New Terms: COMM Questionnaire Question, COMM - Emergency Phone Call or Clinic Visit</i></td>
            </tr>
            <tr class="addition">
               <td>379</td>
               <td colspan="2">COMM - Gotten Angry With People<span class="subclass"> SubClassOf </span>COMM Questionnaire Question. <br><i>New Terms: COMM - Gotten Angry With People, COMM Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>380</td>
               <td colspan="2">COMM - Other Sources for Pain Medication<span class="subclass"> SubClassOf </span>COMM Questionnaire Question. <br><i>New Terms: COMM Questionnaire Question, COMM - Other Sources for Pain Medication</i></td>
            </tr>
            <tr class="addition">
               <td>381</td>
               <td colspan="2">COMM - Others Worry About Your Medications<span class="subclass"> SubClassOf </span>COMM Questionnaire Question. <br><i>New Terms: COMM - Others Worry About Your Medications, COMM Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>382</td>
               <td colspan="2">COMM - Score<span class="subclass"> SubClassOf </span>COMM Questionnaire Question. <br><i>New Terms: COMM Questionnaire Question, COMM - Score</i></td>
            </tr>
            <tr class="addition">
               <td>383</td>
               <td colspan="2">COMM - Seriously Thought of Hurting<span class="some"> Self </span>SubClassOf COMM Questionnaire Question. <br><i>New Terms: COMM Questionnaire Question, COMM - Seriously Thought of Hurting Self</i></td>
            </tr>
            <tr class="addition">
               <td>384</td>
               <td colspan="2">COMM - Take Medications Belonging to Others<span class="subclass"> SubClassOf </span>COMM Questionnaire Question. <br><i>New Terms: COMM Questionnaire Question, COMM - Take Medications Belonging to Others</i></td>
            </tr>
            <tr class="addition">
               <td>385</td>
               <td colspan="2">COMM - Take More Medication Than Prescribed<span class="subclass"> SubClassOf </span>COMM Questionnaire Question. <br><i>New Terms: COMM Questionnaire Question, COMM - Take More Medication Than Prescribed</i></td>
            </tr>
            <tr class="addition">
               <td>386</td>
               <td colspan="2">COMM - Taken Medications Other Than Prescribed<span class="subclass"> SubClassOf </span>COMM Questionnaire Question. <br><i>New Terms: COMM Questionnaire Question, COMM - Taken Medications Other Than Prescribed</i></td>
            </tr>
            <tr class="addition">
               <td>387</td>
               <td colspan="2">COMM - Time Spent Thinking About Opioids<span class="subclass"> SubClassOf </span>COMM Questionnaire Question. <br><i>New Terms: COMM Questionnaire Question, COMM - Time Spent Thinking About Opioids</i></td>
            </tr>
            <tr class="addition">
               <td>388</td>
               <td colspan="2">COMM - Trouble Controlling Anger<span class="subclass"> SubClassOf </span>COMM Questionnaire Question. <br><i>New Terms: COMM - Trouble Controlling Anger, COMM Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>389</td>
               <td colspan="2">COMM - Trouble Thinking Clearly<br><span class="keyword"> or </span>Memory Problems<span class="subclass"> SubClassOf </span>COMM Questionnaire Question. <br><i>New Terms: COMM Questionnaire Question, COMM - Trouble Thinking Clearly or Memory Problems</i></td>
            </tr>
            <tr class="addition">
               <td>390</td>
               <td colspan="2">COMM - Used Pain Medicine For Other Symptoms<span class="subclass"> SubClassOf </span>COMM Questionnaire Question. <br><i>New Terms: COMM Questionnaire Question, COMM - Used Pain Medicine For Other Symptoms</i></td>
            </tr>
            <tr class="addition">
               <td>391</td>
               <td colspan="2">COMM - Visit Emergency Room<span class="subclass"> SubClassOf </span>COMM Questionnaire Question. <br><i>New Terms: COMM - Visit Emergency Room, COMM Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>392</td>
               <td colspan="2">COMM - Worry About Handling Medications<span class="subclass"> SubClassOf </span>COMM Questionnaire Question. <br><i>New Terms: COMM Questionnaire Question, COMM - Worry About Handling Medications</i></td>
            </tr>
            <tr class="addition">
               <td>393</td>
               <td colspan="2">COMM Questionnaire Question<span class="subclass"> SubClassOf </span>Clinical<br><span class="keyword"> or </span>Research Assessment Question. <br><i>New Terms: COMM Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>394</td>
               <td colspan="2">Carbohydrate-Deficient Transferrin Measurement<span class="subclass"> SubClassOf </span>Transferrin Measurement. <br><i>New Terms: Carbohydrate-Deficient Transferrin Measurement</i></td>
            </tr>
            <tr class="addition">
               <td>395</td>
               <td colspan="2">Cellular Sheet Dosage Form<span class="subclass"> SubClassOf </span>Graft Dosage Form. <br><i>New Terms: Cellular Sheet Dosage Form</i></td>
            </tr>
            <tr class="addition">
               <td>396</td>
               <td colspan="2">Cerebral Arterial Aneurysm<span class="subclass"> SubClassOf </span>Cerebral Aneurysm. <br><i>New Terms: Cerebral Arterial Aneurysm</i></td>
            </tr>
            <tr class="addition">
               <td>397</td>
               <td colspan="2">Cerebral Venous Aneurysm<span class="subclass"> SubClassOf </span>Cerebral Aneurysm. <br><i>New Terms: Cerebral Venous Aneurysm</i></td>
            </tr>
            <tr class="addition">
               <td>398</td>
               <td colspan="2">Ceruloplasmin Measurement<span class="subclass"> SubClassOf </span>Protein<br><span class="keyword"> or </span>Enzyme<span class="subclass"> Type </span>Measurement. <br><i>New Terms: Ceruloplasmin Measurement</i></td>
            </tr>
            <tr class="addition">
               <td>399</td>
               <td colspan="2">Chemokine Receptor CXCR3 Measurement<span class="subclass"> SubClassOf </span>Protein<br><span class="keyword"> or </span>Enzyme<span class="subclass"> Type </span>Measurement. <br><i>New Terms: Chemokine Receptor CXCR3 Measurement</i></td>
            </tr>
            <tr class="addition">
               <td>400</td>
               <td colspan="2">Chlamydia trachomatis IgA Antibody Measurement<span class="subclass"> SubClassOf </span>Immunology Test. <br><i>New Terms: Chlamydia trachomatis IgA Antibody Measurement</i></td>
            </tr>
            <tr class="addition">
               <td>401</td>
               <td colspan="2">Chlamydia trachomatis IgG Antibody Measurement<span class="subclass"> SubClassOf </span>Immunology Test. <br><i>New Terms: Chlamydia trachomatis IgG Antibody Measurement</i></td>
            </tr>
            <tr class="addition">
               <td>402</td>
               <td colspan="2">Chlamydia trachomatis IgM Antibody Measurement<span class="subclass"> SubClassOf </span>Immunology Test. <br><i>New Terms: Chlamydia trachomatis IgM Antibody Measurement</i></td>
            </tr>
            <tr class="addition">
               <td>403</td>
               <td colspan="2">Clinical Global Impression Questionnaire<span class="subclass"> SubClassOf </span>Clinical<br><span class="keyword"> or </span>Research Assessment Questionnaire. <br><i>New Terms: Clinical Global Impression Questionnaire</i></td>
            </tr>
            <tr class="addition">
               <td>27</td>
               <td colspan="2">Colon Atresia<span class="subclass"> SubClassOf </span>Large Intestine Atresia. <br><i>New Terms: Colon Atresia</i></td>
            </tr>
            <tr class="addition">
               <td>404</td>
               <td colspan="2">Columbia-Suicidality Severity Rating Scale Questionnaire<span class="subclass"> SubClassOf </span>Clinical<br><span class="keyword"> or </span>Research Assessment Questionnaire. <br><i>New Terms: Columbia-Suicidality Severity Rating Scale Questionnaire</i></td>
            </tr>
            <tr class="addition">
               <td>405</td>
               <td colspan="2">Complete Atrioventricular Canal Defect Balanced<span class="subclass"> SubClassOf </span>Atrioventricular Septal Defect. <br><i>New Terms: Atrioventricular Septal Defect, Complete Atrioventricular Canal Defect Balanced</i></td>
            </tr>
            <tr class="addition">
               <td>406</td>
               <td colspan="2">Complete Atrioventricular Canal Defect Unbalanced<span class="subclass"> SubClassOf </span>Atrioventricular Septal Defect. <br><i>New Terms: Complete Atrioventricular Canal Defect Unbalanced, Atrioventricular Septal Defect</i></td>
            </tr>
            <tr class="addition">
               <td>407</td>
               <td colspan="2">Computed Tomography Dose Index Volume<span class="subclass"> SubClassOf </span>Derived Unit of International System of Units. <br><i>New Terms: Computed Tomography Dose Index Volume</i></td>
            </tr>
            <tr class="addition">
               <td>408</td>
               <td colspan="2">Congenital Aortic Septal Defect<span class="subclass"> SubClassOf </span>Structural Heart Abnormality. <br><i>New Terms: Congenital Aortic Septal Defect</i></td>
            </tr>
            <tr class="addition">
               <td>409</td>
               <td colspan="2">Copies per Milliliter<span class="subclass"> SubClassOf </span>Miscellaneous Concentration Unit. <br><i>New Terms: Copies per Milliliter</i></td>
            </tr>
            <tr class="addition">
               <td>410</td>
               <td colspan="2">Corrected QT Interval<span class="subclass"> SubClassOf </span>Electrocardiographic Finding. <br><i>New Terms: Corrected QT Interval</i></td>
            </tr>
            <tr class="addition">
               <td>411</td>
               <td colspan="2">Current Opioid Misuse Measure Questionnaire<span class="subclass"> SubClassOf </span>Clinical<br><span class="keyword"> or </span>Research Assessment Questionnaire. <br><i>New Terms: Current Opioid Misuse Measure Questionnaire</i></td>
            </tr>
            <tr class="addition">
               <td>412</td>
               <td colspan="2">Cyclin-Dependent Kinase 12<span class="subclass"> SubClassOf </span>Cyclin-Dependent Kinase. <br><i>New Terms: Cyclin-Dependent Kinase 12</i></td>
            </tr>
            <tr class="addition">
               <td>413</td>
               <td colspan="2">Cyclin-Dependent Kinase 12<span class="subclass"> SubClassOf </span>Gene_Product_Encoded_By_Gene<span class="some"> some </span>CDK12 Gene. <br><i>New Terms: Cyclin-Dependent Kinase 12, CDK12 Gene</i></td>
            </tr>
            <tr class="addition">
               <td>414</td>
               <td colspan="2">Cyclin-Dependent Kinase 12<span class="subclass"> SubClassOf </span>Gene_Product_Has_Associated_Anatomy<span class="some"> some </span>Nucleus. <br><i>New Terms: Cyclin-Dependent Kinase 12</i></td>
            </tr>
            <tr class="addition">
               <td>415</td>
               <td colspan="2">Cyclin-Dependent Kinase 12<span class="subclass"> SubClassOf </span>Gene_Product_Has_Biochemical_Function<span class="some"> some </span>Serine/Threonine Protein Kinase. <br><i>New Terms: Cyclin-Dependent Kinase 12</i></td>
            </tr>
            <tr class="addition">
               <td>416</td>
               <td colspan="2">Cyclin-Dependent Kinase 12<span class="subclass"> SubClassOf </span>Gene_Product_Plays_Role_In_Biological_Process<span class="some"> some </span>RNA Splicing. <br><i>New Terms: Cyclin-Dependent Kinase 12</i></td>
            </tr>
            <tr class="addition">
               <td>417</td>
               <td colspan="2">Cyclin-Dependent Kinase 12<span class="subclass"> SubClassOf </span>Gene_Product_Plays_Role_In_Biological_Process<span class="some"> some </span>Serine/Threonine Phosphorylation. <br><i>New Terms: Cyclin-Dependent Kinase 12</i></td>
            </tr>
            <tr class="addition">
               <td>418</td>
               <td colspan="2">DNase-B Antibody Measurement<span class="subclass"> SubClassOf </span>Immunology Test. <br><i>New Terms: DNase-B Antibody Measurement</i></td>
            </tr>
            <tr class="addition">
               <td>419</td>
               <td colspan="2">Deficiency of Steroid 21-Monooxygenase<span class="subclass"> SubClassOf </span>Enzyme Deficiency. <br><i>New Terms: Deficiency of Steroid 21-Monooxygenase</i></td>
            </tr>
            <tr class="addition">
               <td>420</td>
               <td colspan="2">Dextrocardia Situs Solitus<span class="subclass"> SubClassOf </span>Situs Inversus Thoracis. <br><i>New Terms: Dextrocardia Situs Solitus</i></td>
            </tr>
            <tr class="addition">
               <td>421</td>
               <td colspan="2">Diethylene Triamine Pentaacetic Acid Clearance<span class="subclass"> SubClassOf </span>Renal Clearance. <br><i>New Terms: Diethylene Triamine Pentaacetic Acid Clearance</i></td>
            </tr>
            <tr class="addition">
               <td>422</td>
               <td colspan="2">Diopter<span class="subclass"> SubClassOf </span>Miscellaneous Concentration Unit. <br><i>New Terms: Diopter</i></td>
            </tr>
            <tr class="addition">
               <td>423</td>
               <td colspan="2">Discordant<span class="subclass"> SubClassOf </span>Property<br><span class="keyword"> or </span>Attribute. <br><i>New Terms: Discordant</i></td>
            </tr>
            <tr class="addition">
               <td>424</td>
               <td colspan="2">Dose Length Product<span class="subclass"> SubClassOf </span>Derived Unit of International System of Units. <br><i>New Terms: Dose Length Product</i></td>
            </tr>
            <tr class="addition">
               <td>425</td>
               <td colspan="2">Drug Induced Methemoglobinemia<span class="subclass"> SubClassOf </span>Acquired Methemoglobinemia. <br><i>New Terms: Drug Induced Methemoglobinemia</i></td>
            </tr>
            <tr class="addition">
               <td>28</td>
               <td colspan="2">Duodenal Atresia<span class="subclass"> SubClassOf </span>Small Intestine Atresia. <br><i>New Terms: Duodenal Atresia</i></td>
            </tr>
            <tr class="addition">
               <td>426</td>
               <td colspan="2">EDTA Clearance<span class="subclass"> SubClassOf </span>Renal Clearance. <br><i>New Terms: EDTA Clearance</i></td>
            </tr>
            <tr class="addition">
               <td>427</td>
               <td colspan="2">EKG Mean QRS Duration Ventricular Paced<span class="subclass"> SubClassOf </span>EKG Mean QRS Duration. <br><i>New Terms: EKG Mean QRS Duration Ventricular Paced</i></td>
            </tr>
            <tr class="addition">
               <td>428</td>
               <td colspan="2">EQ-5D-3L - Question 1<span class="subclass"> SubClassOf </span>EQ-5D-3L Questionnaire Question. <br><i>New Terms: EQ-5D-3L - Question 1, EQ-5D-3L Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>429</td>
               <td colspan="2">EQ-5D-3L - Question 2<span class="subclass"> SubClassOf </span>EQ-5D-3L Questionnaire Question. <br><i>New Terms: EQ-5D-3L - Question 2, EQ-5D-3L Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>430</td>
               <td colspan="2">EQ-5D-3L - Question 3<span class="subclass"> SubClassOf </span>EQ-5D-3L Questionnaire Question. <br><i>New Terms: EQ-5D-3L - Question 3, EQ-5D-3L Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>431</td>
               <td colspan="2">EQ-5D-3L - Question 4<span class="subclass"> SubClassOf </span>EQ-5D-3L Questionnaire Question. <br><i>New Terms: EQ-5D-3L - Question 4, EQ-5D-3L Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>432</td>
               <td colspan="2">EQ-5D-3L - Question 5<span class="subclass"> SubClassOf </span>EQ-5D-3L Questionnaire Question. <br><i>New Terms: EQ-5D-3L - Question 5, EQ-5D-3L Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>433</td>
               <td colspan="2">EQ-5D-3L - Question 6<span class="subclass"> SubClassOf </span>EQ-5D-3L Questionnaire Question. <br><i>New Terms: EQ-5D-3L - Question 6, EQ-5D-3L Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>434</td>
               <td colspan="2">EQ-5D-3L Questionnaire Question<span class="subclass"> SubClassOf </span>Clinical<br><span class="keyword"> or </span>Research Assessment Question. <br><i>New Terms: EQ-5D-3L Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>435</td>
               <td colspan="2">Ecarin Clotting Time Measurement<span class="subclass"> SubClassOf </span>Coagulation Study. <br><i>New Terms: Ecarin Clotting Time Measurement</i></td>
            </tr>
            <tr class="addition">
               <td>436</td>
               <td colspan="2">Elsiglutide<span class="subclass"> SubClassOf </span>Antidiarrheal Agent. <br><i>New Terms: Elsiglutide</i></td>
            </tr>
            <tr class="addition">
               <td>437</td>
               <td colspan="2">Entity Statement<span class="subclass"> SubClassOf </span>Statement. <br><i>New Terms: Entity Statement</i></td>
            </tr>
            <tr class="addition">
               <td>438</td>
               <td colspan="2">Eosinophil Lysophospholipase<span class="subclass"> SubClassOf </span>Gene_Product_Encoded_By_Gene<span class="some"> some </span>CLC Gene. <br><i>New Terms: Eosinophil Lysophospholipase</i></td>
            </tr>
            <tr class="addition">
               <td>439</td>
               <td colspan="2">Eosinophil Lysophospholipase<span class="subclass"> SubClassOf </span>Gene_Product_Plays_Role_In_Biological_Process<span class="some"> some </span>Hydrolysis. <br><i>New Terms: Eosinophil Lysophospholipase</i></td>
            </tr>
            <tr class="addition">
               <td>440</td>
               <td colspan="2">Eosinophil Lysophospholipase<span class="subclass"> SubClassOf </span>Gene_Product_Plays_Role_In_Biological_Process<span class="some"> some </span>Lipid Metabolic Process. <br><i>New Terms: Eosinophil Lysophospholipase</i></td>
            </tr>
            <tr class="addition">
               <td>441</td>
               <td colspan="2">Eosinophil Lysophospholipase<span class="subclass"> SubClassOf </span>Phospholipase. <br><i>New Terms: Eosinophil Lysophospholipase</i></td>
            </tr>
            <tr class="addition">
               <td>442</td>
               <td colspan="2">Escobar Syndrome<span class="subclass"> SubClassOf </span>Syndrome. <br><i>New Terms: Escobar Syndrome</i></td>
            </tr>
            <tr class="addition">
               <td>443</td>
               <td colspan="2">Escobar Syndrome<span class="subclass"> SubClassOf </span>Systemic Congenital Disorder. <br><i>New Terms: Escobar Syndrome</i></td>
            </tr>
            <tr class="addition">
               <td>444</td>
               <td colspan="2">F-Box Only Protein 11<span class="subclass"> EquivalentTo </span>Ubiquitination Regulation Protein<br><span class="keyword"> and </span>(Gene_Product_Encoded_By_Gene<span class="some"> some </span>FBXO11 Gene)<br><span class="keyword"> and </span>(Gene_Product_Has_Associated_Anatomy<span class="some"> some </span>Cytoplasm)<br><span class="keyword"> and </span>(Gene_Product_Has_Associated_Anatomy<span class="some"> some </span>Nucleolus)<br><span class="keyword"> and </span>(Gene_Product_Has_Biochemical_Function<span class="some"> some </span>Ubiquitination Regulation Protein)<br><span class="keyword"> and </span>(Gene_Product_Has_Structural_Domain_Or_Motif<span class="some"> some </span>F Box Domain)<br><span class="keyword"> and </span>(Gene_Product_Is_Element_In_Pathway<span class="some"> some </span>p53 Pathway for Transcriptional Regulation)<br><span class="keyword"> and </span>(Gene_Product_Is_Physical_Part_Of<span class="some"> some </span>Ubiquitin Protein Ligase)<br><span class="keyword"> and </span>(Gene_Product_Plays_Role_In_Biological_Process<span class="some"> some </span>Protein-Protein Interaction)<br><span class="keyword"> and </span>(Gene_Product_Plays_Role_In_Biological_Process<span class="some"> some </span>Ubiquitinated Protein Degradation)<br><span class="keyword"> and </span>(Gene_Product_Plays_Role_In_Biological_Process<span class="some"> some </span>Ubiquitination). <br><i>New Terms: FBXO11 Gene, F-Box Only Protein 11</i></td>
            </tr>
            <tr class="addition">
               <td>445</td>
               <td colspan="2">FAM22A Gene<span class="subclass"> SubClassOf </span>Regulatory Gene. <br><i>New Terms: FAM22A Gene</i></td>
            </tr>
            <tr class="addition">
               <td>446</td>
               <td colspan="2">FAM22A wt Allele<span class="subclass"> SubClassOf </span>FAM22A Gene. <br><i>New Terms: FAM22A Gene, FAM22A wt Allele</i></td>
            </tr>
            <tr class="addition">
               <td>447</td>
               <td colspan="2">FAM22A wt Allele<span class="subclass"> SubClassOf </span>Gene_In_Chromosomal_Location<span class="some"> some </span>10q23.2. <br><i>New Terms: FAM22A wt Allele</i></td>
            </tr>
            <tr class="addition">
               <td>448</td>
               <td colspan="2">FAM22B Gene<span class="subclass"> SubClassOf </span>Regulatory Gene. <br><i>New Terms: FAM22B Gene</i></td>
            </tr>
            <tr class="addition">
               <td>449</td>
               <td colspan="2">FAM22B wt Allele<span class="subclass"> SubClassOf </span>FAM22B Gene. <br><i>New Terms: FAM22B wt Allele, FAM22B Gene</i></td>
            </tr>
            <tr class="addition">
               <td>450</td>
               <td colspan="2">FAM22B wt Allele<span class="subclass"> SubClassOf </span>Gene_In_Chromosomal_Location<span class="some"> some </span>10q23.2. <br><i>New Terms: FAM22B wt Allele</i></td>
            </tr>
            <tr class="addition">
               <td>451</td>
               <td colspan="2">FBXO11 Gene<span class="subclass"> SubClassOf </span>Gene_Plays_Role_In_Process<span class="some"> some </span>Protein-Protein Interaction. <br><i>New Terms: FBXO11 Gene</i></td>
            </tr>
            <tr class="addition">
               <td>452</td>
               <td colspan="2">FBXO11 Gene<span class="subclass"> SubClassOf </span>Gene_Plays_Role_In_Process<span class="some"> some </span>Ubiquitinated Protein Degradation. <br><i>New Terms: FBXO11 Gene</i></td>
            </tr>
            <tr class="addition">
               <td>453</td>
               <td colspan="2">FBXO11 Gene<span class="subclass"> SubClassOf </span>Gene_Plays_Role_In_Process<span class="some"> some </span>Ubiquitination. <br><i>New Terms: FBXO11 Gene</i></td>
            </tr>
            <tr class="addition">
               <td>454</td>
               <td colspan="2">FBXO11 Gene<span class="subclass"> SubClassOf </span>Regulatory Gene. <br><i>New Terms: FBXO11 Gene</i></td>
            </tr>
            <tr class="addition">
               <td>455</td>
               <td colspan="2">FBXO11 wt Allele<span class="subclass"> SubClassOf </span>FBXO11 Gene. <br><i>New Terms: FBXO11 wt Allele, FBXO11 Gene</i></td>
            </tr>
            <tr class="addition">
               <td>456</td>
               <td colspan="2">FBXO11 wt Allele<span class="subclass"> SubClassOf </span>Gene_In_Chromosomal_Location<span class="some"> some </span>2p16.3. <br><i>New Terms: FBXO11 wt Allele</i></td>
            </tr>
            <tr class="addition">
               <td>457</td>
               <td colspan="2">FBXO11 wt Allele<span class="subclass"> SubClassOf </span>Gene_Is_Element_In_Pathway<span class="some"> some </span>p53 Pathway for Transcriptional Regulation. <br><i>New Terms: FBXO11 wt Allele</i></td>
            </tr>
            <tr class="addition">
               <td>458</td>
               <td colspan="2">FPSR - How Much do You Hurt<span class="subclass"> SubClassOf </span>FPSR Questionnaire Question. <br><i>New Terms: FPSR Questionnaire Question, FPSR - How Much do You Hurt</i></td>
            </tr>
            <tr class="addition">
               <td>459</td>
               <td colspan="2">FPSR Questionnaire Question<span class="subclass"> SubClassOf </span>Clinical<br><span class="keyword"> or </span>Research Assessment Question. <br><i>New Terms: FPSR Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>460</td>
               <td colspan="2">FUS/CREB3L1 Fusion Gene<span class="subclass"> SubClassOf </span>Fusion Gene. <br><i>New Terms: FUS/CREB3L1 Fusion Gene</i></td>
            </tr>
            <tr class="addition">
               <td>461</td>
               <td colspan="2">FUS/CREB3L1 Fusion Protein<span class="subclass"> SubClassOf </span>Fusion Protein. <br><i>New Terms: FUS/CREB3L1 Fusion Protein</i></td>
            </tr>
            <tr class="addition">
               <td>462</td>
               <td colspan="2">FUS/CREB3L1 Fusion Protein<span class="subclass"> SubClassOf </span>Gene_Product_Encoded_By_Gene<span class="some"> some </span>FUS/CREB3L1 Fusion Gene. <br><i>New Terms: FUS/CREB3L1 Fusion Protein, FUS/CREB3L1 Fusion Gene</i></td>
            </tr>
            <tr class="addition">
               <td>463</td>
               <td colspan="2">Faces Pain Scale Revised Questionnaire<span class="subclass"> SubClassOf </span>Clinical<br><span class="keyword"> or </span>Research Assessment Questionnaire. <br><i>New Terms: Faces Pain Scale Revised Questionnaire</i></td>
            </tr>
            <tr class="addition">
               <td>464</td>
               <td colspan="2">Fistulagram<span class="subclass"> SubClassOf </span>Angiography. <br><i>New Terms: Fistulagram</i></td>
            </tr>
            <tr class="addition">
               <td>465</td>
               <td colspan="2">Forearm Circumference<span class="subclass"> SubClassOf </span>Circumference. <br><i>New Terms: Forearm Circumference</i></td>
            </tr>
            <tr class="addition">
               <td>466</td>
               <td colspan="2">Free Glycerol Measurement<span class="subclass"> SubClassOf </span>Chemistry Test. <br><i>New Terms: Free Glycerol Measurement</i></td>
            </tr>
            <tr class="addition">
               <td>467</td>
               <td colspan="2">Functional Bowel Obstruction<span class="subclass"> SubClassOf </span>Bowel Obstruction. <br><i>New Terms: Functional Bowel Obstruction</i></td>
            </tr>
            <tr class="addition">
               <td>468</td>
               <td colspan="2">Geometric Shape<span class="subclass"> SubClassOf </span>Shape. <br><i>New Terms: Geometric Shape</i></td>
            </tr>
            <tr class="addition">
               <td>469</td>
               <td colspan="2">Ginger Flavor<span class="subclass"> SubClassOf </span>Structured Product Labeling Flavor. <br><i>New Terms: Ginger Flavor</i></td>
            </tr>
            <tr class="addition">
               <td>470</td>
               <td colspan="2">Glomerular Filtration Rate from B-2 Microglobulin Adjusted for BSA Measurement<span class="subclass"> SubClassOf </span>Glomerular Filtration Rate. <br><i>New Terms: Glomerular Filtration Rate from B-2 Microglobulin Adjusted for BSA Measurement</i></td>
            </tr>
            <tr class="addition">
               <td>471</td>
               <td colspan="2">Glomerular Filtration Rate from Beta-Trace Protein Adjusted for BSA Measurement<span class="subclass"> SubClassOf </span>Glomerular Filtration Rate. <br><i>New Terms: Glomerular Filtration Rate from Beta-Trace Protein Adjusted for BSA Measurement</i></td>
            </tr>
            <tr class="addition">
               <td>472</td>
               <td colspan="2">Guarana Supplement<span class="subclass"> SubClassOf </span>Dietary Supplement. <br><i>New Terms: Guarana Supplement</i></td>
            </tr>
            <tr class="addition">
               <td>473</td>
               <td colspan="2">HAMD-17 - Agitation<span class="subclass"> SubClassOf </span>HAMD-17 Questionnaire Question. <br><i>New Terms: HAMD-17 - Agitation, HAMD-17 Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>474</td>
               <td colspan="2">HAMD-17 - Depressed Mood<span class="subclass"> SubClassOf </span>HAMD-17 Questionnaire Question. <br><i>New Terms: HAMD-17 - Depressed Mood, HAMD-17 Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>475</td>
               <td colspan="2">HAMD-17 - Feelings of Guilt<span class="subclass"> SubClassOf </span>HAMD-17 Questionnaire Question. <br><i>New Terms: HAMD-17 Questionnaire Question, HAMD-17 - Feelings of Guilt</i></td>
            </tr>
            <tr class="addition">
               <td>476</td>
               <td colspan="2">HAMD-17 - Gastrointestinal Somatic Symptoms<span class="subclass"> SubClassOf </span>HAMD-17 Questionnaire Question. <br><i>New Terms: HAMD-17 - Gastrointestinal Somatic Symptoms, HAMD-17 Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>477</td>
               <td colspan="2">HAMD-17 - General Somatic Symptoms<span class="subclass"> SubClassOf </span>HAMD-17 Questionnaire Question. <br><i>New Terms: HAMD-17 Questionnaire Question, HAMD-17 - General Somatic Symptoms</i></td>
            </tr>
            <tr class="addition">
               <td>478</td>
               <td colspan="2">HAMD-17 - Genital Symptoms<span class="subclass"> SubClassOf </span>HAMD-17 Questionnaire Question. <br><i>New Terms: HAMD-17 Questionnaire Question, HAMD-17 - Genital Symptoms</i></td>
            </tr>
            <tr class="addition">
               <td>479</td>
               <td colspan="2">HAMD-17 - Hypochondriasis<span class="subclass"> SubClassOf </span>HAMD-17 Questionnaire Question. <br><i>New Terms: HAMD-17 Questionnaire Question, HAMD-17 - Hypochondriasis</i></td>
            </tr>
            <tr class="addition">
               <td>480</td>
               <td colspan="2">HAMD-17 - Insight<span class="subclass"> SubClassOf </span>HAMD-17 Questionnaire Question. <br><i>New Terms: HAMD-17 - Insight, HAMD-17 Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>481</td>
               <td colspan="2">HAMD-17 - Insomnia - Early Morning<span class="subclass"> SubClassOf </span>HAMD-17 Questionnaire Question. <br><i>New Terms: HAMD-17 Questionnaire Question, HAMD-17 - Insomnia - Early Morning</i></td>
            </tr>
            <tr class="addition">
               <td>482</td>
               <td colspan="2">HAMD-17 - Insomnia - Early Night<span class="subclass"> SubClassOf </span>HAMD-17 Questionnaire Question. <br><i>New Terms: HAMD-17 - Insomnia - Early Night, HAMD-17 Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>483</td>
               <td colspan="2">HAMD-17 - Insomnia - Middle Night<span class="subclass"> SubClassOf </span>HAMD-17 Questionnaire Question. <br><i>New Terms: HAMD-17 - Insomnia - Middle Night, HAMD-17 Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>484</td>
               <td colspan="2">HAMD-17 - Loss of Weight According to Patient<span class="subclass"> SubClassOf </span>HAMD-17 Questionnaire Question. <br><i>New Terms: HAMD-17 Questionnaire Question, HAMD-17 - Loss of Weight According to Patient</i></td>
            </tr>
            <tr class="addition">
               <td>485</td>
               <td colspan="2">HAMD-17 - Loss of Weight According to Weekly Measurements<span class="subclass"> SubClassOf </span>HAMD-17 Questionnaire Question. <br><i>New Terms: HAMD-17 Questionnaire Question, HAMD-17 - Loss of Weight According to Weekly Measurements</i></td>
            </tr>
            <tr class="addition">
               <td>486</td>
               <td colspan="2">HAMD-17 - Psychic Anxiety<span class="subclass"> SubClassOf </span>HAMD-17 Questionnaire Question. <br><i>New Terms: HAMD-17 Questionnaire Question, HAMD-17 - Psychic Anxiety</i></td>
            </tr>
            <tr class="addition">
               <td>487</td>
               <td colspan="2">HAMD-17 - Retardation<span class="subclass"> SubClassOf </span>HAMD-17 Questionnaire Question. <br><i>New Terms: HAMD-17 Questionnaire Question, HAMD-17 - Retardation</i></td>
            </tr>
            <tr class="addition">
               <td>488</td>
               <td colspan="2">HAMD-17 - Somatic Anxiety<span class="subclass"> SubClassOf </span>HAMD-17 Questionnaire Question. <br><i>New Terms: HAMD-17 Questionnaire Question, HAMD-17 - Somatic Anxiety</i></td>
            </tr>
            <tr class="addition">
               <td>489</td>
               <td colspan="2">HAMD-17 - Suicide<span class="subclass"> SubClassOf </span>HAMD-17 Questionnaire Question. <br><i>New Terms: HAMD-17 - Suicide, HAMD-17 Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>490</td>
               <td colspan="2">HAMD-17 - Total Score<span class="subclass"> SubClassOf </span>HAMD-17 Questionnaire Question. <br><i>New Terms: HAMD-17 Questionnaire Question, HAMD-17 - Total Score</i></td>
            </tr>
            <tr class="addition">
               <td>491</td>
               <td colspan="2">HAMD-17 - Work<br><span class="keyword"> and </span>Activities<span class="subclass"> SubClassOf </span>HAMD-17 Questionnaire Question. <br><i>New Terms: HAMD-17 - Work and Activities, HAMD-17 Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>492</td>
               <td colspan="2">HAMD-17 Questionnaire Question<span class="subclass"> SubClassOf </span>Clinical<br><span class="keyword"> or </span>Research Assessment Question. <br><i>New Terms: HAMD-17 Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>493</td>
               <td colspan="2">HAS2/PLAG1 Fusion Gene<span class="subclass"> SubClassOf </span>Fusion Gene. <br><i>New Terms: HAS2/PLAG1 Fusion Gene</i></td>
            </tr>
            <tr class="addition">
               <td>494</td>
               <td colspan="2">HAS2/PLAG1 Fusion Gene<span class="subclass"> SubClassOf </span>Gene_Involved_In_Pathogenesis_Of_Disease<span class="some"> some </span>Lipoblastoma. <br><i>New Terms: HAS2/PLAG1 Fusion Gene</i></td>
            </tr>
            <tr class="addition">
               <td>495</td>
               <td colspan="2">HAS2/PLAG1 Fusion Gene<span class="subclass"> SubClassOf </span>Gene_Involved_In_Pathogenesis_Of_Disease<span class="some"> some </span>Lipoblastomatosis. <br><i>New Terms: HAS2/PLAG1 Fusion Gene</i></td>
            </tr>
            <tr class="addition">
               <td>496</td>
               <td colspan="2">HDL Cholesterol to LDL Cholesterol Ratio Measurement<span class="subclass"> SubClassOf </span>Lipid Measurement. <br><i>New Terms: HDL Cholesterol to LDL Cholesterol Ratio Measurement</i></td>
            </tr>
            <tr class="addition">
               <td>497</td>
               <td colspan="2">HEY1 Gene<span class="subclass"> SubClassOf </span>Gene_Plays_Role_In_Process<span class="some"> some </span>Protein-Protein Interaction. <br><i>New Terms: HEY1 Gene</i></td>
            </tr>
            <tr class="addition">
               <td>498</td>
               <td colspan="2">HEY1 Gene<span class="subclass"> SubClassOf </span>Gene_Plays_Role_In_Process<span class="some"> some </span>Signal Transduction Inhibition. <br><i>New Terms: HEY1 Gene</i></td>
            </tr>
            <tr class="addition">
               <td>499</td>
               <td colspan="2">HEY1 Gene<span class="subclass"> SubClassOf </span>Gene_Plays_Role_In_Process<span class="some"> some </span>Transcriptional Repression. <br><i>New Terms: HEY1 Gene</i></td>
            </tr>
            <tr class="addition">
               <td>500</td>
               <td colspan="2">HEY1 Gene<span class="subclass"> SubClassOf </span>Transcription Repressor/Corepressor Gene. <br><i>New Terms: HEY1 Gene</i></td>
            </tr>
            <tr class="addition">
               <td>501</td>
               <td colspan="2">HEY1 wt Allele<span class="subclass"> SubClassOf </span>Gene_In_Chromosomal_Location<span class="some"> some </span>8q21. <br><i>New Terms: HEY1 wt Allele</i></td>
            </tr>
            <tr class="addition">
               <td>502</td>
               <td colspan="2">HEY1 wt Allele<span class="subclass"> SubClassOf </span>HEY1 Gene. <br><i>New Terms: HEY1 wt Allele, HEY1 Gene</i></td>
            </tr>
            <tr class="addition">
               <td>503</td>
               <td colspan="2">HGNC_ID<span class="subclass"> SubClassOf </span>NCI Thesaurus Property. <br><i>New Terms: HGNC_ID</i></td>
            </tr>
            <tr class="addition">
               <td>504</td>
               <td colspan="2">HLA-B27 Antigen Measurement<span class="subclass"> SubClassOf </span>Immunology Test. <br><i>New Terms: HLA-B27 Antigen Measurement</i></td>
            </tr>
            <tr class="addition">
               <td>505</td>
               <td colspan="2">HPV E1/E2 Interaction Inhibitor Gel AP611074<span class="subclass"> SubClassOf </span>Antiviral Agent. <br><i>New Terms: HPV E1/E2 Interaction Inhibitor Gel AP611074</i></td>
            </tr>
            <tr class="addition">
               <td>506</td>
               <td colspan="2">Hairy/Enhancer-of-Split Related with YRPW Motif Protein 1<span class="subclass"> EquivalentTo </span>Transcription Regulatory Protein<br><span class="keyword"> and </span>(Gene_Product_Encoded_By_Gene<span class="some"> some </span>HEY1 Gene)<br><span class="keyword"> and </span>(Gene_Product_Has_Biochemical_Function<span class="some"> some </span>Transcription Repressor/Corepressor)<br><span class="keyword"> and </span>(Gene_Product_Has_Structural_Domain_Or_Motif<span class="some"> some </span>bHLH Domain)<br><span class="keyword"> and </span>(Gene_Product_Plays_Role_In_Biological_Process<span class="some"> some </span>Protein-Protein Interaction)<br><span class="keyword"> and </span>(Gene_Product_Plays_Role_In_Biological_Process<span class="some"> some </span>Signal Transduction Inhibition)<br><span class="keyword"> and </span>(Gene_Product_Plays_Role_In_Biological_Process<span class="some"> some </span>Transcriptional Repression). <br><i>New Terms: Hairy/Enhancer-of-Split Related with YRPW Motif Protein 1, HEY1 Gene</i></td>
            </tr>
            <tr class="addition">
               <td>507</td>
               <td colspan="2">Hamilton Depression Rating Scale 17 Item Questionnaire<span class="subclass"> SubClassOf </span>Clinical<br><span class="keyword"> or </span>Research Assessment Questionnaire. <br><i>New Terms: Hamilton Depression Rating Scale 17 Item Questionnaire</i></td>
            </tr>
            <tr class="addition">
               <td>508</td>
               <td colspan="2">Hip Circumference<span class="subclass"> SubClassOf </span>Circumference. <br><i>New Terms: Hip Circumference</i></td>
            </tr>
            <tr class="addition">
               <td>509</td>
               <td colspan="2">Homeostatic Model Assessment of Insulin Resistance<span class="subclass"> SubClassOf </span>Chemistry Test. <br><i>New Terms: Homeostatic Model Assessment of Insulin Resistance</i></td>
            </tr>
            <tr class="addition">
               <td>29</td>
               <td colspan="2">Ileal Atresia<span class="subclass"> SubClassOf </span>Small Intestine Atresia. <br><i>New Terms: Ileal Atresia</i></td>
            </tr>
            <tr class="addition">
               <td>510</td>
               <td colspan="2">Image Annotation Statement<span class="subclass"> SubClassOf </span>Entity Statement. <br><i>New Terms: Image Annotation Statement, Entity Statement</i></td>
            </tr>
            <tr class="addition">
               <td>511</td>
               <td colspan="2">Immature Granulocytes to Leukocytes Ratio Measurement<span class="subclass"> SubClassOf </span>Blood Cell Count Ratio Measurement. <br><i>New Terms: Immature Granulocytes to Leukocytes Ratio Measurement</i></td>
            </tr>
            <tr class="addition">
               <td>512</td>
               <td colspan="2">Immature Lymphocytes Measurement<span class="subclass"> SubClassOf </span>Blood Cell Count Ratio Measurement. <br><i>New Terms: Immature Lymphocytes Measurement</i></td>
            </tr>
            <tr class="addition">
               <td>513</td>
               <td colspan="2">Immature Lymphocytes to Leukocytes Ratio Measurement<span class="subclass"> SubClassOf </span>Blood Cell Count Ratio Measurement. <br><i>New Terms: Immature Lymphocytes to Leukocytes Ratio Measurement</i></td>
            </tr>
            <tr class="addition">
               <td>514</td>
               <td colspan="2">Immature Neutrophils to Leukocytes Ratio Measurement<span class="subclass"> SubClassOf </span>Blood Cell Count Ratio Measurement. <br><i>New Terms: Immature Neutrophils to Leukocytes Ratio Measurement</i></td>
            </tr>
            <tr class="addition">
               <td>515</td>
               <td colspan="2">Intentional Trauma<span class="subclass"> SubClassOf </span>Injury. <br><i>New Terms: Intentional Trauma</i></td>
            </tr>
            <tr class="addition">
               <td>516</td>
               <td colspan="2">Interferon Gamma-1a<span class="subclass"> SubClassOf </span>Recombinant Interferon Gamma. <br><i>New Terms: Interferon Gamma-1a</i></td>
            </tr>
            <tr class="addition">
               <td>517</td>
               <td colspan="2">Interferon Gamma-1b<span class="subclass"> SubClassOf </span>Recombinant Interferon Gamma. <br><i>New Terms: Interferon Gamma-1b</i></td>
            </tr>
            <tr class="addition">
               <td>518</td>
               <td colspan="2">Iohexol Clearance<span class="subclass"> SubClassOf </span>Renal Clearance. <br><i>New Terms: Iohexol Clearance</i></td>
            </tr>
            <tr class="addition">
               <td>30</td>
               <td colspan="2">Jejunal Atresia<span class="subclass"> SubClassOf </span>Small Intestine Atresia. <br><i>New Terms: Jejunal Atresia</i></td>
            </tr>
            <tr class="addition">
               <td>519</td>
               <td colspan="2">Jo-1 Antibody Measurement<span class="subclass"> SubClassOf </span>Immunology Test. <br><i>New Terms: Jo-1 Antibody Measurement</i></td>
            </tr>
            <tr class="addition">
               <td>520</td>
               <td colspan="2">KPS Scale - Karnofsky Performance Status<span class="subclass"> SubClassOf </span>KPS Scale Questionnaire Question. <br><i>New Terms: KPS Scale Questionnaire Question, KPS Scale - Karnofsky Performance Status</i></td>
            </tr>
            <tr class="addition">
               <td>521</td>
               <td colspan="2">KPS Scale Questionnaire Question<span class="subclass"> SubClassOf </span>Clinical<br><span class="keyword"> or </span>Research Assessment Question. <br><i>New Terms: KPS Scale Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>522</td>
               <td colspan="2">Karnofsky Performance Status Scale Questionnaire<span class="subclass"> SubClassOf </span>Clinical<br><span class="keyword"> or </span>Research Assessment Questionnaire. <br><i>New Terms: Karnofsky Performance Status Scale Questionnaire</i></td>
            </tr>
            <tr class="addition">
               <td>523</td>
               <td colspan="2">Kidney Injury Molecule-1 Measurement<span class="subclass"> SubClassOf </span>Protein<br><span class="keyword"> or </span>Enzyme<span class="subclass"> Type </span>Measurement. <br><i>New Terms: Kidney Injury Molecule-1 Measurement</i></td>
            </tr>
            <tr class="addition">
               <td>524</td>
               <td colspan="2">Kukui Nut<span class="subclass"> SubClassOf </span>Tree Nut. <br><i>New Terms: Kukui Nut</i></td>
            </tr>
            <tr class="addition">
               <td>525</td>
               <td colspan="2">Lateral Decubitus Position<span class="subclass"> SubClassOf </span>Body Position. <br><i>New Terms: Lateral Decubitus Position</i></td>
            </tr>
            <tr class="addition">
               <td>526</td>
               <td colspan="2">Lethal Multiple Pterygium Syndrome<span class="subclass"> SubClassOf </span>Syndrome. <br><i>New Terms: Lethal Multiple Pterygium Syndrome</i></td>
            </tr>
            <tr class="addition">
               <td>527</td>
               <td colspan="2">Lethal Multiple Pterygium Syndrome<span class="subclass"> SubClassOf </span>Systemic Congenital Disorder. <br><i>New Terms: Lethal Multiple Pterygium Syndrome</i></td>
            </tr>
            <tr class="addition">
               <td>528</td>
               <td colspan="2">Lichenoid<span class="subclass"> SubClassOf </span>Disease Qualifier. <br><i>New Terms: Lichenoid</i></td>
            </tr>
            <tr class="addition">
               <td>529</td>
               <td colspan="2">Liver Kidney Microsomal<span class="subclass"> Type </span>1 IgA Antibody Measurement<span class="subclass"> SubClassOf </span>Immunology Test. <br><i>New Terms: Liver Kidney Microsomal Type 1 IgA Antibody Measurement</i></td>
            </tr>
            <tr class="addition">
               <td>530</td>
               <td colspan="2">Liver Kidney Microsomal<span class="subclass"> Type </span>1 IgG Antibody Measurement<span class="subclass"> SubClassOf </span>Immunology Test. <br><i>New Terms: Liver Kidney Microsomal Type 1 IgG Antibody Measurement</i></td>
            </tr>
            <tr class="addition">
               <td>531</td>
               <td colspan="2">Liver Kidney Microsomal<span class="subclass"> Type </span>1 IgM Antibody Measurement<span class="subclass"> SubClassOf </span>Immunology Test. <br><i>New Terms: Liver Kidney Microsomal Type 1 IgM Antibody Measurement</i></td>
            </tr>
            <tr class="addition">
               <td>532</td>
               <td colspan="2">MDS-UPDRS - Anxious Mood<span class="subclass"> SubClassOf </span>MDS-UPDRS Questionnaire Question. <br><i>New Terms: MDS-UPDRS - Anxious Mood, MDS-UPDRS Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>533</td>
               <td colspan="2">MDS-UPDRS - Apathy<span class="subclass"> SubClassOf </span>MDS-UPDRS Questionnaire Question. <br><i>New Terms: MDS-UPDRS - Apathy, MDS-UPDRS Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>534</td>
               <td colspan="2">MDS-UPDRS - Arising from Chair<span class="subclass"> SubClassOf </span>MDS-UPDRS Questionnaire Question. <br><i>New Terms: MDS-UPDRS Questionnaire Question, MDS-UPDRS - Arising from Chair</i></td>
            </tr>
            <tr class="addition">
               <td>535</td>
               <td colspan="2">MDS-UPDRS - Body Bradykinesia<span class="subclass"> SubClassOf </span>MDS-UPDRS Questionnaire Question. <br><i>New Terms: MDS-UPDRS - Body Bradykinesia, MDS-UPDRS Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>536</td>
               <td colspan="2">MDS-UPDRS - Chewing<br><span class="keyword"> and </span>Swallowing<span class="subclass"> SubClassOf </span>MDS-UPDRS Questionnaire Question. <br><i>New Terms: MDS-UPDRS Questionnaire Question, MDS-UPDRS - Chewing and Swallowing</i></td>
            </tr>
            <tr class="addition">
               <td>537</td>
               <td colspan="2">MDS-UPDRS - Clinical State on Medication<span class="subclass"> SubClassOf </span>MDS-UPDRS Questionnaire Question. <br><i>New Terms: MDS-UPDRS Questionnaire Question, MDS-UPDRS - Clinical State on Medication</i></td>
            </tr>
            <tr class="addition">
               <td>538</td>
               <td colspan="2">MDS-UPDRS - Cognitive Impairment<span class="subclass"> SubClassOf </span>MDS-UPDRS Questionnaire Question. <br><i>New Terms: MDS-UPDRS Questionnaire Question, MDS-UPDRS - Cognitive Impairment</i></td>
            </tr>
            <tr class="addition">
               <td>539</td>
               <td colspan="2">MDS-UPDRS - Complexity of Motor Fluctuations<span class="subclass"> SubClassOf </span>MDS-UPDRS Questionnaire Question. <br><i>New Terms: MDS-UPDRS Questionnaire Question, MDS-UPDRS - Complexity of Motor Fluctuations</i></td>
            </tr>
            <tr class="addition">
               <td>540</td>
               <td colspan="2">MDS-UPDRS - Consistency of Rest Tremor<span class="subclass"> SubClassOf </span>MDS-UPDRS Questionnaire Question. <br><i>New Terms: MDS-UPDRS Questionnaire Question, MDS-UPDRS - Consistency of Rest Tremor</i></td>
            </tr>
            <tr class="addition">
               <td>541</td>
               <td colspan="2">MDS-UPDRS - Constipation Problems<span class="subclass"> SubClassOf </span>MDS-UPDRS Questionnaire Question. <br><i>New Terms: MDS-UPDRS - Constipation Problems, MDS-UPDRS Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>542</td>
               <td colspan="2">MDS-UPDRS - Daytime Sleepiness<span class="subclass"> SubClassOf </span>MDS-UPDRS Questionnaire Question. <br><i>New Terms: MDS-UPDRS Questionnaire Question, MDS-UPDRS - Daytime Sleepiness</i></td>
            </tr>
            <tr class="addition">
               <td>543</td>
               <td colspan="2">MDS-UPDRS - Depressed Mood<span class="subclass"> SubClassOf </span>MDS-UPDRS Questionnaire Question. <br><i>New Terms: MDS-UPDRS Questionnaire Question, MDS-UPDRS - Depressed Mood</i></td>
            </tr>
            <tr class="addition">
               <td>544</td>
               <td colspan="2">MDS-UPDRS - Doing Hobbies<br><span class="keyword"> and </span>Other Activities<span class="subclass"> SubClassOf </span>MDS-UPDRS Questionnaire Question. <br><i>New Terms: MDS-UPDRS Questionnaire Question, MDS-UPDRS - Doing Hobbies and Other Activities</i></td>
            </tr>
            <tr class="addition">
               <td>545</td>
               <td colspan="2">MDS-UPDRS - Dressing<span class="subclass"> SubClassOf </span>MDS-UPDRS Questionnaire Question. <br><i>New Terms: MDS-UPDRS - Dressing, MDS-UPDRS Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>546</td>
               <td colspan="2">MDS-UPDRS - Dyskinesias During Exam<span class="subclass"> SubClassOf </span>MDS-UPDRS Questionnaire Question. <br><i>New Terms: MDS-UPDRS - Dyskinesias During Exam, MDS-UPDRS Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>547</td>
               <td colspan="2">MDS-UPDRS - Eating Tasks<span class="subclass"> SubClassOf </span>MDS-UPDRS Questionnaire Question. <br><i>New Terms: MDS-UPDRS - Eating Tasks, MDS-UPDRS Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>548</td>
               <td colspan="2">MDS-UPDRS - Facial Expression<span class="subclass"> SubClassOf </span>MDS-UPDRS Questionnaire Question. <br><i>New Terms: MDS-UPDRS Questionnaire Question, MDS-UPDRS - Facial Expression</i></td>
            </tr>
            <tr class="addition">
               <td>549</td>
               <td colspan="2">MDS-UPDRS - Fatigue<span class="subclass"> SubClassOf </span>MDS-UPDRS Questionnaire Question. <br><i>New Terms: MDS-UPDRS Questionnaire Question, MDS-UPDRS - Fatigue</i></td>
            </tr>
            <tr class="addition">
               <td>550</td>
               <td colspan="2">MDS-UPDRS - Features of Dopamine Dysregulation Syndrome<span class="subclass"> SubClassOf </span>MDS-UPDRS Questionnaire Question. <br><i>New Terms: MDS-UPDRS Questionnaire Question, MDS-UPDRS - Features of Dopamine Dysregulation Syndrome</i></td>
            </tr>
            <tr class="addition">
               <td>551</td>
               <td colspan="2">MDS-UPDRS - Freezing<span class="subclass"> SubClassOf </span>MDS-UPDRS Questionnaire Question. <br><i>New Terms: MDS-UPDRS Questionnaire Question, MDS-UPDRS - Freezing</i></td>
            </tr>
            <tr class="addition">
               <td>552</td>
               <td colspan="2">MDS-UPDRS - Freezing of Gait<span class="subclass"> SubClassOf </span>MDS-UPDRS Questionnaire Question. <br><i>New Terms: MDS-UPDRS Questionnaire Question, MDS-UPDRS - Freezing of Gait</i></td>
            </tr>
            <tr class="addition">
               <td>553</td>
               <td colspan="2">MDS-UPDRS - Functional Impact of Dyskinesias<span class="subclass"> SubClassOf </span>MDS-UPDRS Questionnaire Question. <br><i>New Terms: MDS-UPDRS - Functional Impact of Dyskinesias, MDS-UPDRS Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>554</td>
               <td colspan="2">MDS-UPDRS - Functional Impact of Fluctuations<span class="subclass"> SubClassOf </span>MDS-UPDRS Questionnaire Question. <br><i>New Terms: MDS-UPDRS Questionnaire Question, MDS-UPDRS - Functional Impact of Fluctuations</i></td>
            </tr>
            <tr class="addition">
               <td>555</td>
               <td colspan="2">MDS-UPDRS - Gait<span class="subclass"> SubClassOf </span>MDS-UPDRS Questionnaire Question. <br><i>New Terms: MDS-UPDRS - Gait, MDS-UPDRS Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>556</td>
               <td colspan="2">MDS-UPDRS - Get Out of Bed, Car,<br><span class="keyword"> or </span>Deep Chair<span class="subclass"> SubClassOf </span>MDS-UPDRS Questionnaire Question. <br><i>New Terms: MDS-UPDRS - Get Out of Bed, Car, or Deep Chair, MDS-UPDRS Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>557</td>
               <td colspan="2">MDS-UPDRS - Hallucinations<br><span class="keyword"> and </span>Psychosis<span class="subclass"> SubClassOf </span>MDS-UPDRS Questionnaire Question. <br><i>New Terms: MDS-UPDRS Questionnaire Question, MDS-UPDRS - Hallucinations and Psychosis</i></td>
            </tr>
            <tr class="addition">
               <td>558</td>
               <td colspan="2">MDS-UPDRS - Handwriting<span class="subclass"> SubClassOf </span>MDS-UPDRS Questionnaire Question. <br><i>New Terms: MDS-UPDRS Questionnaire Question, MDS-UPDRS - Handwriting</i></td>
            </tr>
            <tr class="addition">
               <td>559</td>
               <td colspan="2">MDS-UPDRS - Hoehn<br><span class="keyword"> and </span>Yahr Stage<span class="subclass"> SubClassOf </span>MDS-UPDRS Questionnaire Question. <br><i>New Terms: MDS-UPDRS - Hoehn and Yahr Stage, MDS-UPDRS Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>560</td>
               <td colspan="2">MDS-UPDRS - Hygiene<span class="subclass"> SubClassOf </span>MDS-UPDRS Questionnaire Question. <br><i>New Terms: MDS-UPDRS Questionnaire Question, MDS-UPDRS - Hygiene</i></td>
            </tr>
            <tr class="addition">
               <td>561</td>
               <td colspan="2">MDS-UPDRS - Kinetic Tremor of Left Hand<span class="subclass"> SubClassOf </span>MDS-UPDRS Questionnaire Question. <br><i>New Terms: MDS-UPDRS - Kinetic Tremor of Left Hand, MDS-UPDRS Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>562</td>
               <td colspan="2">MDS-UPDRS - Left Finger Tapping<span class="subclass"> SubClassOf </span>MDS-UPDRS Questionnaire Question. <br><i>New Terms: MDS-UPDRS Questionnaire Question, MDS-UPDRS - Left Finger Tapping</i></td>
            </tr>
            <tr class="addition">
               <td>563</td>
               <td colspan="2">MDS-UPDRS - Left Hand Movements<span class="subclass"> SubClassOf </span>MDS-UPDRS Questionnaire Question. <br><i>New Terms: MDS-UPDRS Questionnaire Question, MDS-UPDRS - Left Hand Movements</i></td>
            </tr>
            <tr class="addition">
               <td>564</td>
               <td colspan="2">MDS-UPDRS - Left Leg Agility<span class="subclass"> SubClassOf </span>MDS-UPDRS Questionnaire Question. <br><i>New Terms: MDS-UPDRS Questionnaire Question, MDS-UPDRS - Left Leg Agility</i></td>
            </tr>
            <tr class="addition">
               <td>565</td>
               <td colspan="2">MDS-UPDRS - Left Toe Tapping<span class="subclass"> SubClassOf </span>MDS-UPDRS Questionnaire Question. <br><i>New Terms: MDS-UPDRS Questionnaire Question, MDS-UPDRS - Left Toe Tapping</i></td>
            </tr>
            <tr class="addition">
               <td>566</td>
               <td colspan="2">MDS-UPDRS - Lightheadedness on Standing<span class="subclass"> SubClassOf </span>MDS-UPDRS Questionnaire Question. <br><i>New Terms: MDS-UPDRS Questionnaire Question, MDS-UPDRS - Lightheadedness on Standing</i></td>
            </tr>
            <tr class="addition">
               <td>567</td>
               <td colspan="2">MDS-UPDRS - Medication for Parkinson's Disease<span class="subclass"> SubClassOf </span>MDS-UPDRS Questionnaire Question. <br><i>New Terms: MDS-UPDRS Questionnaire Question, MDS-UPDRS - Medication for Parkinson's Disease</i></td>
            </tr>
            <tr class="addition">
               <td>568</td>
               <td colspan="2">MDS-UPDRS - Minutes Since Levodopa Dose<span class="subclass"> SubClassOf </span>MDS-UPDRS Questionnaire Question. <br><i>New Terms: MDS-UPDRS Questionnaire Question, MDS-UPDRS - Minutes Since Levodopa Dose</i></td>
            </tr>
            <tr class="addition">
               <td>569</td>
               <td colspan="2">MDS-UPDRS - Movements Interfere with Ratings<span class="subclass"> SubClassOf </span>MDS-UPDRS Questionnaire Question. <br><i>New Terms: MDS-UPDRS - Movements Interfere with Ratings, MDS-UPDRS Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>570</td>
               <td colspan="2">MDS-UPDRS - Pain<br><span class="keyword"> and </span>Other Sensations<span class="subclass"> SubClassOf </span>MDS-UPDRS Questionnaire Question. <br><i>New Terms: MDS-UPDRS - Pain and Other Sensations, MDS-UPDRS Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>571</td>
               <td colspan="2">MDS-UPDRS - Painful Off-state Dystonia<span class="subclass"> SubClassOf </span>MDS-UPDRS Questionnaire Question. <br><i>New Terms: MDS-UPDRS Questionnaire Question, MDS-UPDRS - Painful Off-state Dystonia</i></td>
            </tr>
            <tr class="addition">
               <td>572</td>
               <td colspan="2">MDS-UPDRS - Postural Stability<span class="subclass"> SubClassOf </span>MDS-UPDRS Questionnaire Question. <br><i>New Terms: MDS-UPDRS Questionnaire Question, MDS-UPDRS - Postural Stability</i></td>
            </tr>
            <tr class="addition">
               <td>573</td>
               <td colspan="2">MDS-UPDRS - Postural Tremor of Right Hand<span class="subclass"> SubClassOf </span>MDS-UPDRS Questionnaire Question. <br><i>New Terms: MDS-UPDRS Questionnaire Question, MDS-UPDRS - Postural Tremor of Right Hand</i></td>
            </tr>
            <tr class="addition">
               <td>574</td>
               <td colspan="2">MDS-UPDRS - Posture<span class="subclass"> SubClassOf </span>MDS-UPDRS Questionnaire Question. <br><i>New Terms: MDS-UPDRS Questionnaire Question, MDS-UPDRS - Posture</i></td>
            </tr>
            <tr class="addition">
               <td>575</td>
               <td colspan="2">MDS-UPDRS - Pronanation-Supination Movement of Left Hand<span class="subclass"> SubClassOf </span>MDS-UPDRS Questionnaire Question. <br><i>New Terms: MDS-UPDRS Questionnaire Question, MDS-UPDRS - Pronanation-Supination Movement of Left
                     Hand</i></td>
            </tr>
            <tr class="addition">
               <td>576</td>
               <td colspan="2">MDS-UPDRS - Pronanation-Supination Movement of Right Hand<span class="subclass"> SubClassOf </span>MDS-UPDRS Questionnaire Question. <br><i>New Terms: MDS-UPDRS Questionnaire Question, MDS-UPDRS - Pronanation-Supination Movement of Right
                     Hand</i></td>
            </tr>
            <tr class="addition">
               <td>577</td>
               <td colspan="2">MDS-UPDRS - Rest Tremor Amplitude Left Lower Extremity<span class="subclass"> SubClassOf </span>MDS-UPDRS Questionnaire Question. <br><i>New Terms: MDS-UPDRS Questionnaire Question, MDS-UPDRS - Rest Tremor Amplitude Left Lower Extremity</i></td>
            </tr>
            <tr class="addition">
               <td>578</td>
               <td colspan="2">MDS-UPDRS - Rest Tremor Amplitude Left Upper Extremity<span class="subclass"> SubClassOf </span>MDS-UPDRS Questionnaire Question. <br><i>New Terms: MDS-UPDRS Questionnaire Question, MDS-UPDRS - Rest Tremor Amplitude Left Upper Extremity</i></td>
            </tr>
            <tr class="addition">
               <td>579</td>
               <td colspan="2">MDS-UPDRS - Rest Tremor Amplitude Lip<br><span class="keyword"> or </span>Jaw<span class="subclass"> SubClassOf </span>MDS-UPDRS Questionnaire Question. <br><i>New Terms: MDS-UPDRS Questionnaire Question, MDS-UPDRS - Rest Tremor Amplitude Lip or Jaw</i></td>
            </tr>
            <tr class="addition">
               <td>580</td>
               <td colspan="2">MDS-UPDRS - Rest Tremor Amplitude Right Lower Extremity<span class="subclass"> SubClassOf </span>MDS-UPDRS Questionnaire Question. <br><i>New Terms: MDS-UPDRS Questionnaire Question, MDS-UPDRS - Rest Tremor Amplitude Right Lower Extremity</i></td>
            </tr>
            <tr class="addition">
               <td>581</td>
               <td colspan="2">MDS-UPDRS - Rest Tremor Amplitude Right Upper Extremity<span class="subclass"> SubClassOf </span>MDS-UPDRS Questionnaire Question. <br><i>New Terms: MDS-UPDRS Questionnaire Question, MDS-UPDRS - Rest Tremor Amplitude Right Upper Extremity</i></td>
            </tr>
            <tr class="addition">
               <td>582</td>
               <td colspan="2">MDS-UPDRS - Right Finger Tapping<span class="subclass"> SubClassOf </span>MDS-UPDRS Questionnaire Question. <br><i>New Terms: MDS-UPDRS Questionnaire Question, MDS-UPDRS - Right Finger Tapping</i></td>
            </tr>
            <tr class="addition">
               <td>583</td>
               <td colspan="2">MDS-UPDRS - Right Hand Movements<span class="subclass"> SubClassOf </span>MDS-UPDRS Questionnaire Question. <br><i>New Terms: MDS-UPDRS - Right Hand Movements, MDS-UPDRS Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>584</td>
               <td colspan="2">MDS-UPDRS - Right Leg Agility<span class="subclass"> SubClassOf </span>MDS-UPDRS Questionnaire Question. <br><i>New Terms: MDS-UPDRS Questionnaire Question, MDS-UPDRS - Right Leg Agility</i></td>
            </tr>
            <tr class="addition">
               <td>585</td>
               <td colspan="2">MDS-UPDRS - Right Toe Tapping<span class="subclass"> SubClassOf </span>MDS-UPDRS Questionnaire Question. <br><i>New Terms: MDS-UPDRS Questionnaire Question, MDS-UPDRS - Right Toe Tapping</i></td>
            </tr>
            <tr class="addition">
               <td>586</td>
               <td colspan="2">MDS-UPDRS - Rigidity Left Lower Extremity<span class="subclass"> SubClassOf </span>MDS-UPDRS Questionnaire Question. <br><i>New Terms: MDS-UPDRS Questionnaire Question, MDS-UPDRS - Rigidity Left Lower Extremity</i></td>
            </tr>
            <tr class="addition">
               <td>587</td>
               <td colspan="2">MDS-UPDRS - Rigidity Left Upper Extremity<span class="subclass"> SubClassOf </span>MDS-UPDRS Questionnaire Question. <br><i>New Terms: MDS-UPDRS Questionnaire Question, MDS-UPDRS - Rigidity Left Upper Extremity</i></td>
            </tr>
            <tr class="addition">
               <td>588</td>
               <td colspan="2">MDS-UPDRS - Rigidity Neck<span class="subclass"> SubClassOf </span>MDS-UPDRS Questionnaire Question. <br><i>New Terms: MDS-UPDRS Questionnaire Question, MDS-UPDRS - Rigidity Neck</i></td>
            </tr>
            <tr class="addition">
               <td>589</td>
               <td colspan="2">MDS-UPDRS - Rigidity Right Lower Extremity<span class="subclass"> SubClassOf </span>MDS-UPDRS Questionnaire Question. <br><i>New Terms: MDS-UPDRS Questionnaire Question, MDS-UPDRS - Rigidity Right Lower Extremity</i></td>
            </tr>
            <tr class="addition">
               <td>590</td>
               <td colspan="2">MDS-UPDRS - Rigidity Right Upper Extremity<span class="subclass"> SubClassOf </span>MDS-UPDRS Questionnaire Question. <br><i>New Terms: MDS-UPDRS - Rigidity Right Upper Extremity, MDS-UPDRS Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>591</td>
               <td colspan="2">MDS-UPDRS - Saliva<br><span class="keyword"> and </span>Drooling<span class="subclass"> SubClassOf </span>MDS-UPDRS Questionnaire Question. <br><i>New Terms: MDS-UPDRS - Saliva and Drooling, MDS-UPDRS Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>592</td>
               <td colspan="2">MDS-UPDRS - Sleep Problems<span class="subclass"> SubClassOf </span>MDS-UPDRS Questionnaire Question. <br><i>New Terms: MDS-UPDRS - Sleep Problems, MDS-UPDRS Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>594</td>
               <td colspan="2">MDS-UPDRS - Speech Problems<span class="subclass"> SubClassOf </span>MDS-UPDRS Questionnaire Question. <br><i>New Terms: MDS-UPDRS - Speech Problems, MDS-UPDRS Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>593</td>
               <td colspan="2">MDS-UPDRS - Speech<span class="subclass"> SubClassOf </span>MDS-UPDRS Questionnaire Question. <br><i>New Terms: MDS-UPDRS Questionnaire Question, MDS-UPDRS - Speech</i></td>
            </tr>
            <tr class="addition">
               <td>595</td>
               <td colspan="2">MDS-UPDRS - Taking Levodopa<span class="subclass"> SubClassOf </span>MDS-UPDRS Questionnaire Question. <br><i>New Terms: MDS-UPDRS Questionnaire Question, MDS-UPDRS - Taking Levodopa</i></td>
            </tr>
            <tr class="addition">
               <td>596</td>
               <td colspan="2">MDS-UPDRS - Time Spent in the Off State<span class="subclass"> SubClassOf </span>MDS-UPDRS Questionnaire Question. <br><i>New Terms: MDS-UPDRS - Time Spent in the Off State, MDS-UPDRS Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>597</td>
               <td colspan="2">MDS-UPDRS - Time Spent with Dyskinesias<span class="subclass"> SubClassOf </span>MDS-UPDRS Questionnaire Question. <br><i>New Terms: MDS-UPDRS - Time Spent with Dyskinesias, MDS-UPDRS Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>598</td>
               <td colspan="2">MDS-UPDRS - Tremor<span class="subclass"> SubClassOf </span>MDS-UPDRS Questionnaire Question. <br><i>New Terms: MDS-UPDRS - Tremor, MDS-UPDRS Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>599</td>
               <td colspan="2">MDS-UPDRS - Turning in Bed<span class="subclass"> SubClassOf </span>MDS-UPDRS Questionnaire Question. <br><i>New Terms: MDS-UPDRS - Turning in Bed, MDS-UPDRS Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>600</td>
               <td colspan="2">MDS-UPDRS - Urinary Problems<span class="subclass"> SubClassOf </span>MDS-UPDRS Questionnaire Question. <br><i>New Terms: MDS-UPDRS Questionnaire Question, MDS-UPDRS - Urinary Problems</i></td>
            </tr>
            <tr class="addition">
               <td>601</td>
               <td colspan="2">MDS-UPDRS - Walking<br><span class="keyword"> and </span>Balance<span class="subclass"> SubClassOf </span>MDS-UPDRS Questionnaire Question. <br><i>New Terms: MDS-UPDRS Questionnaire Question, MDS-UPDRS - Walking and Balance</i></td>
            </tr>
            <tr class="addition">
               <td>602</td>
               <td colspan="2">MDS-UPDRS Questionnaire Question<span class="subclass"> SubClassOf </span>Clinical<br><span class="keyword"> or </span>Research Assessment Question. <br><i>New Terms: MDS-UPDRS Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>603</td>
               <td colspan="2">MLL/ELL Fusion Gene<span class="subclass"> SubClassOf </span>Fusion Gene. <br><i>New Terms: MLL/ELL Fusion Gene</i></td>
            </tr>
            <tr class="addition">
               <td>604</td>
               <td colspan="2">MLL/ELL Fusion Protein<span class="subclass"> SubClassOf </span>Fusion Protein. <br><i>New Terms: MLL/ELL Fusion Protein</i></td>
            </tr>
            <tr class="addition">
               <td>605</td>
               <td colspan="2">MLL/ELL Fusion Protein<span class="subclass"> SubClassOf </span>Gene_Product_Encoded_By_Gene<span class="some"> some </span>MLL/ELL Fusion Gene. <br><i>New Terms: MLL/ELL Fusion Protein, MLL/ELL Fusion Gene</i></td>
            </tr>
            <tr class="addition">
               <td>606</td>
               <td colspan="2">MMSE - Question 1<span class="subclass"> SubClassOf </span>MMSE Questionnaire Question. <br><i>New Terms: MMSE Questionnaire Question, MMSE - Question 1</i></td>
            </tr>
            <tr class="addition">
               <td>607</td>
               <td colspan="2">MMSE - Question 10<span class="subclass"> SubClassOf </span>MMSE Questionnaire Question. <br><i>New Terms: MMSE Questionnaire Question, MMSE - Question 10</i></td>
            </tr>
            <tr class="addition">
               <td>608</td>
               <td colspan="2">MMSE - Question 11<span class="subclass"> SubClassOf </span>MMSE Questionnaire Question. <br><i>New Terms: MMSE Questionnaire Question, MMSE - Question 11</i></td>
            </tr>
            <tr class="addition">
               <td>609</td>
               <td colspan="2">MMSE - Question 12<span class="subclass"> SubClassOf </span>MMSE Questionnaire Question. <br><i>New Terms: MMSE Questionnaire Question, MMSE - Question 12</i></td>
            </tr>
            <tr class="addition">
               <td>610</td>
               <td colspan="2">MMSE - Question 1A<span class="subclass"> SubClassOf </span>MMSE Questionnaire Question. <br><i>New Terms: MMSE Questionnaire Question, MMSE - Question 1A</i></td>
            </tr>
            <tr class="addition">
               <td>611</td>
               <td colspan="2">MMSE - Question 1B<span class="subclass"> SubClassOf </span>MMSE Questionnaire Question. <br><i>New Terms: MMSE Questionnaire Question, MMSE - Question 1B</i></td>
            </tr>
            <tr class="addition">
               <td>612</td>
               <td colspan="2">MMSE - Question 1C<span class="subclass"> SubClassOf </span>MMSE Questionnaire Question. <br><i>New Terms: MMSE Questionnaire Question, MMSE - Question 1C</i></td>
            </tr>
            <tr class="addition">
               <td>613</td>
               <td colspan="2">MMSE - Question 1D<span class="subclass"> SubClassOf </span>MMSE Questionnaire Question. <br><i>New Terms: MMSE Questionnaire Question, MMSE - Question 1D</i></td>
            </tr>
            <tr class="addition">
               <td>614</td>
               <td colspan="2">MMSE - Question 1E<span class="subclass"> SubClassOf </span>MMSE Questionnaire Question. <br><i>New Terms: MMSE Questionnaire Question, MMSE - Question 1E</i></td>
            </tr>
            <tr class="addition">
               <td>615</td>
               <td colspan="2">MMSE - Question 2<span class="subclass"> SubClassOf </span>MMSE Questionnaire Question. <br><i>New Terms: MMSE Questionnaire Question, MMSE - Question 2</i></td>
            </tr>
            <tr class="addition">
               <td>616</td>
               <td colspan="2">MMSE - Question 2A<span class="subclass"> SubClassOf </span>MMSE Questionnaire Question. <br><i>New Terms: MMSE Questionnaire Question, MMSE - Question 2A</i></td>
            </tr>
            <tr class="addition">
               <td>617</td>
               <td colspan="2">MMSE - Question 2B<span class="subclass"> SubClassOf </span>MMSE Questionnaire Question. <br><i>New Terms: MMSE Questionnaire Question, MMSE - Question 2B</i></td>
            </tr>
            <tr class="addition">
               <td>618</td>
               <td colspan="2">MMSE - Question 2C<span class="subclass"> SubClassOf </span>MMSE Questionnaire Question. <br><i>New Terms: MMSE Questionnaire Question, MMSE - Question 2C</i></td>
            </tr>
            <tr class="addition">
               <td>619</td>
               <td colspan="2">MMSE - Question 2D<span class="subclass"> SubClassOf </span>MMSE Questionnaire Question. <br><i>New Terms: MMSE Questionnaire Question, MMSE - Question 2D</i></td>
            </tr>
            <tr class="addition">
               <td>620</td>
               <td colspan="2">MMSE - Question 2E<span class="subclass"> SubClassOf </span>MMSE Questionnaire Question. <br><i>New Terms: MMSE Questionnaire Question, MMSE - Question 2E</i></td>
            </tr>
            <tr class="addition">
               <td>621</td>
               <td colspan="2">MMSE - Question 3<span class="subclass"> SubClassOf </span>MMSE Questionnaire Question. <br><i>New Terms: MMSE - Question 3, MMSE Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>622</td>
               <td colspan="2">MMSE - Question 3A<span class="subclass"> SubClassOf </span>MMSE Questionnaire Question. <br><i>New Terms: MMSE Questionnaire Question, MMSE - Question 3A</i></td>
            </tr>
            <tr class="addition">
               <td>623</td>
               <td colspan="2">MMSE - Question 3B<span class="subclass"> SubClassOf </span>MMSE Questionnaire Question. <br><i>New Terms: MMSE - Question 3B, MMSE Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>624</td>
               <td colspan="2">MMSE - Question 3C<span class="subclass"> SubClassOf </span>MMSE Questionnaire Question. <br><i>New Terms: MMSE - Question 3C, MMSE Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>625</td>
               <td colspan="2">MMSE - Question 4<span class="subclass"> SubClassOf </span>MMSE Questionnaire Question. <br><i>New Terms: MMSE - Question 4, MMSE Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>626</td>
               <td colspan="2">MMSE - Question 4C<span class="subclass"> SubClassOf </span>MMSE Questionnaire Question. <br><i>New Terms: MMSE Questionnaire Question, MMSE - Question 4C</i></td>
            </tr>
            <tr class="addition">
               <td>627</td>
               <td colspan="2">MMSE - Question 4C1<span class="subclass"> SubClassOf </span>MMSE Questionnaire Question. <br><i>New Terms: MMSE Questionnaire Question, MMSE - Question 4C1</i></td>
            </tr>
            <tr class="addition">
               <td>628</td>
               <td colspan="2">MMSE - Question 4C2<span class="subclass"> SubClassOf </span>MMSE Questionnaire Question. <br><i>New Terms: MMSE Questionnaire Question, MMSE - Question 4C2</i></td>
            </tr>
            <tr class="addition">
               <td>629</td>
               <td colspan="2">MMSE - Question 4C3<span class="subclass"> SubClassOf </span>MMSE Questionnaire Question. <br><i>New Terms: MMSE Questionnaire Question, MMSE - Question 4C3</i></td>
            </tr>
            <tr class="addition">
               <td>630</td>
               <td colspan="2">MMSE - Question 4C4<span class="subclass"> SubClassOf </span>MMSE Questionnaire Question. <br><i>New Terms: MMSE Questionnaire Question, MMSE - Question 4C4</i></td>
            </tr>
            <tr class="addition">
               <td>631</td>
               <td colspan="2">MMSE - Question 4C5<span class="subclass"> SubClassOf </span>MMSE Questionnaire Question. <br><i>New Terms: MMSE Questionnaire Question, MMSE - Question 4C5</i></td>
            </tr>
            <tr class="addition">
               <td>632</td>
               <td colspan="2">MMSE - Question 4S<span class="subclass"> SubClassOf </span>MMSE Questionnaire Question. <br><i>New Terms: MMSE Questionnaire Question, MMSE - Question 4S</i></td>
            </tr>
            <tr class="addition">
               <td>633</td>
               <td colspan="2">MMSE - Question 4S1<span class="subclass"> SubClassOf </span>MMSE Questionnaire Question. <br><i>New Terms: MMSE Questionnaire Question, MMSE - Question 4S1</i></td>
            </tr>
            <tr class="addition">
               <td>634</td>
               <td colspan="2">MMSE - Question 4S2<span class="subclass"> SubClassOf </span>MMSE Questionnaire Question. <br><i>New Terms: MMSE - Question 4S2, MMSE Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>635</td>
               <td colspan="2">MMSE - Question 4S3<span class="subclass"> SubClassOf </span>MMSE Questionnaire Question. <br><i>New Terms: MMSE - Question 4S3, MMSE Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>636</td>
               <td colspan="2">MMSE - Question 4S4<span class="subclass"> SubClassOf </span>MMSE Questionnaire Question. <br><i>New Terms: MMSE Questionnaire Question, MMSE - Question 4S4</i></td>
            </tr>
            <tr class="addition">
               <td>637</td>
               <td colspan="2">MMSE - Question 4S5<span class="subclass"> SubClassOf </span>MMSE Questionnaire Question. <br><i>New Terms: MMSE Questionnaire Question, MMSE - Question 4S5</i></td>
            </tr>
            <tr class="addition">
               <td>638</td>
               <td colspan="2">MMSE - Question 5<span class="subclass"> SubClassOf </span>MMSE Questionnaire Question. <br><i>New Terms: MMSE Questionnaire Question, MMSE - Question 5</i></td>
            </tr>
            <tr class="addition">
               <td>639</td>
               <td colspan="2">MMSE - Question 5A<span class="subclass"> SubClassOf </span>MMSE Questionnaire Question. <br><i>New Terms: MMSE - Question 5A, MMSE Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>640</td>
               <td colspan="2">MMSE - Question 5B<span class="subclass"> SubClassOf </span>MMSE Questionnaire Question. <br><i>New Terms: MMSE Questionnaire Question, MMSE - Question 5B</i></td>
            </tr>
            <tr class="addition">
               <td>641</td>
               <td colspan="2">MMSE - Question 5C<span class="subclass"> SubClassOf </span>MMSE Questionnaire Question. <br><i>New Terms: MMSE Questionnaire Question, MMSE - Question 5C</i></td>
            </tr>
            <tr class="addition">
               <td>642</td>
               <td colspan="2">MMSE - Question 6<span class="subclass"> SubClassOf </span>MMSE Questionnaire Question. <br><i>New Terms: MMSE Questionnaire Question, MMSE - Question 6</i></td>
            </tr>
            <tr class="addition">
               <td>643</td>
               <td colspan="2">MMSE - Question 6A<span class="subclass"> SubClassOf </span>MMSE Questionnaire Question. <br><i>New Terms: MMSE Questionnaire Question, MMSE - Question 6A</i></td>
            </tr>
            <tr class="addition">
               <td>644</td>
               <td colspan="2">MMSE - Question 6B<span class="subclass"> SubClassOf </span>MMSE Questionnaire Question. <br><i>New Terms: MMSE Questionnaire Question, MMSE - Question 6B</i></td>
            </tr>
            <tr class="addition">
               <td>645</td>
               <td colspan="2">MMSE - Question 7<span class="subclass"> SubClassOf </span>MMSE Questionnaire Question. <br><i>New Terms: MMSE Questionnaire Question, MMSE - Question 7</i></td>
            </tr>
            <tr class="addition">
               <td>646</td>
               <td colspan="2">MMSE - Question 8<span class="subclass"> SubClassOf </span>MMSE Questionnaire Question. <br><i>New Terms: MMSE Questionnaire Question, MMSE - Question 8</i></td>
            </tr>
            <tr class="addition">
               <td>647</td>
               <td colspan="2">MMSE - Question 8A<span class="subclass"> SubClassOf </span>MMSE Questionnaire Question. <br><i>New Terms: MMSE Questionnaire Question, MMSE - Question 8A</i></td>
            </tr>
            <tr class="addition">
               <td>648</td>
               <td colspan="2">MMSE - Question 8B<span class="subclass"> SubClassOf </span>MMSE Questionnaire Question. <br><i>New Terms: MMSE Questionnaire Question, MMSE - Question 8B</i></td>
            </tr>
            <tr class="addition">
               <td>649</td>
               <td colspan="2">MMSE - Question 8C<span class="subclass"> SubClassOf </span>MMSE Questionnaire Question. <br><i>New Terms: MMSE Questionnaire Question, MMSE - Question 8C</i></td>
            </tr>
            <tr class="addition">
               <td>650</td>
               <td colspan="2">MMSE - Question 9<span class="subclass"> SubClassOf </span>MMSE Questionnaire Question. <br><i>New Terms: MMSE Questionnaire Question, MMSE - Question 9</i></td>
            </tr>
            <tr class="addition">
               <td>651</td>
               <td colspan="2">MMSE Questionnaire Question<span class="subclass"> SubClassOf </span>Clinical<br><span class="keyword"> or </span>Research Assessment Question. <br><i>New Terms: MMSE Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>652</td>
               <td colspan="2">MNSI - Able to Sense Feet When Walking<span class="subclass"> SubClassOf </span>MNSI Questionnaire Question. <br><i>New Terms: MNSI Questionnaire Question, MNSI - Able to Sense Feet When Walking</i></td>
            </tr>
            <tr class="addition">
               <td>653</td>
               <td colspan="2">MNSI - Able to Tell Hot from Cold Water<span class="subclass"> SubClassOf </span>MNSI Questionnaire Question. <br><i>New Terms: MNSI - Able to Tell Hot from Cold Water, MNSI Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>654</td>
               <td colspan="2">MNSI - Burning Pain Legs/Feet<span class="subclass"> SubClassOf </span>MNSI Questionnaire Question. <br><i>New Terms: MNSI Questionnaire Question, MNSI - Burning Pain Legs/Feet</i></td>
            </tr>
            <tr class="addition">
               <td>655</td>
               <td colspan="2">MNSI - Doctor Says Diabetic Neuropathy<span class="subclass"> SubClassOf </span>MNSI Questionnaire Question. <br><i>New Terms: MNSI - Doctor Says Diabetic Neuropathy, MNSI Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>656</td>
               <td colspan="2">MNSI - Ever Had Amputation<span class="subclass"> SubClassOf </span>MNSI Questionnaire Question. <br><i>New Terms: MNSI - Ever Had Amputation, MNSI Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>657</td>
               <td colspan="2">MNSI - Feel Weak All Over Most Times<span class="subclass"> SubClassOf </span>MNSI Questionnaire Question. <br><i>New Terms: MNSI Questionnaire Question, MNSI - Feel Weak All Over Most Times</i></td>
            </tr>
            <tr class="addition">
               <td>658</td>
               <td colspan="2">MNSI - Feet Too Sensitive to Touch<span class="subclass"> SubClassOf </span>MNSI Questionnaire Question. <br><i>New Terms: MNSI - Feet Too Sensitive to Touch, MNSI Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>659</td>
               <td colspan="2">MNSI - History Total<span class="subclass"> SubClassOf </span>MNSI Questionnaire Question. <br><i>New Terms: MNSI - History Total, MNSI Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>660</td>
               <td colspan="2">MNSI - Hurt When Bed Covers Touch Skin<span class="subclass"> SubClassOf </span>MNSI Questionnaire Question. <br><i>New Terms: MNSI - Hurt When Bed Covers Touch Skin, MNSI Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>661</td>
               <td colspan="2">MNSI - Left Ankle Reflexes<span class="subclass"> SubClassOf </span>MNSI Questionnaire Question. <br><i>New Terms: MNSI - Left Ankle Reflexes, MNSI Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>662</td>
               <td colspan="2">MNSI - Left Foot Appears Normal<span class="subclass"> SubClassOf </span>MNSI Questionnaire Question. <br><i>New Terms: MNSI Questionnaire Question, MNSI - Left Foot Appears Normal</i></td>
            </tr>
            <tr class="addition">
               <td>663</td>
               <td colspan="2">MNSI - Left Foot Deformities<span class="subclass"> SubClassOf </span>MNSI Questionnaire Question. <br><i>New Terms: MNSI Questionnaire Question, MNSI - Left Foot Deformities</i></td>
            </tr>
            <tr class="addition">
               <td>664</td>
               <td colspan="2">MNSI - Left Foot Dry Skin, Callus<span class="subclass"> SubClassOf </span>MNSI Questionnaire Question. <br><i>New Terms: MNSI Questionnaire Question, MNSI - Left Foot Dry Skin, Callus</i></td>
            </tr>
            <tr class="addition">
               <td>665</td>
               <td colspan="2">MNSI - Left Foot Fissure<span class="subclass"> SubClassOf </span>MNSI Questionnaire Question. <br><i>New Terms: MNSI Questionnaire Question, MNSI - Left Foot Fissure</i></td>
            </tr>
            <tr class="addition">
               <td>666</td>
               <td colspan="2">MNSI - Left Foot Infection<span class="subclass"> SubClassOf </span>MNSI Questionnaire Question. <br><i>New Terms: MNSI - Left Foot Infection, MNSI Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>667</td>
               <td colspan="2">MNSI - Left Foot Monofilament<span class="subclass"> SubClassOf </span>MNSI Questionnaire Question. <br><i>New Terms: MNSI - Left Foot Monofilament, MNSI Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>668</td>
               <td colspan="2">MNSI - Left Foot Other Abnormal Specify<span class="subclass"> SubClassOf </span>MNSI Questionnaire Question. <br><i>New Terms: MNSI - Left Foot Other Abnormal Specify, MNSI Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>669</td>
               <td colspan="2">MNSI - Left Foot Ulceration<span class="subclass"> SubClassOf </span>MNSI Questionnaire Question. <br><i>New Terms: MNSI Questionnaire Question, MNSI - Left Foot Ulceration</i></td>
            </tr>
            <tr class="addition">
               <td>670</td>
               <td colspan="2">MNSI - Left Foot Vibration Great Toe<span class="subclass"> SubClassOf </span>MNSI Questionnaire Question. <br><i>New Terms: MNSI Questionnaire Question, MNSI - Left Foot Vibration Great Toe</i></td>
            </tr>
            <tr class="addition">
               <td>671</td>
               <td colspan="2">MNSI - Legs Hurt When Walking<span class="subclass"> SubClassOf </span>MNSI Questionnaire Question. <br><i>New Terms: MNSI - Legs Hurt When Walking, MNSI Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>672</td>
               <td colspan="2">MNSI - Legs and/or Feet Numb<span class="subclass"> SubClassOf </span>MNSI Questionnaire Question. <br><i>New Terms: MNSI Questionnaire Question, MNSI - Legs and/or Feet Numb</i></td>
            </tr>
            <tr class="addition">
               <td>673</td>
               <td colspan="2">MNSI - Muscle Cramps Legs/Feet<span class="subclass"> SubClassOf </span>MNSI Questionnaire Question. <br><i>New Terms: MNSI Questionnaire Question, MNSI - Muscle Cramps Legs/Feet</i></td>
            </tr>
            <tr class="addition">
               <td>674</td>
               <td colspan="2">MNSI - Open Sore on Foot<span class="subclass"> SubClassOf </span>MNSI Questionnaire Question. <br><i>New Terms: MNSI Questionnaire Question, MNSI - Open Sore on Foot</i></td>
            </tr>
            <tr class="addition">
               <td>675</td>
               <td colspan="2">MNSI - Physical Assessment Total Score<span class="subclass"> SubClassOf </span>MNSI Questionnaire Question. <br><i>New Terms: MNSI - Physical Assessment Total Score, MNSI Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>676</td>
               <td colspan="2">MNSI - Prickling Feelings Legs/Feet<span class="subclass"> SubClassOf </span>MNSI Questionnaire Question. <br><i>New Terms: MNSI Questionnaire Question, MNSI - Prickling Feelings Legs/Feet</i></td>
            </tr>
            <tr class="addition">
               <td>677</td>
               <td colspan="2">MNSI - Right Ankle Reflexes<span class="subclass"> SubClassOf </span>MNSI Questionnaire Question. <br><i>New Terms: MNSI - Right Ankle Reflexes, MNSI Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>678</td>
               <td colspan="2">MNSI - Right Foot Appears Normal<span class="subclass"> SubClassOf </span>MNSI Questionnaire Question. <br><i>New Terms: MNSI Questionnaire Question, MNSI - Right Foot Appears Normal</i></td>
            </tr>
            <tr class="addition">
               <td>679</td>
               <td colspan="2">MNSI - Right Foot Deformities<span class="subclass"> SubClassOf </span>MNSI Questionnaire Question. <br><i>New Terms: MNSI Questionnaire Question, MNSI - Right Foot Deformities</i></td>
            </tr>
            <tr class="addition">
               <td>680</td>
               <td colspan="2">MNSI - Right Foot Dry Skin, Callus<span class="subclass"> SubClassOf </span>MNSI Questionnaire Question. <br><i>New Terms: MNSI - Right Foot Dry Skin, Callus, MNSI Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>681</td>
               <td colspan="2">MNSI - Right Foot Fissure<span class="subclass"> SubClassOf </span>MNSI Questionnaire Question. <br><i>New Terms: MNSI Questionnaire Question, MNSI - Right Foot Fissure</i></td>
            </tr>
            <tr class="addition">
               <td>682</td>
               <td colspan="2">MNSI - Right Foot Infection<span class="subclass"> SubClassOf </span>MNSI Questionnaire Question. <br><i>New Terms: MNSI Questionnaire Question, MNSI - Right Foot Infection</i></td>
            </tr>
            <tr class="addition">
               <td>683</td>
               <td colspan="2">MNSI - Right Foot Monofilament<span class="subclass"> SubClassOf </span>MNSI Questionnaire Question. <br><i>New Terms: MNSI Questionnaire Question, MNSI - Right Foot Monofilament</i></td>
            </tr>
            <tr class="addition">
               <td>684</td>
               <td colspan="2">MNSI - Right Foot Other Abnormal Specify<span class="subclass"> SubClassOf </span>MNSI Questionnaire Question. <br><i>New Terms: MNSI - Right Foot Other Abnormal Specify, MNSI Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>685</td>
               <td colspan="2">MNSI - Right Foot Ulceration<span class="subclass"> SubClassOf </span>MNSI Questionnaire Question. <br><i>New Terms: MNSI Questionnaire Question, MNSI - Right Foot Ulceration</i></td>
            </tr>
            <tr class="addition">
               <td>686</td>
               <td colspan="2">MNSI - Right Foot Vibration Great Toe<span class="subclass"> SubClassOf </span>MNSI Questionnaire Question. <br><i>New Terms: MNSI Questionnaire Question, MNSI - Right Foot Vibration Great Toe</i></td>
            </tr>
            <tr class="addition">
               <td>687</td>
               <td colspan="2">MNSI - Skin So Dry That Feet Crack Open<span class="subclass"> SubClassOf </span>MNSI Questionnaire Question. <br><i>New Terms: MNSI - Skin So Dry That Feet Crack Open, MNSI Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>688</td>
               <td colspan="2">MNSI - Symptoms Worse at Night<span class="subclass"> SubClassOf </span>MNSI Questionnaire Question. <br><i>New Terms: MNSI Questionnaire Question, MNSI - Symptoms Worse at Night</i></td>
            </tr>
            <tr class="addition">
               <td>689</td>
               <td colspan="2">MNSI Questionnaire Question<span class="subclass"> SubClassOf </span>Clinical<br><span class="keyword"> or </span>Research Assessment Question. <br><i>New Terms: MNSI Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>690</td>
               <td colspan="2">MSN/ALK Fusion Gene<span class="subclass"> SubClassOf </span>Fusion Gene. <br><i>New Terms: MSN/ALK Fusion Gene</i></td>
            </tr>
            <tr class="addition">
               <td>691</td>
               <td colspan="2">MSN/ALK Fusion Gene<span class="subclass"> SubClassOf </span>Gene_Involved_In_Pathogenesis_Of_Disease<span class="some"> some </span>Anaplastic Large Cell Lymphoma, ALK-Positive. <br><i>New Terms: MSN/ALK Fusion Gene</i></td>
            </tr>
            <tr class="addition">
               <td>692</td>
               <td colspan="2">MSN/ALK Fusion Gene<span class="subclass"> SubClassOf </span>Gene_Plays_Role_In_Process<span class="some"> some </span>Tyrosine Phosphorylation. <br><i>New Terms: MSN/ALK Fusion Gene</i></td>
            </tr>
            <tr class="addition">
               <td>693</td>
               <td colspan="2">MSN/ALK Fusion Protein<span class="subclass"> SubClassOf </span>Fusion Protein. <br><i>New Terms: MSN/ALK Fusion Protein</i></td>
            </tr>
            <tr class="addition">
               <td>694</td>
               <td colspan="2">MSN/ALK Fusion Protein<span class="subclass"> SubClassOf </span>Gene_Product_Encoded_By_Gene<span class="some"> some </span>MSN/ALK Fusion Gene. <br><i>New Terms: MSN/ALK Fusion Protein, MSN/ALK Fusion Gene</i></td>
            </tr>
            <tr class="addition">
               <td>695</td>
               <td colspan="2">MSN/ALK Fusion Protein<span class="subclass"> SubClassOf </span>Gene_Product_Plays_Role_In_Biological_Process<span class="some"> some </span>Tyrosine Phosphorylation. <br><i>New Terms: MSN/ALK Fusion Protein</i></td>
            </tr>
            <tr class="addition">
               <td>696</td>
               <td colspan="2">Methemoglobin Reductase Deficiency<span class="subclass"> SubClassOf </span>Enzyme Deficiency. <br><i>New Terms: Methemoglobin Reductase Deficiency</i></td>
            </tr>
            <tr class="addition">
               <td>697</td>
               <td colspan="2">Michigan Neuropathy Screening Instrument Questionnaire<span class="subclass"> SubClassOf </span>Clinical<br><span class="keyword"> or </span>Research Assessment Questionnaire. <br><i>New Terms: Michigan Neuropathy Screening Instrument Questionnaire</i></td>
            </tr>
            <tr class="addition">
               <td>698</td>
               <td colspan="2">Milliampere second<span class="subclass"> SubClassOf </span>Unit of Electric Charge. <br><i>New Terms: Milliampere second</i></td>
            </tr>
            <tr class="addition">
               <td>699</td>
               <td colspan="2">Million Copies per Milliliter<span class="subclass"> SubClassOf </span>Unit of Number Concentration. <br><i>New Terms: Million Copies per Milliliter</i></td>
            </tr>
            <tr class="addition">
               <td>700</td>
               <td colspan="2">Mini-Mental State Examination Questionnaire<span class="subclass"> SubClassOf </span>Clinical<br><span class="keyword"> or </span>Research Assessment Questionnaire. <br><i>New Terms: Mini-Mental State Examination Questionnaire</i></td>
            </tr>
            <tr class="addition">
               <td>701</td>
               <td colspan="2">Movement Disorder Society Unified Parkinson's Disease Rating Scale Questionnaire<span class="subclass"> SubClassOf </span>Clinical<br><span class="keyword"> or </span>Research Assessment Questionnaire. <br><i>New Terms: Movement Disorder Society Unified Parkinson's Disease Rating Scale Questionnaire</i></td>
            </tr>
            <tr class="addition">
               <td>702</td>
               <td colspan="2">NONO/TFE3 Fusion Gene<span class="subclass"> SubClassOf </span>Fusion Gene. <br><i>New Terms: NONO/TFE3 Fusion Gene</i></td>
            </tr>
            <tr class="addition">
               <td>703</td>
               <td colspan="2">NONO/TFE3 Fusion Gene<span class="subclass"> SubClassOf </span>Gene_Involved_In_Pathogenesis_Of_Disease<span class="some"> some </span>Renal Cell Carcinoma Associated with inv(X)(p11;q12). <br><i>New Terms: NONO/TFE3 Fusion Gene</i></td>
            </tr>
            <tr class="addition">
               <td>704</td>
               <td colspan="2">NONO/TFE3 Fusion Protein<span class="subclass"> SubClassOf </span>Fusion Protein. <br><i>New Terms: NONO/TFE3 Fusion Protein</i></td>
            </tr>
            <tr class="addition">
               <td>705</td>
               <td colspan="2">NONO/TFE3 Fusion Protein<span class="subclass"> SubClassOf </span>Gene_Product_Encoded_By_Gene<span class="some"> some </span>NONO/TFE3 Fusion Gene. <br><i>New Terms: NONO/TFE3 Fusion Gene, NONO/TFE3 Fusion Protein</i></td>
            </tr>
            <tr class="addition">
               <td>706</td>
               <td colspan="2">NPI - Question A<span class="subclass"> SubClassOf </span>NPI Questionnaire Question. <br><i>New Terms: NPI - Question A, NPI Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>707</td>
               <td colspan="2">NPI - Question A1<span class="subclass"> SubClassOf </span>NPI Questionnaire Question. <br><i>New Terms: NPI - Question A1, NPI Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>708</td>
               <td colspan="2">NPI - Question A2<span class="subclass"> SubClassOf </span>NPI Questionnaire Question. <br><i>New Terms: NPI - Question A2, NPI Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>709</td>
               <td colspan="2">NPI - Question A3<span class="subclass"> SubClassOf </span>NPI Questionnaire Question. <br><i>New Terms: NPI - Question A3, NPI Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>710</td>
               <td colspan="2">NPI - Question A4<span class="subclass"> SubClassOf </span>NPI Questionnaire Question. <br><i>New Terms: NPI - Question A4, NPI Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>711</td>
               <td colspan="2">NPI - Question A5<span class="subclass"> SubClassOf </span>NPI Questionnaire Question. <br><i>New Terms: NPI - Question A5, NPI Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>712</td>
               <td colspan="2">NPI - Question A6<span class="subclass"> SubClassOf </span>NPI Questionnaire Question. <br><i>New Terms: NPI - Question A6, NPI Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>713</td>
               <td colspan="2">NPI - Question A7<span class="subclass"> SubClassOf </span>NPI Questionnaire Question. <br><i>New Terms: NPI - Question A7, NPI Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>714</td>
               <td colspan="2">NPI - Question A8<span class="subclass"> SubClassOf </span>NPI Questionnaire Question. <br><i>New Terms: NPI - Question A8, NPI Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>715</td>
               <td colspan="2">NPI - Question A9<span class="subclass"> SubClassOf </span>NPI Questionnaire Question. <br><i>New Terms: NPI - Question A9, NPI Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>716</td>
               <td colspan="2">NPI - Question B<span class="subclass"> SubClassOf </span>NPI Questionnaire Question. <br><i>New Terms: NPI - Question B, NPI Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>717</td>
               <td colspan="2">NPI - Question B1<span class="subclass"> SubClassOf </span>NPI Questionnaire Question. <br><i>New Terms: NPI - Question B1, NPI Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>718</td>
               <td colspan="2">NPI - Question B2<span class="subclass"> SubClassOf </span>NPI Questionnaire Question. <br><i>New Terms: NPI Questionnaire Question, NPI - Question B2</i></td>
            </tr>
            <tr class="addition">
               <td>719</td>
               <td colspan="2">NPI - Question B3<span class="subclass"> SubClassOf </span>NPI Questionnaire Question. <br><i>New Terms: NPI Questionnaire Question, NPI - Question B3</i></td>
            </tr>
            <tr class="addition">
               <td>720</td>
               <td colspan="2">NPI - Question B4<span class="subclass"> SubClassOf </span>NPI Questionnaire Question. <br><i>New Terms: NPI - Question B4, NPI Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>721</td>
               <td colspan="2">NPI - Question B5<span class="subclass"> SubClassOf </span>NPI Questionnaire Question. <br><i>New Terms: NPI - Question B5, NPI Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>722</td>
               <td colspan="2">NPI - Question B6<span class="subclass"> SubClassOf </span>NPI Questionnaire Question. <br><i>New Terms: NPI - Question B6, NPI Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>723</td>
               <td colspan="2">NPI - Question B7<span class="subclass"> SubClassOf </span>NPI Questionnaire Question. <br><i>New Terms: NPI - Question B7, NPI Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>724</td>
               <td colspan="2">NPI - Question C<span class="subclass"> SubClassOf </span>NPI Questionnaire Question. <br><i>New Terms: NPI - Question C, NPI Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>725</td>
               <td colspan="2">NPI - Question C1<span class="subclass"> SubClassOf </span>NPI Questionnaire Question. <br><i>New Terms: NPI - Question C1, NPI Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>726</td>
               <td colspan="2">NPI - Question C2<span class="subclass"> SubClassOf </span>NPI Questionnaire Question. <br><i>New Terms: NPI - Question C2, NPI Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>727</td>
               <td colspan="2">NPI - Question C3<span class="subclass"> SubClassOf </span>NPI Questionnaire Question. <br><i>New Terms: NPI - Question C3, NPI Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>728</td>
               <td colspan="2">NPI - Question C4<span class="subclass"> SubClassOf </span>NPI Questionnaire Question. <br><i>New Terms: NPI - Question C4, NPI Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>729</td>
               <td colspan="2">NPI - Question C5<span class="subclass"> SubClassOf </span>NPI Questionnaire Question. <br><i>New Terms: NPI Questionnaire Question, NPI - Question C5</i></td>
            </tr>
            <tr class="addition">
               <td>730</td>
               <td colspan="2">NPI - Question C6<span class="subclass"> SubClassOf </span>NPI Questionnaire Question. <br><i>New Terms: NPI Questionnaire Question, NPI - Question C6</i></td>
            </tr>
            <tr class="addition">
               <td>731</td>
               <td colspan="2">NPI - Question C7<span class="subclass"> SubClassOf </span>NPI Questionnaire Question. <br><i>New Terms: NPI - Question C7, NPI Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>732</td>
               <td colspan="2">NPI - Question C8<span class="subclass"> SubClassOf </span>NPI Questionnaire Question. <br><i>New Terms: NPI - Question C8, NPI Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>733</td>
               <td colspan="2">NPI - Question D<span class="subclass"> SubClassOf </span>NPI Questionnaire Question. <br><i>New Terms: NPI - Question D, NPI Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>734</td>
               <td colspan="2">NPI - Question D1<span class="subclass"> SubClassOf </span>NPI Questionnaire Question. <br><i>New Terms: NPI - Question D1, NPI Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>735</td>
               <td colspan="2">NPI - Question D2<span class="subclass"> SubClassOf </span>NPI Questionnaire Question. <br><i>New Terms: NPI - Question D2, NPI Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>736</td>
               <td colspan="2">NPI - Question D3<span class="subclass"> SubClassOf </span>NPI Questionnaire Question. <br><i>New Terms: NPI - Question D3, NPI Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>737</td>
               <td colspan="2">NPI - Question D4<span class="subclass"> SubClassOf </span>NPI Questionnaire Question. <br><i>New Terms: NPI - Question D4, NPI Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>738</td>
               <td colspan="2">NPI - Question D5<span class="subclass"> SubClassOf </span>NPI Questionnaire Question. <br><i>New Terms: NPI - Question D5, NPI Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>739</td>
               <td colspan="2">NPI - Question D6<span class="subclass"> SubClassOf </span>NPI Questionnaire Question. <br><i>New Terms: NPI - Question D6, NPI Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>740</td>
               <td colspan="2">NPI - Question D7<span class="subclass"> SubClassOf </span>NPI Questionnaire Question. <br><i>New Terms: NPI - Question D7, NPI Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>741</td>
               <td colspan="2">NPI - Question D8<span class="subclass"> SubClassOf </span>NPI Questionnaire Question. <br><i>New Terms: NPI - Question D8, NPI Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>742</td>
               <td colspan="2">NPI - Question E<span class="subclass"> SubClassOf </span>NPI Questionnaire Question. <br><i>New Terms: NPI - Question E, NPI Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>743</td>
               <td colspan="2">NPI - Question E1<span class="subclass"> SubClassOf </span>NPI Questionnaire Question. <br><i>New Terms: NPI - Question E1, NPI Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>744</td>
               <td colspan="2">NPI - Question E2<span class="subclass"> SubClassOf </span>NPI Questionnaire Question. <br><i>New Terms: NPI - Question E2, NPI Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>745</td>
               <td colspan="2">NPI - Question E3<span class="subclass"> SubClassOf </span>NPI Questionnaire Question. <br><i>New Terms: NPI - Question E3, NPI Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>746</td>
               <td colspan="2">NPI - Question E4<span class="subclass"> SubClassOf </span>NPI Questionnaire Question. <br><i>New Terms: NPI - Question E4, NPI Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>747</td>
               <td colspan="2">NPI - Question E5<span class="subclass"> SubClassOf </span>NPI Questionnaire Question. <br><i>New Terms: NPI - Question E5, NPI Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>748</td>
               <td colspan="2">NPI - Question E6<span class="subclass"> SubClassOf </span>NPI Questionnaire Question. <br><i>New Terms: NPI - Question E6, NPI Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>749</td>
               <td colspan="2">NPI - Question E7<span class="subclass"> SubClassOf </span>NPI Questionnaire Question. <br><i>New Terms: NPI - Question E7, NPI Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>750</td>
               <td colspan="2">NPI - Question F<span class="subclass"> SubClassOf </span>NPI Questionnaire Question. <br><i>New Terms: NPI Questionnaire Question, NPI - Question F</i></td>
            </tr>
            <tr class="addition">
               <td>751</td>
               <td colspan="2">NPI - Question F1<span class="subclass"> SubClassOf </span>NPI Questionnaire Question. <br><i>New Terms: NPI - Question F1, NPI Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>752</td>
               <td colspan="2">NPI - Question F2<span class="subclass"> SubClassOf </span>NPI Questionnaire Question. <br><i>New Terms: NPI - Question F2, NPI Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>753</td>
               <td colspan="2">NPI - Question F3<span class="subclass"> SubClassOf </span>NPI Questionnaire Question. <br><i>New Terms: NPI - Question F3, NPI Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>754</td>
               <td colspan="2">NPI - Question F4<span class="subclass"> SubClassOf </span>NPI Questionnaire Question. <br><i>New Terms: NPI - Question F4, NPI Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>755</td>
               <td colspan="2">NPI - Question F5<span class="subclass"> SubClassOf </span>NPI Questionnaire Question. <br><i>New Terms: NPI - Question F5, NPI Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>756</td>
               <td colspan="2">NPI - Question F6<span class="subclass"> SubClassOf </span>NPI Questionnaire Question. <br><i>New Terms: NPI - Question F6, NPI Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>757</td>
               <td colspan="2">NPI - Question F7<span class="subclass"> SubClassOf </span>NPI Questionnaire Question. <br><i>New Terms: NPI - Question F7, NPI Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>758</td>
               <td colspan="2">NPI - Question G<span class="subclass"> SubClassOf </span>NPI Questionnaire Question. <br><i>New Terms: NPI Questionnaire Question, NPI - Question G</i></td>
            </tr>
            <tr class="addition">
               <td>759</td>
               <td colspan="2">NPI - Question G1<span class="subclass"> SubClassOf </span>NPI Questionnaire Question. <br><i>New Terms: NPI - Question G1, NPI Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>760</td>
               <td colspan="2">NPI - Question G2<span class="subclass"> SubClassOf </span>NPI Questionnaire Question. <br><i>New Terms: NPI - Question G2, NPI Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>761</td>
               <td colspan="2">NPI - Question G3<span class="subclass"> SubClassOf </span>NPI Questionnaire Question. <br><i>New Terms: NPI - Question G3, NPI Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>762</td>
               <td colspan="2">NPI - Question G4<span class="subclass"> SubClassOf </span>NPI Questionnaire Question. <br><i>New Terms: NPI - Question G4, NPI Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>763</td>
               <td colspan="2">NPI - Question G5<span class="subclass"> SubClassOf </span>NPI Questionnaire Question. <br><i>New Terms: NPI - Question G5, NPI Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>764</td>
               <td colspan="2">NPI - Question G6<span class="subclass"> SubClassOf </span>NPI Questionnaire Question. <br><i>New Terms: NPI - Question G6, NPI Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>765</td>
               <td colspan="2">NPI - Question G7<span class="subclass"> SubClassOf </span>NPI Questionnaire Question. <br><i>New Terms: NPI - Question G7, NPI Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>766</td>
               <td colspan="2">NPI - Question G8<span class="subclass"> SubClassOf </span>NPI Questionnaire Question. <br><i>New Terms: NPI - Question G8, NPI Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>767</td>
               <td colspan="2">NPI - Question H<span class="subclass"> SubClassOf </span>NPI Questionnaire Question. <br><i>New Terms: NPI - Question H, NPI Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>768</td>
               <td colspan="2">NPI - Question H1<span class="subclass"> SubClassOf </span>NPI Questionnaire Question. <br><i>New Terms: NPI - Question H1, NPI Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>769</td>
               <td colspan="2">NPI - Question H2<span class="subclass"> SubClassOf </span>NPI Questionnaire Question. <br><i>New Terms: NPI - Question H2, NPI Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>770</td>
               <td colspan="2">NPI - Question H3<span class="subclass"> SubClassOf </span>NPI Questionnaire Question. <br><i>New Terms: NPI - Question H3, NPI Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>771</td>
               <td colspan="2">NPI - Question H4<span class="subclass"> SubClassOf </span>NPI Questionnaire Question. <br><i>New Terms: NPI - Question H4, NPI Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>772</td>
               <td colspan="2">NPI - Question H5<span class="subclass"> SubClassOf </span>NPI Questionnaire Question. <br><i>New Terms: NPI - Question H5, NPI Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>773</td>
               <td colspan="2">NPI - Question H6<span class="subclass"> SubClassOf </span>NPI Questionnaire Question. <br><i>New Terms: NPI - Question H6, NPI Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>774</td>
               <td colspan="2">NPI - Question H7<span class="subclass"> SubClassOf </span>NPI Questionnaire Question. <br><i>New Terms: NPI - Question H7, NPI Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>775</td>
               <td colspan="2">NPI - Question I<span class="subclass"> SubClassOf </span>NPI Questionnaire Question. <br><i>New Terms: NPI - Question I, NPI Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>776</td>
               <td colspan="2">NPI - Question I1<span class="subclass"> SubClassOf </span>NPI Questionnaire Question. <br><i>New Terms: NPI - Question I1, NPI Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>777</td>
               <td colspan="2">NPI - Question I2<span class="subclass"> SubClassOf </span>NPI Questionnaire Question. <br><i>New Terms: NPI - Question I2, NPI Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>778</td>
               <td colspan="2">NPI - Question I3<span class="subclass"> SubClassOf </span>NPI Questionnaire Question. <br><i>New Terms: NPI - Question I3, NPI Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>779</td>
               <td colspan="2">NPI - Question I4<span class="subclass"> SubClassOf </span>NPI Questionnaire Question. <br><i>New Terms: NPI - Question I4, NPI Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>780</td>
               <td colspan="2">NPI - Question I5<span class="subclass"> SubClassOf </span>NPI Questionnaire Question. <br><i>New Terms: NPI - Question I5, NPI Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>781</td>
               <td colspan="2">NPI - Question I6<span class="subclass"> SubClassOf </span>NPI Questionnaire Question. <br><i>New Terms: NPI - Question I6, NPI Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>782</td>
               <td colspan="2">NPI - Question I7<span class="subclass"> SubClassOf </span>NPI Questionnaire Question. <br><i>New Terms: NPI - Question I7, NPI Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>783</td>
               <td colspan="2">NPI - Question J<span class="subclass"> SubClassOf </span>NPI Questionnaire Question. <br><i>New Terms: NPI - Question J, NPI Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>784</td>
               <td colspan="2">NPI - Question J1<span class="subclass"> SubClassOf </span>NPI Questionnaire Question. <br><i>New Terms: NPI - Question J1, NPI Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>785</td>
               <td colspan="2">NPI - Question J2<span class="subclass"> SubClassOf </span>NPI Questionnaire Question. <br><i>New Terms: NPI - Question J2, NPI Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>786</td>
               <td colspan="2">NPI - Question J3<span class="subclass"> SubClassOf </span>NPI Questionnaire Question. <br><i>New Terms: NPI - Question J3, NPI Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>787</td>
               <td colspan="2">NPI - Question J4<span class="subclass"> SubClassOf </span>NPI Questionnaire Question. <br><i>New Terms: NPI - Question J4, NPI Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>788</td>
               <td colspan="2">NPI - Question J5<span class="subclass"> SubClassOf </span>NPI Questionnaire Question. <br><i>New Terms: NPI - Question J5, NPI Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>789</td>
               <td colspan="2">NPI - Question J6<span class="subclass"> SubClassOf </span>NPI Questionnaire Question. <br><i>New Terms: NPI - Question J6, NPI Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>790</td>
               <td colspan="2">NPI - Question J7<span class="subclass"> SubClassOf </span>NPI Questionnaire Question. <br><i>New Terms: NPI - Question J7, NPI Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>791</td>
               <td colspan="2">NPI - Question K<span class="subclass"> SubClassOf </span>NPI Questionnaire Question. <br><i>New Terms: NPI - Question K, NPI Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>792</td>
               <td colspan="2">NPI - Question K1<span class="subclass"> SubClassOf </span>NPI Questionnaire Question. <br><i>New Terms: NPI - Question K1, NPI Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>793</td>
               <td colspan="2">NPI - Question K2<span class="subclass"> SubClassOf </span>NPI Questionnaire Question. <br><i>New Terms: NPI - Question K2, NPI Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>794</td>
               <td colspan="2">NPI - Question K3<span class="subclass"> SubClassOf </span>NPI Questionnaire Question. <br><i>New Terms: NPI - Question K3, NPI Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>795</td>
               <td colspan="2">NPI - Question K4<span class="subclass"> SubClassOf </span>NPI Questionnaire Question. <br><i>New Terms: NPI - Question K4, NPI Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>796</td>
               <td colspan="2">NPI - Question K5<span class="subclass"> SubClassOf </span>NPI Questionnaire Question. <br><i>New Terms: NPI - Question K5, NPI Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>797</td>
               <td colspan="2">NPI - Question K6<span class="subclass"> SubClassOf </span>NPI Questionnaire Question. <br><i>New Terms: NPI - Question K6, NPI Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>798</td>
               <td colspan="2">NPI - Question K7<span class="subclass"> SubClassOf </span>NPI Questionnaire Question. <br><i>New Terms: NPI Questionnaire Question, NPI - Question K7</i></td>
            </tr>
            <tr class="addition">
               <td>799</td>
               <td colspan="2">NPI - Question K8<span class="subclass"> SubClassOf </span>NPI Questionnaire Question. <br><i>New Terms: NPI Questionnaire Question, NPI - Question K8</i></td>
            </tr>
            <tr class="addition">
               <td>800</td>
               <td colspan="2">NPI - Question L<span class="subclass"> SubClassOf </span>NPI Questionnaire Question. <br><i>New Terms: NPI - Question L, NPI Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>801</td>
               <td colspan="2">NPI - Question L1<span class="subclass"> SubClassOf </span>NPI Questionnaire Question. <br><i>New Terms: NPI - Question L1, NPI Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>802</td>
               <td colspan="2">NPI - Question L2<span class="subclass"> SubClassOf </span>NPI Questionnaire Question. <br><i>New Terms: NPI - Question L2, NPI Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>803</td>
               <td colspan="2">NPI - Question L3<span class="subclass"> SubClassOf </span>NPI Questionnaire Question. <br><i>New Terms: NPI - Question L3, NPI Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>804</td>
               <td colspan="2">NPI - Question L4<span class="subclass"> SubClassOf </span>NPI Questionnaire Question. <br><i>New Terms: NPI Questionnaire Question, NPI - Question L4</i></td>
            </tr>
            <tr class="addition">
               <td>805</td>
               <td colspan="2">NPI - Question L5<span class="subclass"> SubClassOf </span>NPI Questionnaire Question. <br><i>New Terms: NPI Questionnaire Question, NPI - Question L5</i></td>
            </tr>
            <tr class="addition">
               <td>806</td>
               <td colspan="2">NPI - Question L6<span class="subclass"> SubClassOf </span>NPI Questionnaire Question. <br><i>New Terms: NPI - Question L6, NPI Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>807</td>
               <td colspan="2">NPI - Question L7<span class="subclass"> SubClassOf </span>NPI Questionnaire Question. <br><i>New Terms: NPI - Question L7, NPI Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>808</td>
               <td colspan="2">NPI - Question L8<span class="subclass"> SubClassOf </span>NPI Questionnaire Question. <br><i>New Terms: NPI - Question L8, NPI Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>809</td>
               <td colspan="2">NPI Questionnaire Question<span class="subclass"> SubClassOf </span>Clinical<br><span class="keyword"> or </span>Research Assessment Question. <br><i>New Terms: NPI Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>810</td>
               <td colspan="2">NPM1/RARA Long Fusion Gene<span class="subclass"> SubClassOf </span>Fusion Gene. <br><i>New Terms: NPM1/RARA Long Fusion Gene</i></td>
            </tr>
            <tr class="addition">
               <td>811</td>
               <td colspan="2">NPM1/RARA Long Fusion Gene<span class="subclass"> SubClassOf </span>Gene_Involved_In_Pathogenesis_Of_Disease<span class="some"> some </span>Acute Myeloid Leukemia with t(5;17)(q35;q12). <br><i>New Terms: NPM1/RARA Long Fusion Gene</i></td>
            </tr>
            <tr class="addition">
               <td>812</td>
               <td colspan="2">NPM1/RARA Long Fusion Protein<span class="subclass"> SubClassOf </span>Fusion Protein. <br><i>New Terms: NPM1/RARA Long Fusion Protein</i></td>
            </tr>
            <tr class="addition">
               <td>813</td>
               <td colspan="2">NPM1/RARA Long Fusion Protein<span class="subclass"> SubClassOf </span>Gene_Product_Encoded_By_Gene<span class="some"> some </span>NPM1/RARA Long Fusion Gene. <br><i>New Terms: NPM1/RARA Long Fusion Gene, NPM1/RARA Long Fusion Protein</i></td>
            </tr>
            <tr class="addition">
               <td>814</td>
               <td colspan="2">NPM1/RARA Short Fusion Gene<span class="subclass"> SubClassOf </span>Fusion Gene. <br><i>New Terms: NPM1/RARA Short Fusion Gene</i></td>
            </tr>
            <tr class="addition">
               <td>815</td>
               <td colspan="2">NPM1/RARA Short Fusion Gene<span class="subclass"> SubClassOf </span>Gene_Involved_In_Pathogenesis_Of_Disease<span class="some"> some </span>Acute Myeloid Leukemia with t(5;17)(q35;q12). <br><i>New Terms: NPM1/RARA Short Fusion Gene</i></td>
            </tr>
            <tr class="addition">
               <td>816</td>
               <td colspan="2">NPM1/RARA Short Fusion Protein<span class="subclass"> SubClassOf </span>Fusion Protein. <br><i>New Terms: NPM1/RARA Short Fusion Protein</i></td>
            </tr>
            <tr class="addition">
               <td>817</td>
               <td colspan="2">NPM1/RARA Short Fusion Protein<span class="subclass"> SubClassOf </span>Gene_Product_Encoded_By_Gene<span class="some"> some </span>NPM1/RARA Short Fusion Gene. <br><i>New Terms: NPM1/RARA Short Fusion Protein, NPM1/RARA Short Fusion Gene</i></td>
            </tr>
            <tr class="addition">
               <td>819</td>
               <td colspan="2">Neonatal Aspiration of Amniotic Fluid<span class="subclass"> SubClassOf </span>Neonatal Respiratory System Disorder. <br><i>New Terms: Neonatal Aspiration of Amniotic Fluid</i></td>
            </tr>
            <tr class="addition">
               <td>820</td>
               <td colspan="2">Neonatal Birth Trauma<span class="subclass"> SubClassOf </span>Injury. <br><i>New Terms: Neonatal Birth Trauma</i></td>
            </tr>
            <tr class="addition">
               <td>821</td>
               <td colspan="2">Neuropsychiatric Inventory Questionnaire<span class="subclass"> SubClassOf </span>Clinical<br><span class="keyword"> or </span>Research Assessment Questionnaire. <br><i>New Terms: Neuropsychiatric Inventory Questionnaire</i></td>
            </tr>
            <tr class="addition">
               <td>822</td>
               <td colspan="2">Non-Prostatic Acid Phosphatase Measurement<span class="subclass"> SubClassOf </span>Protein<br><span class="keyword"> or </span>Enzyme<span class="subclass"> Type </span>Measurement. <br><i>New Terms: Non-Prostatic Acid Phosphatase Measurement</i></td>
            </tr>
            <tr class="addition">
               <td>823</td>
               <td colspan="2">Nongerminomatous Germ Cell Tumor<span class="subclass"> EquivalentTo </span>Central Nervous System Germ Cell Tumor<br><span class="keyword"> and </span>(Disease_Excludes_Abnormal_Cell<span class="some"> some </span>Malignant Primitive Germ Cell). <br><i>New Terms: Nongerminomatous Germ Cell Tumor</i></td>
            </tr>
            <tr class="addition">
               <td>824</td>
               <td colspan="2">Oral Mucositis Rating Scale<span class="subclass"> SubClassOf </span>Research<br><span class="keyword"> or </span>Clinical Assessment Tool. <br><i>New Terms: Oral Mucositis Rating Scale</i></td>
            </tr>
            <tr class="addition">
               <td>825</td>
               <td colspan="2">Organ Donor<span class="subclass"> SubClassOf </span>Tissue Donor. <br><i>New Terms: Organ Donor</i></td>
            </tr>
            <tr class="addition">
               <td>826</td>
               <td colspan="2">Ova<br><span class="keyword"> and </span>Parasite Measurement<span class="subclass"> SubClassOf </span>Immunology Test. <br><i>New Terms: Ova and Parasite Measurement</i></td>
            </tr>
            <tr class="addition">
               <td>827</td>
               <td colspan="2">PAX3/FOXO4 Fusion Gene<span class="subclass"> SubClassOf </span>Fusion Gene. <br><i>New Terms: PAX3/FOXO4 Fusion Gene</i></td>
            </tr>
            <tr class="addition">
               <td>828</td>
               <td colspan="2">PAX3/FOXO4 Fusion Protein<span class="subclass"> SubClassOf </span>Fusion Protein. <br><i>New Terms: PAX3/FOXO4 Fusion Protein</i></td>
            </tr>
            <tr class="addition">
               <td>829</td>
               <td colspan="2">PAX3/FOXO4 Fusion Protein<span class="subclass"> SubClassOf </span>Gene_Product_Encoded_By_Gene<span class="some"> some </span>PAX3/FOXO4 Fusion Gene. <br><i>New Terms: PAX3/FOXO4 Fusion Protein, PAX3/FOXO4 Fusion Gene</i></td>
            </tr>
            <tr class="addition">
               <td>830</td>
               <td colspan="2">PAX3/NCOA1 Fusion Gene<span class="subclass"> SubClassOf </span>Fusion Gene. <br><i>New Terms: PAX3/NCOA1 Fusion Gene</i></td>
            </tr>
            <tr class="addition">
               <td>831</td>
               <td colspan="2">PAX3/NCOA1 Fusion Protein<span class="subclass"> SubClassOf </span>Fusion Protein. <br><i>New Terms: PAX3/NCOA1 Fusion Protein</i></td>
            </tr>
            <tr class="addition">
               <td>832</td>
               <td colspan="2">PAX3/NCOA1 Fusion Protein<span class="subclass"> SubClassOf </span>Gene_Product_Encoded_By_Gene<span class="some"> some </span>PAX3/NCOA1 Fusion Gene. <br><i>New Terms: PAX3/NCOA1 Fusion Protein, PAX3/NCOA1 Fusion Gene</i></td>
            </tr>
            <tr class="addition">
               <td>833</td>
               <td colspan="2">PDQUALIF - Bladder Control Difficulty<span class="subclass"> SubClassOf </span>PDQUALIF Questionnaire Question. <br><i>New Terms: PDQUALIF - Bladder Control Difficulty, PDQUALIF Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>834</td>
               <td colspan="2">PDQUALIF - Burden to Others<span class="subclass"> SubClassOf </span>PDQUALIF Questionnaire Question. <br><i>New Terms: PDQUALIF - Burden to Others, PDQUALIF Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>835</td>
               <td colspan="2">PDQUALIF - Communication<span class="subclass"> SubClassOf </span>PDQUALIF Questionnaire Question. <br><i>New Terms: PDQUALIF Questionnaire Question, PDQUALIF - Communication</i></td>
            </tr>
            <tr class="addition">
               <td>836</td>
               <td colspan="2">PDQUALIF - Constipation<span class="subclass"> SubClassOf </span>PDQUALIF Questionnaire Question. <br><i>New Terms: PDQUALIF - Constipation, PDQUALIF Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>837</td>
               <td colspan="2">PDQUALIF - Difficulty in Adjusting to Change<span class="subclass"> SubClassOf </span>PDQUALIF Questionnaire Question. <br><i>New Terms: PDQUALIF - Difficulty in Adjusting to Change, PDQUALIF Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>838</td>
               <td colspan="2">PDQUALIF - Difficulty in Asking for Help<span class="subclass"> SubClassOf </span>PDQUALIF Questionnaire Question. <br><i>New Terms: PDQUALIF - Difficulty in Asking for Help, PDQUALIF Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>839</td>
               <td colspan="2">PDQUALIF - Driving in Past 7 Days<span class="subclass"> SubClassOf </span>PDQUALIF Questionnaire Question. <br><i>New Terms: PDQUALIF - Driving in Past 7 Days, PDQUALIF Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>840</td>
               <td colspan="2">PDQUALIF - Family Relationship Affected<span class="subclass"> SubClassOf </span>PDQUALIF Questionnaire Question. <br><i>New Terms: PDQUALIF - Family Relationship Affected, PDQUALIF Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>841</td>
               <td colspan="2">PDQUALIF - Fatigue in Past 7 Days<span class="subclass"> SubClassOf </span>PDQUALIF Questionnaire Question. <br><i>New Terms: PDQUALIF - Fatigue in Past 7 Days, PDQUALIF Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>842</td>
               <td colspan="2">PDQUALIF - Financial Strain in Past 7 Days<span class="subclass"> SubClassOf </span>PDQUALIF Questionnaire Question. <br><i>New Terms: PDQUALIF - Financial Strain in Past 7 Days, PDQUALIF Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>843</td>
               <td colspan="2">PDQUALIF - House Work in Past 7 Days<span class="subclass"> SubClassOf </span>PDQUALIF Questionnaire Question. <br><i>New Terms: PDQUALIF - House Work in Past 7 Days, PDQUALIF Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>844</td>
               <td colspan="2">PDQUALIF - Imbalance<span class="subclass"> SubClassOf </span>PDQUALIF Questionnaire Question. <br><i>New Terms: PDQUALIF - Imbalance, PDQUALIF Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>845</td>
               <td colspan="2">PDQUALIF - Important to Maintain Independence<span class="subclass"> SubClassOf </span>PDQUALIF Questionnaire Question. <br><i>New Terms: PDQUALIF - Important to Maintain Independence, PDQUALIF Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>846</td>
               <td colspan="2">PDQUALIF - Independent Food Preparation in Past 7 Days<span class="subclass"> SubClassOf </span>PDQUALIF Questionnaire Question. <br><i>New Terms: PDQUALIF - Independent Food Preparation in Past 7 Days, PDQUALIF Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>847</td>
               <td colspan="2">PDQUALIF - Independent Hygiene in Past 7 Days<span class="subclass"> SubClassOf </span>PDQUALIF Questionnaire Question. <br><i>New Terms: PDQUALIF - Independent Hygiene in Past 7 Days, PDQUALIF Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>848</td>
               <td colspan="2">PDQUALIF - Lightheadedness<span class="subclass"> SubClassOf </span>PDQUALIF Questionnaire Question. <br><i>New Terms: PDQUALIF Questionnaire Question, PDQUALIF - Lightheadedness</i></td>
            </tr>
            <tr class="addition">
               <td>849</td>
               <td colspan="2">PDQUALIF - Neuropathy in Hands<br><span class="keyword"> or </span>Feet<span class="subclass"> SubClassOf </span>PDQUALIF Questionnaire Question. <br><i>New Terms: PDQUALIF Questionnaire Question, PDQUALIF - Neuropathy in Hands or Feet</i></td>
            </tr>
            <tr class="addition">
               <td>850</td>
               <td colspan="2">PDQUALIF - Nocturia<span class="subclass"> SubClassOf </span>PDQUALIF Questionnaire Question. <br><i>New Terms: PDQUALIF Questionnaire Question, PDQUALIF - Nocturia</i></td>
            </tr>
            <tr class="addition">
               <td>851</td>
               <td colspan="2">PDQUALIF - Parkinson's Symptoms<span class="subclass"> SubClassOf </span>PDQUALIF Questionnaire Question. <br><i>New Terms: PDQUALIF - Parkinson's Symptoms, PDQUALIF Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>852</td>
               <td colspan="2">PDQUALIF - Positive Outlook Difficult<span class="subclass"> SubClassOf </span>PDQUALIF Questionnaire Question. <br><i>New Terms: PDQUALIF - Positive Outlook Difficult, PDQUALIF Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>853</td>
               <td colspan="2">PDQUALIF - Problem with Communication in the Past 7 Days<span class="subclass"> SubClassOf </span>PDQUALIF Questionnaire Question. <br><i>New Terms: PDQUALIF Questionnaire Question, PDQUALIF - Problem with Communication in the Past
                     7 Days</i></td>
            </tr>
            <tr class="addition">
               <td>854</td>
               <td colspan="2">PDQUALIF -<span class="some"> Self </span>Concept Change<span class="subclass"> SubClassOf </span>PDQUALIF Questionnaire Question. <br><i>New Terms: PDQUALIF - Self Concept Change, PDQUALIF Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>855</td>
               <td colspan="2">PDQUALIF - Sexual Ability<span class="subclass"> SubClassOf </span>PDQUALIF Questionnaire Question. <br><i>New Terms: PDQUALIF - Sexual Ability, PDQUALIF Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>856</td>
               <td colspan="2">PDQUALIF - Sexual Desirability<span class="subclass"> SubClassOf </span>PDQUALIF Questionnaire Question. <br><i>New Terms: PDQUALIF - Sexual Desirability, PDQUALIF Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>857</td>
               <td colspan="2">PDQUALIF - Sleep with Partner in Past 7 Days<span class="subclass"> SubClassOf </span>PDQUALIF Questionnaire Question. <br><i>New Terms: PDQUALIF - Sleep with Partner in Past 7 Days, PDQUALIF Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>858</td>
               <td colspan="2">PDQUALIF - Social Isolation<span class="subclass"> SubClassOf </span>PDQUALIF Questionnaire Question. <br><i>New Terms: PDQUALIF - Social Isolation, PDQUALIF Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>859</td>
               <td colspan="2">PDQUALIF - Social Life Affected<span class="subclass"> SubClassOf </span>PDQUALIF Questionnaire Question. <br><i>New Terms: PDQUALIF Questionnaire Question, PDQUALIF - Social Life Affected</i></td>
            </tr>
            <tr class="addition">
               <td>860</td>
               <td colspan="2">PDQUALIF - Social Life Not Affected<span class="subclass"> SubClassOf </span>PDQUALIF Questionnaire Question. <br><i>New Terms: PDQUALIF - Social Life Not Affected, PDQUALIF Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>861</td>
               <td colspan="2">PDQUALIF - Swallowing Difficulty<span class="subclass"> SubClassOf </span>PDQUALIF Questionnaire Question. <br><i>New Terms: PDQUALIF - Swallowing Difficulty, PDQUALIF Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>862</td>
               <td colspan="2">PDQUALIF - Travel Important<span class="subclass"> SubClassOf </span>PDQUALIF Questionnaire Question. <br><i>New Terms: PDQUALIF - Travel Important, PDQUALIF Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>863</td>
               <td colspan="2">PDQUALIF - Trouble with Sleep Initiation<br><span class="keyword"> or </span>Waking Early<span class="subclass"> SubClassOf </span>PDQUALIF Questionnaire Question. <br><i>New Terms: PDQUALIF - Trouble with Sleep Initiation or Waking Early, PDQUALIF Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>864</td>
               <td colspan="2">PDQUALIF - Trouble with Sleep Maintenance<span class="subclass"> SubClassOf </span>PDQUALIF Questionnaire Question. <br><i>New Terms: PDQUALIF - Trouble with Sleep Maintenance, PDQUALIF Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>865</td>
               <td colspan="2">PDQUALIF - Worry about Future<span class="subclass"> SubClassOf </span>PDQUALIF Questionnaire Question. <br><i>New Terms: PDQUALIF Questionnaire Question, PDQUALIF - Worry about Future</i></td>
            </tr>
            <tr class="addition">
               <td>866</td>
               <td colspan="2">PDQUALIF Questionnaire Question<span class="subclass"> SubClassOf </span>Clinical<br><span class="keyword"> or </span>Research Assessment Question. <br><i>New Terms: PDQUALIF Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>867</td>
               <td colspan="2">Parkinson's Disease Quality of Life Scale Questionnaire<span class="subclass"> SubClassOf </span>Clinical<br><span class="keyword"> or </span>Research Assessment Questionnaire. <br><i>New Terms: Parkinson's Disease Quality of Life Scale Questionnaire</i></td>
            </tr>
            <tr class="addition">
               <td>868</td>
               <td colspan="2">Partner<span class="subclass"> SubClassOf </span>Person. <br><i>New Terms: Partner</i></td>
            </tr>
            <tr class="addition">
               <td>869</td>
               <td colspan="2">Pepsinogen A Measurement<span class="subclass"> SubClassOf </span>Pepsinogen Measurement. <br><i>New Terms: Pepsinogen A Measurement, Pepsinogen Measurement</i></td>
            </tr>
            <tr class="addition">
               <td>870</td>
               <td colspan="2">Pepsinogen C Measurement<span class="subclass"> SubClassOf </span>Pepsinogen Measurement. <br><i>New Terms: Pepsinogen C Measurement, Pepsinogen Measurement</i></td>
            </tr>
            <tr class="addition">
               <td>872</td>
               <td colspan="2">Pepsinogen I Measurement<span class="subclass"> SubClassOf </span>Pepsinogen Measurement. <br><i>New Terms: Pepsinogen Measurement, Pepsinogen I Measurement</i></td>
            </tr>
            <tr class="addition">
               <td>871</td>
               <td colspan="2">Pepsinogen II Measurement<span class="subclass"> SubClassOf </span>Pepsinogen Measurement. <br><i>New Terms: Pepsinogen II Measurement, Pepsinogen Measurement</i></td>
            </tr>
            <tr class="addition">
               <td>873</td>
               <td colspan="2">Pepsinogen Measurement<span class="subclass"> SubClassOf </span>Protein<br><span class="keyword"> or </span>Enzyme<span class="subclass"> Type </span>Measurement. <br><i>New Terms: Pepsinogen Measurement</i></td>
            </tr>
            <tr class="addition">
               <td>874</td>
               <td colspan="2">Plasmodium Measurement<span class="subclass"> SubClassOf </span>Immunology Test. <br><i>New Terms: Plasmodium Measurement</i></td>
            </tr>
            <tr class="addition">
               <td>875</td>
               <td colspan="2">Platelet Hematocrit Measurement<span class="subclass"> SubClassOf </span>Hematology Test. <br><i>New Terms: Platelet Hematocrit Measurement</i></td>
            </tr>
            <tr class="addition">
               <td>876</td>
               <td colspan="2">Prealbumin Measurement<span class="subclass"> SubClassOf </span>Protein<br><span class="keyword"> or </span>Enzyme<span class="subclass"> Type </span>Measurement. <br><i>New Terms: Prealbumin Measurement</i></td>
            </tr>
            <tr class="addition">
               <td>877</td>
               <td colspan="2">Pregnancy Partner<span class="subclass"> SubClassOf </span>Partner. <br><i>New Terms: Pregnancy Partner, Partner</i></td>
            </tr>
            <tr class="addition">
               <td>878</td>
               <td colspan="2">Proerythroblast Measurement<span class="subclass"> SubClassOf </span>Blood Cell Count Ratio Measurement. <br><i>New Terms: Proerythroblast Measurement</i></td>
            </tr>
            <tr class="addition">
               <td>879</td>
               <td colspan="2">Prostatic Fluid<span class="subclass"> SubClassOf </span>Biospecimen. <br><i>New Terms: Prostatic Fluid</i></td>
            </tr>
            <tr class="addition">
               <td>880</td>
               <td colspan="2">Protein FAM22A<span class="subclass"> SubClassOf </span>Gene_Product_Encoded_By_Gene<span class="some"> some </span>FAM22A Gene. <br><i>New Terms: FAM22A Gene, Protein FAM22A</i></td>
            </tr>
            <tr class="addition">
               <td>881</td>
               <td colspan="2">Protein FAM22A<span class="subclass"> SubClassOf </span>Regulatory Protein. <br><i>New Terms: Protein FAM22A</i></td>
            </tr>
            <tr class="addition">
               <td>882</td>
               <td colspan="2">Protein FAM22B<span class="subclass"> SubClassOf </span>Gene_Product_Encoded_By_Gene<span class="some"> some </span>FAM22B Gene. <br><i>New Terms: FAM22B Gene, Protein FAM22B</i></td>
            </tr>
            <tr class="addition">
               <td>883</td>
               <td colspan="2">Protein FAM22B<span class="subclass"> SubClassOf </span>Regulatory Protein. <br><i>New Terms: Protein FAM22B</i></td>
            </tr>
            <tr class="addition">
               <td>884</td>
               <td colspan="2">Protein S Measurement<span class="subclass"> SubClassOf </span>Protein<br><span class="keyword"> or </span>Enzyme<span class="subclass"> Type </span>Measurement. <br><i>New Terms: Protein S Measurement</i></td>
            </tr>
            <tr class="addition">
               <td>885</td>
               <td colspan="2">Pulse Pressure<span class="subclass"> SubClassOf </span>Personal Attribute. <br><i>New Terms: Pulse Pressure</i></td>
            </tr>
            <tr class="addition">
               <td>886</td>
               <td colspan="2">RDQ - Appetite is Not Very Good<span class="subclass"> SubClassOf </span>RDQ Questionnaire Question. <br><i>New Terms: RDQ - Appetite is Not Very Good, RDQ Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>887</td>
               <td colspan="2">RDQ - Avoid Heavy Jobs<span class="subclass"> SubClassOf </span>RDQ Questionnaire Question. <br><i>New Terms: RDQ - Avoid Heavy Jobs, RDQ Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>888</td>
               <td colspan="2">RDQ - Change Position Frequently<span class="subclass"> SubClassOf </span>RDQ Questionnaire Question. <br><i>New Terms: RDQ - Change Position Frequently, RDQ Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>889</td>
               <td colspan="2">RDQ - Difficult to Get Out of a Chair<span class="subclass"> SubClassOf </span>RDQ Questionnaire Question. <br><i>New Terms: RDQ - Difficult to Get Out of a Chair, RDQ Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>890</td>
               <td colspan="2">RDQ - Difficult to Turn Over in Bed<span class="subclass"> SubClassOf </span>RDQ Questionnaire Question. <br><i>New Terms: RDQ - Difficult to Turn Over in Bed, RDQ Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>891</td>
               <td colspan="2">RDQ - Get Dressed More Slowly<span class="subclass"> SubClassOf </span>RDQ Questionnaire Question. <br><i>New Terms: RDQ - Get Dressed More Slowly, RDQ Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>892</td>
               <td colspan="2">RDQ - Get Dressed With Help<span class="subclass"> SubClassOf </span>RDQ Questionnaire Question. <br><i>New Terms: RDQ - Get Dressed With Help, RDQ Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>893</td>
               <td colspan="2">RDQ - Get Other People to Do Things<span class="subclass"> SubClassOf </span>RDQ Questionnaire Question. <br><i>New Terms: RDQ - Get Other People to Do Things, RDQ Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>894</td>
               <td colspan="2">RDQ - Go Upstairs More Slowly<span class="subclass"> SubClassOf </span>RDQ Questionnaire Question. <br><i>New Terms: RDQ - Go Upstairs More Slowly, RDQ Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>895</td>
               <td colspan="2">RDQ - Hold on to Get Out of a Chair<span class="subclass"> SubClassOf </span>RDQ Questionnaire Question. <br><i>New Terms: RDQ - Hold on to Get Out of a Chair, RDQ Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>896</td>
               <td colspan="2">RDQ - Lie Down to Rest More Often<span class="subclass"> SubClassOf </span>RDQ Questionnaire Question. <br><i>New Terms: RDQ - Lie Down to Rest More Often, RDQ Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>897</td>
               <td colspan="2">RDQ - More Irritable With People<span class="subclass"> SubClassOf </span>RDQ Questionnaire Question. <br><i>New Terms: RDQ - More Irritable With People, RDQ Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>898</td>
               <td colspan="2">RDQ - Not Do Any Usual House Jobs<span class="subclass"> SubClassOf </span>RDQ Questionnaire Question. <br><i>New Terms: RDQ - Not Do Any Usual House Jobs, RDQ Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>899</td>
               <td colspan="2">RDQ - Only Stand for Short Periods<span class="subclass"> SubClassOf </span>RDQ Questionnaire Question. <br><i>New Terms: RDQ - Only Stand for Short Periods, RDQ Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>900</td>
               <td colspan="2">RDQ - Only Walk Short Distances<span class="subclass"> SubClassOf </span>RDQ Questionnaire Question. <br><i>New Terms: RDQ - Only Walk Short Distances, RDQ Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>901</td>
               <td colspan="2">RDQ - Painful Almost All the Time<span class="subclass"> SubClassOf </span>RDQ Questionnaire Question. <br><i>New Terms: RDQ - Painful Almost All the Time, RDQ Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>902</td>
               <td colspan="2">RDQ - Sit Down Most of the Day<span class="subclass"> SubClassOf </span>RDQ Questionnaire Question. <br><i>New Terms: RDQ - Sit Down Most of the Day, RDQ Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>903</td>
               <td colspan="2">RDQ - Sleep Less Well<span class="subclass"> SubClassOf </span>RDQ Questionnaire Question. <br><i>New Terms: RDQ - Sleep Less Well, RDQ Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>904</td>
               <td colspan="2">RDQ - Stay at Home<span class="subclass"> SubClassOf </span>RDQ Questionnaire Question. <br><i>New Terms: RDQ - Stay at Home, RDQ Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>905</td>
               <td colspan="2">RDQ - Stay in Bed<span class="subclass"> SubClassOf </span>RDQ Questionnaire Question. <br><i>New Terms: RDQ - Stay in Bed, RDQ Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>906</td>
               <td colspan="2">RDQ - Total Derived Score<span class="subclass"> SubClassOf </span>RDQ Questionnaire Question. <br><i>New Terms: RDQ - Total Derived Score, RDQ Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>907</td>
               <td colspan="2">RDQ - Trouble Putting on Socks<br><span class="keyword"> or </span>Stockings<span class="subclass"> SubClassOf </span>RDQ Questionnaire Question. <br><i>New Terms: RDQ - Trouble Putting on Socks or Stockings, RDQ Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>908</td>
               <td colspan="2">RDQ - Try Not to Bend<br><span class="keyword"> or </span>Kneel<span class="subclass"> SubClassOf </span>RDQ Questionnaire Question. <br><i>New Terms: RDQ - Try Not to Bend or Kneel, RDQ Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>909</td>
               <td colspan="2">RDQ - Use Handrail to Get Upstairs<span class="subclass"> SubClassOf </span>RDQ Questionnaire Question. <br><i>New Terms: RDQ - Use Handrail to Get Upstairs, RDQ Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>910</td>
               <td colspan="2">RDQ - Walk More Slowly<span class="subclass"> SubClassOf </span>RDQ Questionnaire Question. <br><i>New Terms: RDQ - Walk More Slowly, RDQ Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>911</td>
               <td colspan="2">RDQ Questionnaire Question<span class="subclass"> SubClassOf </span>Clinical<br><span class="keyword"> or </span>Research Assessment Question. <br><i>New Terms: RDQ Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>912</td>
               <td colspan="2">RPN1/MECOM Fusion Gene<span class="subclass"> SubClassOf </span>Fusion Gene. <br><i>New Terms: RPN1/MECOM Fusion Gene</i></td>
            </tr>
            <tr class="addition">
               <td>913</td>
               <td colspan="2">RPN1/MECOM Fusion Gene<span class="subclass"> SubClassOf </span>Gene_Involved_In_Pathogenesis_Of_Disease<span class="some"> some </span>Acute Myeloid Leukemia with inv(3)(q21q26.2)<br><span class="keyword"> or </span>t(3;3)(q21;q26.2); RPN1-EVI1. <br><i>New Terms: RPN1/MECOM Fusion Gene</i></td>
            </tr>
            <tr class="addition">
               <td>914</td>
               <td colspan="2">Retinol Binding Protein Measurement<span class="subclass"> SubClassOf </span>Protein<br><span class="keyword"> or </span>Enzyme<span class="subclass"> Type </span>Measurement. <br><i>New Terms: Retinol Binding Protein Measurement</i></td>
            </tr>
            <tr class="addition">
               <td>915</td>
               <td colspan="2">Retinopathy of Prematurity with Plus Disease<span class="subclass"> SubClassOf </span>Retinopathy of Prematurity. <br><i>New Terms: Retinopathy of Prematurity with Plus Disease</i></td>
            </tr>
            <tr class="addition">
               <td>916</td>
               <td colspan="2">Ribonucleoprotein Antibody Measurement<span class="subclass"> SubClassOf </span>Immunology Test. <br><i>New Terms: Ribonucleoprotein Antibody Measurement</i></td>
            </tr>
            <tr class="addition">
               <td>917</td>
               <td colspan="2">Ringed Sideroblast Measurement<span class="subclass"> SubClassOf </span>Cell Count. <br><i>New Terms: Ringed Sideroblast Measurement</i></td>
            </tr>
            <tr class="addition">
               <td>918</td>
               <td colspan="2">Roland Morris Disability Questionnaire<span class="subclass"> SubClassOf </span>Clinical<br><span class="keyword"> or </span>Research Assessment Questionnaire. <br><i>New Terms: Roland Morris Disability Questionnaire</i></td>
            </tr>
            <tr class="addition">
               <td>919</td>
               <td colspan="2">SCL-Interrupting Locus Protein<span class="subclass"> EquivalentTo </span>Signaling Protein<br><span class="keyword"> and </span>(Gene_Product_Encoded_By_Gene<span class="some"> some </span>STIL Gene)<br><span class="keyword"> and </span>(Gene_Product_Expressed_In_Tissue<span class="some"> some </span>Hematopoietic Tissue)<br><span class="keyword"> and </span>(Gene_Product_Has_Associated_Anatomy<span class="some"> some </span>Centrosome)<br><span class="keyword"> and </span>(Gene_Product_Has_Biochemical_Function<span class="some"> some </span>Signaling Protein)<br><span class="keyword"> and </span>(Gene_Product_Is_Element_In_Pathway<span class="some"> some </span>Hedgehog Family-Mediated Signaling Pathway)<br><span class="keyword"> and </span>(Gene_Product_Plays_Role_In_Biological_Process<span class="some"> some </span>Cell Proliferation Regulatory Process)<br><span class="keyword"> and </span>(Gene_Product_Plays_Role_In_Biological_Process<span class="some"> some </span>Intracellular Signaling Process)<br><span class="keyword"> and </span>(Gene_Product_Plays_Role_In_Biological_Process<span class="some"> some </span>Embryogenesis). <br><i>New Terms: SCL-Interrupting Locus Protein, STIL Gene</i></td>
            </tr>
            <tr class="addition">
               <td>920</td>
               <td colspan="2">SF-MPQ-2 - Aching Pain<span class="subclass"> SubClassOf </span>Short-Form MPQ-2 Questionnaire Question. <br><i>New Terms: Short-Form MPQ-2 Questionnaire Question, SF-MPQ-2 - Aching Pain</i></td>
            </tr>
            <tr class="addition">
               <td>921</td>
               <td colspan="2">SF-MPQ-2 - Cold-Freezing Pain<span class="subclass"> SubClassOf </span>Short-Form MPQ-2 Questionnaire Question. <br><i>New Terms: SF-MPQ-2 - Cold-Freezing Pain, Short-Form MPQ-2 Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>922</td>
               <td colspan="2">SF-MPQ-2 - Cramping Pain<span class="subclass"> SubClassOf </span>Short-Form MPQ-2 Questionnaire Question. <br><i>New Terms: SF-MPQ-2 - Cramping Pain, Short-Form MPQ-2 Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>923</td>
               <td colspan="2">SF-MPQ-2 - Electric-Shock Pain<span class="subclass"> SubClassOf </span>Short-Form MPQ-2 Questionnaire Question. <br><i>New Terms: SF-MPQ-2 - Electric-Shock Pain, Short-Form MPQ-2 Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>924</td>
               <td colspan="2">SF-MPQ-2 - Fearful<span class="subclass"> SubClassOf </span>Short-Form MPQ-2 Questionnaire Question. <br><i>New Terms: SF-MPQ-2 - Fearful, Short-Form MPQ-2 Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>925</td>
               <td colspan="2">SF-MPQ-2 - Gnawing Pain<span class="subclass"> SubClassOf </span>Short-Form MPQ-2 Questionnaire Question. <br><i>New Terms: SF-MPQ-2 - Gnawing Pain, Short-Form MPQ-2 Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>926</td>
               <td colspan="2">SF-MPQ-2 - Heavy Pain<span class="subclass"> SubClassOf </span>Short-Form MPQ-2 Questionnaire Question. <br><i>New Terms: Short-Form MPQ-2 Questionnaire Question, SF-MPQ-2 - Heavy Pain</i></td>
            </tr>
            <tr class="addition">
               <td>927</td>
               <td colspan="2">SF-MPQ-2 - Hot-burning Pain<span class="subclass"> SubClassOf </span>Short-Form MPQ-2 Questionnaire Question. <br><i>New Terms: SF-MPQ-2 - Hot-burning Pain, Short-Form MPQ-2 Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>928</td>
               <td colspan="2">SF-MPQ-2 - Itching<span class="subclass"> SubClassOf </span>Short-Form MPQ-2 Questionnaire Question. <br><i>New Terms: SF-MPQ-2 - Itching, Short-Form MPQ-2 Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>929</td>
               <td colspan="2">SF-MPQ-2 - Numbness<span class="subclass"> SubClassOf </span>Short-Form MPQ-2 Questionnaire Question. <br><i>New Terms: Short-Form MPQ-2 Questionnaire Question, SF-MPQ-2 - Numbness</i></td>
            </tr>
            <tr class="addition">
               <td>930</td>
               <td colspan="2">SF-MPQ-2 - Pain Caused by Light Touch<span class="subclass"> SubClassOf </span>Short-Form MPQ-2 Questionnaire Question. <br><i>New Terms: Short-Form MPQ-2 Questionnaire Question, SF-MPQ-2 - Pain Caused by Light Touch</i></td>
            </tr>
            <tr class="addition">
               <td>931</td>
               <td colspan="2">SF-MPQ-2 - Piercing<span class="subclass"> SubClassOf </span>Short-Form MPQ-2 Questionnaire Question. <br><i>New Terms: Short-Form MPQ-2 Questionnaire Question, SF-MPQ-2 - Piercing</i></td>
            </tr>
            <tr class="addition">
               <td>932</td>
               <td colspan="2">SF-MPQ-2 - Punishing-Cruel<span class="subclass"> SubClassOf </span>Short-Form MPQ-2 Questionnaire Question. <br><i>New Terms: Short-Form MPQ-2 Questionnaire Question, SF-MPQ-2 - Punishing-Cruel</i></td>
            </tr>
            <tr class="addition">
               <td>933</td>
               <td colspan="2">SF-MPQ-2 - Sharp Pain<span class="subclass"> SubClassOf </span>Short-Form MPQ-2 Questionnaire Question. <br><i>New Terms: SF-MPQ-2 - Sharp Pain, Short-Form MPQ-2 Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>934</td>
               <td colspan="2">SF-MPQ-2 - Shooting Pain<span class="subclass"> SubClassOf </span>Short-Form MPQ-2 Questionnaire Question. <br><i>New Terms: SF-MPQ-2 - Shooting Pain, Short-Form MPQ-2 Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>935</td>
               <td colspan="2">SF-MPQ-2 - Sickening<span class="subclass"> SubClassOf </span>Short-Form MPQ-2 Questionnaire Question. <br><i>New Terms: Short-Form MPQ-2 Questionnaire Question, SF-MPQ-2 - Sickening</i></td>
            </tr>
            <tr class="addition">
               <td>936</td>
               <td colspan="2">SF-MPQ-2 - Splitting Pain<span class="subclass"> SubClassOf </span>Short-Form MPQ-2 Questionnaire Question. <br><i>New Terms: SF-MPQ-2 - Splitting Pain, Short-Form MPQ-2 Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>937</td>
               <td colspan="2">SF-MPQ-2 - Stabbing Pain<span class="subclass"> SubClassOf </span>Short-Form MPQ-2 Questionnaire Question. <br><i>New Terms: Short-Form MPQ-2 Questionnaire Question, SF-MPQ-2 - Stabbing Pain</i></td>
            </tr>
            <tr class="addition">
               <td>938</td>
               <td colspan="2">SF-MPQ-2 - Tender<span class="subclass"> SubClassOf </span>Short-Form MPQ-2 Questionnaire Question. <br><i>New Terms: Short-Form MPQ-2 Questionnaire Question, SF-MPQ-2 - Tender</i></td>
            </tr>
            <tr class="addition">
               <td>939</td>
               <td colspan="2">SF-MPQ-2 - Throbbing Pain<span class="subclass"> SubClassOf </span>Short-Form MPQ-2 Questionnaire Question. <br><i>New Terms: Short-Form MPQ-2 Questionnaire Question, SF-MPQ-2 - Throbbing Pain</i></td>
            </tr>
            <tr class="addition">
               <td>940</td>
               <td colspan="2">SF-MPQ-2 - Tingling<br><span class="keyword"> or </span>'Pins<br><span class="keyword"> and </span>Needles'<span class="subclass"> SubClassOf </span>Short-Form MPQ-2 Questionnaire Question. <br><i>New Terms: Short-Form MPQ-2 Questionnaire Question, SF-MPQ-2 - Tingling or 'Pins and Needles'</i></td>
            </tr>
            <tr class="addition">
               <td>941</td>
               <td colspan="2">SF-MPQ-2 - Tiring-Exhausting<span class="subclass"> SubClassOf </span>Short-Form MPQ-2 Questionnaire Question. <br><i>New Terms: SF-MPQ-2 - Tiring-Exhausting, Short-Form MPQ-2 Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>942</td>
               <td colspan="2">SF36 v1.0 Standard - Question 1<span class="subclass"> SubClassOf </span>SF36 v1.0 Standard Questionnaire Question. <br><i>New Terms: SF36 v1.0 Standard - Question 1, SF36 v1.0 Standard Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>943</td>
               <td colspan="2">SF36 v1.0 Standard - Question 10<span class="subclass"> SubClassOf </span>SF36 v1.0 Standard Questionnaire Question. <br><i>New Terms: SF36 v1.0 Standard - Question 10, SF36 v1.0 Standard Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>944</td>
               <td colspan="2">SF36 v1.0 Standard - Question 11a<span class="subclass"> SubClassOf </span>SF36 v1.0 Standard Questionnaire Question. <br><i>New Terms: SF36 v1.0 Standard - Question 11a, SF36 v1.0 Standard Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>945</td>
               <td colspan="2">SF36 v1.0 Standard - Question 11b<span class="subclass"> SubClassOf </span>SF36 v1.0 Standard Questionnaire Question. <br><i>New Terms: SF36 v1.0 Standard - Question 11b, SF36 v1.0 Standard Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>946</td>
               <td colspan="2">SF36 v1.0 Standard - Question 11c<span class="subclass"> SubClassOf </span>SF36 v1.0 Standard Questionnaire Question. <br><i>New Terms: SF36 v1.0 Standard - Question 11c, SF36 v1.0 Standard Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>947</td>
               <td colspan="2">SF36 v1.0 Standard - Question 11d<span class="subclass"> SubClassOf </span>SF36 v1.0 Standard Questionnaire Question. <br><i>New Terms: SF36 v1.0 Standard - Question 11d, SF36 v1.0 Standard Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>948</td>
               <td colspan="2">SF36 v1.0 Standard - Question 2<span class="subclass"> SubClassOf </span>SF36 v1.0 Standard Questionnaire Question. <br><i>New Terms: SF36 v1.0 Standard - Question 2, SF36 v1.0 Standard Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>949</td>
               <td colspan="2">SF36 v1.0 Standard - Question 3a<span class="subclass"> SubClassOf </span>SF36 v1.0 Standard Questionnaire Question. <br><i>New Terms: SF36 v1.0 Standard - Question 3a, SF36 v1.0 Standard Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>950</td>
               <td colspan="2">SF36 v1.0 Standard - Question 3b<span class="subclass"> SubClassOf </span>SF36 v1.0 Standard Questionnaire Question. <br><i>New Terms: SF36 v1.0 Standard - Question 3b, SF36 v1.0 Standard Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>951</td>
               <td colspan="2">SF36 v1.0 Standard - Question 3c<span class="subclass"> SubClassOf </span>SF36 v1.0 Standard Questionnaire Question. <br><i>New Terms: SF36 v1.0 Standard - Question 3c, SF36 v1.0 Standard Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>952</td>
               <td colspan="2">SF36 v1.0 Standard - Question 3d<span class="subclass"> SubClassOf </span>SF36 v1.0 Standard Questionnaire Question. <br><i>New Terms: SF36 v1.0 Standard - Question 3d, SF36 v1.0 Standard Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>953</td>
               <td colspan="2">SF36 v1.0 Standard - Question 3e<span class="subclass"> SubClassOf </span>SF36 v1.0 Standard Questionnaire Question. <br><i>New Terms: SF36 v1.0 Standard - Question 3e, SF36 v1.0 Standard Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>954</td>
               <td colspan="2">SF36 v1.0 Standard - Question 3f<span class="subclass"> SubClassOf </span>SF36 v1.0 Standard Questionnaire Question. <br><i>New Terms: SF36 v1.0 Standard - Question 3f, SF36 v1.0 Standard Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>955</td>
               <td colspan="2">SF36 v1.0 Standard - Question 3g<span class="subclass"> SubClassOf </span>SF36 v1.0 Standard Questionnaire Question. <br><i>New Terms: SF36 v1.0 Standard - Question 3g, SF36 v1.0 Standard Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>956</td>
               <td colspan="2">SF36 v1.0 Standard - Question 3h<span class="subclass"> SubClassOf </span>SF36 v1.0 Standard Questionnaire Question. <br><i>New Terms: SF36 v1.0 Standard - Question 3h, SF36 v1.0 Standard Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>957</td>
               <td colspan="2">SF36 v1.0 Standard - Question 3i<span class="subclass"> SubClassOf </span>SF36 v1.0 Standard Questionnaire Question. <br><i>New Terms: SF36 v1.0 Standard Questionnaire Question, SF36 v1.0 Standard - Question 3i</i></td>
            </tr>
            <tr class="addition">
               <td>958</td>
               <td colspan="2">SF36 v1.0 Standard - Question 3j<span class="subclass"> SubClassOf </span>SF36 v1.0 Standard Questionnaire Question. <br><i>New Terms: SF36 v1.0 Standard Questionnaire Question, SF36 v1.0 Standard - Question 3j</i></td>
            </tr>
            <tr class="addition">
               <td>959</td>
               <td colspan="2">SF36 v1.0 Standard - Question 4a<span class="subclass"> SubClassOf </span>SF36 v1.0 Standard Questionnaire Question. <br><i>New Terms: SF36 v1.0 Standard - Question 4a, SF36 v1.0 Standard Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>960</td>
               <td colspan="2">SF36 v1.0 Standard - Question 4b<span class="subclass"> SubClassOf </span>SF36 v1.0 Standard Questionnaire Question. <br><i>New Terms: SF36 v1.0 Standard - Question 4b, SF36 v1.0 Standard Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>961</td>
               <td colspan="2">SF36 v1.0 Standard - Question 4c<span class="subclass"> SubClassOf </span>SF36 v1.0 Standard Questionnaire Question. <br><i>New Terms: SF36 v1.0 Standard - Question 4c, SF36 v1.0 Standard Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>962</td>
               <td colspan="2">SF36 v1.0 Standard - Question 4d<span class="subclass"> SubClassOf </span>SF36 v1.0 Standard Questionnaire Question. <br><i>New Terms: SF36 v1.0 Standard - Question 4d, SF36 v1.0 Standard Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>963</td>
               <td colspan="2">SF36 v1.0 Standard - Question 5a<span class="subclass"> SubClassOf </span>SF36 v1.0 Standard Questionnaire Question. <br><i>New Terms: SF36 v1.0 Standard - Question 5a, SF36 v1.0 Standard Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>964</td>
               <td colspan="2">SF36 v1.0 Standard - Question 5b<span class="subclass"> SubClassOf </span>SF36 v1.0 Standard Questionnaire Question. <br><i>New Terms: SF36 v1.0 Standard - Question 5b, SF36 v1.0 Standard Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>965</td>
               <td colspan="2">SF36 v1.0 Standard - Question 5c<span class="subclass"> SubClassOf </span>SF36 v1.0 Standard Questionnaire Question. <br><i>New Terms: SF36 v1.0 Standard - Question 5c, SF36 v1.0 Standard Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>966</td>
               <td colspan="2">SF36 v1.0 Standard - Question 6<span class="subclass"> SubClassOf </span>SF36 v1.0 Standard Questionnaire Question. <br><i>New Terms: SF36 v1.0 Standard - Question 6, SF36 v1.0 Standard Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>967</td>
               <td colspan="2">SF36 v1.0 Standard - Question 7<span class="subclass"> SubClassOf </span>SF36 v1.0 Standard Questionnaire Question. <br><i>New Terms: SF36 v1.0 Standard - Question 7, SF36 v1.0 Standard Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>968</td>
               <td colspan="2">SF36 v1.0 Standard - Question 8<span class="subclass"> SubClassOf </span>SF36 v1.0 Standard Questionnaire Question. <br><i>New Terms: SF36 v1.0 Standard - Question 8, SF36 v1.0 Standard Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>969</td>
               <td colspan="2">SF36 v1.0 Standard - Question 9a<span class="subclass"> SubClassOf </span>SF36 v1.0 Standard Questionnaire Question. <br><i>New Terms: SF36 v1.0 Standard - Question 9a, SF36 v1.0 Standard Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>970</td>
               <td colspan="2">SF36 v1.0 Standard - Question 9b<span class="subclass"> SubClassOf </span>SF36 v1.0 Standard Questionnaire Question. <br><i>New Terms: SF36 v1.0 Standard - Question 9b, SF36 v1.0 Standard Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>971</td>
               <td colspan="2">SF36 v1.0 Standard - Question 9c<span class="subclass"> SubClassOf </span>SF36 v1.0 Standard Questionnaire Question. <br><i>New Terms: SF36 v1.0 Standard - Question 9c, SF36 v1.0 Standard Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>972</td>
               <td colspan="2">SF36 v1.0 Standard - Question 9d<span class="subclass"> SubClassOf </span>SF36 v1.0 Standard Questionnaire Question. <br><i>New Terms: SF36 v1.0 Standard - Question 9d, SF36 v1.0 Standard Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>973</td>
               <td colspan="2">SF36 v1.0 Standard - Question 9e<span class="subclass"> SubClassOf </span>SF36 v1.0 Standard Questionnaire Question. <br><i>New Terms: SF36 v1.0 Standard Questionnaire Question, SF36 v1.0 Standard - Question 9e</i></td>
            </tr>
            <tr class="addition">
               <td>974</td>
               <td colspan="2">SF36 v1.0 Standard - Question 9f<span class="subclass"> SubClassOf </span>SF36 v1.0 Standard Questionnaire Question. <br><i>New Terms: SF36 v1.0 Standard Questionnaire Question, SF36 v1.0 Standard - Question 9f</i></td>
            </tr>
            <tr class="addition">
               <td>975</td>
               <td colspan="2">SF36 v1.0 Standard - Question 9g<span class="subclass"> SubClassOf </span>SF36 v1.0 Standard Questionnaire Question. <br><i>New Terms: SF36 v1.0 Standard - Question 9g, SF36 v1.0 Standard Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>976</td>
               <td colspan="2">SF36 v1.0 Standard - Question 9h<span class="subclass"> SubClassOf </span>SF36 v1.0 Standard Questionnaire Question. <br><i>New Terms: SF36 v1.0 Standard - Question 9h, SF36 v1.0 Standard Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>977</td>
               <td colspan="2">SF36 v1.0 Standard - Question 9i<span class="subclass"> SubClassOf </span>SF36 v1.0 Standard Questionnaire Question. <br><i>New Terms: SF36 v1.0 Standard - Question 9i, SF36 v1.0 Standard Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>978</td>
               <td colspan="2">SF36 v1.0 Standard Questionnaire Question<span class="subclass"> SubClassOf </span>Clinical<br><span class="keyword"> or </span>Research Assessment Question. <br><i>New Terms: SF36 v1.0 Standard Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>979</td>
               <td colspan="2">SOAPP-R - Any Additional Information<span class="subclass"> SubClassOf </span>SOAPP-R Questionnaire Question. <br><i>New Terms: SOAPP-R Questionnaire Question, SOAPP-R - Any Additional Information</i></td>
            </tr>
            <tr class="addition">
               <td>980</td>
               <td colspan="2">SOAPP-R - Argument Where Someone Got Hurt<span class="subclass"> SubClassOf </span>SOAPP-R Questionnaire Question. <br><i>New Terms: SOAPP-R - Argument Where Someone Got Hurt, SOAPP-R Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>981</td>
               <td colspan="2">SOAPP-R - Attended AA<br><span class="keyword"> or </span>NA Meeting<span class="subclass"> SubClassOf </span>SOAPP-R Questionnaire Question. <br><i>New Terms: SOAPP-R Questionnaire Question, SOAPP-R - Attended AA or NA Meeting</i></td>
            </tr>
            <tr class="addition">
               <td>982</td>
               <td colspan="2">SOAPP-R - Concerned People Will Judge You<span class="subclass"> SubClassOf </span>SOAPP-R Questionnaire Question. <br><i>New Terms: SOAPP-R - Concerned People Will Judge You, SOAPP-R Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>983</td>
               <td colspan="2">SOAPP-R - Felt Consumed to Get Pain Medication<span class="subclass"> SubClassOf </span>SOAPP-R Questionnaire Question. <br><i>New Terms: SOAPP-R Questionnaire Question, SOAPP-R - Felt Consumed to Get Pain Medication</i></td>
            </tr>
            <tr class="addition">
               <td>984</td>
               <td colspan="2">SOAPP-R - Felt Craving for Medication<span class="subclass"> SubClassOf </span>SOAPP-R Questionnaire Question. <br><i>New Terms: SOAPP-R Questionnaire Question, SOAPP-R - Felt Craving for Medication</i></td>
            </tr>
            <tr class="addition">
               <td>985</td>
               <td colspan="2">SOAPP-R - Felt Impatient With Doctors<span class="subclass"> SubClassOf </span>SOAPP-R Questionnaire Question. <br><i>New Terms: SOAPP-R Questionnaire Question, SOAPP-R - Felt Impatient With Doctors</i></td>
            </tr>
            <tr class="addition">
               <td>986</td>
               <td colspan="2">SOAPP-R - Felt That Things Are Overwhelming<span class="subclass"> SubClassOf </span>SOAPP-R Questionnaire Question. <br><i>New Terms: SOAPP-R - Felt That Things Are Overwhelming, SOAPP-R Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>987</td>
               <td colspan="2">SOAPP-R - How Often Borrowed Pain Medication<span class="subclass"> SubClassOf </span>SOAPP-R Questionnaire Question. <br><i>New Terms: SOAPP-R Questionnaire Question, SOAPP-R - How Often Borrowed Pain Medication</i></td>
            </tr>
            <tr class="addition">
               <td>988</td>
               <td colspan="2">SOAPP-R - How Often Counted Pain Pills<span class="subclass"> SubClassOf </span>SOAPP-R Questionnaire Question. <br><i>New Terms: SOAPP-R Questionnaire Question, SOAPP-R - How Often Counted Pain Pills</i></td>
            </tr>
            <tr class="addition">
               <td>989</td>
               <td colspan="2">SOAPP-R - How Often Feel Bored<span class="subclass"> SubClassOf </span>SOAPP-R Questionnaire Question. <br><i>New Terms: SOAPP-R Questionnaire Question, SOAPP-R - How Often Feel Bored</i></td>
            </tr>
            <tr class="addition">
               <td>990</td>
               <td colspan="2">SOAPP-R - How Often Friends Had Problem<span class="subclass"> SubClassOf </span>SOAPP-R Questionnaire Question. <br><i>New Terms: SOAPP-R - How Often Friends Had Problem, SOAPP-R Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>991</td>
               <td colspan="2">SOAPP-R - How Often Mood Swings<span class="subclass"> SubClassOf </span>SOAPP-R Questionnaire Question. <br><i>New Terms: SOAPP-R Questionnaire Question, SOAPP-R - How Often Mood Swings</i></td>
            </tr>
            <tr class="addition">
               <td>992</td>
               <td colspan="2">SOAPP-R - How Often Sexually Abused<span class="subclass"> SubClassOf </span>SOAPP-R Questionnaire Question. <br><i>New Terms: SOAPP-R Questionnaire Question, SOAPP-R - How Often Sexually Abused</i></td>
            </tr>
            <tr class="addition">
               <td>993</td>
               <td colspan="2">SOAPP-R - How Often Taken More Pain Medication<span class="subclass"> SubClassOf </span>SOAPP-R Questionnaire Question. <br><i>New Terms: SOAPP-R Questionnaire Question, SOAPP-R - How Often Taken More Pain Medication</i></td>
            </tr>
            <tr class="addition">
               <td>994</td>
               <td colspan="2">SOAPP-R - How Often Tension at Home<span class="subclass"> SubClassOf </span>SOAPP-R Questionnaire Question. <br><i>New Terms: SOAPP-R Questionnaire Question, SOAPP-R - How Often Tension at Home</i></td>
            </tr>
            <tr class="addition">
               <td>995</td>
               <td colspan="2">SOAPP-R - Legal Problems<br><span class="keyword"> or </span>Arrested<span class="subclass"> SubClassOf </span>SOAPP-R Questionnaire Question. <br><i>New Terms: SOAPP-R Questionnaire Question, SOAPP-R - Legal Problems or Arrested</i></td>
            </tr>
            <tr class="addition">
               <td>996</td>
               <td colspan="2">SOAPP-R - Need Higher Doses of Medication<span class="subclass"> SubClassOf </span>SOAPP-R Questionnaire Question. <br><i>New Terms: SOAPP-R Questionnaire Question, SOAPP-R - Need Higher Doses of Medication</i></td>
            </tr>
            <tr class="addition">
               <td>997</td>
               <td colspan="2">SOAPP-R - Others Expressed Concern Over Medication Use<span class="subclass"> SubClassOf </span>SOAPP-R Questionnaire Question. <br><i>New Terms: SOAPP-R - Others Expressed Concern Over Medication Use, SOAPP-R Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>998</td>
               <td colspan="2">SOAPP-R - Others Kept You From what You Deserve<span class="subclass"> SubClassOf </span>SOAPP-R Questionnaire Question. <br><i>New Terms: SOAPP-R Questionnaire Question, SOAPP-R - Others Kept You From what You Deserve</i></td>
            </tr>
            <tr class="addition">
               <td>999</td>
               <td colspan="2">SOAPP-R - Others Suggested Drug<br><span class="keyword"> or </span>Alcohol Problem<span class="subclass"> SubClassOf </span>SOAPP-R Questionnaire Question. <br><i>New Terms: SOAPP-R Questionnaire Question, SOAPP-R - Others Suggested Drug or Alcohol Problem</i></td>
            </tr>
            <tr class="addition">
               <td>1000</td>
               <td colspan="2">SOAPP-R - Others Told You Bad Temper<span class="subclass"> SubClassOf </span>SOAPP-R Questionnaire Question. <br><i>New Terms: SOAPP-R Questionnaire Question, SOAPP-R - Others Told You Bad Temper</i></td>
            </tr>
            <tr class="addition">
               <td>1001</td>
               <td colspan="2">SOAPP-R - Run Out of Pain Medication Early<span class="subclass"> SubClassOf </span>SOAPP-R Questionnaire Question. <br><i>New Terms: SOAPP-R Questionnaire Question, SOAPP-R - Run Out of Pain Medication Early</i></td>
            </tr>
            <tr class="addition">
               <td>1002</td>
               <td colspan="2">SOAPP-R - Score<span class="subclass"> SubClassOf </span>SOAPP-R Questionnaire Question. <br><i>New Terms: SOAPP-R - Score, SOAPP-R Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>1003</td>
               <td colspan="2">SOAPP-R - Treated for Alcohol<br><span class="keyword"> or </span>Drug Problem<span class="subclass"> SubClassOf </span>SOAPP-R Questionnaire Question. <br><i>New Terms: SOAPP-R Questionnaire Question, SOAPP-R - Treated for Alcohol or Drug Problem</i></td>
            </tr>
            <tr class="addition">
               <td>1004</td>
               <td colspan="2">SOAPP-R - Worried About Being Left Alone<span class="subclass"> SubClassOf </span>SOAPP-R Questionnaire Question. <br><i>New Terms: SOAPP-R Questionnaire Question, SOAPP-R - Worried About Being Left Alone</i></td>
            </tr>
            <tr class="addition">
               <td>1005</td>
               <td colspan="2">SOAPP-R Questionnaire Question<span class="subclass"> SubClassOf </span>Clinical<br><span class="keyword"> or </span>Research Assessment Question. <br><i>New Terms: SOAPP-R Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>1006</td>
               <td colspan="2">SRSF2 Gene<span class="subclass"> SubClassOf </span>Gene_Plays_Role_In_Process<span class="some"> some </span>RNA Binding. <br><i>New Terms: SRSF2 Gene</i></td>
            </tr>
            <tr class="addition">
               <td>1007</td>
               <td colspan="2">SRSF2 Gene<span class="subclass"> SubClassOf </span>Gene_Plays_Role_In_Process<span class="some"> some </span>RNA Splicing. <br><i>New Terms: SRSF2 Gene</i></td>
            </tr>
            <tr class="addition">
               <td>1008</td>
               <td colspan="2">SRSF2 Gene<span class="subclass"> SubClassOf </span>Gene_Plays_Role_In_Process<span class="some"> some </span>Transcription Termination. <br><i>New Terms: SRSF2 Gene</i></td>
            </tr>
            <tr class="addition">
               <td>1009</td>
               <td colspan="2">SRSF2 Gene<span class="subclass"> SubClassOf </span>Gene_Plays_Role_In_Process<span class="some"> some </span>mRNA Export. <br><i>New Terms: SRSF2 Gene</i></td>
            </tr>
            <tr class="addition">
               <td>1010</td>
               <td colspan="2">SRSF2 Gene<span class="subclass"> SubClassOf </span>mRNA Transport Gene. <br><i>New Terms: SRSF2 Gene</i></td>
            </tr>
            <tr class="addition">
               <td>1011</td>
               <td colspan="2">SRSF2 wt Allele<span class="subclass"> EquivalentTo </span>SRSF2 Gene<br><span class="keyword"> and </span>(Gene_In_Chromosomal_Location<span class="some"> some </span>17q25.1)<br><span class="keyword"> and </span>(Gene_Is_Element_In_Pathway<span class="some"> some </span>Spliceosome Assembly Pathway)<br><span class="keyword"> and </span>(Gene_Is_Element_In_Pathway<span class="some"> some </span>Spliceosome Pathway). <br><i>New Terms: SRSF2 Gene, SRSF2 wt Allele</i></td>
            </tr>
            <tr class="addition">
               <td>1012</td>
               <td colspan="2">SS18L1/SSX1 Fusion Gene<span class="subclass"> SubClassOf </span>Fusion Gene. <br><i>New Terms: SS18L1/SSX1 Fusion Gene</i></td>
            </tr>
            <tr class="addition">
               <td>1013</td>
               <td colspan="2">SS18L1/SSX1 Fusion Protein<span class="subclass"> SubClassOf </span>Fusion Protein. <br><i>New Terms: SS18L1/SSX1 Fusion Protein</i></td>
            </tr>
            <tr class="addition">
               <td>1014</td>
               <td colspan="2">SS18L1/SSX1 Fusion Protein<span class="subclass"> SubClassOf </span>Gene_Product_Encoded_By_Gene<span class="some"> some </span>SS18L1/SSX1 Fusion Gene. <br><i>New Terms: SS18L1/SSX1 Fusion Gene, SS18L1/SSX1 Fusion Protein</i></td>
            </tr>
            <tr class="addition">
               <td>1015</td>
               <td colspan="2">STIL Gene<span class="subclass"> SubClassOf </span>Gene_Plays_Role_In_Process<span class="some"> some </span>Cell Proliferation Regulatory Process. <br><i>New Terms: STIL Gene</i></td>
            </tr>
            <tr class="addition">
               <td>1017</td>
               <td colspan="2">STIL Gene<span class="subclass"> SubClassOf </span>Gene_Plays_Role_In_Process<span class="some"> some </span>Embryogenesis. <br><i>New Terms: STIL Gene</i></td>
            </tr>
            <tr class="addition">
               <td>1016</td>
               <td colspan="2">STIL Gene<span class="subclass"> SubClassOf </span>Gene_Plays_Role_In_Process<span class="some"> some </span>Intracellular Signaling Process. <br><i>New Terms: STIL Gene</i></td>
            </tr>
            <tr class="addition">
               <td>1018</td>
               <td colspan="2">STIL Gene<span class="subclass"> SubClassOf </span>Signaling Pathway Gene. <br><i>New Terms: STIL Gene</i></td>
            </tr>
            <tr class="addition">
               <td>1019</td>
               <td colspan="2">STIL wt Allele<span class="subclass"> EquivalentTo </span>STIL Gene<br><span class="keyword"> and </span>(Gene_In_Chromosomal_Location<span class="some"> some </span>1p32)<br><span class="keyword"> and </span>(Gene_Is_Element_In_Pathway<span class="some"> some </span>Hedgehog Family-Mediated Signaling Pathway). <br><i>New Terms: STIL Gene, STIL wt Allele</i></td>
            </tr>
            <tr class="addition">
               <td>1020</td>
               <td colspan="2">Scl-70 Antibody Measurement<span class="subclass"> SubClassOf </span>Immunology Test. <br><i>New Terms: Scl-70 Antibody Measurement</i></td>
            </tr>
            <tr class="addition">
               <td>1021</td>
               <td colspan="2">Screener<br><span class="keyword"> and </span>Opioid Assessment for Patients with Pain Revised Questionnaire<span class="subclass"> SubClassOf </span>Clinical<br><span class="keyword"> or </span>Research Assessment Questionnaire. <br><i>New Terms: Screener and Opioid Assessment for Patients with Pain Revised Questionnaire</i></td>
            </tr>
            <tr class="addition">
               <td>1022</td>
               <td colspan="2">Serine/Arginine-Rich Splicing Factor 2<span class="subclass"> EquivalentTo </span>RNA Binding Protein<br><span class="keyword"> and </span>(Gene_Product_Encoded_By_Gene<span class="some"> some </span>SRSF2 Gene)<br><span class="keyword"> and </span>(Gene_Product_Has_Associated_Anatomy<span class="some"> some </span>Nucleus)<br><span class="keyword"> and </span>(Gene_Product_Has_Biochemical_Function<span class="some"> some </span>RNA Binding Protein)<br><span class="keyword"> and </span>(Gene_Product_Has_Structural_Domain_Or_Motif<span class="some"> some </span>RNA Recognition Motif)<br><span class="keyword"> and </span>(Gene_Product_Is_Element_In_Pathway<span class="some"> some </span>Spliceosome Assembly Pathway)<br><span class="keyword"> and </span>(Gene_Product_Is_Element_In_Pathway<span class="some"> some </span>Spliceosome Pathway)<br><span class="keyword"> and </span>(Gene_Product_Plays_Role_In_Biological_Process<span class="some"> some </span>RNA Binding)<br><span class="keyword"> and </span>(Gene_Product_Plays_Role_In_Biological_Process<span class="some"> some </span>RNA Splicing)<br><span class="keyword"> and </span>(Gene_Product_Plays_Role_In_Biological_Process<span class="some"> some </span>Transcription Termination)<br><span class="keyword"> and </span>(Gene_Product_Plays_Role_In_Biological_Process<span class="some"> some </span>mRNA Export). <br><i>New Terms: SRSF2 Gene, Serine/Arginine-Rich Splicing Factor 2</i></td>
            </tr>
            <tr class="addition">
               <td>1023</td>
               <td colspan="2">Sexual Partner<span class="subclass"> SubClassOf </span>Partner. <br><i>New Terms: Sexual Partner, Partner</i></td>
            </tr>
            <tr class="addition">
               <td>1026</td>
               <td colspan="2">Short Form 36 Health Survey Standard, US Version 1.0 Questionnaire<span class="subclass"> SubClassOf </span>SF-36. <br><i>New Terms: Short Form 36 Health Survey Standard, US Version 1.0 Questionnaire</i></td>
            </tr>
            <tr class="addition">
               <td>1027</td>
               <td colspan="2">Short Segment Hirschsprung Disease<span class="subclass"> SubClassOf </span>Aganglionic Megacolon. <br><i>New Terms: Short Segment Hirschsprung Disease</i></td>
            </tr>
            <tr class="addition">
               <td>1024</td>
               <td colspan="2">Short-Form MPQ-2 Questionnaire Question<span class="subclass"> SubClassOf </span>Clinical<br><span class="keyword"> or </span>Research Assessment Question. <br><i>New Terms: Short-Form MPQ-2 Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>1025</td>
               <td colspan="2">Short-Form McGill Pain Questionnaire-2<span class="subclass"> SubClassOf </span>Clinical<br><span class="keyword"> or </span>Research Assessment Questionnaire. <br><i>New Terms: Short-Form McGill Pain Questionnaire-2</i></td>
            </tr>
            <tr class="addition">
               <td>1028</td>
               <td colspan="2">Sideroblast Measurement<span class="subclass"> SubClassOf </span>Cell Count. <br><i>New Terms: Sideroblast Measurement</i></td>
            </tr>
            <tr class="addition">
               <td>1029</td>
               <td colspan="2">Sign<br><span class="keyword"> or </span>Symptom<span class="subclass"> SubClassOf </span>Finding. <br><i>New Terms: Sign or Symptom</i></td>
            </tr>
            <tr class="addition">
               <td>1030</td>
               <td colspan="2">Soluble Transferrin Receptor Measurement<span class="subclass"> SubClassOf </span>Protein<br><span class="keyword"> or </span>Enzyme<span class="subclass"> Type </span>Measurement. <br><i>New Terms: Soluble Transferrin Receptor Measurement</i></td>
            </tr>
            <tr class="addition">
               <td>1031</td>
               <td colspan="2">Spina Bifida Occulta<span class="subclass"> SubClassOf </span>Myelocele. <br><i>New Terms: Spina Bifida Occulta</i></td>
            </tr>
            <tr class="addition">
               <td>1032</td>
               <td colspan="2">Splicing Factor U2AF 35 kDa Subunit<span class="subclass"> EquivalentTo </span>RNA Binding Protein<br><span class="keyword"> and </span>(Gene_Product_Encoded_By_Gene<span class="some"> some </span>U2AF1 Gene)<br><span class="keyword"> and </span>(Gene_Product_Has_Associated_Anatomy<span class="some"> some </span>Nucleus)<br><span class="keyword"> and </span>(Gene_Product_Has_Biochemical_Function<span class="some"> some </span>RNA Binding Protein)<br><span class="keyword"> and </span>(Gene_Product_Has_Structural_Domain_Or_Motif<span class="some"> some </span>RNA Recognition Motif)<br><span class="keyword"> and </span>(Gene_Product_Is_Element_In_Pathway<span class="some"> some </span>Shigellosis Pathway)<br><span class="keyword"> and </span>(Gene_Product_Is_Element_In_Pathway<span class="some"> some </span>Spliceosome Assembly Pathway)<br><span class="keyword"> and </span>(Gene_Product_Is_Element_In_Pathway<span class="some"> some </span>Spliceosome Pathway)<br><span class="keyword"> and </span>(Gene_Product_Plays_Role_In_Biological_Process<span class="some"> some </span>RNA Binding)<br><span class="keyword"> and </span>(Gene_Product_Plays_Role_In_Biological_Process<span class="some"> some </span>RNA Splicing)<br><span class="keyword"> and </span>(Gene_Product_Plays_Role_In_Biological_Process<span class="some"> some </span>Transcription Termination)<br><span class="keyword"> and </span>(Gene_Product_Plays_Role_In_Biological_Process<span class="some"> some </span>mRNA Export). <br><i>New Terms: U2AF1 Gene, Splicing Factor U2AF 35 kDa Subunit</i></td>
            </tr>
            <tr class="addition">
               <td>1033</td>
               <td colspan="2">Synthetic Breast Cancer Peptides-Tetanus Toxoid-Poly ICLC Vaccine<span class="subclass"> SubClassOf </span>Antineoplastic Vaccine. <br><i>New Terms: Synthetic Breast Cancer Peptides-Tetanus Toxoid-Poly ICLC Vaccine</i></td>
            </tr>
            <tr class="addition">
               <td>1034</td>
               <td colspan="2">TFG/ALK Extra Long Form Fusion Gene<span class="subclass"> SubClassOf </span>Gene_Plays_Role_In_Process<span class="some"> some </span>Tyrosine Phosphorylation. <br><i>New Terms: TFG/ALK Extra Long Form Fusion Gene</i></td>
            </tr>
            <tr class="addition">
               <td>1035</td>
               <td colspan="2">TFG/ALK Extra Long Form Fusion Gene<span class="subclass"> SubClassOf </span>TFG/ALK Fusion Gene. <br><i>New Terms: TFG/ALK Fusion Gene, TFG/ALK Extra Long Form Fusion Gene</i></td>
            </tr>
            <tr class="addition">
               <td>1036</td>
               <td colspan="2">TFG/ALK Extra Long Form Fusion Protein<span class="subclass"> SubClassOf </span>Gene_Product_Encoded_By_Gene<span class="some"> some </span>TFG/ALK Extra Long Form Fusion Gene. <br><i>New Terms: TFG/ALK Extra Long Form Fusion Gene, TFG/ALK Extra Long Form Fusion Protein</i></td>
            </tr>
            <tr class="addition">
               <td>1037</td>
               <td colspan="2">TFG/ALK Extra Long Form Fusion Protein<span class="subclass"> SubClassOf </span>Gene_Product_Plays_Role_In_Biological_Process<span class="some"> some </span>Tyrosine Phosphorylation. <br><i>New Terms: TFG/ALK Extra Long Form Fusion Protein</i></td>
            </tr>
            <tr class="addition">
               <td>1038</td>
               <td colspan="2">TFG/ALK Extra Long Form Fusion Protein<span class="subclass"> SubClassOf </span>TFG/ALK Fusion Protein. <br><i>New Terms: TFG/ALK Fusion Protein, TFG/ALK Extra Long Form Fusion Protein</i></td>
            </tr>
            <tr class="addition">
               <td>1039</td>
               <td colspan="2">TFG/ALK Fusion Gene<span class="subclass"> SubClassOf </span>Fusion Gene. <br><i>New Terms: TFG/ALK Fusion Gene</i></td>
            </tr>
            <tr class="addition">
               <td>1040</td>
               <td colspan="2">TFG/ALK Fusion Gene<span class="subclass"> SubClassOf </span>Gene_Involved_In_Pathogenesis_Of_Disease<span class="some"> some </span>Anaplastic Large Cell Lymphoma, ALK-Positive. <br><i>New Terms: TFG/ALK Fusion Gene</i></td>
            </tr>
            <tr class="addition">
               <td>1041</td>
               <td colspan="2">TFG/ALK Fusion Gene<span class="subclass"> SubClassOf </span>Gene_Plays_Role_In_Process<span class="some"> some </span>Tyrosine Phosphorylation. <br><i>New Terms: TFG/ALK Fusion Gene</i></td>
            </tr>
            <tr class="addition">
               <td>1042</td>
               <td colspan="2">TFG/ALK Fusion Protein<span class="subclass"> SubClassOf </span>Fusion Protein. <br><i>New Terms: TFG/ALK Fusion Protein</i></td>
            </tr>
            <tr class="addition">
               <td>1043</td>
               <td colspan="2">TFG/ALK Fusion Protein<span class="subclass"> SubClassOf </span>Gene_Product_Encoded_By_Gene<span class="some"> some </span>TFG/ALK Fusion Gene. <br><i>New Terms: TFG/ALK Fusion Protein, TFG/ALK Fusion Gene</i></td>
            </tr>
            <tr class="addition">
               <td>1044</td>
               <td colspan="2">TFG/ALK Fusion Protein<span class="subclass"> SubClassOf </span>Gene_Product_Plays_Role_In_Biological_Process<span class="some"> some </span>Tyrosine Phosphorylation. <br><i>New Terms: TFG/ALK Fusion Protein</i></td>
            </tr>
            <tr class="addition">
               <td>1045</td>
               <td colspan="2">TFG/ALK Long Form Fusion Gene<span class="subclass"> SubClassOf </span>Gene_Plays_Role_In_Process<span class="some"> some </span>Tyrosine Phosphorylation. <br><i>New Terms: TFG/ALK Long Form Fusion Gene</i></td>
            </tr>
            <tr class="addition">
               <td>1046</td>
               <td colspan="2">TFG/ALK Long Form Fusion Gene<span class="subclass"> SubClassOf </span>TFG/ALK Fusion Gene. <br><i>New Terms: TFG/ALK Fusion Gene, TFG/ALK Long Form Fusion Gene</i></td>
            </tr>
            <tr class="addition">
               <td>1047</td>
               <td colspan="2">TFG/ALK Long Form Fusion Protein<span class="subclass"> SubClassOf </span>Gene_Product_Encoded_By_Gene<span class="some"> some </span>TFG/ALK Long Form Fusion Gene. <br><i>New Terms: TFG/ALK Long Form Fusion Protein, TFG/ALK Long Form Fusion Gene</i></td>
            </tr>
            <tr class="addition">
               <td>1048</td>
               <td colspan="2">TFG/ALK Long Form Fusion Protein<span class="subclass"> SubClassOf </span>Gene_Product_Plays_Role_In_Biological_Process<span class="some"> some </span>Tyrosine Phosphorylation. <br><i>New Terms: TFG/ALK Long Form Fusion Protein</i></td>
            </tr>
            <tr class="addition">
               <td>1049</td>
               <td colspan="2">TFG/ALK Long Form Fusion Protein<span class="subclass"> SubClassOf </span>TFG/ALK Fusion Protein. <br><i>New Terms: TFG/ALK Long Form Fusion Protein, TFG/ALK Fusion Protein</i></td>
            </tr>
            <tr class="addition">
               <td>1050</td>
               <td colspan="2">TFG/ALK Short Form Fusion Gene<span class="subclass"> SubClassOf </span>Gene_Plays_Role_In_Process<span class="some"> some </span>Tyrosine Phosphorylation. <br><i>New Terms: TFG/ALK Short Form Fusion Gene</i></td>
            </tr>
            <tr class="addition">
               <td>1051</td>
               <td colspan="2">TFG/ALK Short Form Fusion Gene<span class="subclass"> SubClassOf </span>TFG/ALK Fusion Gene. <br><i>New Terms: TFG/ALK Short Form Fusion Gene, TFG/ALK Fusion Gene</i></td>
            </tr>
            <tr class="addition">
               <td>1052</td>
               <td colspan="2">TFG/ALK Short Form Fusion Protein<span class="subclass"> SubClassOf </span>Gene_Product_Encoded_By_Gene<span class="some"> some </span>TFG/ALK Short Form Fusion Gene. <br><i>New Terms: TFG/ALK Short Form Fusion Gene, TFG/ALK Short Form Fusion Protein</i></td>
            </tr>
            <tr class="addition">
               <td>1053</td>
               <td colspan="2">TFG/ALK Short Form Fusion Protein<span class="subclass"> SubClassOf </span>Gene_Product_Plays_Role_In_Biological_Process<span class="some"> some </span>Tyrosine Phosphorylation. <br><i>New Terms: TFG/ALK Short Form Fusion Protein</i></td>
            </tr>
            <tr class="addition">
               <td>1054</td>
               <td colspan="2">TFG/ALK Short Form Fusion Protein<span class="subclass"> SubClassOf </span>TFG/ALK Fusion Protein. <br><i>New Terms: TFG/ALK Fusion Protein, TFG/ALK Short Form Fusion Protein</i></td>
            </tr>
            <tr class="addition">
               <td>1055</td>
               <td colspan="2">TPM3/ALK Fusion Gene<span class="subclass"> SubClassOf </span>Fusion Gene. <br><i>New Terms: TPM3/ALK Fusion Gene</i></td>
            </tr>
            <tr class="addition">
               <td>1056</td>
               <td colspan="2">TPM3/ALK Fusion Gene<span class="subclass"> SubClassOf </span>Gene_Involved_In_Pathogenesis_Of_Disease<span class="some"> some </span>Anaplastic Large Cell Lymphoma, ALK-Positive. <br><i>New Terms: TPM3/ALK Fusion Gene</i></td>
            </tr>
            <tr class="addition">
               <td>1057</td>
               <td colspan="2">TPM3/ALK Fusion Gene<span class="subclass"> SubClassOf </span>Gene_Involved_In_Pathogenesis_Of_Disease<span class="some"> some </span>Inflammatory Myofibroblastic Tumor. <br><i>New Terms: TPM3/ALK Fusion Gene</i></td>
            </tr>
            <tr class="addition">
               <td>1058</td>
               <td colspan="2">TPM3/ALK Fusion Gene<span class="subclass"> SubClassOf </span>Gene_Plays_Role_In_Process<span class="some"> some </span>Tyrosine Phosphorylation. <br><i>New Terms: TPM3/ALK Fusion Gene</i></td>
            </tr>
            <tr class="addition">
               <td>1059</td>
               <td colspan="2">TPM3/ALK Fusion Protein<span class="subclass"> SubClassOf </span>Fusion Protein. <br><i>New Terms: TPM3/ALK Fusion Protein</i></td>
            </tr>
            <tr class="addition">
               <td>1060</td>
               <td colspan="2">TPM3/ALK Fusion Protein<span class="subclass"> SubClassOf </span>Gene_Product_Encoded_By_Gene<span class="some"> some </span>TPM3/ALK Fusion Gene. <br><i>New Terms: TPM3/ALK Fusion Protein, TPM3/ALK Fusion Gene</i></td>
            </tr>
            <tr class="addition">
               <td>1061</td>
               <td colspan="2">TPM3/ALK Fusion Protein<span class="subclass"> SubClassOf </span>Gene_Product_Plays_Role_In_Biological_Process<span class="some"> some </span>Tyrosine Phosphorylation. <br><i>New Terms: TPM3/ALK Fusion Protein</i></td>
            </tr>
            <tr class="addition">
               <td>1062</td>
               <td colspan="2">TPM4/ALK Fusion Gene<span class="subclass"> SubClassOf </span>Fusion Gene. <br><i>New Terms: TPM4/ALK Fusion Gene</i></td>
            </tr>
            <tr class="addition">
               <td>1063</td>
               <td colspan="2">TPM4/ALK Fusion Gene<span class="subclass"> SubClassOf </span>Gene_Involved_In_Pathogenesis_Of_Disease<span class="some"> some </span>Anaplastic Large Cell Lymphoma, ALK-Positive. <br><i>New Terms: TPM4/ALK Fusion Gene</i></td>
            </tr>
            <tr class="addition">
               <td>1064</td>
               <td colspan="2">TPM4/ALK Fusion Gene<span class="subclass"> SubClassOf </span>Gene_Involved_In_Pathogenesis_Of_Disease<span class="some"> some </span>Inflammatory Myofibroblastic Tumor. <br><i>New Terms: TPM4/ALK Fusion Gene</i></td>
            </tr>
            <tr class="addition">
               <td>1065</td>
               <td colspan="2">TPM4/ALK Fusion Gene<span class="subclass"> SubClassOf </span>Gene_Plays_Role_In_Process<span class="some"> some </span>Tyrosine Phosphorylation. <br><i>New Terms: TPM4/ALK Fusion Gene</i></td>
            </tr>
            <tr class="addition">
               <td>1066</td>
               <td colspan="2">TPM4/ALK Fusion Protein<span class="subclass"> SubClassOf </span>Fusion Protein. <br><i>New Terms: TPM4/ALK Fusion Protein</i></td>
            </tr>
            <tr class="addition">
               <td>1067</td>
               <td colspan="2">TPM4/ALK Fusion Protein<span class="subclass"> SubClassOf </span>Gene_Product_Encoded_By_Gene<span class="some"> some </span>TPM4/ALK Fusion Gene. <br><i>New Terms: TPM4/ALK Fusion Gene, TPM4/ALK Fusion Protein</i></td>
            </tr>
            <tr class="addition">
               <td>1068</td>
               <td colspan="2">TPM4/ALK Fusion Protein<span class="subclass"> SubClassOf </span>Gene_Product_Plays_Role_In_Biological_Process<span class="some"> some </span>Tyrosine Phosphorylation. <br><i>New Terms: TPM4/ALK Fusion Protein</i></td>
            </tr>
            <tr class="addition">
               <td>1069</td>
               <td colspan="2">Task<span class="subclass"> SubClassOf </span>Work. <br><i>New Terms: Task</i></td>
            </tr>
            <tr class="addition">
               <td>1070</td>
               <td colspan="2">Third Degree Relative<span class="subclass"> SubClassOf </span>Relative. <br><i>New Terms: Third Degree Relative</i></td>
            </tr>
            <tr class="addition">
               <td>1071</td>
               <td colspan="2">Thousand Copies per Milliliter<span class="subclass"> SubClassOf </span>Unit of Number Concentration. <br><i>New Terms: Thousand Copies per Milliliter</i></td>
            </tr>
            <tr class="addition">
               <td>1072</td>
               <td colspan="2">Total Colonic Aganglionosis<span class="subclass"> SubClassOf </span>Total Intestinal Aganglionosis. <br><i>New Terms: Total Colonic Aganglionosis, Total Intestinal Aganglionosis</i></td>
            </tr>
            <tr class="addition">
               <td>1073</td>
               <td colspan="2">Total Intestinal Aganglionosis<span class="subclass"> SubClassOf </span>Aganglionic Megacolon. <br><i>New Terms: Total Intestinal Aganglionosis</i></td>
            </tr>
            <tr class="addition">
               <td>1074</td>
               <td colspan="2">Transient Tachypnea of the Newborn<span class="subclass"> SubClassOf </span>Neonatal Respiratory System Disorder. <br><i>New Terms: Transient Tachypnea of the Newborn</i></td>
            </tr>
            <tr class="addition">
               <td>1075</td>
               <td colspan="2">Tricyclic Antidepressant Measurement<span class="subclass"> SubClassOf </span>CNS Affecting Drug Measurement. <br><i>New Terms: Tricyclic Antidepressant Measurement</i></td>
            </tr>
            <tr class="addition">
               <td>1076</td>
               <td colspan="2">Trivalent Live-Attenuated Influenza Vaccine<span class="subclass"> SubClassOf </span>Polyvalent Vaccine. <br><i>New Terms: Trivalent Live-Attenuated Influenza Vaccine</i></td>
            </tr>
            <tr class="addition">
               <td>1083</td>
               <td colspan="2">U2 Small Nuclear Ribonucleoprotein Auxiliary Factor 35 kDa Subunit-Related Protein
                  2<span class="subclass"> EquivalentTo </span>RNA Binding Protein<br><span class="keyword"> and </span>(Gene_Product_Encoded_By_Gene<span class="some"> some </span>ZRSR2 Gene)<br><span class="keyword"> and </span>(Gene_Product_Has_Associated_Anatomy<span class="some"> some </span>Nucleus)<br><span class="keyword"> and </span>(Gene_Product_Has_Biochemical_Function<span class="some"> some </span>RNA Binding Protein)<br><span class="keyword"> and </span>(Gene_Product_Has_Structural_Domain_Or_Motif<span class="some"> some </span>C3H1 Zinc Finger)<br><span class="keyword"> and </span>(Gene_Product_Has_Structural_Domain_Or_Motif<span class="some"> some </span>RNA Recognition Motif)<br><span class="keyword"> and </span>(Gene_Product_Plays_Role_In_Biological_Process<span class="some"> some </span>RNA Binding)<br><span class="keyword"> and </span>(Gene_Product_Plays_Role_In_Biological_Process<span class="some"> some </span>RNA Splicing). <br><i>New Terms: U2 Small Nuclear Ribonucleoprotein Auxiliary Factor 35 kDa Subunit-Related Protein
                     2, ZRSR2 Gene</i></td>
            </tr>
            <tr class="addition">
               <td>1077</td>
               <td colspan="2">U2AF1 Gene<span class="subclass"> SubClassOf </span>Gene_Plays_Role_In_Process<span class="some"> some </span>RNA Binding. <br><i>New Terms: U2AF1 Gene</i></td>
            </tr>
            <tr class="addition">
               <td>1078</td>
               <td colspan="2">U2AF1 Gene<span class="subclass"> SubClassOf </span>Gene_Plays_Role_In_Process<span class="some"> some </span>RNA Splicing. <br><i>New Terms: U2AF1 Gene</i></td>
            </tr>
            <tr class="addition">
               <td>1079</td>
               <td colspan="2">U2AF1 Gene<span class="subclass"> SubClassOf </span>Gene_Plays_Role_In_Process<span class="some"> some </span>Transcription Termination. <br><i>New Terms: U2AF1 Gene</i></td>
            </tr>
            <tr class="addition">
               <td>1080</td>
               <td colspan="2">U2AF1 Gene<span class="subclass"> SubClassOf </span>Gene_Plays_Role_In_Process<span class="some"> some </span>mRNA Export. <br><i>New Terms: U2AF1 Gene</i></td>
            </tr>
            <tr class="addition">
               <td>1081</td>
               <td colspan="2">U2AF1 Gene<span class="subclass"> SubClassOf </span>mRNA Transport Gene. <br><i>New Terms: U2AF1 Gene</i></td>
            </tr>
            <tr class="addition">
               <td>1082</td>
               <td colspan="2">U2AF1 wt Allele<span class="subclass"> EquivalentTo </span>U2AF1 Gene<br><span class="keyword"> and </span>(Gene_In_Chromosomal_Location<span class="some"> some </span>21q22.3)<br><span class="keyword"> and </span>(Gene_Is_Element_In_Pathway<span class="some"> some </span>Shigellosis Pathway)<br><span class="keyword"> and </span>(Gene_Is_Element_In_Pathway<span class="some"> some </span>Spliceosome Assembly Pathway)<br><span class="keyword"> and </span>(Gene_Is_Element_In_Pathway<span class="some"> some </span>Spliceosome Pathway). <br><i>New Terms: U2AF1 Gene, U2AF1 wt Allele</i></td>
            </tr>
            <tr class="addition">
               <td>1084</td>
               <td colspan="2">UPDRS - Question 1<span class="subclass"> SubClassOf </span>UPDRS Questionnaire Question. <br><i>New Terms: UPDRS - Question 1, UPDRS Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>1085</td>
               <td colspan="2">UPDRS - Question 10<span class="subclass"> SubClassOf </span>UPDRS Questionnaire Question. <br><i>New Terms: UPDRS Questionnaire Question, UPDRS - Question 10</i></td>
            </tr>
            <tr class="addition">
               <td>1086</td>
               <td colspan="2">UPDRS - Question 11<span class="subclass"> SubClassOf </span>UPDRS Questionnaire Question. <br><i>New Terms: UPDRS Questionnaire Question, UPDRS - Question 11</i></td>
            </tr>
            <tr class="addition">
               <td>1087</td>
               <td colspan="2">UPDRS - Question 12<span class="subclass"> SubClassOf </span>UPDRS Questionnaire Question. <br><i>New Terms: UPDRS Questionnaire Question, UPDRS - Question 12</i></td>
            </tr>
            <tr class="addition">
               <td>1088</td>
               <td colspan="2">UPDRS - Question 13<span class="subclass"> SubClassOf </span>UPDRS Questionnaire Question. <br><i>New Terms: UPDRS Questionnaire Question, UPDRS - Question 13</i></td>
            </tr>
            <tr class="addition">
               <td>1089</td>
               <td colspan="2">UPDRS - Question 14<span class="subclass"> SubClassOf </span>UPDRS Questionnaire Question. <br><i>New Terms: UPDRS Questionnaire Question, UPDRS - Question 14</i></td>
            </tr>
            <tr class="addition">
               <td>1090</td>
               <td colspan="2">UPDRS - Question 15<span class="subclass"> SubClassOf </span>UPDRS Questionnaire Question. <br><i>New Terms: UPDRS Questionnaire Question, UPDRS - Question 15</i></td>
            </tr>
            <tr class="addition">
               <td>1091</td>
               <td colspan="2">UPDRS - Question 16<span class="subclass"> SubClassOf </span>UPDRS Questionnaire Question. <br><i>New Terms: UPDRS Questionnaire Question, UPDRS - Question 16</i></td>
            </tr>
            <tr class="addition">
               <td>1092</td>
               <td colspan="2">UPDRS - Question 17<span class="subclass"> SubClassOf </span>UPDRS Questionnaire Question. <br><i>New Terms: UPDRS Questionnaire Question, UPDRS - Question 17</i></td>
            </tr>
            <tr class="addition">
               <td>1093</td>
               <td colspan="2">UPDRS - Question 18<span class="subclass"> SubClassOf </span>UPDRS Questionnaire Question. <br><i>New Terms: UPDRS Questionnaire Question, UPDRS - Question 18</i></td>
            </tr>
            <tr class="addition">
               <td>1094</td>
               <td colspan="2">UPDRS - Question 19<span class="subclass"> SubClassOf </span>UPDRS Questionnaire Question. <br><i>New Terms: UPDRS Questionnaire Question, UPDRS - Question 19</i></td>
            </tr>
            <tr class="addition">
               <td>1095</td>
               <td colspan="2">UPDRS - Question 2<span class="subclass"> SubClassOf </span>UPDRS Questionnaire Question. <br><i>New Terms: UPDRS - Question 2, UPDRS Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>1096</td>
               <td colspan="2">UPDRS - Question 20<span class="subclass"> SubClassOf </span>UPDRS Questionnaire Question. <br><i>New Terms: UPDRS Questionnaire Question, UPDRS - Question 20</i></td>
            </tr>
            <tr class="addition">
               <td>1097</td>
               <td colspan="2">UPDRS - Question 21<span class="subclass"> SubClassOf </span>UPDRS Questionnaire Question. <br><i>New Terms: UPDRS Questionnaire Question, UPDRS - Question 21</i></td>
            </tr>
            <tr class="addition">
               <td>1098</td>
               <td colspan="2">UPDRS - Question 22<span class="subclass"> SubClassOf </span>UPDRS Questionnaire Question. <br><i>New Terms: UPDRS Questionnaire Question, UPDRS - Question 22</i></td>
            </tr>
            <tr class="addition">
               <td>1099</td>
               <td colspan="2">UPDRS - Question 23<span class="subclass"> SubClassOf </span>UPDRS Questionnaire Question. <br><i>New Terms: UPDRS Questionnaire Question, UPDRS - Question 23</i></td>
            </tr>
            <tr class="addition">
               <td>1100</td>
               <td colspan="2">UPDRS - Question 24<span class="subclass"> SubClassOf </span>UPDRS Questionnaire Question. <br><i>New Terms: UPDRS Questionnaire Question, UPDRS - Question 24</i></td>
            </tr>
            <tr class="addition">
               <td>1101</td>
               <td colspan="2">UPDRS - Question 25<span class="subclass"> SubClassOf </span>UPDRS Questionnaire Question. <br><i>New Terms: UPDRS Questionnaire Question, UPDRS - Question 25</i></td>
            </tr>
            <tr class="addition">
               <td>1102</td>
               <td colspan="2">UPDRS - Question 26<span class="subclass"> SubClassOf </span>UPDRS Questionnaire Question. <br><i>New Terms: UPDRS Questionnaire Question, UPDRS - Question 26</i></td>
            </tr>
            <tr class="addition">
               <td>1103</td>
               <td colspan="2">UPDRS - Question 27<span class="subclass"> SubClassOf </span>UPDRS Questionnaire Question. <br><i>New Terms: UPDRS Questionnaire Question, UPDRS - Question 27</i></td>
            </tr>
            <tr class="addition">
               <td>1104</td>
               <td colspan="2">UPDRS - Question 28<span class="subclass"> SubClassOf </span>UPDRS Questionnaire Question. <br><i>New Terms: UPDRS Questionnaire Question, UPDRS - Question 28</i></td>
            </tr>
            <tr class="addition">
               <td>1105</td>
               <td colspan="2">UPDRS - Question 29<span class="subclass"> SubClassOf </span>UPDRS Questionnaire Question. <br><i>New Terms: UPDRS Questionnaire Question, UPDRS - Question 29</i></td>
            </tr>
            <tr class="addition">
               <td>1106</td>
               <td colspan="2">UPDRS - Question 3<span class="subclass"> SubClassOf </span>UPDRS Questionnaire Question. <br><i>New Terms: UPDRS Questionnaire Question, UPDRS - Question 3</i></td>
            </tr>
            <tr class="addition">
               <td>1107</td>
               <td colspan="2">UPDRS - Question 30<span class="subclass"> SubClassOf </span>UPDRS Questionnaire Question. <br><i>New Terms: UPDRS Questionnaire Question, UPDRS - Question 30</i></td>
            </tr>
            <tr class="addition">
               <td>1108</td>
               <td colspan="2">UPDRS - Question 31<span class="subclass"> SubClassOf </span>UPDRS Questionnaire Question. <br><i>New Terms: UPDRS Questionnaire Question, UPDRS - Question 31</i></td>
            </tr>
            <tr class="addition">
               <td>1109</td>
               <td colspan="2">UPDRS - Question 32<span class="subclass"> SubClassOf </span>UPDRS Questionnaire Question. <br><i>New Terms: UPDRS Questionnaire Question, UPDRS - Question 32</i></td>
            </tr>
            <tr class="addition">
               <td>1110</td>
               <td colspan="2">UPDRS - Question 33<span class="subclass"> SubClassOf </span>UPDRS Questionnaire Question. <br><i>New Terms: UPDRS Questionnaire Question, UPDRS - Question 33</i></td>
            </tr>
            <tr class="addition">
               <td>1111</td>
               <td colspan="2">UPDRS - Question 34<span class="subclass"> SubClassOf </span>UPDRS Questionnaire Question. <br><i>New Terms: UPDRS Questionnaire Question, UPDRS - Question 34</i></td>
            </tr>
            <tr class="addition">
               <td>1112</td>
               <td colspan="2">UPDRS - Question 35<span class="subclass"> SubClassOf </span>UPDRS Questionnaire Question. <br><i>New Terms: UPDRS Questionnaire Question, UPDRS - Question 35</i></td>
            </tr>
            <tr class="addition">
               <td>1113</td>
               <td colspan="2">UPDRS - Question 36<span class="subclass"> SubClassOf </span>UPDRS Questionnaire Question. <br><i>New Terms: UPDRS Questionnaire Question, UPDRS - Question 36</i></td>
            </tr>
            <tr class="addition">
               <td>1114</td>
               <td colspan="2">UPDRS - Question 37<span class="subclass"> SubClassOf </span>UPDRS Questionnaire Question. <br><i>New Terms: UPDRS Questionnaire Question, UPDRS - Question 37</i></td>
            </tr>
            <tr class="addition">
               <td>1115</td>
               <td colspan="2">UPDRS - Question 38<span class="subclass"> SubClassOf </span>UPDRS Questionnaire Question. <br><i>New Terms: UPDRS - Question 38, UPDRS Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>1116</td>
               <td colspan="2">UPDRS - Question 39<span class="subclass"> SubClassOf </span>UPDRS Questionnaire Question. <br><i>New Terms: UPDRS - Question 39, UPDRS Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>1117</td>
               <td colspan="2">UPDRS - Question 4<span class="subclass"> SubClassOf </span>UPDRS Questionnaire Question. <br><i>New Terms: UPDRS Questionnaire Question, UPDRS - Question 4</i></td>
            </tr>
            <tr class="addition">
               <td>1118</td>
               <td colspan="2">UPDRS - Question 40<span class="subclass"> SubClassOf </span>UPDRS Questionnaire Question. <br><i>New Terms: UPDRS Questionnaire Question, UPDRS - Question 40</i></td>
            </tr>
            <tr class="addition">
               <td>1119</td>
               <td colspan="2">UPDRS - Question 41<span class="subclass"> SubClassOf </span>UPDRS Questionnaire Question. <br><i>New Terms: UPDRS Questionnaire Question, UPDRS - Question 41</i></td>
            </tr>
            <tr class="addition">
               <td>1120</td>
               <td colspan="2">UPDRS - Question 42<span class="subclass"> SubClassOf </span>UPDRS Questionnaire Question. <br><i>New Terms: UPDRS Questionnaire Question, UPDRS - Question 42</i></td>
            </tr>
            <tr class="addition">
               <td>1121</td>
               <td colspan="2">UPDRS - Question 43<span class="subclass"> SubClassOf </span>UPDRS Questionnaire Question. <br><i>New Terms: UPDRS Questionnaire Question, UPDRS - Question 43</i></td>
            </tr>
            <tr class="addition">
               <td>1122</td>
               <td colspan="2">UPDRS - Question 44<span class="subclass"> SubClassOf </span>UPDRS Questionnaire Question. <br><i>New Terms: UPDRS Questionnaire Question, UPDRS - Question 44</i></td>
            </tr>
            <tr class="addition">
               <td>1123</td>
               <td colspan="2">UPDRS - Question 5<span class="subclass"> SubClassOf </span>UPDRS Questionnaire Question. <br><i>New Terms: UPDRS Questionnaire Question, UPDRS - Question 5</i></td>
            </tr>
            <tr class="addition">
               <td>1124</td>
               <td colspan="2">UPDRS - Question 6<span class="subclass"> SubClassOf </span>UPDRS Questionnaire Question. <br><i>New Terms: UPDRS Questionnaire Question, UPDRS - Question 6</i></td>
            </tr>
            <tr class="addition">
               <td>1125</td>
               <td colspan="2">UPDRS - Question 7<span class="subclass"> SubClassOf </span>UPDRS Questionnaire Question. <br><i>New Terms: UPDRS Questionnaire Question, UPDRS - Question 7</i></td>
            </tr>
            <tr class="addition">
               <td>1126</td>
               <td colspan="2">UPDRS - Question 8<span class="subclass"> SubClassOf </span>UPDRS Questionnaire Question. <br><i>New Terms: UPDRS Questionnaire Question, UPDRS - Question 8</i></td>
            </tr>
            <tr class="addition">
               <td>1127</td>
               <td colspan="2">UPDRS - Question 9<span class="subclass"> SubClassOf </span>UPDRS Questionnaire Question. <br><i>New Terms: UPDRS - Question 9, UPDRS Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>1128</td>
               <td colspan="2">UPDRS Questionnaire Question<span class="subclass"> SubClassOf </span>Clinical<br><span class="keyword"> or </span>Research Assessment Question. <br><i>New Terms: UPDRS Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>1129</td>
               <td colspan="2">Unified Parkinson's Disease Rating Scale Questionnaire<span class="subclass"> SubClassOf </span>Clinical<br><span class="keyword"> or </span>Research Assessment Questionnaire. <br><i>New Terms: Unified Parkinson's Disease Rating Scale Questionnaire</i></td>
            </tr>
            <tr class="addition">
               <td>1130</td>
               <td colspan="2">WPAI:SHP v2.0 - Currently Employed<span class="subclass"> SubClassOf </span>WPAI:SHP v2.0 Questionnaire Question. <br><i>New Terms: WPAI:SHP v2.0 Questionnaire Question, WPAI:SHP v2.0 - Currently Employed</i></td>
            </tr>
            <tr class="addition">
               <td>1131</td>
               <td colspan="2">WPAI:SHP v2.0 - Hours Actually Worked<span class="subclass"> SubClassOf </span>WPAI:SHP v2.0 Questionnaire Question. <br><i>New Terms: WPAI:SHP v2.0 Questionnaire Question, WPAI:SHP v2.0 - Hours Actually Worked</i></td>
            </tr>
            <tr class="addition">
               <td>1132</td>
               <td colspan="2">WPAI:SHP v2.0 - Missed Work Hours Due to Other Reasons<span class="subclass"> SubClassOf </span>WPAI:SHP v2.0 Questionnaire Question. <br><i>New Terms: WPAI:SHP v2.0 Questionnaire Question, WPAI:SHP v2.0 - Missed Work Hours Due to Other
                     Reasons</i></td>
            </tr>
            <tr class="addition">
               <td>1133</td>
               <td colspan="2">WPAI:SHP v2.0 - Missed Work Hours Due to Problem<span class="subclass"> SubClassOf </span>WPAI:SHP v2.0 Questionnaire Question. <br><i>New Terms: WPAI:SHP v2.0 Questionnaire Question, WPAI:SHP v2.0 - Missed Work Hours Due to Problem</i></td>
            </tr>
            <tr class="addition">
               <td>1134</td>
               <td colspan="2">WPAI:SHP v2.0 - Problem Affects Productivity<span class="subclass"> SubClassOf </span>WPAI:SHP v2.0 Questionnaire Question. <br><i>New Terms: WPAI:SHP v2.0 Questionnaire Question, WPAI:SHP v2.0 - Problem Affects Productivity</i></td>
            </tr>
            <tr class="addition">
               <td>1135</td>
               <td colspan="2">WPAI:SHP v2.0 - Problem Affects Regular Daily Activity<span class="subclass"> SubClassOf </span>WPAI:SHP v2.0 Questionnaire Question. <br><i>New Terms: WPAI:SHP v2.0 Questionnaire Question, WPAI:SHP v2.0 - Problem Affects Regular Daily
                     Activity</i></td>
            </tr>
            <tr class="addition">
               <td>1136</td>
               <td colspan="2">WPAI:SHP v2.0 Questionnaire Question<span class="subclass"> SubClassOf </span>Clinical<br><span class="keyword"> or </span>Research Assessment Question. <br><i>New Terms: WPAI:SHP v2.0 Questionnaire Question</i></td>
            </tr>
            <tr class="addition">
               <td>1137</td>
               <td colspan="2">Waist Circumference<span class="subclass"> SubClassOf </span>Circumference. <br><i>New Terms: Waist Circumference</i></td>
            </tr>
            <tr class="addition">
               <td>1138</td>
               <td colspan="2">Work Productivity<br><span class="keyword"> and </span>Activity Impairment Specific Health Problems Version 2.0 Questionnaire<span class="subclass"> SubClassOf </span>Clinical<br><span class="keyword"> or </span>Research Assessment Questionnaire. <br><i>New Terms: Work Productivity and Activity Impairment Specific Health Problems Version 2.0 Questionnaire</i></td>
            </tr>
            <tr class="addition">
               <td>1139</td>
               <td colspan="2">Worklist<span class="subclass"> SubClassOf </span>List. <br><i>New Terms: Worklist</i></td>
            </tr>
            <tr class="addition">
               <td>1141</td>
               <td colspan="2">YWHAE Gene<span class="subclass"> SubClassOf </span>Gene_Plays_Role_In_Process<span class="some"> some </span>G2 to M Transition Process. <br><i>New Terms: YWHAE Gene</i></td>
            </tr>
            <tr class="addition">
               <td>1140</td>
               <td colspan="2">YWHAE Gene<span class="subclass"> SubClassOf </span>Gene_Plays_Role_In_Process<span class="some"> some </span>Intracellular Signaling Process. <br><i>New Terms: YWHAE Gene</i></td>
            </tr>
            <tr class="addition">
               <td>1142</td>
               <td colspan="2">YWHAE Gene<span class="subclass"> SubClassOf </span>Gene_Plays_Role_In_Process<span class="some"> some </span>Positive Regulation of Apoptosis. <br><i>New Terms: YWHAE Gene</i></td>
            </tr>
            <tr class="addition">
               <td>1143</td>
               <td colspan="2">YWHAE Gene<span class="subclass"> SubClassOf </span>Gene_Plays_Role_In_Process<span class="some"> some </span>Signal Transduction. <br><i>New Terms: YWHAE Gene</i></td>
            </tr>
            <tr class="addition">
               <td>1144</td>
               <td colspan="2">YWHAE Gene<span class="subclass"> SubClassOf </span>Signaling Pathway Gene. <br><i>New Terms: YWHAE Gene</i></td>
            </tr>
            <tr class="addition">
               <td>1145</td>
               <td colspan="2">YWHAE wt Allele<span class="subclass"> EquivalentTo </span>YWHAE Gene<br><span class="keyword"> and </span>(Gene_In_Chromosomal_Location<span class="some"> some </span>17p13.3)<br><span class="keyword"> and </span>(Gene_Is_Element_In_Pathway<span class="some"> some </span>Cell Cycle Pathway)<br><span class="keyword"> and </span>(Gene_Is_Element_In_Pathway<span class="some"> some </span>HDAC Class II Signaling Pathway)<br><span class="keyword"> and </span>(Gene_Is_Element_In_Pathway<span class="some"> some </span>IGF1 Pathway)<br><span class="keyword"> and </span>(Gene_Is_Element_In_Pathway<span class="some"> some </span>Lissencephaly-1 Gene in Neuronal Migration<br><span class="keyword"> and </span>Development)<br><span class="keyword"> and </span>(Gene_Is_Element_In_Pathway<span class="some"> some </span>Nerve Growth Factor Receptor Signaling Pathway)<br><span class="keyword"> and </span>(Gene_Is_Element_In_Pathway<span class="some"> some </span>Neurotrophin Signaling Pathway)<br><span class="keyword"> and </span>(Gene_Is_Element_In_Pathway<span class="some"> some </span>Oocyte Meiosis Pathway)<br><span class="keyword"> and </span>(Gene_Is_Element_In_Pathway<span class="some"> some </span>TGF-Beta Receptor Signaling Pathway)<br><span class="keyword"> and </span>(Gene_Is_Element_In_Pathway<span class="some"> some </span>Telomerase Regulation Pathway). <br><i>New Terms: YWHAE wt Allele, YWHAE Gene</i></td>
            </tr>
            <tr class="addition">
               <td>1146</td>
               <td colspan="2">ZRSR2 Gene<span class="subclass"> SubClassOf </span>Gene_Plays_Role_In_Process<span class="some"> some </span>RNA Binding. <br><i>New Terms: ZRSR2 Gene</i></td>
            </tr>
            <tr class="addition">
               <td>1147</td>
               <td colspan="2">ZRSR2 Gene<span class="subclass"> SubClassOf </span>Gene_Plays_Role_In_Process<span class="some"> some </span>RNA Splicing. <br><i>New Terms: ZRSR2 Gene</i></td>
            </tr>
            <tr class="addition">
               <td>1148</td>
               <td colspan="2">ZRSR2 Gene<span class="subclass"> SubClassOf </span>Ligand Binding Protein Gene. <br><i>New Terms: ZRSR2 Gene</i></td>
            </tr>
            <tr class="addition">
               <td>1149</td>
               <td colspan="2">ZRSR2 wt Allele<span class="subclass"> SubClassOf </span>Gene_In_Chromosomal_Location<span class="some"> some </span>Xp22.1. <br><i>New Terms: ZRSR2 wt Allele</i></td>
            </tr>
            <tr class="addition">
               <td>1150</td>
               <td colspan="2">ZRSR2 wt Allele<span class="subclass"> SubClassOf </span>ZRSR2 Gene. <br><i>New Terms: ZRSR2 wt Allele, ZRSR2 Gene</i></td>
            </tr>
            <tr class="addition">
               <td>1151</td>
               <td colspan="2">Zirconium Zr 89 Desferrioxamine B Monoclonal Antibody huJ591<span class="subclass"> SubClassOf </span>Radioimmunoconjugate. <br><i>New Terms: Zirconium Zr 89 Desferrioxamine B Monoclonal Antibody huJ591</i></td>
            </tr>
            <tr class="addition">
               <td>1154</td>
               <td colspan="2">mTOR1/2 Kinase Inhibitor ME-344<span class="subclass"> SubClassOf </span>mTOR Inhibitor. <br><i>New Terms: mTOR1/2 Kinase Inhibitor ME-344</i></td>
            </tr>
         </tbody>
         <tbody id="add" style="display:none">
            <tr class="withoutstyle">
               <td colspan="3">
                  <h4 style="display: inline-block;">Pure Additions with Shared Terms (225)</h4> [<a href="#">back to top</a>]
               </td>
            </tr>
            <tr>
               <th class="addition">ID</th>
               <th class="addition" colspan="2">Addition to Ontology 2</th>
            </tr>
            <tr class="addition">
               <td>1155</td>
               <td colspan="2">ALK Gene<span class="subclass"> SubClassOf </span>Gene_Involved_In_Pathogenesis_Of_Disease<span class="some"> some </span>Lung Adenocarcinoma. <br></td>
            </tr>
            <tr class="addition">
               <td>1156</td>
               <td colspan="2">ASPSCR1/TFE3 Fusion Gene<span class="subclass"> SubClassOf </span>Gene_Involved_In_Pathogenesis_Of_Disease<span class="some"> some </span>Alveolar Soft Part Sarcoma. <br></td>
            </tr>
            <tr class="addition">
               <td>1157</td>
               <td colspan="2">Abnormal Pigmentation<span class="subclass"> SubClassOf </span>Sign. <br></td>
            </tr>
            <tr class="addition">
               <td>1158</td>
               <td colspan="2">Acute Myeloid Leukemia with t(6;9)(p23;q34); DEK-NUP214<span class="subclass"> EquivalentTo </span>Acute Myeloid Leukemia with Recurrent Genetic Abnormalities<br><span class="keyword"> and </span>((Disease_Has_Cytogenetic_Abnormality<span class="some"> some </span>t(6;9)(p23;q34))<br><span class="keyword"> and </span>(Disease_Has_Molecular_Abnormality<span class="some"> some </span>DEK-NUP214 Fusion Protein Expression))<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>DEK/NUP214 Fusion Gene)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>NUP214 Gene)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Basophilia)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Bone Marrow Dysplasia Present)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Unfavorable Clinical Outcome). <br></td>
            </tr>
            <tr class="addition">
               <td>1159</td>
               <td colspan="2">Acute Myeloid Leukemia with t(8;21)(q22;q22); RUNX1-RUNX1T1<span class="subclass"> EquivalentTo </span>Acute Myeloid Leukemia with Recurrent Genetic Abnormalities<br><span class="keyword"> and </span>((Disease_Has_Cytogenetic_Abnormality<span class="some"> some </span>t(8;21)(q22;q22))<br><span class="keyword"> and </span>(Disease_Has_Molecular_Abnormality<span class="some"> some </span>AML1-ETO Fusion Protein Expression))<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> some </span>Neoplastic Myeloblast with Abundant Basophilic Cytoplasm)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> some </span>Bone Marrow Stem Cell with Predominant Neutrophil Differentiation)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>RUNX1T1 Gene)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>RUNX1/RUNX1T1 Fusion Gene)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Auer Rods Present)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Favorable Clinical Outcome)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Myeloblasts 20 Percent<br><span class="keyword"> or </span>More of Bone Marrow Nucleated Cells). <br></td>
            </tr>
            <tr class="addition">
               <td>1160</td>
               <td colspan="2">Acute Myeloid Leukemia with t(9;11)(p22;q23); MLLT3-MLL<span class="subclass"> EquivalentTo </span>Acute Myeloid Leukemia with Recurrent Genetic Abnormalities<br><span class="keyword"> and </span>((Disease_Has_Cytogenetic_Abnormality<span class="some"> some </span>t(9;11)(p22;q23))<br><span class="keyword"> and </span>(Disease_Has_Molecular_Abnormality<span class="some"> some </span>MLLT3-MLL Fusion Protein Expression))<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> some </span>Multipotent Bone Marrow Stem Cell)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>MLL/MLLT3 Fusion Gene)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>MLL Gene)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Disseminated Intravascular Coagulation). <br></td>
            </tr>
            <tr class="addition">
               <td>1161</td>
               <td colspan="2">Acute Promyelocytic Leukemia with t(15;17)(q22;q12); PML-RARA<span class="subclass"> EquivalentTo </span>Acute Myeloid Leukemia with Recurrent Genetic Abnormalities<br><span class="keyword"> and </span>((Disease_Has_Cytogenetic_Abnormality<span class="some"> some </span>t(15;17)(q22;q12))<br><span class="keyword"> and </span>(Disease_Has_Molecular_Abnormality<span class="some"> some </span>PML-RARA Fusion Protein Expression))<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> some </span>Neoplastic Promyelocyte)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> some </span>Neoplastic Promyelocytes in Bone Marrow Markedly Increased)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> some </span>Bone Marrow Stem Cell with Potential to Differentiate to Granulocytic Lineage)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>PML/RARA Fusion Gene)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>RARA Gene)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Faggot Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Disseminated Intravascular Coagulation). <br></td>
            </tr>
            <tr class="addition">
               <td>1162</td>
               <td colspan="2">Akathisia<span class="subclass"> SubClassOf </span>Nervous System Finding. <br></td>
            </tr>
            <tr class="addition">
               <td>1163</td>
               <td colspan="2">Akathisia<span class="subclass"> SubClassOf </span>Sign. <br></td>
            </tr>
            <tr class="addition">
               <td>1164</td>
               <td colspan="2">Ambulation Difficulty<span class="subclass"> SubClassOf </span>Sign. <br></td>
            </tr>
            <tr class="addition">
               <td>1165</td>
               <td colspan="2">Anhidrosis<span class="subclass"> SubClassOf </span>Sign. <br></td>
            </tr>
            <tr class="addition">
               <td>1166</td>
               <td colspan="2">Aphasia<span class="subclass"> SubClassOf </span>Sign. <br></td>
            </tr>
            <tr class="addition">
               <td>1167</td>
               <td colspan="2">Astacus astacus<span class="subclass"> SubClassOf </span>Crustacean. <br></td>
            </tr>
            <tr class="addition">
               <td>1168</td>
               <td colspan="2">Asthenia<span class="subclass"> SubClassOf </span>Sign. <br></td>
            </tr>
            <tr class="addition">
               <td>1169</td>
               <td colspan="2">Asymptomatic<span class="subclass"> SubClassOf </span>Symptom. <br></td>
            </tr>
            <tr class="addition">
               <td>1179</td>
               <td colspan="2">B Lymphoblastic Leukemia/Lymphoma with t(12;21)(p13;q22); TEL-AML1 (ETV6-RUNX1)<span class="subclass"> EquivalentTo </span>B Lymphoblastic Leukemia/Lymphoma with Recurrent Genetic Abnormalities<br><span class="keyword"> and </span>((Disease_Has_Cytogenetic_Abnormality<span class="some"> some </span>t(12;21)(p13;q22))<br><span class="keyword"> and </span>(Disease_Has_Molecular_Abnormality<span class="some"> some </span>TEL-AML1 Fusion Protein Expression))<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>RUNX1 Gene)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>ETV6/RUNX1 Fusion Gene)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Favorable Clinical Outcome). <br></td>
            </tr>
            <tr class="addition">
               <td>1180</td>
               <td colspan="2">B Lymphoblastic Leukemia/Lymphoma with t(1;19)(q23;p13.3); E2A-PBX1 (TCF3-PBX1)<span class="subclass"> EquivalentTo </span>B Lymphoblastic Leukemia/Lymphoma with Recurrent Genetic Abnormalities<br><span class="keyword"> and </span>((Disease_Has_Cytogenetic_Abnormality<span class="some"> some </span>t(1;19)(q23;p13.3))<br><span class="keyword"> and </span>(Disease_Has_Molecular_Abnormality<span class="some"> some </span>TCF3-PBX1 Fusion Protein Expression))<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>PBX1 Gene)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>TCF3/PBX1 Fusion Gene). <br></td>
            </tr>
            <tr class="addition">
               <td>1181</td>
               <td colspan="2">B Lymphoblastic Leukemia/Lymphoma with t(9;22)(q34;q11.2); BCR-ABL1<span class="subclass"> EquivalentTo </span>B Lymphoblastic Leukemia/Lymphoma with Recurrent Genetic Abnormalities<br><span class="keyword"> and </span>((Disease_Has_Cytogenetic_Abnormality<span class="some"> some </span>Philadelphia Chromosome)<br><span class="keyword"> and </span>(Disease_Has_Cytogenetic_Abnormality<span class="some"> some </span>t(9;22)(q34;q11))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>p190 Fusion Protein Expression)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>p210 Fusion Protein Expression))<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>ABL1 Gene)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>BCR/ABL1 Fusion Gene)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Unfavorable Clinical Outcome). <br></td>
            </tr>
            <tr class="addition">
               <td>1170</td>
               <td colspan="2">B-Symptoms<span class="subclass"> SubClassOf </span>Sign. <br></td>
            </tr>
            <tr class="addition">
               <td>1171</td>
               <td colspan="2">BCR/ABL1 Fusion Gene<span class="subclass"> SubClassOf </span>Gene_Involved_In_Pathogenesis_Of_Disease<span class="some"> some </span>B Lymphoblastic Leukemia/Lymphoma with t(9;22)(q34;q11.2); BCR-ABL1. <br></td>
            </tr>
            <tr class="addition">
               <td>1172</td>
               <td colspan="2">BCR/ABL1 Fusion Gene<span class="subclass"> SubClassOf </span>Gene_Involved_In_Pathogenesis_Of_Disease<span class="some"> some </span>Chronic Myelogenous Leukemia, BCR-ABL1 Positive. <br></td>
            </tr>
            <tr class="addition">
               <td>1173</td>
               <td colspan="2">BCR/ABL1 Fusion Gene<span class="subclass"> SubClassOf </span>Gene_Involved_In_Pathogenesis_Of_Disease<span class="some"> some </span>Mixed Phenotype Acute Leukemia with t(9;22)(q34;q11.2); BCR-ABL1. <br></td>
            </tr>
            <tr class="addition">
               <td>1174</td>
               <td colspan="2">BCR/FGFR1 Fusion Gene<span class="subclass"> SubClassOf </span>Gene_Involved_In_Pathogenesis_Of_Disease<span class="some"> some </span>Myeloid<br><span class="keyword"> and </span>Lymphoid Neoplasms with FGFR1 Rearrangement. <br></td>
            </tr>
            <tr class="addition">
               <td>1175</td>
               <td colspan="2">BIRC3/MALT1 Fusion Gene<span class="subclass"> SubClassOf </span>Gene_Involved_In_Pathogenesis_Of_Disease<span class="some"> some </span>Bronchial Mucosa-Associated Lymphoid Tissue Lymphoma. <br></td>
            </tr>
            <tr class="addition">
               <td>1176</td>
               <td colspan="2">BIRC3/MALT1 Fusion Gene<span class="subclass"> SubClassOf </span>Gene_Involved_In_Pathogenesis_Of_Disease<span class="some"> some </span>Gastric Mucosa-Associated Lymphoid Tissue Lymphoma. <br></td>
            </tr>
            <tr class="addition">
               <td>1177</td>
               <td colspan="2">BIRC3/MALT1 Fusion Gene<span class="subclass"> SubClassOf </span>Gene_Involved_In_Pathogenesis_Of_Disease<span class="some"> some </span>Small Intestinal Mucosa-Associated Lymphoid Tissue Lymphoma. <br></td>
            </tr>
            <tr class="addition">
               <td>1178</td>
               <td colspan="2">BRD4/C15orf55 Fusion Gene<span class="subclass"> SubClassOf </span>Gene_Involved_In_Pathogenesis_Of_Disease<span class="some"> some </span>NUT Midline Carcinoma. <br></td>
            </tr>
            <tr class="addition">
               <td>1182</td>
               <td colspan="2">Baptisia tinctoria Leaf<span class="subclass"> SubClassOf </span>Leaf. <br></td>
            </tr>
            <tr class="addition">
               <td>1183</td>
               <td colspan="2">Belladonna Leaf<span class="subclass"> SubClassOf </span>Leaf. <br></td>
            </tr>
            <tr class="addition">
               <td>1184</td>
               <td colspan="2">Below Normal Body Height<span class="subclass"> SubClassOf </span>Sign. <br></td>
            </tr>
            <tr class="addition">
               <td>1185</td>
               <td colspan="2">Body Odor<span class="subclass"> SubClassOf </span>Sign. <br></td>
            </tr>
            <tr class="addition">
               <td>1219</td>
               <td colspan="2">Body Substance Discharge<span class="subclass"> SubClassOf </span>Sign. <br></td>
            </tr>
            <tr class="addition">
               <td>1186</td>
               <td colspan="2">Bordetella pertussis Filamentous Hemagglutinin Antigen, B<span class="subclass"> SubClassOf </span>Retired Concept Current Year. <br></td>
            </tr>
            <tr class="addition">
               <td>1187</td>
               <td colspan="2">Bordetella pertussis Filamentous Hemagglutinin Antigen, C<span class="subclass"> SubClassOf </span>Retired Concept Current Year. <br></td>
            </tr>
            <tr class="addition">
               <td>1328</td>
               <td colspan="2">CCDC6/RET Fusion Gene<span class="subclass"> SubClassOf </span>Gene_Involved_In_Pathogenesis_Of_Disease<span class="some"> some </span>Thyroid Gland Papillary Carcinoma. <br></td>
            </tr>
            <tr class="addition">
               <td>1188</td>
               <td colspan="2">CCND1 Gene<span class="subclass"> SubClassOf </span>Gene_Involved_In_Pathogenesis_Of_Disease<span class="some"> some </span>Parathyroid Gland Adenoma. <br></td>
            </tr>
            <tr class="addition">
               <td>1259</td>
               <td colspan="2">CDC73 Gene<span class="subclass"> SubClassOf </span>Gene_Involved_In_Pathogenesis_Of_Disease<span class="some"> some </span>Familial Isolated Hyperparathyroidism. <br></td>
            </tr>
            <tr class="addition">
               <td>1260</td>
               <td colspan="2">CDC73 Gene<span class="subclass"> SubClassOf </span>Gene_Involved_In_Pathogenesis_Of_Disease<span class="some"> some </span>Hyperparathyroidism-Jaw Tumor Syndrome. <br></td>
            </tr>
            <tr class="addition">
               <td>1261</td>
               <td colspan="2">CDC73 Gene<span class="subclass"> SubClassOf </span>Gene_Involved_In_Pathogenesis_Of_Disease<span class="some"> some </span>Parathyroid Gland Carcinoma. <br></td>
            </tr>
            <tr class="addition">
               <td>1189</td>
               <td colspan="2">CDK2/TRKA Inhibitor PHA-848125 AC<span class="subclass"> SubClassOf </span>Cyclin-Dependent Kinase Inhibitor. <br></td>
            </tr>
            <tr class="addition">
               <td>1190</td>
               <td colspan="2">CDKN2A Gene<span class="subclass"> SubClassOf </span>Gene_Involved_In_Pathogenesis_Of_Disease<span class="some"> some </span>Malignant Mesothelioma. <br></td>
            </tr>
            <tr class="addition">
               <td>1191</td>
               <td colspan="2">CLC Gene<span class="subclass"> SubClassOf </span>Gene_Plays_Role_In_Process<span class="some"> some </span>Lipid Metabolic Process. <br></td>
            </tr>
            <tr class="addition">
               <td>1192</td>
               <td colspan="2">CLTC/ALK Fusion Gene<span class="subclass"> SubClassOf </span>Gene_Involved_In_Pathogenesis_Of_Disease<span class="some"> some </span>Anaplastic Large Cell Lymphoma, ALK-Positive. <br></td>
            </tr>
            <tr class="addition">
               <td>1193</td>
               <td colspan="2">CLTC/ALK Fusion Gene<span class="subclass"> SubClassOf </span>Gene_Involved_In_Pathogenesis_Of_Disease<span class="some"> some </span>Inflammatory Myofibroblastic Tumor. <br></td>
            </tr>
            <tr class="addition">
               <td>1194</td>
               <td colspan="2">CRTC1/MAML2 Fusion Gene<span class="subclass"> SubClassOf </span>Gene_Involved_In_Pathogenesis_Of_Disease<span class="some"> some </span>Salivary Gland Mucoepidermoid Carcinoma. <br></td>
            </tr>
            <tr class="addition">
               <td>1195</td>
               <td colspan="2">Cachexia<span class="subclass"> SubClassOf </span>Sign. <br></td>
            </tr>
            <tr class="addition">
               <td>1196</td>
               <td colspan="2">Calendula officinalis Flowering Top<span class="subclass"> SubClassOf </span>Flower. <br></td>
            </tr>
            <tr class="addition">
               <td>1262</td>
               <td colspan="2">Calluna vulgaris Flowering Top<span class="subclass"> SubClassOf </span>Flower. <br></td>
            </tr>
            <tr class="addition">
               <td>1197</td>
               <td colspan="2">Cardiotrophin-Like Cytokine Factor 1<span class="subclass"> EquivalentTo </span>Interleukin<br><span class="keyword"> and </span>(Gene_Product_Encoded_By_Gene<span class="some"> some </span>CLCF1 Gene)<br><span class="keyword"> and </span>(Gene_Product_Has_Biochemical_Function<span class="some"> some </span>Interleukin)<br><span class="keyword"> and </span>(Gene_Product_Has_Organism_Source<span class="some"> some </span>Human)<br><span class="keyword"> and </span>(Gene_Product_Is_Element_In_Pathway<span class="some"> some </span>Cytokine-Cytokine Receptor Signaling Pathway)<br><span class="keyword"> and </span>(Gene_Product_Is_Element_In_Pathway<span class="some"> some </span>Jak-STAT Signaling Pathway)<br><span class="keyword"> and </span>(Gene_Product_Plays_Role_In_Biological_Process<span class="some"> some </span>B Cell Proliferation)<br><span class="keyword"> and </span>(Gene_Product_Plays_Role_In_Biological_Process<span class="some"> some </span>Nerve Cell Survival). <br></td>
            </tr>
            <tr class="addition">
               <td>1198</td>
               <td colspan="2">Celeriac, Cooked<span class="subclass"> SubClassOf </span>Retired Concept Current Year. <br></td>
            </tr>
            <tr class="addition">
               <td>1199</td>
               <td colspan="2">Celeriac, Raw<span class="subclass"> SubClassOf </span>Retired Concept Current Year. <br></td>
            </tr>
            <tr class="addition">
               <td>1200</td>
               <td colspan="2">Cerebral Edema<span class="subclass"> SubClassOf </span>Nervous System Finding. <br></td>
            </tr>
            <tr class="addition">
               <td>1202</td>
               <td colspan="2">Chronic Myelogenous Leukemia, BCR-ABL1 Positive<span class="subclass"> EquivalentTo </span>Myeloproliferative Neoplasm<br><span class="keyword"> and </span>Common Hematopoietic Neoplasm<br><span class="keyword"> and </span>Myeloid Leukemia<br><span class="keyword"> and </span>(Disease_Excludes_Molecular_Abnormality<span class="some"> some </span>FGFR1 Gene Rearrangement)<br><span class="keyword"> and </span>(Disease_Excludes_Molecular_Abnormality<span class="some"> some </span>PDGFRA Gene Rearrangement)<br><span class="keyword"> and </span>(Disease_Excludes_Molecular_Abnormality<span class="some"> some </span>PDGFRB Gene Rearrangement)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> some </span>Hypercellular Bone Marrow)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> some </span>Splenomegaly)<br><span class="keyword"> and </span>(Disease_Has_Molecular_Abnormality<span class="some"> some </span>BCR-ABL1 Fusion Protein Expression)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> some </span>Pluripotent Bone Marrow Stem Cell)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>ABL1 Gene)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>BCR/ABL1 Fusion Gene). <br></td>
            </tr>
            <tr class="addition">
               <td>1203</td>
               <td colspan="2">Claudication<span class="subclass"> SubClassOf </span>Sign. <br></td>
            </tr>
            <tr class="addition">
               <td>1204</td>
               <td colspan="2">Clostridium tetani Toxoid Antigen, B<span class="subclass"> SubClassOf </span>Retired Concept Current Year. <br></td>
            </tr>
            <tr class="addition">
               <td>1205</td>
               <td colspan="2">Colic<span class="subclass"> SubClassOf </span>Non-Neoplastic Intestinal Disorder. <br></td>
            </tr>
            <tr class="addition">
               <td>1206</td>
               <td colspan="2">Complement Hemolytic Activity Assay<span class="subclass"> SubClassOf </span>Assay. <br></td>
            </tr>
            <tr class="addition">
               <td>1207</td>
               <td colspan="2">Confusion<span class="subclass"> SubClassOf </span>Nervous System Finding. <br></td>
            </tr>
            <tr class="addition">
               <td>1208</td>
               <td colspan="2">Confusion<span class="subclass"> SubClassOf </span>Sign. <br></td>
            </tr>
            <tr class="addition">
               <td>1209</td>
               <td colspan="2">Coprophagia<span class="subclass"> SubClassOf </span>Sign. <br></td>
            </tr>
            <tr class="addition">
               <td>1210</td>
               <td colspan="2">Corynebacterium diphtheriae Toxoid Antigen, C<span class="subclass"> SubClassOf </span>Retired Concept Current Year. <br></td>
            </tr>
            <tr class="addition">
               <td>1211</td>
               <td colspan="2">Cyanosis<span class="subclass"> SubClassOf </span>Sign. <br></td>
            </tr>
            <tr class="addition">
               <td>1212</td>
               <td colspan="2">Cyanotic Attacks in Children<span class="subclass"> SubClassOf </span>Sign. <br></td>
            </tr>
            <tr class="addition">
               <td>1216</td>
               <td colspan="2">Decreased Core Body Temperature<span class="subclass"> SubClassOf </span>Sign. <br></td>
            </tr>
            <tr class="addition">
               <td>1217</td>
               <td colspan="2">Delayed Puberty<span class="subclass"> SubClassOf </span>Reproductive System Finding. <br></td>
            </tr>
            <tr class="addition">
               <td>1218</td>
               <td colspan="2">Digitalis lanata Leaf<span class="subclass"> SubClassOf </span>Leaf. <br></td>
            </tr>
            <tr class="addition">
               <td>1220</td>
               <td colspan="2">Distress<span class="subclass"> SubClassOf </span>Sign. <br></td>
            </tr>
            <tr class="addition">
               <td>1221</td>
               <td colspan="2">Diverticulosis<span class="subclass"> SubClassOf </span>Gastrointestinal System Finding. <br></td>
            </tr>
            <tr class="addition">
               <td>1222</td>
               <td colspan="2">Dyskinesia<span class="subclass"> SubClassOf </span>Connective<br><span class="keyword"> and </span>Soft Tissue Finding. <br></td>
            </tr>
            <tr class="addition">
               <td>1223</td>
               <td colspan="2">Dysphasia<span class="subclass"> SubClassOf </span>Sign. <br></td>
            </tr>
            <tr class="addition">
               <td>1224</td>
               <td colspan="2">EML4/ALK Fusion Gene<span class="subclass"> SubClassOf </span>Gene_Involved_In_Pathogenesis_Of_Disease<span class="some"> some </span>Lung Adenocarcinoma. <br></td>
            </tr>
            <tr class="addition">
               <td>1225</td>
               <td colspan="2">ERC1/RET Fusion Gene<span class="subclass"> SubClassOf </span>Gene_Involved_In_Pathogenesis_Of_Disease<span class="some"> some </span>Thyroid Gland Papillary Carcinoma. <br></td>
            </tr>
            <tr class="addition">
               <td>1226</td>
               <td colspan="2">ERG Gene<span class="subclass"> SubClassOf </span>Gene_Involved_In_Pathogenesis_Of_Disease<span class="some"> some </span>Prostate Carcinoma. <br></td>
            </tr>
            <tr class="addition">
               <td>1227</td>
               <td colspan="2">ETV6/JAK2 Fusion Gene<span class="subclass"> SubClassOf </span>Gene_Involved_In_Pathogenesis_Of_Disease<span class="some"> some </span>Philadelphia Chromosome Negative BCR-ABL1 Negative Chronic Myelogenous Leukemia. <br></td>
            </tr>
            <tr class="addition">
               <td>1228</td>
               <td colspan="2">ETV6/NTRK3 Fusion Gene<span class="subclass"> SubClassOf </span>Gene_Involved_In_Pathogenesis_Of_Disease<span class="some"> some </span>Cellular Congenital Mesoblastic Nephroma. <br></td>
            </tr>
            <tr class="addition">
               <td>1229</td>
               <td colspan="2">ETV6/NTRK3 Fusion Gene<span class="subclass"> SubClassOf </span>Gene_Involved_In_Pathogenesis_Of_Disease<span class="some"> some </span>Infantile Fibrosarcoma. <br></td>
            </tr>
            <tr class="addition">
               <td>1230</td>
               <td colspan="2">ETV6/NTRK3 Fusion Gene<span class="subclass"> SubClassOf </span>Gene_Involved_In_Pathogenesis_Of_Disease<span class="some"> some </span>Secretory Breast Carcinoma. <br></td>
            </tr>
            <tr class="addition">
               <td>1231</td>
               <td colspan="2">ETV6/PDGFRB Fusion Gene<span class="subclass"> SubClassOf </span>Gene_Involved_In_Pathogenesis_Of_Disease<span class="some"> some </span>Myeloid Neoplasms with PDGFRB Rearrangement. <br></td>
            </tr>
            <tr class="addition">
               <td>1232</td>
               <td colspan="2">EWSR1/ATF1 Fusion Gene<span class="subclass"> SubClassOf </span>Gene_Involved_In_Pathogenesis_Of_Disease<span class="some"> some </span>Clear Cell Sarcoma of Soft Tissue. <br></td>
            </tr>
            <tr class="addition">
               <td>1233</td>
               <td colspan="2">EWSR1/DDIT3 Fusion Gene<span class="subclass"> SubClassOf </span>Gene_Involved_In_Pathogenesis_Of_Disease<span class="some"> some </span>Myxoid/Round Cell Liposarcoma. <br></td>
            </tr>
            <tr class="addition">
               <td>1234</td>
               <td colspan="2">EWSR1/ERG Fusion Gene<span class="subclass"> SubClassOf </span>Gene_Involved_In_Pathogenesis_Of_Disease<span class="some"> some </span>Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor. <br></td>
            </tr>
            <tr class="addition">
               <td>1235</td>
               <td colspan="2">EWSR1/ETV1 Fusion Gene<span class="subclass"> SubClassOf </span>Gene_Involved_In_Pathogenesis_Of_Disease<span class="some"> some </span>Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor. <br></td>
            </tr>
            <tr class="addition">
               <td>1236</td>
               <td colspan="2">EWSR1/ETV4 Fusion Gene<span class="subclass"> SubClassOf </span>Gene_Involved_In_Pathogenesis_Of_Disease<span class="some"> some </span>Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor. <br></td>
            </tr>
            <tr class="addition">
               <td>1237</td>
               <td colspan="2">EWSR1/FEV Fusion Gene<span class="subclass"> SubClassOf </span>Gene_Involved_In_Pathogenesis_Of_Disease<span class="some"> some </span>Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor. <br></td>
            </tr>
            <tr class="addition">
               <td>1238</td>
               <td colspan="2">EWSR1/FLI1 Fusion Gene<span class="subclass"> SubClassOf </span>Gene_Involved_In_Pathogenesis_Of_Disease<span class="some"> some </span>Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor. <br></td>
            </tr>
            <tr class="addition">
               <td>1239</td>
               <td colspan="2">EWSR1/NR4A3 Fusion Gene<span class="subclass"> SubClassOf </span>Gene_Involved_In_Pathogenesis_Of_Disease<span class="some"> some </span>Extraskeletal Myxoid Chondrosarcoma. <br></td>
            </tr>
            <tr class="addition">
               <td>1240</td>
               <td colspan="2">EWSR1/PATZ1 Fusion Gene<span class="subclass"> SubClassOf </span>Gene_Involved_In_Pathogenesis_Of_Disease<span class="some"> some </span>Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor. <br></td>
            </tr>
            <tr class="addition">
               <td>1241</td>
               <td colspan="2">EWSR1/WT1 Fusion Gene<span class="subclass"> SubClassOf </span>Gene_Involved_In_Pathogenesis_Of_Disease<span class="some"> some </span>Desmoplastic Small Round Cell Tumor. <br></td>
            </tr>
            <tr class="addition">
               <td>1242</td>
               <td colspan="2">Enlarging Abdomen<span class="subclass"> SubClassOf </span>Sign. <br></td>
            </tr>
            <tr class="addition">
               <td>1243</td>
               <td colspan="2">Euphoria<span class="subclass"> SubClassOf </span>Nervous System Finding. <br></td>
            </tr>
            <tr class="addition">
               <td>1244</td>
               <td colspan="2">Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor<span class="subclass"> EquivalentTo </span>Embryonal Neoplasm<br><span class="keyword"> and </span>(((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>inv(22q12))<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(1;22)(p36.1;q12))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>EWSR1-PATZ1 Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(11;22)(q24;q12))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>EWSR1-FLI1 Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(16;21)(p11;q22))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>FUS-ERG Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(17;22)(q21;q12))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>EWSR1-ETV4 Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(21;22)(q22;q12))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>EWSR1-ERG Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(2;22)(q33;q12))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>EWSR1-FEV Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(7;22)(p22;q12))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>EWSR1-ETV1 Fusion Protein Expression)))<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> some </span>Primitive Round to Oval Cell)<br><span class="keyword"> and </span>(Disease_Has_Normal_Tissue_Origin<span class="some"> some </span>Neural Crest)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>EWSR1/ERG Fusion Gene)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>EWSR1/ETV1 Fusion Gene)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>EWSR1/ETV4 Fusion Gene)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>EWSR1/FEV Fusion Gene)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>EWSR1/FLI1 Fusion Gene)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>EWSR1/PATZ1 Fusion Gene)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>EWSR1 Gene)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>FUS/ERG Fusion Gene)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Malignant Small Round Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Anemia)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Fever)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hemorrhagic Change)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Homer Wright Rosette Formation)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Necrotic Change). <br></td>
            </tr>
            <tr class="addition">
               <td>1295</td>
               <td colspan="2">Extraskeletal Myxoid Chondrosarcoma<span class="subclass"> EquivalentTo </span>Malignant Soft Tissue Neoplasm of Uncertain Differentiation<br><span class="keyword"> and </span>Soft Tissue Sarcoma<br><span class="keyword"> and </span>(((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(3;9)(q11-12;q22))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>TFG-NR4A3 Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(9;15)(q22;q21))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>TCF12-NR4A3 Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(9;17)(q22;q11))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>TAF15-NR4A3 Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(9;22)(q22-31;q12))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>EWSR1-NR4A3 Fusion Protein Expression)))<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> some </span>Malignant Cell with Eosinophilic Cytoplasm)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> some </span>Well-Circumscribed Lesion)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> some </span>Extraosseous Lesion)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> some </span>Multinodular Pattern)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> some </span>Myxoid Stroma Formation)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>EWSR1/NR4A3 Fusion Gene)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>TAF15/NR4A3 Fusion Gene)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>TCF12/NR4A3 Fusion Gene)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>TFG/NR4A3 Fusion Gene)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Cord-Like Pattern)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Cribriform Pattern)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Cystic Change)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hemorrhagic Change)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Spindle Cell Pattern). <br></td>
            </tr>
            <tr class="addition">
               <td>1245</td>
               <td colspan="2">FIP1L1/PDGFRA Fusion Gene<span class="subclass"> SubClassOf </span>Gene_Involved_In_Pathogenesis_Of_Disease<span class="some"> some </span>Myeloid<br><span class="keyword"> and </span>Lymphoid Neoplasms with PDGFRA Rearrangement. <br></td>
            </tr>
            <tr class="addition">
               <td>1246</td>
               <td colspan="2">FUS/ATF1 Fusion Gene<span class="subclass"> SubClassOf </span>Gene_Involved_In_Pathogenesis_Of_Disease<span class="some"> some </span>Angiomatoid Fibrous Histiocytoma. <br></td>
            </tr>
            <tr class="addition">
               <td>1247</td>
               <td colspan="2">FUS/CREB3L2 Fusion Gene<span class="subclass"> SubClassOf </span>Gene_Involved_In_Pathogenesis_Of_Disease<span class="some"> some </span>Low Grade Fibromyxoid Sarcoma. <br></td>
            </tr>
            <tr class="addition">
               <td>1248</td>
               <td colspan="2">FUS/DDIT3 Fusion Gene<span class="subclass"> SubClassOf </span>Gene_Involved_In_Pathogenesis_Of_Disease<span class="some"> some </span>Myxoid/Round Cell Liposarcoma. <br></td>
            </tr>
            <tr class="addition">
               <td>1249</td>
               <td colspan="2">FUS/ERG Fusion Gene<span class="subclass"> SubClassOf </span>Gene_Involved_In_Pathogenesis_Of_Disease<span class="some"> some </span>Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor. <br></td>
            </tr>
            <tr class="addition">
               <td>1250</td>
               <td colspan="2">Fall<span class="subclass"> SubClassOf </span>Event. <br></td>
            </tr>
            <tr class="addition">
               <td>1251</td>
               <td colspan="2">Familial Isolated Hyperparathyroidism<span class="subclass"> SubClassOf </span>Disease_Mapped_To_Gene<span class="some"> some </span>CDC73 Gene. <br></td>
            </tr>
            <tr class="addition">
               <td>1252</td>
               <td colspan="2">Familial Isolated Hyperparathyroidism<span class="subclass"> SubClassOf </span>Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>CDC73 Gene Mutation. <br></td>
            </tr>
            <tr class="addition">
               <td>1253</td>
               <td colspan="2">Fecal Incontinence<span class="subclass"> SubClassOf </span>Disturbance in Bowel Function. <br></td>
            </tr>
            <tr class="addition">
               <td>1254</td>
               <td colspan="2">Fever<span class="subclass"> SubClassOf </span>Sign. <br></td>
            </tr>
            <tr class="addition">
               <td>1255</td>
               <td colspan="2">Foeniculum vulgare Leaf<span class="subclass"> SubClassOf </span>Leaf. <br></td>
            </tr>
            <tr class="addition">
               <td>1256</td>
               <td colspan="2">GNAS Gene<span class="subclass"> SubClassOf </span>Gene_Involved_In_Pathogenesis_Of_Disease<span class="some"> some </span>Growth Hormone-Producing Pituitary Gland Adenoma. <br></td>
            </tr>
            <tr class="addition">
               <td>1257</td>
               <td colspan="2">GOLGA5/RET Fusion Gene<span class="subclass"> SubClassOf </span>Gene_Involved_In_Pathogenesis_Of_Disease<span class="some"> some </span>Thyroid Gland Papillary Carcinoma. <br></td>
            </tr>
            <tr class="addition">
               <td>1258</td>
               <td colspan="2">HMGA2/LPP Long Fusion Gene<span class="subclass"> SubClassOf </span>Gene_Involved_In_Pathogenesis_Of_Disease<span class="some"> some </span>Conventional Lipoma. <br></td>
            </tr>
            <tr class="addition">
               <td>1263</td>
               <td colspan="2">Hoarseness<span class="subclass"> SubClassOf </span>Sign. <br></td>
            </tr>
            <tr class="addition">
               <td>1264</td>
               <td colspan="2">Hot Flashes<span class="subclass"> SubClassOf </span>Sign. <br></td>
            </tr>
            <tr class="addition">
               <td>1265</td>
               <td colspan="2">Hydrangea serrata Leaf<span class="subclass"> SubClassOf </span>Leaf. <br></td>
            </tr>
            <tr class="addition">
               <td>1266</td>
               <td colspan="2">Hydroxyurea<span class="subclass"> EquivalentTo </span>Antimetabolite<br><span class="keyword"> and </span>Ribonucleotide Reductase Inhibitor<br><span class="keyword"> and </span>(Chemical_Or_Drug_Affects_Gene_Product<span class="some"> some </span>Ribonucleotide Reductase)<br><span class="keyword"> and </span>(Chemical_Or_Drug_Has_Mechanism_Of_Action<span class="some"> some </span>Enzyme Inhibition)<br><span class="keyword"> and </span>(Chemical_Or_Drug_Has_Physiologic_Effect<span class="some"> some </span>DNA Repair Inhibition)<br><span class="keyword"> and </span>(Chemical_Or_Drug_Has_Physiologic_Effect<span class="some"> some </span>DNA Synthesis Inhibition)<br><span class="keyword"> and </span>(Chemical_Or_Drug_Has_Physiologic_Effect<span class="some"> some </span>Negative Regulation of G1 to S Transition)<br><span class="keyword"> and </span>(Chemical_Or_Drug_Has_Physiologic_Effect<span class="some"> some </span>Nucleotide Synthesis Inhibition). <br></td>
            </tr>
            <tr class="addition">
               <td>1267</td>
               <td colspan="2">Hyperactivity<span class="subclass"> SubClassOf </span>Nervous System Finding. <br></td>
            </tr>
            <tr class="addition">
               <td>1268</td>
               <td colspan="2">Hyperactivity<span class="subclass"> SubClassOf </span>Sign. <br></td>
            </tr>
            <tr class="addition">
               <td>1269</td>
               <td colspan="2">Hyperhidrosis<span class="subclass"> SubClassOf </span>Sign. <br></td>
            </tr>
            <tr class="addition">
               <td>1270</td>
               <td colspan="2">Hyperthermia<span class="subclass"> SubClassOf </span>Sign. <br></td>
            </tr>
            <tr class="addition">
               <td>1271</td>
               <td colspan="2">Hypohidrosis<span class="subclass"> SubClassOf </span>Sign. <br></td>
            </tr>
            <tr class="addition">
               <td>1272</td>
               <td colspan="2">Hysteria<span class="subclass"> SubClassOf </span>Nervous System Finding. <br></td>
            </tr>
            <tr class="addition">
               <td>1377</td>
               <td colspan="2">Incontinence<span class="subclass"> SubClassOf </span>Sign. <br></td>
            </tr>
            <tr class="addition">
               <td>1274</td>
               <td colspan="2">Increased Sputum Excretion<span class="subclass"> SubClassOf </span>Respiratory System Finding. <br></td>
            </tr>
            <tr class="addition">
               <td>1275</td>
               <td colspan="2">Increased Sputum Excretion<span class="subclass"> SubClassOf </span>Sign. <br></td>
            </tr>
            <tr class="addition">
               <td>1276</td>
               <td colspan="2">JAZF1/SUZ12 Fusion Gene<span class="subclass"> SubClassOf </span>Gene_Involved_In_Pathogenesis_Of_Disease<span class="some"> some </span>Uterine Corpus Endometrial Stromal Neoplasm. <br></td>
            </tr>
            <tr class="addition">
               <td>1277</td>
               <td colspan="2">KRAS Gene<span class="subclass"> SubClassOf </span>Gene_Involved_In_Pathogenesis_Of_Disease<span class="some"> some </span>Atypical Adenomatous Lung Hyperplasia. <br></td>
            </tr>
            <tr class="addition">
               <td>1278</td>
               <td colspan="2">KRAS Gene<span class="subclass"> SubClassOf </span>Gene_Involved_In_Pathogenesis_Of_Disease<span class="some"> some </span>Lung Adenocarcinoma. <br></td>
            </tr>
            <tr class="addition">
               <td>1279</td>
               <td colspan="2">Lasinavir<span class="subclass"> SubClassOf </span>HIV Protease Inhibitor. <br></td>
            </tr>
            <tr class="addition">
               <td>1280</td>
               <td colspan="2">Limonene<span class="subclass"> SubClassOf </span>Retired Concept Current Year. <br></td>
            </tr>
            <tr class="addition">
               <td>1213</td>
               <td colspan="2">Limonene, (+)-<span class="subclass"> SubClassOf </span>Terpene. <br></td>
            </tr>
            <tr class="addition">
               <td>1215</td>
               <td colspan="2">Limonene, (+/-)-<span class="subclass"> SubClassOf </span>Terpene. <br></td>
            </tr>
            <tr class="addition">
               <td>1281</td>
               <td colspan="2">MEN1 Gene<span class="subclass"> SubClassOf </span>Gene_Involved_In_Pathogenesis_Of_Disease<span class="some"> some </span>Parathyroid Gland Adenoma. <br></td>
            </tr>
            <tr class="addition">
               <td>1282</td>
               <td colspan="2">MLL/AFF1 Fusion Gene<span class="subclass"> SubClassOf </span>Gene_Involved_In_Pathogenesis_Of_Disease<span class="some"> some </span>Acute Myeloid Leukemia with Variant MLL Translocations. <br></td>
            </tr>
            <tr class="addition">
               <td>1283</td>
               <td colspan="2">MLL/AFF1 Fusion Gene<span class="subclass"> SubClassOf </span>Gene_Involved_In_Pathogenesis_Of_Disease<span class="some"> some </span>B Lymphoblastic Leukemia/Lymphoma with t(v;11q23); MLL Rearranged. <br></td>
            </tr>
            <tr class="addition">
               <td>1285</td>
               <td colspan="2">MLL/MLLT1 Fusion Gene<span class="subclass"> SubClassOf </span>Gene_Involved_In_Pathogenesis_Of_Disease<span class="some"> some </span>Acute Myeloid Leukemia with Variant MLL Translocations. <br></td>
            </tr>
            <tr class="addition">
               <td>1284</td>
               <td colspan="2">MLL/MLLT10 Fusion Gene<span class="subclass"> SubClassOf </span>Gene_Involved_In_Pathogenesis_Of_Disease<span class="some"> some </span>Acute Myeloid Leukemia with Variant MLL Translocations. <br></td>
            </tr>
            <tr class="addition">
               <td>1286</td>
               <td colspan="2">MLL/MLLT3 Fusion Gene<span class="subclass"> SubClassOf </span>Gene_Involved_In_Pathogenesis_Of_Disease<span class="some"> some </span>Acute Myeloid Leukemia with t(9;11)(p22;q23); MLLT3-MLL. <br></td>
            </tr>
            <tr class="addition">
               <td>1287</td>
               <td colspan="2">MLLT10/CLP1 Fusion Gene<span class="subclass"> SubClassOf </span>Gene_Involved_In_Pathogenesis_Of_Disease<span class="some"> some </span>Acute Myeloid Leukemia with Variant MLL Translocations. <br></td>
            </tr>
            <tr class="addition">
               <td>1288</td>
               <td colspan="2">Mediastinal Shift<span class="subclass"> SubClassOf </span>Sign. <br></td>
            </tr>
            <tr class="addition">
               <td>1289</td>
               <td colspan="2">Membrane Breakage<span class="subclass"> SubClassOf </span>Sign. <br></td>
            </tr>
            <tr class="addition">
               <td>1290</td>
               <td colspan="2">Miscellaneous Antimetabolite<span class="subclass"> SubClassOf </span>Retired Concept Current Year. <br></td>
            </tr>
            <tr class="addition">
               <td>1291</td>
               <td colspan="2">Mixed Phenotype Acute Leukemia with t(9;22)(q34;q11.2); BCR-ABL1<span class="subclass"> EquivalentTo </span>Mixed Phenotype Acute Leukemia<br><span class="keyword"> and </span>((Disease_Has_Cytogenetic_Abnormality<span class="some"> some </span>t(9;22)(q34;q11))<br><span class="keyword"> and </span>(Disease_Has_Molecular_Abnormality<span class="some"> some </span>BCR-ABL1 Fusion Protein Expression))<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> some </span>Blasts of Mixed Phenotype Present)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>ABL1 Gene)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>BCR/ABL1 Fusion Gene)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Unfavorable Clinical Outcome). <br></td>
            </tr>
            <tr class="addition">
               <td>1292</td>
               <td colspan="2">Myeloid Neoplasms with PDGFRB Rearrangement<span class="subclass"> EquivalentTo </span>Myeloid Neoplasm<br><span class="keyword"> and </span>Myeloid<br><span class="keyword"> and </span>Lymphoid Neoplasms with Eosinophilia<br><span class="keyword"> and </span>Abnormalities of PDGFRA, PDGFRB,<br><span class="keyword"> or </span>FGFR1<br><span class="keyword"> and </span>(Disease_Has_Molecular_Abnormality<span class="some"> some </span>PDGFRB Gene Rearrangement)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>ETV6/PDGFRB Fusion Gene)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>PDGFRB Gene)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(5;12)(q31;p12))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Eosinophilia)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>ETV6-PDGFRB Fusion Protein Expression). <br></td>
            </tr>
            <tr class="addition">
               <td>1293</td>
               <td colspan="2">Myeloid<br><span class="keyword"> and </span>Lymphoid Neoplasms with FGFR1 Rearrangement<span class="subclass"> EquivalentTo </span>Myeloid<br><span class="keyword"> and </span>Lymphoid Neoplasms with Eosinophilia<br><span class="keyword"> and </span>Abnormalities of PDGFRA, PDGFRB,<br><span class="keyword"> or </span>FGFR1<br><span class="keyword"> and </span>(Disease_Has_Molecular_Abnormality<span class="some"> some </span>FGFR1 Gene Rearrangement)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>BCR/FGFR1 Fusion Gene)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>FGFR1 Gene)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>BCR-FGFR1 Fusion Protein Expression). <br></td>
            </tr>
            <tr class="addition">
               <td>1294</td>
               <td colspan="2">Myeloid<br><span class="keyword"> and </span>Lymphoid Neoplasms with PDGFRA Rearrangement<span class="subclass"> EquivalentTo </span>Myeloid<br><span class="keyword"> and </span>Lymphoid Neoplasms with Eosinophilia<br><span class="keyword"> and </span>Abnormalities of PDGFRA, PDGFRB,<br><span class="keyword"> or </span>FGFR1<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> some </span>Eosinophilia)<br><span class="keyword"> and </span>(Disease_Has_Molecular_Abnormality<span class="some"> some </span>PDGFRA Gene Rearrangement)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>FIP1L1/PDGFRA Fusion Gene)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>PDGFRA Gene)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>FIP1L1-PDGFRalpha Fusion Protein Expression). <br></td>
            </tr>
            <tr class="addition">
               <td>1296</td>
               <td colspan="2">Myxoid/Round Cell Liposarcoma<span class="subclass"> EquivalentTo </span>Liposarcoma<br><span class="keyword"> and </span>(((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(12;16)(q13;p11))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>FUS-DDIT3 Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(12;22)(q13;q12))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>EWSR1-DDIT3 Fusion Protein Expression)))<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> some </span>Primitive Mesenchymal Cell)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> some </span>Well-Circumscribed Lesion)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>DDIT3 Gene)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>EWSR1/DDIT3 Fusion Gene)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>FUS/DDIT3 Fusion Gene). <br></td>
            </tr>
            <tr class="addition">
               <td>1297</td>
               <td colspan="2">NCOA4/RET Fusion Gene<span class="subclass"> SubClassOf </span>Gene_Involved_In_Pathogenesis_Of_Disease<span class="some"> some </span>Thyroid Gland Papillary Carcinoma. <br></td>
            </tr>
            <tr class="addition">
               <td>1298</td>
               <td colspan="2">NPM1/ALK Fusion Gene<span class="subclass"> SubClassOf </span>Gene_Involved_In_Pathogenesis_Of_Disease<span class="some"> some </span>Anaplastic Large Cell Lymphoma, ALK-Positive. <br></td>
            </tr>
            <tr class="addition">
               <td>1299</td>
               <td colspan="2">NUMA1/RARA Fusion Gene<span class="subclass"> SubClassOf </span>Gene_Involved_In_Pathogenesis_Of_Disease<span class="some"> some </span>Acute Myeloid Leukemia with t(11;17)(q13;q21). <br></td>
            </tr>
            <tr class="addition">
               <td>1300</td>
               <td colspan="2">Neonatal Research Network Terminology<span class="subclass"> SubClassOf </span>NICHD Terminology. <br></td>
            </tr>
            <tr class="addition">
               <td>1214</td>
               <td colspan="2">Netrin Receptor DCC<span class="subclass"> SubClassOf </span>Cell Adhesion Molecule. <br></td>
            </tr>
            <tr class="addition">
               <td>1301</td>
               <td colspan="2">Obesity<span class="subclass"> SubClassOf </span>Sign. <br></td>
            </tr>
            <tr class="addition">
               <td>1302</td>
               <td colspan="2">Overweight<span class="subclass"> SubClassOf </span>Sign. <br></td>
            </tr>
            <tr class="addition">
               <td>1305</td>
               <td colspan="2">PAX3/FOXO1 Fusion Gene<span class="subclass"> SubClassOf </span>Gene_Involved_In_Pathogenesis_Of_Disease<span class="some"> some </span>Alveolar Rhabdomyosarcoma. <br></td>
            </tr>
            <tr class="addition">
               <td>1303</td>
               <td colspan="2">PAX3/FOXO1 Fusion Protein<span class="subclass"> SubClassOf </span>Gene_Product_Encoded_By_Gene<span class="some"> some </span>PAX3/FOXO1 Fusion Gene. <br></td>
            </tr>
            <tr class="addition">
               <td>1304</td>
               <td colspan="2">PAX3/FOXO1 Fusion Protein<span class="subclass"> SubClassOf </span>Gene_Product_Plays_Role_In_Biological_Process<span class="some"> some </span>Transcriptional Activation. <br></td>
            </tr>
            <tr class="addition">
               <td>1306</td>
               <td colspan="2">PAX3/FOXO1 Fusion Protein<span class="subclass"> SubClassOf </span>Retired Concept Current Year. <br></td>
            </tr>
            <tr class="addition">
               <td>1307</td>
               <td colspan="2">PAX7/FOXO1 Fusion Gene<span class="subclass"> SubClassOf </span>Gene_Involved_In_Pathogenesis_Of_Disease<span class="some"> some </span>Alveolar Rhabdomyosarcoma. <br></td>
            </tr>
            <tr class="addition">
               <td>1309</td>
               <td colspan="2">PAX8/PPARG Fusion Gene<span class="subclass"> SubClassOf </span>Gene_Involved_In_Pathogenesis_Of_Disease<span class="some"> some </span>Thyroid Gland Follicular Adenoma. <br></td>
            </tr>
            <tr class="addition">
               <td>1308</td>
               <td colspan="2">PAX8/PPARG Fusion Gene<span class="subclass"> SubClassOf </span>Gene_Involved_In_Pathogenesis_Of_Disease<span class="some"> some </span>Thyroid Gland Follicular Carcinoma. <br></td>
            </tr>
            <tr class="addition">
               <td>1310</td>
               <td colspan="2">PCM1/RET Fusion Gene<span class="subclass"> SubClassOf </span>Gene_Involved_In_Pathogenesis_Of_Disease<span class="some"> some </span>Thyroid Gland Papillary Carcinoma. <br></td>
            </tr>
            <tr class="addition">
               <td>1311</td>
               <td colspan="2">PML/RARA Fusion Gene<span class="subclass"> SubClassOf </span>Gene_Involved_In_Pathogenesis_Of_Disease<span class="some"> some </span>Acute Promyelocytic Leukemia with t(15;17)(q22;q12); PML-RARA. <br></td>
            </tr>
            <tr class="addition">
               <td>1312</td>
               <td colspan="2">PRCC/TFE3 Fusion Gene<span class="subclass"> SubClassOf </span>Gene_Involved_In_Pathogenesis_Of_Disease<span class="some"> some </span>Renal Cell Carcinoma Associated with t(X;1)(p11.2;q21). <br></td>
            </tr>
            <tr class="addition">
               <td>1313</td>
               <td colspan="2">PRKAR1A/RET Fusion Gene<span class="subclass"> SubClassOf </span>Gene_Involved_In_Pathogenesis_Of_Disease<span class="some"> some </span>Thyroid Gland Papillary Carcinoma. <br></td>
            </tr>
            <tr class="addition">
               <td>1314</td>
               <td colspan="2">PSA Failure<span class="subclass"> SubClassOf </span>Laboratory Test Result. <br></td>
            </tr>
            <tr class="addition">
               <td>1316</td>
               <td colspan="2">Paranoia<span class="subclass"> SubClassOf </span>Psychiatric Disorder. <br></td>
            </tr>
            <tr class="addition">
               <td>1317</td>
               <td colspan="2">Paraparesis<span class="subclass"> SubClassOf </span>Sign. <br></td>
            </tr>
            <tr class="addition">
               <td>1318</td>
               <td colspan="2">Personality Change<span class="subclass"> SubClassOf </span>Nervous System Finding. <br></td>
            </tr>
            <tr class="addition">
               <td>1319</td>
               <td colspan="2">Personality Change<span class="subclass"> SubClassOf </span>Sign. <br></td>
            </tr>
            <tr class="addition">
               <td>1320</td>
               <td colspan="2">Philadelphia Chromosome Negative BCR-ABL1 Negative Chronic Myelogenous Leukemia<span class="subclass"> SubClassOf </span>Disease_Mapped_To_Gene<span class="some"> some </span>ETV6/JAK2 Fusion Gene. <br></td>
            </tr>
            <tr class="addition">
               <td>1315</td>
               <td colspan="2">Phosphatidylinositol-3,4,5-Trisphosphate 3-Phosphatase<br><span class="keyword"> and </span>Dual-Specificity Protein Phosphatase PTEN<span class="subclass"> EquivalentTo </span>Phosphatase<br><span class="keyword"> and </span>(Gene_Product_Encoded_By_Gene<span class="some"> some </span>PTEN Gene)<br><span class="keyword"> and </span>(Gene_Product_Has_Biochemical_Function<span class="some"> some </span>Dual-Specificity Phosphoprotein Phosphatase)<br><span class="keyword"> and </span>(Gene_Product_Has_Biochemical_Function<span class="some"> some </span>Signaling Protein)<br><span class="keyword"> and </span>(Gene_Product_Is_Element_In_Pathway<span class="some"> some </span>CTCF Pathway)<br><span class="keyword"> and </span>(Gene_Product_Is_Element_In_Pathway<span class="some"> some </span>Hepatocyte Growth Factor Receptor Signaling Pathway BioCarta)<br><span class="keyword"> and </span>(Gene_Product_Is_Element_In_Pathway<span class="some"> some </span>PTEN-Dependent Cell Cycle Arrest<br><span class="keyword"> and </span>Apoptosis Pathway)<br><span class="keyword"> and </span>(Gene_Product_Is_Element_In_Pathway<span class="some"> some </span>Phosphatidylinositol Signaling System Pathway)<br><span class="keyword"> and </span>(Gene_Product_Is_Element_In_Pathway<span class="some"> some </span>Skeletal Muscle Hypertrophy Pathway)<br><span class="keyword"> and </span>(Gene_Product_Is_Element_In_Pathway<span class="some"> some </span>eIF4 Regulation Pathway)<br><span class="keyword"> and </span>(Gene_Product_Is_Element_In_Pathway<span class="some"> some </span>mTOR Signaling Pathway BioCarta)<br><span class="keyword"> and </span>(Gene_Product_Malfunction_Associated_With_Disease<span class="some"> some </span>Cowden Syndrome)<br><span class="keyword"> and </span>(Gene_Product_Plays_Role_In_Biological_Process<span class="some"> some </span>Negative Regulation of G1 Phase)<br><span class="keyword"> and </span>(Gene_Product_Plays_Role_In_Biological_Process<span class="some"> some </span>Protein Dephosphorylation)<br><span class="keyword"> and </span>(Gene_Product_Plays_Role_In_Biological_Process<span class="some"> some </span>Signal Transduction)<br><span class="keyword"> and </span>(Gene_Product_Plays_Role_In_Biological_Process<span class="some"> some </span>Tumor Suppression). <br></td>
            </tr>
            <tr class="addition">
               <td>1321</td>
               <td colspan="2">Plethoric Face<span class="subclass"> SubClassOf </span>Sign. <br></td>
            </tr>
            <tr class="addition">
               <td>1323</td>
               <td colspan="2">Polydipsia<span class="subclass"> SubClassOf </span>Sign. <br></td>
            </tr>
            <tr class="addition">
               <td>1324</td>
               <td colspan="2">Precocious Puberty<span class="subclass"> SubClassOf </span>Reproductive System Finding. <br></td>
            </tr>
            <tr class="addition">
               <td>1325</td>
               <td colspan="2">Prostration<span class="subclass"> SubClassOf </span>Sign. <br></td>
            </tr>
            <tr class="addition">
               <td>1326</td>
               <td colspan="2">Pyrogenic Reaction<span class="subclass"> SubClassOf </span>Sign. <br></td>
            </tr>
            <tr class="addition">
               <td>1327</td>
               <td colspan="2">RBM15/MKL1 Fusion Gene<span class="subclass"> SubClassOf </span>Gene_Involved_In_Pathogenesis_Of_Disease<span class="some"> some </span>Acute Myeloid Leukemia (Megakaryoblastic) with t(1;22)(p13;q13); RBM15-MKL1. <br></td>
            </tr>
            <tr class="addition">
               <td>1329</td>
               <td colspan="2">RET Gene<span class="subclass"> SubClassOf </span>Gene_Involved_In_Pathogenesis_Of_Disease<span class="some"> some </span>Thyroid Gland Medullary Carcinoma. <br></td>
            </tr>
            <tr class="addition">
               <td>1330</td>
               <td colspan="2">RET Gene<span class="subclass"> SubClassOf </span>Gene_Involved_In_Pathogenesis_Of_Disease<span class="some"> some </span>Thyroid Gland Papillary Carcinoma. <br></td>
            </tr>
            <tr class="addition">
               <td>1331</td>
               <td colspan="2">RNF213/ALK Fusion Gene<span class="subclass"> SubClassOf </span>Gene_Involved_In_Pathogenesis_Of_Disease<span class="some"> some </span>Anaplastic Large Cell Lymphoma, ALK-Positive. <br></td>
            </tr>
            <tr class="addition">
               <td>1332</td>
               <td colspan="2">RUNX1/RUNX1T1 Fusion Gene<span class="subclass"> SubClassOf </span>Gene_Involved_In_Pathogenesis_Of_Disease<span class="some"> some </span>Acute Myeloid Leukemia with t(8;21)(q22;q22); RUNX1-RUNX1T1. <br></td>
            </tr>
            <tr class="addition">
               <td>1333</td>
               <td colspan="2">Rathyronine<span class="subclass"> SubClassOf </span>Retired Concept Current Year. <br></td>
            </tr>
            <tr class="addition">
               <td>1334</td>
               <td colspan="2">Regurgitation<span class="subclass"> SubClassOf </span>Sign. <br></td>
            </tr>
            <tr class="addition">
               <td>1336</td>
               <td colspan="2">Reptilase Time Measurement<span class="subclass"> SubClassOf </span>Coagulation Study. <br></td>
            </tr>
            <tr class="addition">
               <td>1335</td>
               <td colspan="2">Reptilase Time<span class="subclass"> SubClassOf </span>Retired Concept Current Year. <br></td>
            </tr>
            <tr class="addition">
               <td>1339</td>
               <td colspan="2">SDHB Gene Mutation<span class="subclass"> SubClassOf </span>Mitochondrial Complex II Gene Mutation. <br></td>
            </tr>
            <tr class="addition">
               <td>1337</td>
               <td colspan="2">SDHB Gene<span class="subclass"> SubClassOf </span>Gene_Involved_In_Pathogenesis_Of_Disease<span class="some"> some </span>Hereditary Paraganglioma. <br></td>
            </tr>
            <tr class="addition">
               <td>1338</td>
               <td colspan="2">SDHB Gene<span class="subclass"> SubClassOf </span>Gene_Involved_In_Pathogenesis_Of_Disease<span class="some"> some </span>Hereditary Paraganglioma-Pheochromocytoma Syndrome. <br></td>
            </tr>
            <tr class="addition">
               <td>1342</td>
               <td colspan="2">SDHC Gene Mutation<span class="subclass"> SubClassOf </span>Mitochondrial Complex II Gene Mutation. <br></td>
            </tr>
            <tr class="addition">
               <td>1340</td>
               <td colspan="2">SDHC Gene<span class="subclass"> SubClassOf </span>Gene_Involved_In_Pathogenesis_Of_Disease<span class="some"> some </span>Hereditary Paraganglioma. <br></td>
            </tr>
            <tr class="addition">
               <td>1341</td>
               <td colspan="2">SDHC Gene<span class="subclass"> SubClassOf </span>Gene_Involved_In_Pathogenesis_Of_Disease<span class="some"> some </span>Hereditary Paraganglioma-Pheochromocytoma Syndrome. <br></td>
            </tr>
            <tr class="addition">
               <td>1345</td>
               <td colspan="2">SDHD Gene Mutation<span class="subclass"> SubClassOf </span>Mitochondrial Complex II Gene Mutation. <br></td>
            </tr>
            <tr class="addition">
               <td>1343</td>
               <td colspan="2">SDHD Gene<span class="subclass"> SubClassOf </span>Gene_Involved_In_Pathogenesis_Of_Disease<span class="some"> some </span>Hereditary Paraganglioma. <br></td>
            </tr>
            <tr class="addition">
               <td>1344</td>
               <td colspan="2">SDHD Gene<span class="subclass"> SubClassOf </span>Gene_Involved_In_Pathogenesis_Of_Disease<span class="some"> some </span>Hereditary Paraganglioma-Pheochromocytoma Syndrome. <br></td>
            </tr>
            <tr class="addition">
               <td>1346</td>
               <td colspan="2">SFPQ/TFE3 Fusion Gene<span class="subclass"> SubClassOf </span>Gene_Involved_In_Pathogenesis_Of_Disease<span class="some"> some </span>Renal Cell Carcinoma Associated with t(X;1)(p11.2;p34). <br></td>
            </tr>
            <tr class="addition">
               <td>1348</td>
               <td colspan="2">SS18/SSX1 Fusion Gene<span class="subclass"> SubClassOf </span>Gene_Involved_In_Pathogenesis_Of_Disease<span class="some"> some </span>Synovial Sarcoma. <br></td>
            </tr>
            <tr class="addition">
               <td>1349</td>
               <td colspan="2">SS18/SSX2 Fusion Gene<span class="subclass"> SubClassOf </span>Gene_Involved_In_Pathogenesis_Of_Disease<span class="some"> some </span>Synovial Sarcoma. <br></td>
            </tr>
            <tr class="addition">
               <td>1350</td>
               <td colspan="2">SS18/SSX4 Fusion Gene<span class="subclass"> SubClassOf </span>Gene_Involved_In_Pathogenesis_Of_Disease<span class="some"> some </span>Synovial Sarcoma. <br></td>
            </tr>
            <tr class="addition">
               <td>1351</td>
               <td colspan="2">STAT5B/RARA Fusion Gene<span class="subclass"> SubClassOf </span>Gene_Involved_In_Pathogenesis_Of_Disease<span class="some"> some </span>Acute Myeloid Leukemia with t(17;17)(q11;q11). <br></td>
            </tr>
            <tr class="addition">
               <td>1347</td>
               <td colspan="2">STIL/TAL1 Fusion Gene<span class="subclass"> SubClassOf </span>Fusion Gene. <br></td>
            </tr>
            <tr class="addition">
               <td>1352</td>
               <td colspan="2">Serine/Arginine-Rich Splicing Factor 3<span class="subclass"> EquivalentTo </span>RNA Binding Protein<br><span class="keyword"> and </span>(Gene_Product_Encoded_By_Gene<span class="some"> some </span>SRSF3 Gene)<br><span class="keyword"> and </span>(Gene_Product_Has_Associated_Anatomy<span class="some"> some </span>Nucleus)<br><span class="keyword"> and </span>(Gene_Product_Has_Biochemical_Function<span class="some"> some </span>RNA Binding Protein)<br><span class="keyword"> and </span>(Gene_Product_Has_Structural_Domain_Or_Motif<span class="some"> some </span>RNA Recognition Motif)<br><span class="keyword"> and </span>(Gene_Product_Is_Element_In_Pathway<span class="some"> some </span>Spliceosome Pathway)<br><span class="keyword"> and </span>(Gene_Product_Plays_Role_In_Biological_Process<span class="some"> some </span>RNA Binding)<br><span class="keyword"> and </span>(Gene_Product_Plays_Role_In_Biological_Process<span class="some"> some </span>RNA Splicing)<br><span class="keyword"> and </span>(Gene_Product_Plays_Role_In_Biological_Process<span class="some"> some </span>Transcription Termination)<br><span class="keyword"> and </span>(Gene_Product_Plays_Role_In_Biological_Process<span class="some"> some </span>mRNA Export). <br></td>
            </tr>
            <tr class="addition">
               <td>1353</td>
               <td colspan="2">Shivering<span class="subclass"> SubClassOf </span>Sign. <br></td>
            </tr>
            <tr class="addition">
               <td>1375</td>
               <td colspan="2">Sodium Phosphate, Tribasic<span class="subclass"> SubClassOf </span>Electrolyte Replacement Agent. <br></td>
            </tr>
            <tr class="addition">
               <td>1354</td>
               <td colspan="2">Sputum Excretion Difficulty<span class="subclass"> SubClassOf </span>Respiratory System Finding. <br></td>
            </tr>
            <tr class="addition">
               <td>1355</td>
               <td colspan="2">Sputum Excretion Difficulty<span class="subclass"> SubClassOf </span>Sign. <br></td>
            </tr>
            <tr class="addition">
               <td>1356</td>
               <td colspan="2">Suffocation<span class="subclass"> SubClassOf </span>Sign. <br></td>
            </tr>
            <tr class="addition">
               <td>1357</td>
               <td colspan="2">Suicidal Ideation<span class="subclass"> SubClassOf </span>Psychiatric Disorder. <br></td>
            </tr>
            <tr class="addition">
               <td>1358</td>
               <td colspan="2">Sweating<span class="subclass"> SubClassOf </span>Sign. <br></td>
            </tr>
            <tr class="addition">
               <td>1359</td>
               <td colspan="2">Swelling<span class="subclass"> SubClassOf </span>Sign. <br></td>
            </tr>
            <tr class="addition">
               <td>1360</td>
               <td colspan="2">Syncope<span class="subclass"> SubClassOf </span>Nervous System Finding. <br></td>
            </tr>
            <tr class="addition">
               <td>1361</td>
               <td colspan="2">Syncope<span class="subclass"> SubClassOf </span>Sign. <br></td>
            </tr>
            <tr class="addition">
               <td>1362</td>
               <td colspan="2">TAF15/NR4A3 Fusion Gene<span class="subclass"> SubClassOf </span>Gene_Involved_In_Pathogenesis_Of_Disease<span class="some"> some </span>Extraskeletal Myxoid Chondrosarcoma. <br></td>
            </tr>
            <tr class="addition">
               <td>1363</td>
               <td colspan="2">TCF12/NR4A3 Fusion Gene<span class="subclass"> SubClassOf </span>Gene_Involved_In_Pathogenesis_Of_Disease<span class="some"> some </span>Extraskeletal Myxoid Chondrosarcoma. <br></td>
            </tr>
            <tr class="addition">
               <td>1364</td>
               <td colspan="2">TCF3/PBX1 Fusion Gene<span class="subclass"> SubClassOf </span>Gene_Involved_In_Pathogenesis_Of_Disease<span class="some"> some </span>B Lymphoblastic Leukemia/Lymphoma with t(1;19)(q23;p13.3); E2A-PBX1 (TCF3-PBX1). <br></td>
            </tr>
            <tr class="addition">
               <td>1365</td>
               <td colspan="2">TFG/NR4A3 Fusion Gene<span class="subclass"> SubClassOf </span>Gene_Involved_In_Pathogenesis_Of_Disease<span class="some"> some </span>Extraskeletal Myxoid Chondrosarcoma. <br></td>
            </tr>
            <tr class="addition">
               <td>1366</td>
               <td colspan="2">TMPRSS2/ERG Fusion Gene<span class="subclass"> SubClassOf </span>Gene_Involved_In_Pathogenesis_Of_Disease<span class="some"> some </span>Prostate Carcinoma. <br></td>
            </tr>
            <tr class="addition">
               <td>1367</td>
               <td colspan="2">TP53 Gene<span class="subclass"> SubClassOf </span>Gene_Involved_In_Pathogenesis_Of_Disease<span class="some"> some </span>Lung Carcinoma. <br></td>
            </tr>
            <tr class="addition">
               <td>1368</td>
               <td colspan="2">TPM3/NTRK1 Fusion Gene<span class="subclass"> SubClassOf </span>Gene_Involved_In_Pathogenesis_Of_Disease<span class="some"> some </span>Thyroid Gland Papillary Carcinoma. <br></td>
            </tr>
            <tr class="addition">
               <td>1369</td>
               <td colspan="2">TRIM24/RET Fusion Gene<span class="subclass"> SubClassOf </span>Gene_Involved_In_Pathogenesis_Of_Disease<span class="some"> some </span>Thyroid Gland Papillary Carcinoma. <br></td>
            </tr>
            <tr class="addition">
               <td>1370</td>
               <td colspan="2">TRIM33/RET Fusion Gene<span class="subclass"> SubClassOf </span>Gene_Involved_In_Pathogenesis_Of_Disease<span class="some"> some </span>Thyroid Gland Papillary Carcinoma. <br></td>
            </tr>
            <tr class="addition">
               <td>1371</td>
               <td colspan="2">Tearing<span class="subclass"> SubClassOf </span>Sign. <br></td>
            </tr>
            <tr class="addition">
               <td>1372</td>
               <td colspan="2">Telinavir<span class="subclass"> SubClassOf </span>HIV Protease Inhibitor. <br></td>
            </tr>
            <tr class="addition">
               <td>1373</td>
               <td colspan="2">Tenderness<span class="subclass"> SubClassOf </span>Sign. <br></td>
            </tr>
            <tr class="addition">
               <td>1374</td>
               <td colspan="2">Thyroid Hormone Iodination Alteration<span class="subclass"> SubClassOf </span>Endocrine System Finding. <br></td>
            </tr>
            <tr class="addition">
               <td>1322</td>
               <td colspan="2">Toxicodendron vernix Leafy Twig<span class="subclass"> SubClassOf </span>Twig. <br></td>
            </tr>
            <tr class="addition">
               <td>1376</td>
               <td colspan="2">Unstable Personality<span class="subclass"> SubClassOf </span>Psychiatric Disorder. <br></td>
            </tr>
            <tr class="addition">
               <td>1273</td>
               <td colspan="2">Urinary Incontinence<span class="subclass"> SubClassOf </span>Urinary Tract Finding. <br></td>
            </tr>
            <tr class="addition">
               <td>1201</td>
               <td colspan="2">Voice Alteration<span class="subclass"> SubClassOf </span>Sign. <br></td>
            </tr>
            <tr class="addition">
               <td>1378</td>
               <td colspan="2">Weight Change<span class="subclass"> SubClassOf </span>Sign. <br></td>
            </tr>
            <tr class="addition">
               <td>1379</td>
               <td colspan="2">ZBTB16/RARA Fusion Gene<span class="subclass"> SubClassOf </span>Gene_Involved_In_Pathogenesis_Of_Disease<span class="some"> some </span>Acute Myeloid Leukemia with t(11;17)(q23;q21). <br></td>
            </tr>
         </tbody>
         <tbody id="addnt" style="display:none">
            <tr class="withoutstyle">
               <td colspan="3"><a name="add"></a><h4 style="display: inline-block;">Pure Additions with New Terms (13)</h4> [<a href="#">back to top</a>]
               </td>
            </tr>
            <tr>
               <th class="addition">ID</th>
               <th class="addition" colspan="2">Addition to Ontology 2</th>
            </tr>
            <tr class="addition">
               <td>1380</td>
               <td colspan="2">Acute Myeloid Leukemia with inv(3)(q21q26.2)<br><span class="keyword"> or </span>t(3;3)(q21;q26.2); RPN1-EVI1<span class="subclass"> EquivalentTo </span>Acute Myeloid Leukemia with Recurrent Genetic Abnormalities<br><span class="keyword"> and </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(3;3)(q21;q26.2))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>RPN1-EVI1 Fusion Protein Expression))<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> some </span>Aggressive Clinical Course)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>MECOM Gene)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>RPN1/MECOM Fusion Gene)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>inv(3)(q21q26.2))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Bone Marrow Dysplasia Present)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>RPN1-EVI1 Fusion Protein Expression). <br><i>New Terms: RPN1/MECOM Fusion Gene</i></td>
            </tr>
            <tr class="addition">
               <td>1381</td>
               <td colspan="2">Cardiovascular System Signs<br><span class="keyword"> and </span>Symptoms<span class="subclass"> SubClassOf </span>Sign<br><span class="keyword"> or </span>Symptom. <br><i>New Terms: Sign or Symptom</i></td>
            </tr>
            <tr class="addition">
               <td>1382</td>
               <td colspan="2">Central Nervous System Teratoma<span class="subclass"> EquivalentTo </span>Nongerminomatous Germ Cell Tumor<br><span class="keyword"> and </span>Teratoma. <br><i>New Terms: Nongerminomatous Germ Cell Tumor</i></td>
            </tr>
            <tr class="addition">
               <td>1383</td>
               <td colspan="2">Endocrine System Signs<br><span class="keyword"> and </span>Symptoms<span class="subclass"> SubClassOf </span>Sign<br><span class="keyword"> or </span>Symptom. <br><i>New Terms: Sign or Symptom</i></td>
            </tr>
            <tr class="addition">
               <td>1384</td>
               <td colspan="2">Gastrointestinal System Signs<br><span class="keyword"> and </span>Symptoms<span class="subclass"> SubClassOf </span>Sign<br><span class="keyword"> or </span>Symptom. <br><i>New Terms: Sign or Symptom</i></td>
            </tr>
            <tr class="addition">
               <td>1385</td>
               <td colspan="2">Genitourinary Signs<br><span class="keyword"> and </span>Symptoms<span class="subclass"> SubClassOf </span>Sign<br><span class="keyword"> or </span>Symptom. <br><i>New Terms: Sign or Symptom</i></td>
            </tr>
            <tr class="addition">
               <td>1386</td>
               <td colspan="2">Integumentary System Signs<br><span class="keyword"> and </span>Symptoms<span class="subclass"> SubClassOf </span>Sign<br><span class="keyword"> or </span>Symptom. <br><i>New Terms: Sign or Symptom</i></td>
            </tr>
            <tr class="addition">
               <td>1387</td>
               <td colspan="2">Mental<br><span class="keyword"> and </span>Behavioral Signs<br><span class="keyword"> and </span>Symptoms<span class="subclass"> SubClassOf </span>Sign<br><span class="keyword"> or </span>Symptom. <br><i>New Terms: Sign or Symptom</i></td>
            </tr>
            <tr class="addition">
               <td>1388</td>
               <td colspan="2">Neurological Signs<br><span class="keyword"> and </span>Symptoms<span class="subclass"> SubClassOf </span>Sign<br><span class="keyword"> or </span>Symptom. <br><i>New Terms: Sign or Symptom</i></td>
            </tr>
            <tr class="addition">
               <td>1389</td>
               <td colspan="2">Respiratory System Signs<br><span class="keyword"> and </span>Symptoms<span class="subclass"> SubClassOf </span>Sign<br><span class="keyword"> or </span>Symptom. <br><i>New Terms: Sign or Symptom</i></td>
            </tr>
            <tr class="addition">
               <td>1390</td>
               <td colspan="2">Sign<span class="subclass"> SubClassOf </span>Sign<br><span class="keyword"> or </span>Symptom. <br><i>New Terms: Sign or Symptom</i></td>
            </tr>
            <tr class="addition">
               <td>1391</td>
               <td colspan="2">Symptom<span class="subclass"> SubClassOf </span>Sign<br><span class="keyword"> or </span>Symptom. <br><i>New Terms: Sign or Symptom</i></td>
            </tr>
            <tr class="addition">
               <td>1392</td>
               <td colspan="2">Ventilation<br><span class="keyword"> or </span>Perfusion Signs<br><span class="keyword"> and </span>Symptoms<span class="subclass"> SubClassOf </span>Sign<br><span class="keyword"> or </span>Symptom. <br><i>New Terms: Sign or Symptom</i></td>
            </tr>
         </tbody>
         <tbody id="stequiv" style="display:none">
            <tr class="withoutstyle">
               <td colspan="3"><a name="aed"></a><h4 style="display: inline-block;">Modified Definitions with Shared Terms (43)</h4> [<a href="#">back to top</a>]
               </td>
            </tr>
            <tr>
               <th class="addition">ID</th>
               <th class="normaladd">Source Definition in Ontology 1</th>
               <th class="addition">Target Definition in Ontology 2</th>
            </tr>
            <tr class="addition">
               <td>1393</td>
               <td>Acute Myeloid Leukemia (Megakaryoblastic) with t(1;22)(p13;q13); RBM15-MKL1<span class="subclass"> EquivalentTo </span>Acute Myeloid Leukemia with Recurrent Genetic Abnormalities<br><span class="keyword"> and </span>((Disease_Has_Cytogenetic_Abnormality<span class="some"> some </span>t(1;22)(p13;q13))<br><span class="keyword"> and </span>(Disease_Has_Molecular_Abnormality<span class="some"> some </span>RBM15-MKL1 Fusion Protein Expression))<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> some </span>Neoplastic Megakaryoblast)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>MKL1 Gene)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>RBM15 Gene). 
               </td>
               <td>Acute Myeloid Leukemia (Megakaryoblastic) with t(1;22)(p13;q13); RBM15-MKL1<span class="subclass"> EquivalentTo </span>Acute Myeloid Leukemia with Recurrent Genetic Abnormalities<br><span class="keyword"> and </span>((Disease_Has_Cytogenetic_Abnormality<span class="some"> some </span>t(1;22)(p13;q13))<br><span class="keyword"> and </span>(Disease_Has_Molecular_Abnormality<span class="some"> some </span>RBM15-MKL1 Fusion Protein Expression))<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> some </span>Neoplastic Megakaryoblast)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>MKL1 Gene)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>RBM15/MKL1 Fusion Gene)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>RBM15 Gene).<br></td>
            </tr>
            <tr class="addition">
               <td>1394</td>
               <td>Acute Myeloid Leukemia with Variant MLL Translocations<span class="subclass"> EquivalentTo </span>Acute Myeloid Leukemia with Recurrent Genetic Abnormalities<br><span class="keyword"> and </span>(((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(10;11)(p11;q23))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>MLL-AF10 Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(11;19)(q23;p13.1))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>MLL-EEN Fusion Protein Expression)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>MLL-ELL Fusion Protein Expression)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>MLL-ENL Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(4;11)(q21;q23))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>MLL-AF4 Fusion Protein Expression)))<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> some </span>Multipotent Bone Marrow Stem Cell)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>MLL Gene). 
               </td>
               <td>Acute Myeloid Leukemia with Variant MLL Translocations<span class="subclass"> EquivalentTo </span>Acute Myeloid Leukemia with Recurrent Genetic Abnormalities<br><span class="keyword"> and </span>(((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(10;11)(p11;q23))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>MLL-AF10 Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(11;19)(q23;p13.1))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>MLL-EEN Fusion Protein Expression)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>MLL-ELL Fusion Protein Expression)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>MLL-ENL Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(4;11)(q21;q23))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>MLL-AF4 Fusion Protein Expression)))<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> some </span>Multipotent Bone Marrow Stem Cell)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>MLL/AFF1 Fusion Gene)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>MLL/MLLT10 Fusion Gene)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>MLL/MLLT1 Fusion Gene)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>MLLT10/CLP1 Fusion Gene)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>MLL Gene).<br></td>
            </tr>
            <tr class="addition">
               <td>1395</td>
               <td>Acute Myeloid Leukemia with t(11;17)(q13;q21)<span class="subclass"> EquivalentTo </span>Acute Myeloid Leukemia with a Variant RARA Translocation<br><span class="keyword"> and </span>((Disease_Has_Cytogenetic_Abnormality<span class="some"> some </span>t(11;17)(q13;q21))<br><span class="keyword"> and </span>(Disease_Has_Molecular_Abnormality<span class="some"> some </span>NUMA1-RARA Fusion Protein Expression)). 
               </td>
               <td>Acute Myeloid Leukemia with t(11;17)(q13;q21)<span class="subclass"> EquivalentTo </span>Acute Myeloid Leukemia with a Variant RARA Translocation<br><span class="keyword"> and </span>((Disease_Has_Cytogenetic_Abnormality<span class="some"> some </span>t(11;17)(q13;q21))<br><span class="keyword"> and </span>(Disease_Has_Molecular_Abnormality<span class="some"> some </span>NUMA1-RARA Fusion Protein Expression))<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>NUMA1/RARA Fusion Gene).<br></td>
            </tr>
            <tr class="addition">
               <td>1396</td>
               <td>Acute Myeloid Leukemia with t(11;17)(q23;q21)<span class="subclass"> EquivalentTo </span>Acute Myeloid Leukemia with a Variant RARA Translocation<br><span class="keyword"> and </span>((Disease_Has_Cytogenetic_Abnormality<span class="some"> some </span>t(11;17)(q23;q21))<br><span class="keyword"> and </span>(Disease_Has_Molecular_Abnormality<span class="some"> some </span>ZBTB16-RARA Fusion Protein Expression)). 
               </td>
               <td>Acute Myeloid Leukemia with t(11;17)(q23;q21)<span class="subclass"> EquivalentTo </span>Acute Myeloid Leukemia with a Variant RARA Translocation<br><span class="keyword"> and </span>((Disease_Has_Cytogenetic_Abnormality<span class="some"> some </span>t(11;17)(q23;q21))<br><span class="keyword"> and </span>(Disease_Has_Molecular_Abnormality<span class="some"> some </span>ZBTB16-RARA Fusion Protein Expression))<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>ZBTB16/RARA Fusion Gene).<br></td>
            </tr>
            <tr class="addition">
               <td>1397</td>
               <td>Acute Myeloid Leukemia with t(17;17)(q11;q11)<span class="subclass"> EquivalentTo </span>Acute Myeloid Leukemia with a Variant RARA Translocation<br><span class="keyword"> and </span>((Disease_Has_Cytogenetic_Abnormality<span class="some"> some </span>t(17;17)(q11;q11))<br><span class="keyword"> and </span>(Disease_Has_Molecular_Abnormality<span class="some"> some </span>STAT5B-RARA Fusion Protein Expression)). 
               </td>
               <td>Acute Myeloid Leukemia with t(17;17)(q11;q11)<span class="subclass"> EquivalentTo </span>Acute Myeloid Leukemia with a Variant RARA Translocation<br><span class="keyword"> and </span>((Disease_Has_Cytogenetic_Abnormality<span class="some"> some </span>t(17;17)(q11;q11))<br><span class="keyword"> and </span>(Disease_Has_Molecular_Abnormality<span class="some"> some </span>STAT5B-RARA Fusion Protein Expression))<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>STAT5B/RARA Fusion Gene).<br></td>
            </tr>
            <tr class="addition">
               <td>1398</td>
               <td>Alveolar Rhabdomyosarcoma<span class="subclass"> EquivalentTo </span>Rhabdomyosarcoma<br><span class="keyword"> and </span>Sarcoma Differentiation Score 3<br><span class="keyword"> and </span>(((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(1;13)(q36;q14))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>PAX3-FOXO1 Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(2;13)(q35;q14))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>PAX7-FOXO1 Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(2;2)(q35;p23))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>PAX3-NCOA1 Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(X;2)(q13;q35))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>PAX3-FOXO4 Fusion Protein Expression)))<br><span class="keyword"> and </span>(Disease_Excludes_Finding<span class="some"> some </span>Well-Circumscribed Lesion)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> some </span>Round Cell with Primitive Myoblastic Differentiation)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>PAX3 Gene)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>PAX7 Gene). 
               </td>
               <td>Alveolar Rhabdomyosarcoma<span class="subclass"> EquivalentTo </span>Rhabdomyosarcoma<br><span class="keyword"> and </span>Sarcoma Differentiation Score 3<br><span class="keyword"> and </span>(((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(1;13)(q36;q14))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>PAX3-FOXO1 Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(2;13)(q35;q14))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>PAX7-FOXO1 Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(2;2)(q35;p23))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>PAX3-NCOA1 Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(X;2)(q13;q35))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>PAX3-FOXO4 Fusion Protein Expression)))<br><span class="keyword"> and </span>(Disease_Excludes_Finding<span class="some"> some </span>Well-Circumscribed Lesion)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> some </span>Round Cell with Primitive Myoblastic Differentiation)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>PAX3/FOXO1 Fusion Gene)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>PAX3 Gene)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>PAX7/FOXO1 Fusion Gene)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>PAX7 Gene).<br></td>
            </tr>
            <tr class="addition">
               <td>1399</td>
               <td>Alveolar Soft Part Sarcoma<span class="subclass"> EquivalentTo </span>Malignant Soft Tissue Neoplasm of Uncertain Differentiation<br><span class="keyword"> and </span>Sarcoma Differentiation Score 3<br><span class="keyword"> and </span>Sarcoma NCI Grade 3<br><span class="keyword"> and </span>Soft Tissue Sarcoma<br><span class="keyword"> and </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>ASPL-TFE3 Fusion Protein Expression)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Unbalanced Translocation)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(X;17)(p11.2;q25)))<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> some </span>Malignant Epithelioid Cell)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> some </span>Crystal Formation)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> some </span>Organoid Pattern)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> some </span>Pseudoalveolar Pattern)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hemorrhage)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Necrotic Change). 
               </td>
               <td>Alveolar Soft Part Sarcoma<span class="subclass"> EquivalentTo </span>Malignant Soft Tissue Neoplasm of Uncertain Differentiation<br><span class="keyword"> and </span>Sarcoma Differentiation Score 3<br><span class="keyword"> and </span>Sarcoma NCI Grade 3<br><span class="keyword"> and </span>Soft Tissue Sarcoma<br><span class="keyword"> and </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>ASPL-TFE3 Fusion Protein Expression)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Unbalanced Translocation)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(X;17)(p11.2;q25)))<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> some </span>Malignant Epithelioid Cell)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> some </span>Crystal Formation)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> some </span>Organoid Pattern)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> some </span>Pseudoalveolar Pattern)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>ASPSCR1/TFE3 Fusion Gene)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hemorrhage)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Necrotic Change).<br></td>
            </tr>
            <tr class="addition">
               <td>1400</td>
               <td>Angiomatoid Fibrous Histiocytoma<span class="subclass"> EquivalentTo </span>Intermediate Soft Tissue Neoplasm<br><span class="keyword"> and </span>Soft Tissue Neoplasm of Uncertain Differentiation<br><span class="keyword"> and </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(12;16)(q13;p11))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>FUS-ATF1 Fusion Protein Expression))<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> some </span>Well-Circumscribed Lesion)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> some </span>Hemorrhagic Change)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> some </span>Hemosiderin Deposition)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> some </span>Pseudoangiomatoid Space Formation)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> some </span>Subcutaneous Involvement)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Neoplastic Epithelioid Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Neoplastic Spindle Cell). 
               </td>
               <td>Angiomatoid Fibrous Histiocytoma<span class="subclass"> EquivalentTo </span>Intermediate Soft Tissue Neoplasm<br><span class="keyword"> and </span>Soft Tissue Neoplasm of Uncertain Differentiation<br><span class="keyword"> and </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(12;16)(q13;p11))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>FUS-ATF1 Fusion Protein Expression))<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> some </span>Well-Circumscribed Lesion)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> some </span>Hemorrhagic Change)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> some </span>Hemosiderin Deposition)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> some </span>Pseudoangiomatoid Space Formation)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> some </span>Subcutaneous Involvement)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>FUS/ATF1 Fusion Gene)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Neoplastic Epithelioid Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Neoplastic Spindle Cell).<br></td>
            </tr>
            <tr class="addition">
               <td>1401</td>
               <td>Atypical Adenomatous Lung Hyperplasia<span class="subclass"> EquivalentTo </span>Atypical Hyperplasia<br><span class="keyword"> and </span>Lung Neoplasm<br><span class="keyword"> and </span>Pulmonary Precancerous Condition<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> some </span>Neoplastic Epithelial Cell)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> some </span>Multifocal Lesion)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> some </span>Alveolar Cell)<br><span class="keyword"> and </span>(Disease_Has_Normal_Tissue_Origin<span class="some"> some </span>Alveolar Epithelium)<br><span class="keyword"> and </span>(Disease_Has_Primary_Anatomic_Site<span class="some"> some </span>Alveolus)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 3p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 9)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>KRAS Gene Mutation). 
               </td>
               <td>Atypical Adenomatous Lung Hyperplasia<span class="subclass"> EquivalentTo </span>Atypical Hyperplasia<br><span class="keyword"> and </span>Lung Neoplasm<br><span class="keyword"> and </span>Pulmonary Precancerous Condition<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> some </span>Neoplastic Epithelial Cell)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> some </span>Multifocal Lesion)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> some </span>Alveolar Cell)<br><span class="keyword"> and </span>(Disease_Has_Normal_Tissue_Origin<span class="some"> some </span>Alveolar Epithelium)<br><span class="keyword"> and </span>(Disease_Has_Primary_Anatomic_Site<span class="some"> some </span>Alveolus)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>KRAS Gene)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 3p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 9)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>KRAS Gene Mutation).<br></td>
            </tr>
            <tr class="addition">
               <td>1402</td>
               <td>B Lymphoblastic Leukemia/Lymphoma with t(v;11q23); MLL Rearranged<span class="subclass"> EquivalentTo </span>B Lymphoblastic Leukemia/Lymphoma with Recurrent Genetic Abnormalities<br><span class="keyword"> and </span>((Disease_Has_Cytogenetic_Abnormality<span class="some"> some </span>t(11;v)(q23;v))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>MLL-AF4 Fusion Protein Expression)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>MLLT3-MLL Fusion Protein Expression))<br><span class="keyword"> and </span>(Disease_Excludes_Finding<span class="some"> some </span>Blasts of Mixed Phenotype Present)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>MLL Gene)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Unfavorable Clinical Outcome). 
               </td>
               <td>B Lymphoblastic Leukemia/Lymphoma with t(v;11q23); MLL Rearranged<span class="subclass"> EquivalentTo </span>B Lymphoblastic Leukemia/Lymphoma with Recurrent Genetic Abnormalities<br><span class="keyword"> and </span>((Disease_Has_Cytogenetic_Abnormality<span class="some"> some </span>t(11;v)(q23;v))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>MLL-AF4 Fusion Protein Expression)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>MLLT3-MLL Fusion Protein Expression))<br><span class="keyword"> and </span>(Disease_Excludes_Finding<span class="some"> some </span>Blasts of Mixed Phenotype Present)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>MLL/AFF1 Fusion Gene)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>MLL Gene)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Unfavorable Clinical Outcome).<br></td>
            </tr>
            <tr class="addition">
               <td>1403</td>
               <td>Bronchial Mucosa-Associated Lymphoid Tissue Lymphoma<span class="subclass"> EquivalentTo </span>Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue<br><span class="keyword"> and </span>Lung Mature B-Cell Neoplasm<br><span class="keyword"> and </span>Lung Non-Hodgkin Lymphoma<br><span class="keyword"> and </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(11;18)(q21;q21))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>API2-MLT Fusion Protein Expression))<br><span class="keyword"> and </span>(Disease_Has_Normal_Tissue_Origin<span class="some"> some </span>Bronchus-Associated Lymphoid Tissue)<br><span class="keyword"> and </span>(Disease_Has_Primary_Anatomic_Site<span class="some"> some </span>Bronchus)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>MALT1 Gene)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(1;14)(p22;q32)). 
               </td>
               <td>Bronchial Mucosa-Associated Lymphoid Tissue Lymphoma<span class="subclass"> EquivalentTo </span>Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue<br><span class="keyword"> and </span>Lung Mature B-Cell Neoplasm<br><span class="keyword"> and </span>Lung Non-Hodgkin Lymphoma<br><span class="keyword"> and </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(11;18)(q21;q21))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>API2-MLT Fusion Protein Expression))<br><span class="keyword"> and </span>(Disease_Has_Normal_Tissue_Origin<span class="some"> some </span>Bronchus-Associated Lymphoid Tissue)<br><span class="keyword"> and </span>(Disease_Has_Primary_Anatomic_Site<span class="some"> some </span>Bronchus)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>BIRC3/MALT1 Fusion Gene)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>MALT1 Gene)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(1;14)(p22;q32)).<br></td>
            </tr>
            <tr class="addition">
               <td>1404</td>
               <td>CLC wt Allele<span class="subclass"> EquivalentTo </span>CLC Gene<br><span class="keyword"> and </span>(Gene_Found_In_Organism<span class="some"> some </span>Human)<br><span class="keyword"> and </span>(Gene_Has_Physical_Location<span class="some"> some </span>19: 44920508-44913736)<br><span class="keyword"> and </span>(Gene_In_Chromosomal_Location<span class="some"> some </span>19q13.1)<br><span class="keyword"> and </span>(Gene_Is_Element_In_Pathway<span class="some"> some </span>Phospholipid Degradation Pathway). 
               </td>
               <td>CLC wt Allele<span class="subclass"> EquivalentTo </span>CLC Gene<br><span class="keyword"> and </span>(Gene_Found_In_Organism<span class="some"> some </span>Human)<br><span class="keyword"> and </span>(Gene_Has_Physical_Location<span class="some"> some </span>19: 44920508-44913736)<br><span class="keyword"> and </span>(Gene_In_Chromosomal_Location<span class="some"> some </span>19q13.1).<br></td>
            </tr>
            <tr class="addition">
               <td>1406</td>
               <td>Cellular Congenital Mesoblastic Nephroma<span class="subclass"> EquivalentTo </span>Congenital Mesoblastic Nephroma<br><span class="keyword"> and </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Trisomy 11)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(12;15)(p13;q26))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>ETV6-NTRK3 Fusion Protein Expression))<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> some </span>High Mitotic Activity)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> some </span>Increased Cellularity Present)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>NTRK3 Gene)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Necrotic Change). 
               </td>
               <td>Cellular Congenital Mesoblastic Nephroma<span class="subclass"> EquivalentTo </span>Congenital Mesoblastic Nephroma<br><span class="keyword"> and </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Trisomy 11)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(12;15)(p13;q26))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>ETV6-NTRK3 Fusion Protein Expression))<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> some </span>High Mitotic Activity)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> some </span>Increased Cellularity Present)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>ETV6/NTRK3 Fusion Gene)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>NTRK3 Gene)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Necrotic Change).<br></td>
            </tr>
            <tr class="addition">
               <td>1408</td>
               <td>Clear Cell Sarcoma of Soft Tissue<span class="subclass"> EquivalentTo </span>Neoplasm of Uncertain Histogenesis<br><span class="keyword"> and </span>Soft Tissue Sarcoma<br><span class="keyword"> and </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(12;22)(q13;q12))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>EWSR1-ATF1 Fusion Protein Expression))<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> some </span>Malignant Polygonal Cell with Eosinophilic Cytoplasm)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> some </span>Fascicular Pattern)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> some </span>Nested Pattern)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Malignant Spindle Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Wreath-Like Multinucleated Giant Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 7)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 8)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Melanosomes Present)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Slow Growing Mass). 
               </td>
               <td>Clear Cell Sarcoma of Soft Tissue<span class="subclass"> EquivalentTo </span>Neoplasm of Uncertain Histogenesis<br><span class="keyword"> and </span>Soft Tissue Sarcoma<br><span class="keyword"> and </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(12;22)(q13;q12))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>EWSR1-ATF1 Fusion Protein Expression))<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> some </span>Malignant Polygonal Cell with Eosinophilic Cytoplasm)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> some </span>Fascicular Pattern)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> some </span>Nested Pattern)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>EWSR1/ATF1 Fusion Gene)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Malignant Spindle Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Wreath-Like Multinucleated Giant Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 7)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 8)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Melanosomes Present)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Slow Growing Mass).<br></td>
            </tr>
            <tr class="addition">
               <td>1407</td>
               <td>Conventional Lipoma<span class="subclass"> EquivalentTo </span>Lipoma<br><span class="keyword"> and </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(3;12)(q27-28;q13-15))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>HMGIC-LPP Fusion Protein Expression))<br><span class="keyword"> and </span>(Disease_Excludes_Abnormal_Cell<span class="some"> some </span>Neoplastic Lipoblast)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> some </span>Neoplastic Mature Adipocyte)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> some </span>Well-Circumscribed Lesion)<br><span class="keyword"> and </span>(Disease_Mapped_To_Chromosome<span class="some"> some </span>Chromosome 13)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>HMGA2 Gene)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 13q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(1;12)(p32-34;q13-15))<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(2;12)(p22-24;q13-15))<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(2;12)(q35-37;q13-15))<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(5;12)(q33;q13-15))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Painless Mass). 
               </td>
               <td>Conventional Lipoma<span class="subclass"> EquivalentTo </span>Lipoma<br><span class="keyword"> and </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(3;12)(q27-28;q13-15))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>HMGIC-LPP Fusion Protein Expression))<br><span class="keyword"> and </span>(Disease_Excludes_Abnormal_Cell<span class="some"> some </span>Neoplastic Lipoblast)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> some </span>Neoplastic Mature Adipocyte)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> some </span>Well-Circumscribed Lesion)<br><span class="keyword"> and </span>(Disease_Mapped_To_Chromosome<span class="some"> some </span>Chromosome 13)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>HMGA2/LPP Long Fusion Gene)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>HMGA2 Gene)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 13q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(1;12)(p32-34;q13-15))<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(2;12)(p22-24;q13-15))<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(2;12)(q35-37;q13-15))<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(5;12)(q33;q13-15))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Painless Mass).<br></td>
            </tr>
            <tr class="addition">
               <td>1409</td>
               <td>Dermatofibrosarcoma Protuberans<span class="subclass"> EquivalentTo </span>Cutaneous Fibrohistiocytic Neoplasm<br><span class="keyword"> and </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(17;22)(q22;q13))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>COL1A1-PDGFbeta Fusion Protein Expression))<br><span class="keyword"> and </span>(Disease_Excludes_Finding<span class="some"> some </span>Well-Circumscribed Lesion)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> some </span>Neoplastic Spindle-Shaped Fibrohistiocytic Cell)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> some </span>Invasive Lesion)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> some </span>Multinodular Mass)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> some </span>Storiform Growth Pattern)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Supernumerary Circular Chromosome). 
               </td>
               <td>Dermatofibrosarcoma Protuberans<span class="subclass"> EquivalentTo </span>Cutaneous Fibrohistiocytic Neoplasm<br><span class="keyword"> and </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(17;22)(q22;q13))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>COL1A1-PDGFbeta Fusion Protein Expression))<br><span class="keyword"> and </span>(Disease_Excludes_Finding<span class="some"> some </span>Well-Circumscribed Lesion)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> some </span>Neoplastic Spindle-Shaped Fibrohistiocytic Cell)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> some </span>Invasive Lesion)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> some </span>Multinodular Mass)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> some </span>Storiform Growth Pattern)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>COL1A1/PDGFB Fusion Gene)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Supernumerary Circular Chromosome).<br></td>
            </tr>
            <tr class="addition">
               <td>1410</td>
               <td>Desmoplastic Small Round Cell Tumor<span class="subclass"> EquivalentTo </span>Malignant Soft Tissue Neoplasm of Uncertain Differentiation<br><span class="keyword"> and </span>Small Cell Sarcoma<br><span class="keyword"> and </span>Soft Tissue Sarcoma<br><span class="keyword"> and </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(11;22)(p13;q12))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>EWSR1-WT1 Fusion Protein Expression))<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> some </span>Malignant Small Round Cell)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> some </span>Desmoplastic Stroma Formation)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>EWSR1 Gene)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Abdominal Mass)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Ascites)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>High Mitotic Activity)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Pain)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Tumor Cell Necrosis). 
               </td>
               <td>Desmoplastic Small Round Cell Tumor<span class="subclass"> EquivalentTo </span>Malignant Soft Tissue Neoplasm of Uncertain Differentiation<br><span class="keyword"> and </span>Small Cell Sarcoma<br><span class="keyword"> and </span>Soft Tissue Sarcoma<br><span class="keyword"> and </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(11;22)(p13;q12))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>EWSR1-WT1 Fusion Protein Expression))<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> some </span>Malignant Small Round Cell)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> some </span>Desmoplastic Stroma Formation)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>EWSR1/WT1 Fusion Gene)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>EWSR1 Gene)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Abdominal Mass)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Ascites)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>High Mitotic Activity)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Pain)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Tumor Cell Necrosis).<br></td>
            </tr>
            <tr class="addition">
               <td>1433</td>
               <td>ETV6/RUNX1 Fusion Gene<span class="subclass"> EquivalentTo </span>Fusion Gene<br><span class="keyword"> and </span>(Gene_Found_In_Organism<span class="some"> some </span>Human)<br><span class="keyword"> and </span>(Gene_Has_Abnormality<span class="some"> some </span>t(12;21)(p13;q22))<br><span class="keyword"> and </span>(Gene_Is_Biomarker_Of<span class="some"> some </span>Acute Myeloid Leukemia)<br><span class="keyword"> and </span>(Gene_Plays_Role_In_Process<span class="some"> some </span>Transcriptional Regulation)<br><span class="keyword"> and </span>(Gene_Plays_Role_In_Process<span class="some"> some </span>Tumorigenesis). 
               </td>
               <td>ETV6/RUNX1 Fusion Gene<span class="subclass"> EquivalentTo </span>Fusion Gene<br><span class="keyword"> and </span>(Gene_Found_In_Organism<span class="some"> some </span>Human)<br><span class="keyword"> and </span>(Gene_Has_Abnormality<span class="some"> some </span>t(12;21)(p13;q22))<br><span class="keyword"> and </span>(Gene_Involved_In_Pathogenesis_Of_Disease<span class="some"> some </span>B Lymphoblastic Leukemia/Lymphoma with t(12;21)(p13;q22); TEL-AML1 (ETV6-RUNX1))<br><span class="keyword"> and </span>(Gene_Is_Biomarker_Of<span class="some"> some </span>Acute Myeloid Leukemia)<br><span class="keyword"> and </span>(Gene_Plays_Role_In_Process<span class="some"> some </span>Transcriptional Regulation)<br><span class="keyword"> and </span>(Gene_Plays_Role_In_Process<span class="some"> some </span>Tumorigenesis).<br></td>
            </tr>
            <tr class="addition">
               <td>1412</td>
               <td>Gastric Mucosa-Associated Lymphoid Tissue Lymphoma<span class="subclass"> EquivalentTo </span>Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue<br><span class="keyword"> and </span>Gastric Non-Hodgkin Lymphoma<br><span class="keyword"> and </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(11;18)(q21;q21))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>API2-MLT Fusion Protein Expression))<br><span class="keyword"> and </span>(Disease_Has_Normal_Tissue_Origin<span class="some"> some </span>Gut-Associated Lymphoid Tissue)<br><span class="keyword"> and </span>(Disease_Has_Primary_Anatomic_Site<span class="some"> some </span>Stomach)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>MALT1 Gene)<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Hepatitis C Infection). 
               </td>
               <td>Gastric Mucosa-Associated Lymphoid Tissue Lymphoma<span class="subclass"> EquivalentTo </span>Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue<br><span class="keyword"> and </span>Gastric Non-Hodgkin Lymphoma<br><span class="keyword"> and </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(11;18)(q21;q21))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>API2-MLT Fusion Protein Expression))<br><span class="keyword"> and </span>(Disease_Has_Normal_Tissue_Origin<span class="some"> some </span>Gut-Associated Lymphoid Tissue)<br><span class="keyword"> and </span>(Disease_Has_Primary_Anatomic_Site<span class="some"> some </span>Stomach)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>BIRC3/MALT1 Fusion Gene)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>MALT1 Gene)<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Hepatitis C Infection).<br></td>
            </tr>
            <tr class="addition">
               <td>1413</td>
               <td>Growth Hormone-Producing Pituitary Gland Adenoma<span class="subclass"> EquivalentTo </span>Growth Hormone-Producing Pituitary Gland Neoplasm<br><span class="keyword"> and </span>Pituitary Gland Adenoma<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 17)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 19)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 22)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 5)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 9)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 1)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 11)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 18)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 2)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>CDKN2A Gene Inactivation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>GNAS Gene Mutation). 
               </td>
               <td>Growth Hormone-Producing Pituitary Gland Adenoma<span class="subclass"> EquivalentTo </span>Growth Hormone-Producing Pituitary Gland Neoplasm<br><span class="keyword"> and </span>Pituitary Gland Adenoma<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>GNAS Gene)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 17)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 19)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 22)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 5)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 9)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 1)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 11)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 18)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 2)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>CDKN2A Gene Inactivation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>GNAS Gene Mutation).<br></td>
            </tr>
            <tr class="addition">
               <td>1414</td>
               <td>Hereditary Paraganglioma<span class="subclass"> EquivalentTo </span>Extra-Adrenal Paraganglioma<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> some </span>Hereditary Lesion)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Multifocal Lesion)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Nesting (Zellballen) Growth Pattern)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Trabecular Pattern). 
               </td>
               <td>Hereditary Paraganglioma<span class="subclass"> EquivalentTo </span>Extra-Adrenal Paraganglioma<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> some </span>Hereditary Lesion)<br><span class="keyword"> and </span>(Disease_Has_Molecular_Abnormality<span class="some"> some </span>Mitochondrial Complex II Gene Mutation)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>SDHB Gene)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>SDHC Gene)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>SDHD Gene)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Multifocal Lesion)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Nesting (Zellballen) Growth Pattern)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Trabecular Pattern)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>SDHB Gene Mutation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>SDHC Gene Mutation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>SDHD Gene Mutation).<br></td>
            </tr>
            <tr class="addition">
               <td>1415</td>
               <td>Hereditary Paraganglioma-Pheochromocytoma Syndrome<span class="subclass"> EquivalentTo </span>Endocrine Syndrome<br><span class="keyword"> and </span>Hereditary Neoplastic Syndrome<br><span class="keyword"> and </span>((Disease_Has_Molecular_Abnormality<span class="some"> some </span>Mitochondrial Complex II Gene Mutation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>SDHB Gene Mutation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>SDHC Gene Mutation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>SDHD Gene Mutation))<br><span class="keyword"> and </span>(Disease_Has_Associated_Disease<span class="some"> some </span>Paraganglioma). 
               </td>
               <td>Hereditary Paraganglioma-Pheochromocytoma Syndrome<span class="subclass"> EquivalentTo </span>Endocrine Syndrome<br><span class="keyword"> and </span>Hereditary Neoplastic Syndrome<br><span class="keyword"> and </span>((Disease_Has_Molecular_Abnormality<span class="some"> some </span>Mitochondrial Complex II Gene Mutation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>SDHB Gene Mutation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>SDHC Gene Mutation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>SDHD Gene Mutation))<br><span class="keyword"> and </span>(Disease_Has_Associated_Disease<span class="some"> some </span>Paraganglioma)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>SDHB Gene)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>SDHC Gene)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>SDHD Gene).<br></td>
            </tr>
            <tr class="addition">
               <td>1416</td>
               <td>Hyperparathyroidism-Jaw Tumor Syndrome<span class="subclass"> EquivalentTo </span>Hereditary Neoplastic Syndrome<br><span class="keyword"> and </span>(Disease_Has_Associated_Disease<span class="some"> some </span>Primary Hyperparathyroidism)<br><span class="keyword"> and </span>(Disease_Has_Molecular_Abnormality<span class="some"> some </span>CDC73 Gene Mutation)<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Papillary Renal Cell Carcinoma)<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Parathyroid Gland Adenoma)<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Parathyroid Gland Carcinoma)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Renal Cyst). 
               </td>
               <td>Hyperparathyroidism-Jaw Tumor Syndrome<span class="subclass"> EquivalentTo </span>Hereditary Neoplastic Syndrome<br><span class="keyword"> and </span>(Disease_Has_Associated_Disease<span class="some"> some </span>Primary Hyperparathyroidism)<br><span class="keyword"> and </span>(Disease_Has_Molecular_Abnormality<span class="some"> some </span>CDC73 Gene Mutation)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>CDC73 Gene)<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Papillary Renal Cell Carcinoma)<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Parathyroid Gland Adenoma)<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Parathyroid Gland Carcinoma)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Renal Cyst).<br></td>
            </tr>
            <tr class="addition">
               <td>1417</td>
               <td>Infantile Fibrosarcoma<span class="subclass"> EquivalentTo </span>Childhood Fibrosarcoma<br><span class="keyword"> and </span>Conventional Fibrosarcoma<br><span class="keyword"> and </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(12;15)(p13;q26))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>ETV6-NTRK3 Fusion Protein Expression))<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>NTRK3 Gene)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Trisomy 11)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Trisomy 17)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Trisomy 20)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Trisomy 8)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Favorable Clinical Outcome). 
               </td>
               <td>Infantile Fibrosarcoma<span class="subclass"> EquivalentTo </span>Childhood Fibrosarcoma<br><span class="keyword"> and </span>Conventional Fibrosarcoma<br><span class="keyword"> and </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(12;15)(p13;q26))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>ETV6-NTRK3 Fusion Protein Expression))<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>ETV6/NTRK3 Fusion Gene)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>NTRK3 Gene)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Trisomy 11)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Trisomy 17)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Trisomy 20)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Trisomy 8)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Favorable Clinical Outcome).<br></td>
            </tr>
            <tr class="addition">
               <td>1418</td>
               <td>Low Grade Fibromyxoid Sarcoma<span class="subclass"> EquivalentTo </span>Soft Tissue Fibrosarcoma<br><span class="keyword"> and </span>((Disease_Has_Cytogenetic_Abnormality<span class="some"> some </span>Balanced Chromosomal Translocation)<br><span class="keyword"> and </span>(Disease_Has_Cytogenetic_Abnormality<span class="some"> some </span>t(7;16)(q32-34;p11))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>FUS-CREB3L1 Fusion Protein Expression)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>FUS-CREB3L2 Fusion Protein Expression))<br><span class="keyword"> and </span>(Disease_Excludes_Finding<span class="some"> some </span>Nuclear Pleomorphism)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> some </span>Malignant Spindle-Shaped Fibroblast)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> some </span>Fibrotic Stroma Formation)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> some </span>Low Grade Lesion)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> some </span>Myxoid Stroma Formation)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> some </span>Whorling Growth Pattern)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>FUS Gene)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Favorable Clinical Outcome)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Mild Cytologic Atypia). 
               </td>
               <td>Low Grade Fibromyxoid Sarcoma<span class="subclass"> EquivalentTo </span>Soft Tissue Fibrosarcoma<br><span class="keyword"> and </span>((Disease_Has_Cytogenetic_Abnormality<span class="some"> some </span>Balanced Chromosomal Translocation)<br><span class="keyword"> and </span>(Disease_Has_Cytogenetic_Abnormality<span class="some"> some </span>t(7;16)(q32-34;p11))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>FUS-CREB3L1 Fusion Protein Expression)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>FUS-CREB3L2 Fusion Protein Expression))<br><span class="keyword"> and </span>(Disease_Excludes_Finding<span class="some"> some </span>Nuclear Pleomorphism)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> some </span>Malignant Spindle-Shaped Fibroblast)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> some </span>Fibrotic Stroma Formation)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> some </span>Low Grade Lesion)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> some </span>Myxoid Stroma Formation)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> some </span>Whorling Growth Pattern)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>FUS/CREB3L2 Fusion Gene)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>FUS Gene)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Favorable Clinical Outcome)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Mild Cytologic Atypia).<br></td>
            </tr>
            <tr class="addition">
               <td>1419</td>
               <td>Lung Adenocarcinoma<span class="subclass"> EquivalentTo </span>Non-Small Cell Adenocarcinoma<br><span class="keyword"> and </span>Non-Small Cell Lung Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 1q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 20q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 3q24-qter)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 5p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 8q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 13q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 4q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 6q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 8p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 9)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome Y)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>KRAS2 Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>LKB1 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Loss of Chromosome 5q). 
               </td>
               <td>Lung Adenocarcinoma<span class="subclass"> EquivalentTo </span>Non-Small Cell Adenocarcinoma<br><span class="keyword"> and </span>Non-Small Cell Lung Carcinoma<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>ALK Gene)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>EML4/ALK Fusion Gene)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>KRAS Gene)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 1q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 20q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 3q24-qter)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 5p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 8q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 13q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 4q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 6q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 8p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 9)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome Y)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>KRAS2 Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>LKB1 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Loss of Chromosome 5q).<br></td>
            </tr>
            <tr class="addition">
               <td>1420</td>
               <td>Lung Carcinoma<span class="subclass"> EquivalentTo </span>Carcinoma<br><span class="keyword"> and </span>Malignant Lung Neoplasm<br><span class="keyword"> and </span>(Disease_Has_Primary_Anatomic_Site<span class="some"> some </span>Lung). 
               </td>
               <td>Lung Carcinoma<span class="subclass"> EquivalentTo </span>Carcinoma<br><span class="keyword"> and </span>Malignant Lung Neoplasm<br><span class="keyword"> and </span>(Disease_Has_Primary_Anatomic_Site<span class="some"> some </span>Lung)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>TP53 Gene).<br></td>
            </tr>
            <tr class="addition">
               <td>1421</td>
               <td>Malignant Mesothelioma<span class="subclass"> EquivalentTo </span>Mesothelioma<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> some </span>Malignant Mesothelial Cell). 
               </td>
               <td>Malignant Mesothelioma<span class="subclass"> EquivalentTo </span>Mesothelioma<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> some </span>Malignant Mesothelial Cell)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>CDKN2A Gene).<br></td>
            </tr>
            <tr class="addition">
               <td>1405</td>
               <td>NUT Midline Carcinoma<span class="subclass"> EquivalentTo </span>Undifferentiated Carcinoma<br><span class="keyword"> and </span>(Disease_Has_Cytogenetic_Abnormality<span class="some"> some </span>t(15;19)(q13;p13.1))<br><span class="keyword"> and </span>(Disease_Has_Molecular_Abnormality<span class="some"> some </span>BRD4-NUT Fusion Protein Expression). 
               </td>
               <td>NUT Midline Carcinoma<span class="subclass"> EquivalentTo </span>Undifferentiated Carcinoma<br><span class="keyword"> and </span>(Disease_Has_Cytogenetic_Abnormality<span class="some"> some </span>t(15;19)(q13;p13.1))<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> some </span>Aggressive Clinical Course)<br><span class="keyword"> and </span>(Disease_Has_Molecular_Abnormality<span class="some"> some </span>BRD4-NUT Fusion Protein Expression)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>BRD4/C15orf55 Fusion Gene).<br></td>
            </tr>
            <tr class="addition">
               <td>1424</td>
               <td>Parathyroid Gland Adenoma<span class="subclass"> EquivalentTo </span>Adenoma<br><span class="keyword"> and </span>Benign Endocrine Neoplasm<br><span class="keyword"> and </span>Benign Parathyroid Gland Neoplasm<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> some </span>Neoplastic Parathyroid Gland Cell)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> some </span>Parathyroid Gland Parenchymal Cell)<br><span class="keyword"> and </span>(Disease_Has_Normal_Tissue_Origin<span class="some"> some </span>Parathyroid Gland Epithelial Tissue)<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Primary Hyperparathyroidism)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Acinar Pattern)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Encapsulated Mass)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Follicular Structures Present)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Solid Growth Pattern)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Trabecular Pattern)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Aneuploidy)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>MEN1 Gene Inactivation). 
               </td>
               <td>Parathyroid Gland Adenoma<span class="subclass"> EquivalentTo </span>Adenoma<br><span class="keyword"> and </span>Benign Endocrine Neoplasm<br><span class="keyword"> and </span>Benign Parathyroid Gland Neoplasm<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> some </span>Neoplastic Parathyroid Gland Cell)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> some </span>Parathyroid Gland Parenchymal Cell)<br><span class="keyword"> and </span>(Disease_Has_Normal_Tissue_Origin<span class="some"> some </span>Parathyroid Gland Epithelial Tissue)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>CCND1 Gene)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>MEN1 Gene)<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Primary Hyperparathyroidism)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Acinar Pattern)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Encapsulated Mass)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Follicular Structures Present)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Solid Growth Pattern)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Trabecular Pattern)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Aneuploidy)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>MEN1 Gene Inactivation).<br></td>
            </tr>
            <tr class="addition">
               <td>1425</td>
               <td>Parathyroid Gland Carcinoma<span class="subclass"> EquivalentTo </span>Adenocarcinoma<br><span class="keyword"> and </span>Malignant Endocrine Neoplasm<br><span class="keyword"> and </span>Malignant Parathyroid Gland Neoplasm<br><span class="keyword"> and </span>Neck Carcinoma<br><span class="keyword"> and </span>((Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>CCND1 Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Cyclin D1 Protein Overexpression))<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> some </span>Malignant Parathyroid Gland Cell)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> some </span>Parathyroid Gland Parenchymal Cell)<br><span class="keyword"> and </span>(Disease_Has_Normal_Tissue_Origin<span class="some"> some </span>Parathyroid Gland Epithelial Tissue)<br><span class="keyword"> and </span>(Disease_Has_Primary_Anatomic_Site<span class="some"> some </span>Parathyroid Gland)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Malignant Parathyroid Gland Chief Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Malignant Parathyroid Gland Clear Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Malignant Parathyroid Gland Oncocyte)<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Primary Hyperparathyroidism)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Broad Fibrous Bands Formation)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Capsular Invasion)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hemosiderin Deposition)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Mitotic Activity)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Neck Mass)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Perineural Invasion)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Solid Growth Pattern)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Trabecular Pattern)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Tumor Vascular Invasion)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Aneuploidy)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>CDC73 Gene Mutation). 
               </td>
               <td>Parathyroid Gland Carcinoma<span class="subclass"> EquivalentTo </span>Adenocarcinoma<br><span class="keyword"> and </span>Malignant Endocrine Neoplasm<br><span class="keyword"> and </span>Malignant Parathyroid Gland Neoplasm<br><span class="keyword"> and </span>Neck Carcinoma<br><span class="keyword"> and </span>((Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>CCND1 Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Cyclin D1 Protein Overexpression))<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> some </span>Malignant Parathyroid Gland Cell)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> some </span>Parathyroid Gland Parenchymal Cell)<br><span class="keyword"> and </span>(Disease_Has_Normal_Tissue_Origin<span class="some"> some </span>Parathyroid Gland Epithelial Tissue)<br><span class="keyword"> and </span>(Disease_Has_Primary_Anatomic_Site<span class="some"> some </span>Parathyroid Gland)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>CDC73 Gene)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Malignant Parathyroid Gland Chief Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Malignant Parathyroid Gland Clear Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Malignant Parathyroid Gland Oncocyte)<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Primary Hyperparathyroidism)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Broad Fibrous Bands Formation)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Capsular Invasion)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hemosiderin Deposition)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Mitotic Activity)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Neck Mass)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Perineural Invasion)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Solid Growth Pattern)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Trabecular Pattern)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Tumor Vascular Invasion)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Aneuploidy)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>CDC73 Gene Mutation).<br></td>
            </tr>
            <tr class="addition">
               <td>1426</td>
               <td>Prostate Carcinoma<span class="subclass"> EquivalentTo </span>Carcinoma<br><span class="keyword"> and </span>Malignant Prostate Neoplasm<br><span class="keyword"> and </span>((Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>ERG Gene Rearrangement)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>TMPRSS2-ERG Fusion Protein Expression))<br><span class="keyword"> and </span>(Disease_Has_Normal_Tissue_Origin<span class="some"> some </span>Prostatic Epithelium)<br><span class="keyword"> and </span>(Disease_Has_Primary_Anatomic_Site<span class="some"> some </span>Prostate Gland). 
               </td>
               <td>Prostate Carcinoma<span class="subclass"> EquivalentTo </span>Carcinoma<br><span class="keyword"> and </span>Malignant Prostate Neoplasm<br><span class="keyword"> and </span>((Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>ERG Gene Rearrangement)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>TMPRSS2-ERG Fusion Protein Expression))<br><span class="keyword"> and </span>(Disease_Has_Normal_Tissue_Origin<span class="some"> some </span>Prostatic Epithelium)<br><span class="keyword"> and </span>(Disease_Has_Primary_Anatomic_Site<span class="some"> some </span>Prostate Gland)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>ERG Gene)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>TMPRSS2/ERG Fusion Gene).<br></td>
            </tr>
            <tr class="addition">
               <td>1427</td>
               <td>Renal Cell Carcinoma Associated with t(X;1)(p11.2;p34)<span class="subclass"> EquivalentTo </span>Renal Cell Carcinoma Associated with Xp11.2 Translocations/TFE3 Gene Fusions<br><span class="keyword"> and </span>((Disease_Has_Cytogenetic_Abnormality<span class="some"> some </span>t(X;1)(p11.2;p34))<br><span class="keyword"> and </span>(Disease_Has_Molecular_Abnormality<span class="some"> some </span>PSF-TFE3 Fusion Protein Expression)). 
               </td>
               <td>Renal Cell Carcinoma Associated with t(X;1)(p11.2;p34)<span class="subclass"> EquivalentTo </span>Renal Cell Carcinoma Associated with Xp11.2 Translocations/TFE3 Gene Fusions<br><span class="keyword"> and </span>((Disease_Has_Cytogenetic_Abnormality<span class="some"> some </span>t(X;1)(p11.2;p34))<br><span class="keyword"> and </span>(Disease_Has_Molecular_Abnormality<span class="some"> some </span>PSF-TFE3 Fusion Protein Expression))<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>SFPQ/TFE3 Fusion Gene).<br></td>
            </tr>
            <tr class="addition">
               <td>1428</td>
               <td>Renal Cell Carcinoma Associated with t(X;1)(p11.2;q21)<span class="subclass"> EquivalentTo </span>Renal Cell Carcinoma Associated with Xp11.2 Translocations/TFE3 Gene Fusions<br><span class="keyword"> and </span>((Disease_Has_Cytogenetic_Abnormality<span class="some"> some </span>t(X;1)(p11.2;q21))<br><span class="keyword"> and </span>(Disease_Has_Molecular_Abnormality<span class="some"> some </span>PRCC-TFE3 Fusion Protein Expression))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Psammoma Body Formation). 
               </td>
               <td>Renal Cell Carcinoma Associated with t(X;1)(p11.2;q21)<span class="subclass"> EquivalentTo </span>Renal Cell Carcinoma Associated with Xp11.2 Translocations/TFE3 Gene Fusions<br><span class="keyword"> and </span>((Disease_Has_Cytogenetic_Abnormality<span class="some"> some </span>t(X;1)(p11.2;q21))<br><span class="keyword"> and </span>(Disease_Has_Molecular_Abnormality<span class="some"> some </span>PRCC-TFE3 Fusion Protein Expression))<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>PRCC/TFE3 Fusion Gene)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Psammoma Body Formation).<br></td>
            </tr>
            <tr class="addition">
               <td>1429</td>
               <td>Salivary Gland Mucoepidermoid Carcinoma<span class="subclass"> EquivalentTo </span>Mucoepidermoid Carcinoma<br><span class="keyword"> and </span>Salivary Gland Carcinoma<br><span class="keyword"> and </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(11;19)(q14-21;p12-13))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>MECT1-MAML2 Fusion Protein Expression)). 
               </td>
               <td>Salivary Gland Mucoepidermoid Carcinoma<span class="subclass"> EquivalentTo </span>Mucoepidermoid Carcinoma<br><span class="keyword"> and </span>Salivary Gland Carcinoma<br><span class="keyword"> and </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(11;19)(q14-21;p12-13))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>MECT1-MAML2 Fusion Protein Expression))<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>CRTC1/MAML2 Fusion Gene).<br></td>
            </tr>
            <tr class="addition">
               <td>1430</td>
               <td>Secretory Breast Carcinoma<span class="subclass"> EquivalentTo </span>Breast Adenocarcinoma<br><span class="keyword"> and </span>Invasive Breast Carcinoma<br><span class="keyword"> and </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(12;15)(p13;q26))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>ETV6-NTRK3 Fusion Protein Expression))<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> some </span>Adenocarcinoma Cell with Abundant Pale Staining Cytoplasm)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> some </span>Intracytoplasmic<br><span class="keyword"> and </span>Extracytoplasmic Eosinophilic Material Present)<br><span class="keyword"> and </span>(Disease_Is_Grade<span class="some"> some </span>Low Grade)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Well-Circumscribed Lesion)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Favorable Clinical Outcome). 
               </td>
               <td>Secretory Breast Carcinoma<span class="subclass"> EquivalentTo </span>Breast Adenocarcinoma<br><span class="keyword"> and </span>Invasive Breast Carcinoma<br><span class="keyword"> and </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(12;15)(p13;q26))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>ETV6-NTRK3 Fusion Protein Expression))<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> some </span>Adenocarcinoma Cell with Abundant Pale Staining Cytoplasm)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> some </span>Intracytoplasmic<br><span class="keyword"> and </span>Extracytoplasmic Eosinophilic Material Present)<br><span class="keyword"> and </span>(Disease_Is_Grade<span class="some"> some </span>Low Grade)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>ETV6/NTRK3 Fusion Gene)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Well-Circumscribed Lesion)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Favorable Clinical Outcome).<br></td>
            </tr>
            <tr class="addition">
               <td>1431</td>
               <td>Small Intestinal Mucosa-Associated Lymphoid Tissue Lymphoma<span class="subclass"> EquivalentTo </span>Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue<br><span class="keyword"> and </span>Small Intestinal B-Cell Non-Hodgkin Lymphoma<br><span class="keyword"> and </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(11;18)(q21;q21))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>API2-MLT Fusion Protein Expression))<br><span class="keyword"> and </span>(Disease_Has_Normal_Tissue_Origin<span class="some"> some </span>Gut-Associated Lymphoid Tissue)<br><span class="keyword"> and </span>(Disease_Has_Normal_Tissue_Origin<span class="some"> some </span>Small Intestinal Mucosa)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>MALT1 Gene)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(1;14)(p22;q32)). 
               </td>
               <td>Small Intestinal Mucosa-Associated Lymphoid Tissue Lymphoma<span class="subclass"> EquivalentTo </span>Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue<br><span class="keyword"> and </span>Small Intestinal B-Cell Non-Hodgkin Lymphoma<br><span class="keyword"> and </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(11;18)(q21;q21))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>API2-MLT Fusion Protein Expression))<br><span class="keyword"> and </span>(Disease_Has_Normal_Tissue_Origin<span class="some"> some </span>Gut-Associated Lymphoid Tissue)<br><span class="keyword"> and </span>(Disease_Has_Normal_Tissue_Origin<span class="some"> some </span>Small Intestinal Mucosa)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>BIRC3/MALT1 Fusion Gene)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>MALT1 Gene)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(1;14)(p22;q32)).<br></td>
            </tr>
            <tr class="addition">
               <td>1432</td>
               <td>Synovial Sarcoma<span class="subclass"> EquivalentTo </span>Malignant Soft Tissue Neoplasm of Uncertain Differentiation<br><span class="keyword"> and </span>Sarcoma NCI Grade 3<br><span class="keyword"> and </span>Soft Tissue Sarcoma<br><span class="keyword"> and </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(X;18)(p11;q11))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>SS18-SSX1 Fusion Protein Expression)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>SS18-SSX2 Fusion Protein Expression)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>SS18-SSX4 Fusion Protein Expression))<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>SS18 Gene). 
               </td>
               <td>Synovial Sarcoma<span class="subclass"> EquivalentTo </span>Malignant Soft Tissue Neoplasm of Uncertain Differentiation<br><span class="keyword"> and </span>Sarcoma NCI Grade 3<br><span class="keyword"> and </span>Soft Tissue Sarcoma<br><span class="keyword"> and </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(X;18)(p11;q11))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>SS18-SSX1 Fusion Protein Expression)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>SS18-SSX2 Fusion Protein Expression)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>SS18-SSX4 Fusion Protein Expression))<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>SS18/SSX1 Fusion Gene)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>SS18/SSX2 Fusion Gene)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>SS18/SSX4 Fusion Gene)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>SS18 Gene).<br></td>
            </tr>
            <tr class="addition">
               <td>1434</td>
               <td>Thyroid Gland Follicular Adenoma<span class="subclass"> EquivalentTo </span>Adenoma<br><span class="keyword"> and </span>Benign Endocrine Neoplasm<br><span class="keyword"> and </span>Benign Thyroid Gland Neoplasm<br><span class="keyword"> and </span>Thyroid Gland Nodule<br><span class="keyword"> and </span>(Disease_Excludes_Finding<span class="some"> some </span>Capsular Invasion)<br><span class="keyword"> and </span>(Disease_Excludes_Finding<span class="some"> some </span>Ground Glass Nuclear Inclusion)<br><span class="keyword"> and </span>(Disease_Excludes_Finding<span class="some"> some </span>Nuclear Clearing)<br><span class="keyword"> and </span>(Disease_Excludes_Finding<span class="some"> some </span>Nuclear Grooves)<br><span class="keyword"> and </span>(Disease_Excludes_Finding<span class="some"> some </span>Nuclear Pseudoinclusion)<br><span class="keyword"> and </span>(Disease_Excludes_Finding<span class="some"> some </span>Tumor Vascular Invasion)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> some </span>Neoplastic Thyroid Gland Follicular Cell)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> some </span>Monoclonal Cellular Population Present)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> some </span>Encapsulated Mass)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> some </span>Follicular Structures Present)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> some </span>Thyroglobulin Positive Neoplastic Cells Present)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> some </span>Thyroid Gland Follicular Cell)<br><span class="keyword"> and </span>(Disease_Has_Normal_Tissue_Origin<span class="some"> some </span>Thyroid Gland Follicle)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 10)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 13)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 19)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 3p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Trisomy 7)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Radiation Toxicity). 
               </td>
               <td>Thyroid Gland Follicular Adenoma<span class="subclass"> EquivalentTo </span>Adenoma<br><span class="keyword"> and </span>Benign Endocrine Neoplasm<br><span class="keyword"> and </span>Benign Thyroid Gland Neoplasm<br><span class="keyword"> and </span>Thyroid Gland Nodule<br><span class="keyword"> and </span>(Disease_Excludes_Finding<span class="some"> some </span>Capsular Invasion)<br><span class="keyword"> and </span>(Disease_Excludes_Finding<span class="some"> some </span>Ground Glass Nuclear Inclusion)<br><span class="keyword"> and </span>(Disease_Excludes_Finding<span class="some"> some </span>Nuclear Clearing)<br><span class="keyword"> and </span>(Disease_Excludes_Finding<span class="some"> some </span>Nuclear Grooves)<br><span class="keyword"> and </span>(Disease_Excludes_Finding<span class="some"> some </span>Nuclear Pseudoinclusion)<br><span class="keyword"> and </span>(Disease_Excludes_Finding<span class="some"> some </span>Tumor Vascular Invasion)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> some </span>Neoplastic Thyroid Gland Follicular Cell)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> some </span>Monoclonal Cellular Population Present)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> some </span>Encapsulated Mass)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> some </span>Follicular Structures Present)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> some </span>Thyroglobulin Positive Neoplastic Cells Present)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> some </span>Thyroid Gland Follicular Cell)<br><span class="keyword"> and </span>(Disease_Has_Normal_Tissue_Origin<span class="some"> some </span>Thyroid Gland Follicle)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>PAX8/PPARG Fusion Gene)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>PPARG Gene)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 10)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 13)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 19)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 3p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Trisomy 7)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Radiation Toxicity).<br></td>
            </tr>
            <tr class="addition">
               <td>1411</td>
               <td>Thyroid Gland Follicular Carcinoma<span class="subclass"> EquivalentTo </span>Differentiated Thyroid Gland Carcinoma<br><span class="keyword"> and </span>(Disease_Excludes_Finding<span class="some"> some </span>Ground Glass Nuclear Inclusion)<br><span class="keyword"> and </span>(Disease_Excludes_Finding<span class="some"> some </span>Nuclear Clearing)<br><span class="keyword"> and </span>(Disease_Excludes_Finding<span class="some"> some </span>Nuclear Grooves)<br><span class="keyword"> and </span>(Disease_Excludes_Finding<span class="some"> some </span>Nuclear Pseudoinclusion)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Encapsulated Mass)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Follicular Structures Present)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Solid Growth Pattern)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Trabecular Pattern)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>HRAS Gene Mutation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>NRAS Gene Mutation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>PPAR-gamma Rearrangement)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>PTEN Gene Inactivation). 
               </td>
               <td>Thyroid Gland Follicular Carcinoma<span class="subclass"> EquivalentTo </span>Differentiated Thyroid Gland Carcinoma<br><span class="keyword"> and </span>(Disease_Excludes_Finding<span class="some"> some </span>Ground Glass Nuclear Inclusion)<br><span class="keyword"> and </span>(Disease_Excludes_Finding<span class="some"> some </span>Nuclear Clearing)<br><span class="keyword"> and </span>(Disease_Excludes_Finding<span class="some"> some </span>Nuclear Grooves)<br><span class="keyword"> and </span>(Disease_Excludes_Finding<span class="some"> some </span>Nuclear Pseudoinclusion)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>PAX8/PPARG Fusion Gene)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>PPARG Gene)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Encapsulated Mass)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Follicular Structures Present)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Solid Growth Pattern)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Trabecular Pattern)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>HRAS Gene Mutation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>NRAS Gene Mutation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>PPAR-gamma Rearrangement)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>PTEN Gene Inactivation).<br></td>
            </tr>
            <tr class="addition">
               <td>1422</td>
               <td>Thyroid Gland Medullary Carcinoma<span class="subclass"> EquivalentTo </span>Neuroendocrine Carcinoma<br><span class="keyword"> and </span>Thyroid Gland Carcinoma<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> some </span>Calcitonin Positive Neoplastic Cells Present)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> some </span>Well-Circumscribed Lesion)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> some </span>Serum Calcitonin Level Increased)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> some </span>C-Cell)<br><span class="keyword"> and </span>(Disease_Has_Normal_Tissue_Origin<span class="some"> some </span>Thyroid Gland Follicle)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Malignant Neuroendocrine Polygonal Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Malignant Neuroendocrine Small Round Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Malignant Neuroendocrine Spindle Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Paraneoplastic Syndrome)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Cold Nodule)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Metastatic Malignant Neoplasm to the Lymph Node)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Organoid Pattern)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Trabecular Pattern). 
               </td>
               <td>Thyroid Gland Medullary Carcinoma<span class="subclass"> EquivalentTo </span>Neuroendocrine Carcinoma<br><span class="keyword"> and </span>Thyroid Gland Carcinoma<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> some </span>Calcitonin Positive Neoplastic Cells Present)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> some </span>Well-Circumscribed Lesion)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> some </span>Serum Calcitonin Level Increased)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> some </span>C-Cell)<br><span class="keyword"> and </span>(Disease_Has_Normal_Tissue_Origin<span class="some"> some </span>Thyroid Gland Follicle)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>RET Gene)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Malignant Neuroendocrine Polygonal Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Malignant Neuroendocrine Small Round Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Malignant Neuroendocrine Spindle Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Paraneoplastic Syndrome)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Cold Nodule)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Metastatic Malignant Neoplasm to the Lymph Node)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Organoid Pattern)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Trabecular Pattern).<br></td>
            </tr>
            <tr class="addition">
               <td>1423</td>
               <td>Thyroid Gland Papillary Carcinoma<span class="subclass"> EquivalentTo </span>Papillary Adenocarcinoma<br><span class="keyword"> and </span>Differentiated Thyroid Gland Carcinoma<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> some </span>Ground Glass Nuclear Inclusion)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> some </span>Nuclear Grooves)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> some </span>Nuclear Pseudoinclusion)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Cystic Change)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Indolent Clinical Course)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Psammoma Body Formation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>BRAF Gene Mutation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>HRAS Gene Mutation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>KRAS Gene Mutation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>NRAS Gene Mutation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>RET/PTC Rearrangement)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>TRK Rearrangement). 
               </td>
               <td>Thyroid Gland Papillary Carcinoma<span class="subclass"> EquivalentTo </span>Papillary Adenocarcinoma<br><span class="keyword"> and </span>Differentiated Thyroid Gland Carcinoma<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> some </span>Ground Glass Nuclear Inclusion)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> some </span>Nuclear Grooves)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> some </span>Nuclear Pseudoinclusion)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>ERC1/RET Fusion Gene)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>GOLGA5/RET Fusion Gene)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>NCOA4/RET Fusion Gene)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>PCM1/RET Fusion Gene)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>PRKAR1A/RET Fusion Gene)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>CCDC6/RET Fusion Gene)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>RET Gene)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>TPM3/NTRK1 Fusion Gene)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>TRIM24/RET Fusion Gene)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>TRIM33/RET Fusion Gene)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Cystic Change)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Indolent Clinical Course)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Psammoma Body Formation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>BRAF Gene Mutation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>HRAS Gene Mutation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>KRAS Gene Mutation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>NRAS Gene Mutation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>RET/PTC Rearrangement)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>TRK Rearrangement).<br></td>
            </tr>
            <tr class="addition">
               <td>1435</td>
               <td>Uterine Corpus Endometrial Stromal Neoplasm<span class="subclass"> EquivalentTo </span>Endometrial Stromal Neoplasm<br><span class="keyword"> and </span>Uterine Corpus Soft Tissue Neoplasm<br><span class="keyword"> and </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(7;17)(p15;q21))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>JAZF1-JJAZ1 Fusion Protein Expression))<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> some </span>Endometrial Stromal Cell). 
               </td>
               <td>Uterine Corpus Endometrial Stromal Neoplasm<span class="subclass"> EquivalentTo </span>Endometrial Stromal Neoplasm<br><span class="keyword"> and </span>Uterine Corpus Soft Tissue Neoplasm<br><span class="keyword"> and </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(7;17)(p15;q21))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>JAZF1-JJAZ1 Fusion Protein Expression))<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> some </span>Endometrial Stromal Cell)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>JAZF1/SUZ12 Fusion Gene).<br></td>
            </tr>
         </tbody>
         <tbody id="stequivnt" style="display:none">
            <tr class="withoutstyle">
               <td colspan="3"><a name="aednt"></a><h4 style="display: inline-block;">Modified Definitions with New Terms (10)</h4> [<a href="#">back to top</a>]
               </td>
            </tr>
            <tr>
               <th class="addition">ID</th>
               <th class="normaladd">Source Definition in Ontology 1</th>
               <th class="addition">Target Definition in Ontology 2</th>
            </tr>
            <tr class="addition">
               <td>1437</td>
               <td>Acute Myeloid Leukemia with inv(16)(p13.1q22)<br><span class="keyword"> or </span>t(16;16)(p13.1;q22); CBFB-MYH11<span class="subclass"> EquivalentTo </span>Acute Myeloid Leukemia with Recurrent Genetic Abnormalities<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> some </span>Abnormal Eosinophil)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> some </span>Neoplastic Monoblast)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> some </span>Neoplastic Monocyte)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> some </span>Neoplastic Neutrophilic Precursor)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> some </span>Neoplastic Promonocyte)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> some </span>Abnormal Eosinophilic Granules Present)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> some </span>Blasts 20 Percent<br><span class="keyword"> or </span>More of Bone Marrow Nucleated Cells)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> some </span>Bone Marrow Eosinophilia)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> some </span>Neoplastic Granulocytes<br><span class="keyword"> and </span>Precursors 20 Percent<br><span class="keyword"> or </span>More of Bone Marrow Cells)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> some </span>Neoplastic Monocytes<br><span class="keyword"> and </span>Precursors 20 Percent<br><span class="keyword"> or </span>More of Bone Marrow Cells)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> some </span>Bone Marrow Stem Cell with Potential to Differentiate to Granulocytic<br><span class="keyword"> and </span>Monocytic Lineages)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>CBFB Gene)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>MYH11 Gene)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Auer Rods Present)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Favorable Clinical Outcome). 
               </td>
               <td>Acute Myeloid Leukemia with inv(16)(p13.1q22)<br><span class="keyword"> or </span>t(16;16)(p13.1;q22); CBFB-MYH11<span class="subclass"> EquivalentTo </span>Acute Myeloid Leukemia with Recurrent Genetic Abnormalities<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> some </span>Abnormal Eosinophil)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> some </span>Neoplastic Monoblast)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> some </span>Neoplastic Monocyte)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> some </span>Neoplastic Neutrophilic Precursor)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> some </span>Neoplastic Promonocyte)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> some </span>Abnormal Eosinophilic Granules Present)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> some </span>Blasts 20 Percent<br><span class="keyword"> or </span>More of Bone Marrow Nucleated Cells)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> some </span>Bone Marrow Eosinophilia)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> some </span>Neoplastic Granulocytes<br><span class="keyword"> and </span>Precursors 20 Percent<br><span class="keyword"> or </span>More of Bone Marrow Cells)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> some </span>Neoplastic Monocytes<br><span class="keyword"> and </span>Precursors 20 Percent<br><span class="keyword"> or </span>More of Bone Marrow Cells)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> some </span>Bone Marrow Stem Cell with Potential to Differentiate to Granulocytic<br><span class="keyword"> and </span>Monocytic Lineages)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>CBFB/MYH11 Fusion Gene)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>CBFB Gene)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>MYH11 Gene)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Auer Rods Present)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Favorable Clinical Outcome).<br><i>New Terms: CBFB/MYH11 Fusion Gene</i></td>
            </tr>
            <tr class="addition">
               <td>1438</td>
               <td>Acute Myeloid Leukemia with t(5;17)(q35;q12)<span class="subclass"> EquivalentTo </span>Acute Myeloid Leukemia with a Variant RARA Translocation<br><span class="keyword"> and </span>((Disease_Has_Cytogenetic_Abnormality<span class="some"> some </span>t(5;17)(q35;q12))<br><span class="keyword"> and </span>(Disease_Has_Molecular_Abnormality<span class="some"> some </span>NPM1-RARA Fusion Protein Expression)). 
               </td>
               <td>Acute Myeloid Leukemia with t(5;17)(q35;q12)<span class="subclass"> EquivalentTo </span>Acute Myeloid Leukemia with a Variant RARA Translocation<br><span class="keyword"> and </span>((Disease_Has_Cytogenetic_Abnormality<span class="some"> some </span>t(5;17)(q35;q12))<br><span class="keyword"> and </span>(Disease_Has_Molecular_Abnormality<span class="some"> some </span>NPM1-RARA Fusion Protein Expression))<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>NPM1/RARA Long Fusion Gene)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>NPM1/RARA Short Fusion Gene).<br><i>New Terms: NPM1/RARA Long Fusion Gene, NPM1/RARA Short Fusion Gene</i></td>
            </tr>
            <tr class="addition">
               <td>1436</td>
               <td>Anaplastic Large Cell Lymphoma, ALK-Positive<span class="subclass"> EquivalentTo </span>Anaplastic Large Cell Lymphoma<br><span class="keyword"> and </span>(((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>inv(2)(p23q35))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>ATIC-ALK Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(1;2)(q25;p23))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>TPM3-ALK Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(2;17)(p23;q23))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>CLTC-ALK Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(2;17)(p23;q35))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>ALO17-ALK Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(2;19)(p23;p13))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>TPM4-ALK Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(2;22)(p23;q11))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>MYH9-ALK Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(2;3)(p23;q21))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>TFG-ALK Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(2;5)(p23;q35))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>NPM-ALK Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(X;2)(q11-12;p23))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>MSN-ALK Fusion Protein Expression)))<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> some </span>Hallmark Cell)<br><span class="keyword"> and </span>(Disease_Has_Molecular_Abnormality<span class="some"> some </span>ALK Fusion Protein Expression)<br><span class="keyword"> and </span>(Disease_Has_Molecular_Abnormality<span class="some"> some </span>Rearrangement of 2p23)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> some </span>Activated Mature Cytotoxic T-Lymphocyte)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>ALK Gene)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Doughnut Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Hodgkin-Like Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Reed-Sternberg-Like Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Extranodal Disease)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Favorable Clinical Outcome)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Lymphadenopathy). 
               </td>
               <td>Anaplastic Large Cell Lymphoma, ALK-Positive<span class="subclass"> EquivalentTo </span>Anaplastic Large Cell Lymphoma<br><span class="keyword"> and </span>(((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>inv(2)(p23q35))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>ATIC-ALK Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(1;2)(q25;p23))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>TPM3-ALK Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(2;17)(p23;q23))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>CLTC-ALK Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(2;17)(p23;q35))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>ALO17-ALK Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(2;19)(p23;p13))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>TPM4-ALK Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(2;22)(p23;q11))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>MYH9-ALK Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(2;3)(p23;q21))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>TFG-ALK Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(2;5)(p23;q35))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>NPM-ALK Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(X;2)(q11-12;p23))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>MSN-ALK Fusion Protein Expression)))<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> some </span>Hallmark Cell)<br><span class="keyword"> and </span>(Disease_Has_Molecular_Abnormality<span class="some"> some </span>ALK Fusion Protein Expression)<br><span class="keyword"> and </span>(Disease_Has_Molecular_Abnormality<span class="some"> some </span>Rearrangement of 2p23)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> some </span>Activated Mature Cytotoxic T-Lymphocyte)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>ALK Gene)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>ATIC/ALK Fusion Gene)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>CLTC/ALK Fusion Gene)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>MSN/ALK Fusion Gene)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>NPM1/ALK Fusion Gene)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>RNF213/ALK Fusion Gene)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>TFG/ALK Fusion Gene)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>TPM3/ALK Fusion Gene)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>TPM4/ALK Fusion Gene)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Doughnut Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Hodgkin-Like Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Reed-Sternberg-Like Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Extranodal Disease)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Favorable Clinical Outcome)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Lymphadenopathy).<br><i>New Terms: TPM4/ALK Fusion Gene, TFG/ALK Fusion Gene, ATIC/ALK Fusion Gene, MSN/ALK Fusion Gene,
                     TPM3/ALK Fusion Gene</i></td>
            </tr>
            <tr class="addition">
               <td>1439</td>
               <td>Central Nervous System Choriocarcinoma<span class="subclass"> EquivalentTo </span>Choriocarcinoma<br><span class="keyword"> and </span>Malignant Central Nervous System Germ Cell Tumor. 
               </td>
               <td>Central Nervous System Choriocarcinoma<span class="subclass"> EquivalentTo </span>Choriocarcinoma<br><span class="keyword"> and </span>Malignant Central Nervous System Germ Cell Tumor<br><span class="keyword"> and </span>Nongerminomatous Germ Cell Tumor.<br><i>New Terms: Nongerminomatous Germ Cell Tumor</i></td>
            </tr>
            <tr class="addition">
               <td>1440</td>
               <td>Central Nervous System Embryonal Carcinoma<span class="subclass"> EquivalentTo </span>Extragonadal Embryonal Carcinoma<br><span class="keyword"> and </span>Malignant Central Nervous System Germ Cell Tumor. 
               </td>
               <td>Central Nervous System Embryonal Carcinoma<span class="subclass"> EquivalentTo </span>Extragonadal Embryonal Carcinoma<br><span class="keyword"> and </span>Malignant Central Nervous System Germ Cell Tumor<br><span class="keyword"> and </span>Nongerminomatous Germ Cell Tumor.<br><i>New Terms: Nongerminomatous Germ Cell Tumor</i></td>
            </tr>
            <tr class="addition">
               <td>1445</td>
               <td>Central Nervous System Yolk Sac Tumor<span class="subclass"> EquivalentTo </span>Malignant Central Nervous System Germ Cell Tumor<br><span class="keyword"> and </span>Yolk Sac Tumor<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Honeycomb Pattern)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Sinusoidal Growth Pattern). 
               </td>
               <td>Central Nervous System Yolk Sac Tumor<span class="subclass"> EquivalentTo </span>Malignant Central Nervous System Germ Cell Tumor<br><span class="keyword"> and </span>Nongerminomatous Germ Cell Tumor<br><span class="keyword"> and </span>Yolk Sac Tumor<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Honeycomb Pattern)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Sinusoidal Growth Pattern).<br><i>New Terms: Nongerminomatous Germ Cell Tumor</i></td>
            </tr>
            <tr class="addition">
               <td>1441</td>
               <td>Inflammatory Myofibroblastic Tumor<span class="subclass"> EquivalentTo </span>Intermediate Fibrocytic Neoplasm<br><span class="keyword"> and </span>(((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(1;2)(q25;p23))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>TPM3-ALK Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(2;17)(p23;q23))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>CLTC-ALK Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(2;19)(p23;p13))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>TPM4-ALK Fusion Protein Expression)))<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> some </span>Neoplastic Spindle-Shaped Myofibroblast)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> some </span>Eosinophilic Infiltrate)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> some </span>Lymphocytic Infiltrate)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> some </span>Plasmacytic Infiltrate)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>ALK Gene)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>HMGA2 Gene)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Ganglion-Like Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Neoplastic Stellate Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Well-Circumscribed Lesion)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Fascicular Pattern)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Fever)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Multinodular Lesion)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Myxoid Background)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Pain). 
               </td>
               <td>Inflammatory Myofibroblastic Tumor<span class="subclass"> EquivalentTo </span>Intermediate Fibrocytic Neoplasm<br><span class="keyword"> and </span>(((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(1;2)(q25;p23))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>TPM3-ALK Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(2;17)(p23;q23))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>CLTC-ALK Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(2;19)(p23;p13))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>TPM4-ALK Fusion Protein Expression)))<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> some </span>Neoplastic Spindle-Shaped Myofibroblast)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> some </span>Eosinophilic Infiltrate)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> some </span>Lymphocytic Infiltrate)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> some </span>Plasmacytic Infiltrate)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>ALK Gene)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>CLTC/ALK Fusion Gene)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>HMGA2 Gene)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>TPM3/ALK Fusion Gene)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>TPM4/ALK Fusion Gene)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Ganglion-Like Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Neoplastic Stellate Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Well-Circumscribed Lesion)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Fascicular Pattern)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Fever)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Multinodular Lesion)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Myxoid Background)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Pain).<br><i>New Terms: TPM4/ALK Fusion Gene, TPM3/ALK Fusion Gene</i></td>
            </tr>
            <tr class="addition">
               <td>1442</td>
               <td>Lipoblastoma<span class="subclass"> EquivalentTo </span>Benign Lipomatous Neoplasm<br><span class="keyword"> and </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Rearrangement of 8q11-13)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>COL1A2-PLAG1 Fusion Protein Expression)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>HAS2-PLAG1 Fusion Protein Expression))<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> some </span>Neoplastic Lipoblast)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> some </span>Neoplastic Mature Adipocyte)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> some </span>Well-Circumscribed Lesion)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> some </span>Localized Disease)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> some </span>Slow Growing Painless Mass)<br><span class="keyword"> and </span>(Disease_Mapped_To_Chromosome<span class="some"> some </span>Chromosome 8)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>PLAG1 Gene)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 8). 
               </td>
               <td>Lipoblastoma<span class="subclass"> EquivalentTo </span>Benign Lipomatous Neoplasm<br><span class="keyword"> and </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Rearrangement of 8q11-13)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>COL1A2-PLAG1 Fusion Protein Expression)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>HAS2-PLAG1 Fusion Protein Expression))<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> some </span>Neoplastic Lipoblast)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> some </span>Neoplastic Mature Adipocyte)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> some </span>Well-Circumscribed Lesion)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> some </span>Localized Disease)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> some </span>Slow Growing Painless Mass)<br><span class="keyword"> and </span>(Disease_Mapped_To_Chromosome<span class="some"> some </span>Chromosome 8)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>COL1A2/PLAG1 Fusion Gene)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>HAS2/PLAG1 Fusion Gene)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>PLAG1 Gene)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 8).<br><i>New Terms: HAS2/PLAG1 Fusion Gene, COL1A2/PLAG1 Fusion Gene</i></td>
            </tr>
            <tr class="addition">
               <td>1443</td>
               <td>Lipoblastomatosis<span class="subclass"> EquivalentTo </span>Benign Lipomatous Neoplasm<br><span class="keyword"> and </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Rearrangement of 8q11-13)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>COL1A2-PLAG1 Fusion Protein Expression)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>HAS2-PLAG1 Fusion Protein Expression))<br><span class="keyword"> and </span>(Disease_Excludes_Finding<span class="some"> some </span>Localized Disease)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> some </span>Neoplastic Lipoblast)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> some </span>Neoplastic Mature Adipocyte)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> some </span>Multifocal Lesion)<br><span class="keyword"> and </span>(Disease_Mapped_To_Chromosome<span class="some"> some </span>Chromosome 8)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>PLAG1 Gene)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 8). 
               </td>
               <td>Lipoblastomatosis<span class="subclass"> EquivalentTo </span>Benign Lipomatous Neoplasm<br><span class="keyword"> and </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Rearrangement of 8q11-13)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>COL1A2-PLAG1 Fusion Protein Expression)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>HAS2-PLAG1 Fusion Protein Expression))<br><span class="keyword"> and </span>(Disease_Excludes_Finding<span class="some"> some </span>Localized Disease)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> some </span>Neoplastic Lipoblast)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> some </span>Neoplastic Mature Adipocyte)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> some </span>Multifocal Lesion)<br><span class="keyword"> and </span>(Disease_Mapped_To_Chromosome<span class="some"> some </span>Chromosome 8)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>COL1A2/PLAG1 Fusion Gene)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>HAS2/PLAG1 Fusion Gene)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>PLAG1 Gene)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 8).<br><i>New Terms: HAS2/PLAG1 Fusion Gene, COL1A2/PLAG1 Fusion Gene</i></td>
            </tr>
            <tr class="addition">
               <td>1444</td>
               <td>Renal Cell Carcinoma Associated with inv(X)(p11;q12)<span class="subclass"> EquivalentTo </span>Renal Cell Carcinoma Associated with Xp11.2 Translocations/TFE3 Gene Fusions<br><span class="keyword"> and </span>((Disease_Has_Cytogenetic_Abnormality<span class="some"> some </span>inv(X)(p11;q12))<br><span class="keyword"> and </span>(Disease_Has_Molecular_Abnormality<span class="some"> some </span>NONO-TFE3 Fusion Protein Expression)). 
               </td>
               <td>Renal Cell Carcinoma Associated with inv(X)(p11;q12)<span class="subclass"> EquivalentTo </span>Renal Cell Carcinoma Associated with Xp11.2 Translocations/TFE3 Gene Fusions<br><span class="keyword"> and </span>((Disease_Has_Cytogenetic_Abnormality<span class="some"> some </span>inv(X)(p11;q12))<br><span class="keyword"> and </span>(Disease_Has_Molecular_Abnormality<span class="some"> some </span>NONO-TFE3 Fusion Protein Expression))<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>NONO/TFE3 Fusion Gene).<br><i>New Terms: NONO/TFE3 Fusion Gene</i></td>
            </tr>
         </tbody>
         <tbody id="ared" style="display:none">
            <tr class="withoutstyle">
               <td colspan="3">
                  <h4 style="display: inline-block;">Redundant (1)</h4> [<a href="#">back to top</a>]
               </td>
            </tr>
            <tr>
               <th class="addition">ID</th>
               <th class="normaladd">Justifications in Ontology 1</th>
               <th class="addition">Axiom in Ontology 2</th>
            </tr>
            <tr class="addition">
               <td rowspan="1">1446</td>
               <td><i>(1)</i>&nbsp; Hydrolase Gene<span class="subclass"> SubClassOf </span>Gene_Plays_Role_In_Process<span class="some"> some </span>Hydrolysis. 
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(2)</i>&nbsp; Esterase Gene<span class="subclass"> SubClassOf </span>Hydrolase Gene. 
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(3)</i>&nbsp; CLC Gene<span class="subclass"> SubClassOf </span>Esterase Gene. 
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br></td>
               <td rowspan="1">CLC Gene<span class="subclass"> SubClassOf </span>Gene_Plays_Role_In_Process<span class="some"> some </span>Hydrolysis. 
               </td>
            </tr>
         </tbody>
         <tbody id="aweak" style="display:none">
            <tr class="withoutstyle">
               <td colspan="3">
                  <h4 style="display: inline-block;">Retrospective Novel Redundant (9)</h4> [<a href="#">back to top</a>]
               </td>
            </tr>
            <tr>
               <th class="addition">ID</th>
               <th class="normaladd">Justifications in Ontology 1</th>
               <th class="addition">Axiom in Ontology 2</th>
            </tr>
            <tr class="addition">
               <td rowspan="1">1447</td>
               <td><i>(1)</i>&nbsp; Megacolon<span class="subclass"> SubClassOf </span>Non-Neoplastic Intestinal Disorder. 
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(2)</i>&nbsp; Aganglionic Megacolon<span class="subclass"> SubClassOf </span>Megacolon. 
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
               <td rowspan="1">Aganglionic Megacolon<span class="subclass"> SubClassOf </span>Non-Neoplastic Intestinal Disorder. 
               </td>
            </tr>
            <tr class="addition">
               <td rowspan="1">1448</td>
               <td><i>(1)</i>&nbsp; Apocynum venetum<span class="subclass"> SubClassOf </span>Vascular Plant. 
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(2)</i>&nbsp; Apocynum androsaemifolium<span class="subclass"> SubClassOf </span>Apocynum venetum. 
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
               <td rowspan="1">Apocynum androsaemifolium<span class="subclass"> SubClassOf </span>Vascular Plant. 
               </td>
            </tr>
            <tr class="addition">
               <td rowspan="1">1449</td>
               <td><i>(1)</i>&nbsp; Apocynum venetum<span class="subclass"> SubClassOf </span>Vascular Plant. 
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(2)</i>&nbsp; Apocynum cannabinum<span class="subclass"> SubClassOf </span>Apocynum venetum. 
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
               <td rowspan="1">Apocynum cannabinum<span class="subclass"> SubClassOf </span>Vascular Plant. 
               </td>
            </tr>
            <tr class="addition">
               <td rowspan="1">1450</td>
               <td><i>(1)</i>&nbsp; B Lymphoblastic Leukemia/Lymphoma with t(12;21)(p13;q22); TEL-AML1 (ETV6-RUNX1)<span class="subclass"> EquivalentTo </span>B Lymphoblastic Leukemia/Lymphoma with Recurrent Genetic Abnormalities<br><span class="keyword"> and </span>((Disease_Has_Cytogenetic_Abnormality<span class="some"> some </span>t(12;21)(p13;q22))<br><span class="keyword"> and </span>(Disease_Has_Molecular_Abnormality<span class="some"> some </span>TEL-AML1 Fusion Protein Expression))<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>ETV6 Gene)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>RUNX1 Gene)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Favorable Clinical Outcome). 
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; B Acute Lymphoblastic Leukemia with t(12;21)(p13;q22); TEL-AML1 (ETV6-RUNX1)<span class="subclass"> EquivalentTo </span>B Lymphoblastic Leukemia/Lymphoma with t(12;21)(p13;q22); TEL-AML1 (ETV6-RUNX1)<br><span class="keyword"> and </span>B Acute Lymphoblastic Leukemia<br><span class="keyword"> and </span>((Disease_Has_Cytogenetic_Abnormality<span class="some"> some </span>t(12;21)(p13;q22))<br><span class="keyword"> and </span>(Disease_Has_Molecular_Abnormality<span class="some"> some </span>TEL-AML1 Fusion Protein Expression))<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>ETV6 Gene)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>RUNX1 Gene)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Extensive Bone Marrow<br><span class="keyword"> and </span>Blood Involvement)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Favorable Clinical Outcome). 
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
               <td rowspan="1">B Acute Lymphoblastic Leukemia with t(12;21)(p13;q22); TEL-AML1 (ETV6-RUNX1)<span class="subclass"> EquivalentTo </span>B Lymphoblastic Leukemia/Lymphoma with t(12;21)(p13;q22); TEL-AML1 (ETV6-RUNX1)<br><span class="keyword"> and </span>B Acute Lymphoblastic Leukemia<br><span class="keyword"> and </span>((Disease_Has_Cytogenetic_Abnormality<span class="some"> some </span>t(12;21)(p13;q22))<br><span class="keyword"> and </span>(Disease_Has_Molecular_Abnormality<span class="some"> some </span>TEL-AML1 Fusion Protein Expression))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Extensive Bone Marrow<br><span class="keyword"> and </span>Blood Involvement)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Favorable Clinical Outcome). 
               </td>
            </tr>
            <tr class="addition">
               <td rowspan="1">1451</td>
               <td><i>(1)</i>&nbsp; Bromebric Acid<span class="subclass"> SubClassOf </span>Miscellaneous Antimetabolite. 
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Miscellaneous Antimetabolite<span class="subclass"> SubClassOf </span>Antimetabolite. 
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
               <td rowspan="1">Bromebric Acid<span class="subclass"> SubClassOf </span>Antimetabolite. 
               </td>
            </tr>
            <tr class="addition">
               <td rowspan="1">1452</td>
               <td><i>(1)</i>&nbsp; Cytembena<span class="subclass"> SubClassOf </span>Miscellaneous Antimetabolite. 
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Miscellaneous Antimetabolite<span class="subclass"> SubClassOf </span>Antimetabolite. 
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
               <td rowspan="1">Cytembena<span class="subclass"> SubClassOf </span>Antimetabolite. 
               </td>
            </tr>
            <tr class="addition">
               <td rowspan="1">1453</td>
               <td><i>(1)</i>&nbsp; Miscellaneous Antimetabolite<span class="subclass"> SubClassOf </span>Antimetabolite. 
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Guanazole<span class="subclass"> SubClassOf </span>Miscellaneous Antimetabolite. 
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
               <td rowspan="1">Guanazole<span class="subclass"> SubClassOf </span>Antimetabolite. 
               </td>
            </tr>
            <tr class="addition">
               <td rowspan="1">1454</td>
               <td><i>(1)</i>&nbsp; Myosotis arvensis<span class="subclass"> SubClassOf </span>Myosotis alpestris. 
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Myosotis alpestris<span class="subclass"> SubClassOf </span>Vascular Plant. 
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br></td>
               <td rowspan="1">Myosotis arvensis<span class="subclass"> SubClassOf </span>Vascular Plant. 
               </td>
            </tr>
            <tr class="addition">
               <td rowspan="1">1455</td>
               <td><i>(1)</i>&nbsp; Piscidia piscipula<span class="subclass"> SubClassOf </span>Vascular Plant. 
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(2)</i>&nbsp; Piscidia erythrina<span class="subclass"> SubClassOf </span>Piscidia piscipula. 
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
               <td rowspan="1">Piscidia erythrina<span class="subclass"> SubClassOf </span>Vascular Plant. 
               </td>
            </tr>
         </tbody>
         <tbody id="rem" style="display:none">
            <tr class="withoutstyle">
               <td colspan="3">
                  <h4 style="display: inline-block;">Pure Removals with Shared Terms (158)</h4> [<a href="#">back to top</a>]
               </td>
            </tr>
            <tr>
               <th class="removal">ID</th>
               <th class="removal" colspan="2">Removal from Ontology 1</th>
            </tr>
            <tr class="removal">
               <td>1456</td>
               <td colspan="2">ABL1 Gene<span class="subclass"> SubClassOf </span>Gene_Involved_In_Pathogenesis_Of_Disease<span class="some"> some </span>B Acute Lymphoblastic Leukemia with t(9;22)(q34;q11.2); BCR-ABL1.<br></td>
            </tr>
            <tr class="removal">
               <td>1457</td>
               <td colspan="2">Abnormal Pigmentation<span class="subclass"> SubClassOf </span>Other Finding.<br></td>
            </tr>
            <tr class="removal">
               <td>1458</td>
               <td colspan="2">Acute Myeloid Leukemia with inv(3)(q21q26.2)<br><span class="keyword"> or </span>t(3;3)(q21;q26.2); RPN1-EVI1<span class="subclass"> EquivalentTo </span>Acute Myeloid Leukemia with Recurrent Genetic Abnormalities<br><span class="keyword"> and </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(3;3)(q21;q26.2))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>RPN1-EVI1 Fusion Protein Expression))<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> some </span>Aggressive Clinical Course)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>MECOM Gene)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>RPN1 Gene)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>inv(3)(q21q26.2))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Bone Marrow Dysplasia Present)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>RPN1-EVI1 Fusion Protein Expression).<br></td>
            </tr>
            <tr class="removal">
               <td>1459</td>
               <td colspan="2">Acute Myeloid Leukemia with t(6;9)(p23;q34); DEK-NUP214<span class="subclass"> EquivalentTo </span>Acute Myeloid Leukemia with Recurrent Genetic Abnormalities<br><span class="keyword"> and </span>((Disease_Has_Cytogenetic_Abnormality<span class="some"> some </span>t(6;9)(p23;q34))<br><span class="keyword"> and </span>(Disease_Has_Molecular_Abnormality<span class="some"> some </span>DEK-NUP214 Fusion Protein Expression))<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>DEK Gene)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>NUP214 Gene)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Basophilia)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Bone Marrow Dysplasia Present)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Unfavorable Clinical Outcome).<br></td>
            </tr>
            <tr class="removal">
               <td>1460</td>
               <td colspan="2">Acute Myeloid Leukemia with t(8;21)(q22;q22); RUNX1-RUNX1T1<span class="subclass"> EquivalentTo </span>Acute Myeloid Leukemia with Recurrent Genetic Abnormalities<br><span class="keyword"> and </span>((Disease_Has_Cytogenetic_Abnormality<span class="some"> some </span>t(8;21)(q22;q22))<br><span class="keyword"> and </span>(Disease_Has_Molecular_Abnormality<span class="some"> some </span>AML1-ETO Fusion Protein Expression))<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> some </span>Neoplastic Myeloblast with Abundant Basophilic Cytoplasm)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> some </span>Bone Marrow Stem Cell with Predominant Neutrophil Differentiation)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>RUNX1T1 Gene)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>RUNX1 Gene)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Auer Rods Present)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Favorable Clinical Outcome)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Myeloblasts 20 Percent<br><span class="keyword"> or </span>More of Bone Marrow Nucleated Cells).<br></td>
            </tr>
            <tr class="removal">
               <td>1461</td>
               <td colspan="2">Acute Myeloid Leukemia with t(9;11)(p22;q23); MLLT3-MLL<span class="subclass"> EquivalentTo </span>Acute Myeloid Leukemia with Recurrent Genetic Abnormalities<br><span class="keyword"> and </span>((Disease_Has_Cytogenetic_Abnormality<span class="some"> some </span>t(9;11)(p22;q23))<br><span class="keyword"> and </span>(Disease_Has_Molecular_Abnormality<span class="some"> some </span>MLLT3-MLL Fusion Protein Expression))<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> some </span>Multipotent Bone Marrow Stem Cell)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>MLLT3 Gene)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>MLL Gene)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Disseminated Intravascular Coagulation).<br></td>
            </tr>
            <tr class="removal">
               <td>1462</td>
               <td colspan="2">Acute Promyelocytic Leukemia with t(15;17)(q22;q12); PML-RARA<span class="subclass"> EquivalentTo </span>Acute Myeloid Leukemia with Recurrent Genetic Abnormalities<br><span class="keyword"> and </span>((Disease_Has_Cytogenetic_Abnormality<span class="some"> some </span>t(15;17)(q22;q12))<br><span class="keyword"> and </span>(Disease_Has_Molecular_Abnormality<span class="some"> some </span>PML-RARA Fusion Protein Expression))<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> some </span>Neoplastic Promyelocyte)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> some </span>Neoplastic Promyelocytes in Bone Marrow Markedly Increased)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> some </span>Bone Marrow Stem Cell with Potential to Differentiate to Granulocytic Lineage)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>PML Gene)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>RARA Gene)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Faggot Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Disseminated Intravascular Coagulation).<br></td>
            </tr>
            <tr class="removal">
               <td>1463</td>
               <td colspan="2">Aganglionic Megacolon<span class="subclass"> SubClassOf </span>Megacolon.<br></td>
            </tr>
            <tr class="removal">
               <td>1464</td>
               <td colspan="2">Akathisia<span class="subclass"> SubClassOf </span>Other Finding.<br></td>
            </tr>
            <tr class="removal">
               <td>1465</td>
               <td colspan="2">Ambulation Difficulty<span class="subclass"> SubClassOf </span>Symptom.<br></td>
            </tr>
            <tr class="removal">
               <td>1466</td>
               <td colspan="2">Anhidrosis<span class="subclass"> SubClassOf </span>Symptom.<br></td>
            </tr>
            <tr class="removal">
               <td>1467</td>
               <td colspan="2">Aphasia<span class="subclass"> SubClassOf </span>Symptom.<br></td>
            </tr>
            <tr class="removal">
               <td>1468</td>
               <td colspan="2">Apocynum androsaemifolium<span class="subclass"> SubClassOf </span>Apocynum venetum.<br></td>
            </tr>
            <tr class="removal">
               <td>1469</td>
               <td colspan="2">Apocynum cannabinum<span class="subclass"> SubClassOf </span>Apocynum venetum.<br></td>
            </tr>
            <tr class="removal">
               <td>1470</td>
               <td colspan="2">Astacus astacus<span class="subclass"> SubClassOf </span>Vascular Plant.<br></td>
            </tr>
            <tr class="removal">
               <td>1471</td>
               <td colspan="2">Asthenia<span class="subclass"> SubClassOf </span>Symptom.<br></td>
            </tr>
            <tr class="removal">
               <td>1472</td>
               <td colspan="2">Asymptomatic<span class="subclass"> SubClassOf </span>Other Finding.<br></td>
            </tr>
            <tr class="removal">
               <td>1480</td>
               <td colspan="2">B Lymphoblastic Leukemia/Lymphoma with t(12;21)(p13;q22); TEL-AML1 (ETV6-RUNX1)<span class="subclass"> EquivalentTo </span>B Lymphoblastic Leukemia/Lymphoma with Recurrent Genetic Abnormalities<br><span class="keyword"> and </span>((Disease_Has_Cytogenetic_Abnormality<span class="some"> some </span>t(12;21)(p13;q22))<br><span class="keyword"> and </span>(Disease_Has_Molecular_Abnormality<span class="some"> some </span>TEL-AML1 Fusion Protein Expression))<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>ETV6 Gene)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>RUNX1 Gene)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Favorable Clinical Outcome).<br></td>
            </tr>
            <tr class="removal">
               <td>1481</td>
               <td colspan="2">B Lymphoblastic Leukemia/Lymphoma with t(1;19)(q23;p13.3); E2A-PBX1 (TCF3-PBX1)<span class="subclass"> EquivalentTo </span>B Lymphoblastic Leukemia/Lymphoma with Recurrent Genetic Abnormalities<br><span class="keyword"> and </span>((Disease_Has_Cytogenetic_Abnormality<span class="some"> some </span>t(1;19)(q23;p13.3))<br><span class="keyword"> and </span>(Disease_Has_Molecular_Abnormality<span class="some"> some </span>TCF3-PBX1 Fusion Protein Expression))<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>PBX1 Gene)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>TCF3 Gene).<br></td>
            </tr>
            <tr class="removal">
               <td>1482</td>
               <td colspan="2">B Lymphoblastic Leukemia/Lymphoma with t(9;22)(q34;q11.2); BCR-ABL1<span class="subclass"> EquivalentTo </span>B Lymphoblastic Leukemia/Lymphoma with Recurrent Genetic Abnormalities<br><span class="keyword"> and </span>((Disease_Has_Cytogenetic_Abnormality<span class="some"> some </span>Philadelphia Chromosome)<br><span class="keyword"> and </span>(Disease_Has_Cytogenetic_Abnormality<span class="some"> some </span>t(9;22)(q34;q11))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>p190 Fusion Protein Expression)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>p210 Fusion Protein Expression))<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>ABL1 Gene)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>BCR Gene)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Unfavorable Clinical Outcome).<br></td>
            </tr>
            <tr class="removal">
               <td>1473</td>
               <td colspan="2">B-Symptoms<span class="subclass"> SubClassOf </span>Symptom.<br></td>
            </tr>
            <tr class="removal">
               <td>1479</td>
               <td colspan="2">BCR Gene<span class="subclass"> SubClassOf </span>Gene_Involved_In_Pathogenesis_Of_Disease<span class="some"> some </span>B Acute Lymphoblastic Leukemia with t(9;22)(q34;q11.2); BCR-ABL1.<br></td>
            </tr>
            <tr class="removal">
               <td>1476</td>
               <td colspan="2">BCR Gene<span class="subclass"> SubClassOf </span>Gene_Involved_In_Pathogenesis_Of_Disease<span class="some"> some </span>B Lymphoblastic Leukemia/Lymphoma with t(9;22)(q34;q11.2); BCR-ABL1.<br></td>
            </tr>
            <tr class="removal">
               <td>1477</td>
               <td colspan="2">BCR Gene<span class="subclass"> SubClassOf </span>Gene_Involved_In_Pathogenesis_Of_Disease<span class="some"> some </span>Chronic Myelogenous Leukemia, BCR-ABL1 Positive.<br></td>
            </tr>
            <tr class="removal">
               <td>1478</td>
               <td colspan="2">BCR Gene<span class="subclass"> SubClassOf </span>Gene_Involved_In_Pathogenesis_Of_Disease<span class="some"> some </span>Mixed Phenotype Acute Leukemia with t(9;22)(q34;q11.2); BCR-ABL1.<br></td>
            </tr>
            <tr class="removal">
               <td>1474</td>
               <td colspan="2">BCR/ABL1 Fusion Gene<span class="subclass"> SubClassOf </span>Gene_Associated_With_Disease<span class="some"> some </span>B Lymphoblastic Leukemia/Lymphoma with t(9;22)(q34;q11.2); BCR-ABL1.<br></td>
            </tr>
            <tr class="removal">
               <td>1475</td>
               <td colspan="2">BCR/ABL1 Fusion Gene<span class="subclass"> SubClassOf </span>Gene_Associated_With_Disease<span class="some"> some </span>Chronic Myelogenous Leukemia, BCR-ABL1 Positive.<br></td>
            </tr>
            <tr class="removal">
               <td>1483</td>
               <td colspan="2">Below Normal Body Height<span class="subclass"> SubClassOf </span>Other Finding.<br></td>
            </tr>
            <tr class="removal">
               <td>1484</td>
               <td colspan="2">Body Odor<span class="subclass"> SubClassOf </span>Symptom.<br></td>
            </tr>
            <tr class="removal">
               <td>1512</td>
               <td colspan="2">Body Substance Discharge<span class="subclass"> SubClassOf </span>Symptom.<br></td>
            </tr>
            <tr class="removal">
               <td>1485</td>
               <td colspan="2">Bordetella pertussis Filamentous Hemagglutinin Antigen, B<span class="subclass"> SubClassOf </span>Bordetella Pertussis Antigen.<br></td>
            </tr>
            <tr class="removal">
               <td>1486</td>
               <td colspan="2">Bordetella pertussis Filamentous Hemagglutinin Antigen, C<span class="subclass"> SubClassOf </span>Bordetella Pertussis Antigen.<br></td>
            </tr>
            <tr class="removal">
               <td>1487</td>
               <td colspan="2">Bromebric Acid<span class="subclass"> SubClassOf </span>Miscellaneous Antimetabolite.<br></td>
            </tr>
            <tr class="removal">
               <td>1577</td>
               <td colspan="2">CCDC6/RET Fusion Gene<span class="subclass"> SubClassOf </span>Gene_Associated_With_Disease<span class="some"> some </span>Thyroid Gland Papillary Carcinoma.<br></td>
            </tr>
            <tr class="removal">
               <td>1534</td>
               <td colspan="2">CDC73 Gene<span class="subclass"> SubClassOf </span>Gene_Associated_With_Disease<span class="some"> some </span>Parathyroid Gland Carcinoma.<br></td>
            </tr>
            <tr class="removal">
               <td>1488</td>
               <td colspan="2">CLCF1 wt Allele<span class="subclass"> SubClassOf </span>Gene_Is_Element_In_Pathway<span class="some"> some </span>Phospholipid Degradation Pathway.<br></td>
            </tr>
            <tr class="removal">
               <td>1489</td>
               <td colspan="2">Cachexia<span class="subclass"> SubClassOf </span>Symptom.<br></td>
            </tr>
            <tr class="removal">
               <td>1490</td>
               <td colspan="2">Cardiotrophin-Like Cytokine Factor 1<span class="subclass"> EquivalentTo </span>Interleukin<br><span class="keyword"> and </span>(Gene_Product_Encoded_By_Gene<span class="some"> some </span>CLCF1 Gene)<br><span class="keyword"> and </span>(Gene_Product_Has_Biochemical_Function<span class="some"> some </span>Interleukin)<br><span class="keyword"> and </span>(Gene_Product_Has_Organism_Source<span class="some"> some </span>Human)<br><span class="keyword"> and </span>(Gene_Product_Is_Element_In_Pathway<span class="some"> some </span>Phospholipid Degradation Pathway)<br><span class="keyword"> and </span>(Gene_Product_Plays_Role_In_Biological_Process<span class="some"> some </span>B Cell Proliferation)<br><span class="keyword"> and </span>(Gene_Product_Plays_Role_In_Biological_Process<span class="some"> some </span>Nerve Cell Survival).<br></td>
            </tr>
            <tr class="removal">
               <td>1491</td>
               <td colspan="2">Cardiovascular System Signs<br><span class="keyword"> and </span>Symptoms<span class="subclass"> SubClassOf </span>Symptom.<br></td>
            </tr>
            <tr class="removal">
               <td>1492</td>
               <td colspan="2">Celeriac, Cooked<span class="subclass"> SubClassOf </span>Celeriac.<br></td>
            </tr>
            <tr class="removal">
               <td>1493</td>
               <td colspan="2">Celeriac, Raw<span class="subclass"> SubClassOf </span>Celeriac.<br></td>
            </tr>
            <tr class="removal">
               <td>1495</td>
               <td colspan="2">Chronic Myelogenous Leukemia, BCR-ABL1 Positive<span class="subclass"> EquivalentTo </span>Myeloproliferative Neoplasm<br><span class="keyword"> and </span>Common Hematopoietic Neoplasm<br><span class="keyword"> and </span>Myeloid Leukemia<br><span class="keyword"> and </span>(Disease_Excludes_Molecular_Abnormality<span class="some"> some </span>FGFR1 Gene Rearrangement)<br><span class="keyword"> and </span>(Disease_Excludes_Molecular_Abnormality<span class="some"> some </span>PDGFRA Gene Rearrangement)<br><span class="keyword"> and </span>(Disease_Excludes_Molecular_Abnormality<span class="some"> some </span>PDGFRB Gene Rearrangement)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> some </span>Hypercellular Bone Marrow)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> some </span>Splenomegaly)<br><span class="keyword"> and </span>(Disease_Has_Molecular_Abnormality<span class="some"> some </span>BCR-ABL1 Fusion Protein Expression)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> some </span>Pluripotent Bone Marrow Stem Cell)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>ABL1 Gene)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>BCR Gene).<br></td>
            </tr>
            <tr class="removal">
               <td>1496</td>
               <td colspan="2">Claudication<span class="subclass"> SubClassOf </span>Symptom.<br></td>
            </tr>
            <tr class="removal">
               <td>1497</td>
               <td colspan="2">Clostridium tetani Toxoid Antigen, B<span class="subclass"> SubClassOf </span>Clostridium Tetani Antigen.<br></td>
            </tr>
            <tr class="removal">
               <td>1498</td>
               <td colspan="2">Colic<span class="subclass"> SubClassOf </span>Pain.<br></td>
            </tr>
            <tr class="removal">
               <td>1499</td>
               <td colspan="2">Complement Hemolytic Activity Assay<span class="subclass"> SubClassOf </span>Hematology Test.<br></td>
            </tr>
            <tr class="removal">
               <td>1500</td>
               <td colspan="2">Confusion<span class="subclass"> SubClassOf </span>Symptom.<br></td>
            </tr>
            <tr class="removal">
               <td>1501</td>
               <td colspan="2">Coprophagia<span class="subclass"> SubClassOf </span>Symptom.<br></td>
            </tr>
            <tr class="removal">
               <td>1502</td>
               <td colspan="2">Corynebacterium diphtheriae Toxoid Antigen, C<span class="subclass"> SubClassOf </span>Corynebacterium diphtheriae Antigen.<br></td>
            </tr>
            <tr class="removal">
               <td>1503</td>
               <td colspan="2">Cyanosis<span class="subclass"> SubClassOf </span>Symptom.<br></td>
            </tr>
            <tr class="removal">
               <td>1504</td>
               <td colspan="2">Cyanotic Attacks in Children<span class="subclass"> SubClassOf </span>Other Finding.<br></td>
            </tr>
            <tr class="removal">
               <td>1505</td>
               <td colspan="2">Cytembena<span class="subclass"> SubClassOf </span>Miscellaneous Antimetabolite.<br></td>
            </tr>
            <tr class="removal">
               <td>1508</td>
               <td colspan="2">DEK Gene<span class="subclass"> SubClassOf </span>Gene_Involved_In_Pathogenesis_Of_Disease<span class="some"> some </span>Acute Myeloid Leukemia with t(6;9)(p23;q34); DEK-NUP214.<br></td>
            </tr>
            <tr class="removal">
               <td>1510</td>
               <td colspan="2">Decreased Core Body Temperature<span class="subclass"> SubClassOf </span>Body Temperature Associated Symptom.<br></td>
            </tr>
            <tr class="removal">
               <td>1511</td>
               <td colspan="2">Delayed Puberty<span class="subclass"> SubClassOf </span>Other Finding.<br></td>
            </tr>
            <tr class="removal">
               <td>1513</td>
               <td colspan="2">Distress<span class="subclass"> SubClassOf </span>Other Finding.<br></td>
            </tr>
            <tr class="removal">
               <td>1514</td>
               <td colspan="2">Diverticulosis<span class="subclass"> SubClassOf </span>Other Finding.<br></td>
            </tr>
            <tr class="removal">
               <td>1515</td>
               <td colspan="2">Dyskinesia<span class="subclass"> SubClassOf </span>Other Finding.<br></td>
            </tr>
            <tr class="removal">
               <td>1516</td>
               <td colspan="2">Dysphasia<span class="subclass"> SubClassOf </span>Symptom.<br></td>
            </tr>
            <tr class="removal">
               <td>1517</td>
               <td colspan="2">ERG Gene<span class="subclass"> SubClassOf </span>Gene_Involved_In_Pathogenesis_Of_Disease<span class="some"> some </span>Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor.<br></td>
            </tr>
            <tr class="removal">
               <td>1518</td>
               <td colspan="2">ETV1 Gene<span class="subclass"> SubClassOf </span>Gene_Involved_In_Pathogenesis_Of_Disease<span class="some"> some </span>Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor.<br></td>
            </tr>
            <tr class="removal">
               <td>1519</td>
               <td colspan="2">ETV6 Gene<span class="subclass"> SubClassOf </span>Gene_Involved_In_Pathogenesis_Of_Disease<span class="some"> some </span>B Acute Lymphoblastic Leukemia with t(12;21)(p13;q22); TEL-AML1 (ETV6-RUNX1).<br></td>
            </tr>
            <tr class="removal">
               <td>1520</td>
               <td colspan="2">ETV6 Gene<span class="subclass"> SubClassOf </span>Gene_Involved_In_Pathogenesis_Of_Disease<span class="some"> some </span>B Lymphoblastic Leukemia/Lymphoma with t(12;21)(p13;q22); TEL-AML1 (ETV6-RUNX1).<br></td>
            </tr>
            <tr class="removal">
               <td>1521</td>
               <td colspan="2">EWSR1 Gene<span class="subclass"> SubClassOf </span>Gene_Involved_In_Pathogenesis_Of_Disease<span class="some"> some </span>Extraskeletal Myxoid Chondrosarcoma.<br></td>
            </tr>
            <tr class="removal">
               <td>1522</td>
               <td colspan="2">Endocrine System Signs<br><span class="keyword"> and </span>Symptoms<span class="subclass"> SubClassOf </span>Symptom.<br></td>
            </tr>
            <tr class="removal">
               <td>1523</td>
               <td colspan="2">Enlarging Abdomen<span class="subclass"> SubClassOf </span>Symptom.<br></td>
            </tr>
            <tr class="removal">
               <td>1524</td>
               <td colspan="2">Euphoria<span class="subclass"> SubClassOf </span>Symptom.<br></td>
            </tr>
            <tr class="removal">
               <td>1525</td>
               <td colspan="2">Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor<span class="subclass"> EquivalentTo </span>Embryonal Neoplasm<br><span class="keyword"> and </span>(((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>inv(22q12))<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(1;22)(p36.1;q12))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>EWSR1-PATZ1 Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(11;22)(q24;q12))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>EWSR1-FLI1 Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(16;21)(p11;q22))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>FUS-ERG Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(17;22)(q21;q12))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>EWSR1-ETV4 Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(21;22)(q22;q12))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>EWSR1-ERG Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(2;22)(q33;q12))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>EWSR1-FEV Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(7;22)(p22;q12))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>EWSR1-ETV1 Fusion Protein Expression)))<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> some </span>Primitive Round to Oval Cell)<br><span class="keyword"> and </span>(Disease_Has_Normal_Tissue_Origin<span class="some"> some </span>Neural Crest)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>ETS Family Gene)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>EWSR1 Gene)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Malignant Small Round Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Anemia)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Fever)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hemorrhagic Change)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Homer Wright Rosette Formation)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Necrotic Change).<br></td>
            </tr>
            <tr class="removal">
               <td>1557</td>
               <td colspan="2">Extraskeletal Myxoid Chondrosarcoma<span class="subclass"> EquivalentTo </span>Malignant Soft Tissue Neoplasm of Uncertain Differentiation<br><span class="keyword"> and </span>Soft Tissue Sarcoma<br><span class="keyword"> and </span>(((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(3;9)(q11-12;q22))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>TFG-NR4A3 Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(9;15)(q22;q21))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>TCF12-NR4A3 Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(9;17)(q22;q11))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>TAF15-NR4A3 Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(9;22)(q22-31;q12))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>EWSR1-NR4A3 Fusion Protein Expression)))<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> some </span>Malignant Cell with Eosinophilic Cytoplasm)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> some </span>Well-Circumscribed Lesion)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> some </span>Extraosseous Lesion)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> some </span>Multinodular Pattern)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> some </span>Myxoid Stroma Formation)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>EWSR1 Gene)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Cord-Like Pattern)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Cribriform Pattern)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Cystic Change)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hemorrhagic Change)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Spindle Cell Pattern).<br></td>
            </tr>
            <tr class="removal">
               <td>1526</td>
               <td colspan="2">FEV Gene<span class="subclass"> SubClassOf </span>Gene_Involved_In_Pathogenesis_Of_Disease<span class="some"> some </span>Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor.<br></td>
            </tr>
            <tr class="removal">
               <td>1527</td>
               <td colspan="2">FLI1 Gene<span class="subclass"> SubClassOf </span>Gene_Involved_In_Pathogenesis_Of_Disease<span class="some"> some </span>Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor.<br></td>
            </tr>
            <tr class="removal">
               <td>1528</td>
               <td colspan="2">Fall<span class="subclass"> SubClassOf </span>Symptom.<br></td>
            </tr>
            <tr class="removal">
               <td>1529</td>
               <td colspan="2">Fever<span class="subclass"> SubClassOf </span>Body Temperature Associated Symptom.<br></td>
            </tr>
            <tr class="removal">
               <td>1530</td>
               <td colspan="2">GNAS Gene<span class="subclass"> SubClassOf </span>Gene_Associated_With_Disease<span class="some"> some </span>Pituitary Gland Adenoma.<br></td>
            </tr>
            <tr class="removal">
               <td>1531</td>
               <td colspan="2">Gastrointestinal System Signs<br><span class="keyword"> and </span>Symptoms<span class="subclass"> SubClassOf </span>Symptom.<br></td>
            </tr>
            <tr class="removal">
               <td>1532</td>
               <td colspan="2">Genitourinary Signs<br><span class="keyword"> and </span>Symptoms<span class="subclass"> SubClassOf </span>Symptom.<br></td>
            </tr>
            <tr class="removal">
               <td>1533</td>
               <td colspan="2">Guanazole<span class="subclass"> SubClassOf </span>Miscellaneous Antimetabolite.<br></td>
            </tr>
            <tr class="removal">
               <td>1535</td>
               <td colspan="2">Hoarseness<span class="subclass"> SubClassOf </span>Symptom.<br></td>
            </tr>
            <tr class="removal">
               <td>1536</td>
               <td colspan="2">Hot Flashes<span class="subclass"> SubClassOf </span>Body Temperature Associated Symptom.<br></td>
            </tr>
            <tr class="removal">
               <td>1537</td>
               <td colspan="2">Hydroxyurea<span class="subclass"> EquivalentTo </span>Miscellaneous Antimetabolite<br><span class="keyword"> and </span>Ribonucleotide Reductase Inhibitor<br><span class="keyword"> and </span>(Chemical_Or_Drug_Affects_Gene_Product<span class="some"> some </span>Ribonucleotide Reductase)<br><span class="keyword"> and </span>(Chemical_Or_Drug_Has_Mechanism_Of_Action<span class="some"> some </span>Enzyme Inhibition)<br><span class="keyword"> and </span>(Chemical_Or_Drug_Has_Physiologic_Effect<span class="some"> some </span>DNA Repair Inhibition)<br><span class="keyword"> and </span>(Chemical_Or_Drug_Has_Physiologic_Effect<span class="some"> some </span>DNA Synthesis Inhibition)<br><span class="keyword"> and </span>(Chemical_Or_Drug_Has_Physiologic_Effect<span class="some"> some </span>Negative Regulation of G1 to S Transition)<br><span class="keyword"> and </span>(Chemical_Or_Drug_Has_Physiologic_Effect<span class="some"> some </span>Nucleotide Synthesis Inhibition).<br></td>
            </tr>
            <tr class="removal">
               <td>1538</td>
               <td colspan="2">Hyperactivity<span class="subclass"> SubClassOf </span>Symptom.<br></td>
            </tr>
            <tr class="removal">
               <td>1539</td>
               <td colspan="2">Hyperhidrosis<span class="subclass"> SubClassOf </span>Symptom.<br></td>
            </tr>
            <tr class="removal">
               <td>1540</td>
               <td colspan="2">Hyperthermia<span class="subclass"> SubClassOf </span>Body Temperature Associated Symptom.<br></td>
            </tr>
            <tr class="removal">
               <td>1541</td>
               <td colspan="2">Hypohidrosis<span class="subclass"> SubClassOf </span>Symptom.<br></td>
            </tr>
            <tr class="removal">
               <td>1542</td>
               <td colspan="2">Hysteria<span class="subclass"> SubClassOf </span>Symptom.<br></td>
            </tr>
            <tr class="removal">
               <td>1611</td>
               <td colspan="2">Incontinence<span class="subclass"> SubClassOf </span>Symptom.<br></td>
            </tr>
            <tr class="removal">
               <td>1543</td>
               <td colspan="2">Increased Sputum Excretion<span class="subclass"> SubClassOf </span>Symptom.<br></td>
            </tr>
            <tr class="removal">
               <td>1544</td>
               <td colspan="2">Integumentary System Signs<br><span class="keyword"> and </span>Symptoms<span class="subclass"> SubClassOf </span>Integumentary System Finding.<br></td>
            </tr>
            <tr class="removal">
               <td>1545</td>
               <td colspan="2">Integumentary System Signs<br><span class="keyword"> and </span>Symptoms<span class="subclass"> SubClassOf </span>Symptom.<br></td>
            </tr>
            <tr class="removal">
               <td>1546</td>
               <td colspan="2">Limonene<span class="subclass"> SubClassOf </span>Terpene.<br></td>
            </tr>
            <tr class="removal">
               <td>1506</td>
               <td colspan="2">Limonene, (+)-<span class="subclass"> SubClassOf </span>Terpene Compound.<br></td>
            </tr>
            <tr class="removal">
               <td>1509</td>
               <td colspan="2">Limonene, (+/-)-<span class="subclass"> SubClassOf </span>Terpene Compound.<br></td>
            </tr>
            <tr class="removal">
               <td>1547</td>
               <td colspan="2">MLLT3 Gene<span class="subclass"> SubClassOf </span>Gene_Involved_In_Pathogenesis_Of_Disease<span class="some"> some </span>Acute Myeloid Leukemia with t(9;11)(p22;q23); MLLT3-MLL.<br></td>
            </tr>
            <tr class="removal">
               <td>1548</td>
               <td colspan="2">Mediastinal Shift<span class="subclass"> SubClassOf </span>Other Finding.<br></td>
            </tr>
            <tr class="removal">
               <td>1549</td>
               <td colspan="2">Membrane Breakage<span class="subclass"> SubClassOf </span>Other Finding.<br></td>
            </tr>
            <tr class="removal">
               <td>1550</td>
               <td colspan="2">Mental<br><span class="keyword"> and </span>Behavioral Signs<br><span class="keyword"> and </span>Symptoms<span class="subclass"> SubClassOf </span>Symptom.<br></td>
            </tr>
            <tr class="removal">
               <td>1551</td>
               <td colspan="2">Miscellaneous Antimetabolite<span class="subclass"> SubClassOf </span>Antimetabolite.<br></td>
            </tr>
            <tr class="removal">
               <td>1552</td>
               <td colspan="2">Mixed Phenotype Acute Leukemia with t(9;22)(q34;q11.2); BCR-ABL1<span class="subclass"> EquivalentTo </span>Mixed Phenotype Acute Leukemia<br><span class="keyword"> and </span>((Disease_Has_Cytogenetic_Abnormality<span class="some"> some </span>t(9;22)(q34;q11))<br><span class="keyword"> and </span>(Disease_Has_Molecular_Abnormality<span class="some"> some </span>BCR-ABL1 Fusion Protein Expression))<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> some </span>Blasts of Mixed Phenotype Present)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>ABL1 Gene)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>BCR Gene)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Unfavorable Clinical Outcome).<br></td>
            </tr>
            <tr class="removal">
               <td>1553</td>
               <td colspan="2">Myeloid Neoplasms with PDGFRB Rearrangement<span class="subclass"> EquivalentTo </span>Myeloid Neoplasm<br><span class="keyword"> and </span>Myeloid<br><span class="keyword"> and </span>Lymphoid Neoplasms with Eosinophilia<br><span class="keyword"> and </span>Abnormalities of PDGFRA, PDGFRB,<br><span class="keyword"> or </span>FGFR1<br><span class="keyword"> and </span>(Disease_Has_Molecular_Abnormality<span class="some"> some </span>PDGFRB Gene Rearrangement)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>ETV6 Gene)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>PDGFRB Gene)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(5;12)(q31;p12))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Eosinophilia)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>ETV6-PDGFRB Fusion Protein Expression).<br></td>
            </tr>
            <tr class="removal">
               <td>1554</td>
               <td colspan="2">Myeloid<br><span class="keyword"> and </span>Lymphoid Neoplasms with FGFR1 Rearrangement<span class="subclass"> EquivalentTo </span>Myeloid<br><span class="keyword"> and </span>Lymphoid Neoplasms with Eosinophilia<br><span class="keyword"> and </span>Abnormalities of PDGFRA, PDGFRB,<br><span class="keyword"> or </span>FGFR1<br><span class="keyword"> and </span>(Disease_Has_Molecular_Abnormality<span class="some"> some </span>FGFR1 Gene Rearrangement)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>BCR Gene)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>FGFR1 Gene)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>BCR-FGFR1 Fusion Protein Expression).<br></td>
            </tr>
            <tr class="removal">
               <td>1555</td>
               <td colspan="2">Myeloid<br><span class="keyword"> and </span>Lymphoid Neoplasms with PDGFRA Rearrangement<span class="subclass"> EquivalentTo </span>Myeloid<br><span class="keyword"> and </span>Lymphoid Neoplasms with Eosinophilia<br><span class="keyword"> and </span>Abnormalities of PDGFRA, PDGFRB,<br><span class="keyword"> or </span>FGFR1<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> some </span>Eosinophilia)<br><span class="keyword"> and </span>(Disease_Has_Molecular_Abnormality<span class="some"> some </span>PDGFRA Gene Rearrangement)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>FIP1L1 Gene)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>PDGFRA Gene)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>FIP1L1-PDGFRalpha Fusion Protein Expression).<br></td>
            </tr>
            <tr class="removal">
               <td>1556</td>
               <td colspan="2">Myosotis arvensis<span class="subclass"> SubClassOf </span>Myosotis alpestris.<br></td>
            </tr>
            <tr class="removal">
               <td>1558</td>
               <td colspan="2">Myxoid/Round Cell Liposarcoma<span class="subclass"> EquivalentTo </span>Liposarcoma<br><span class="keyword"> and </span>(((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(12;16)(q13;p11))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>FUS-DDIT3 Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(12;22)(q13;q12))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>EWSR1-DDIT3 Fusion Protein Expression)))<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> some </span>Primitive Mesenchymal Cell)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> some </span>Well-Circumscribed Lesion)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>DDIT3 Gene)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>EWSR1 Gene)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>FUS Gene).<br></td>
            </tr>
            <tr class="removal">
               <td>1507</td>
               <td colspan="2">Netrin Receptor DCC<span class="subclass"> SubClassOf </span>Translation Process Protein.<br></td>
            </tr>
            <tr class="removal">
               <td>1559</td>
               <td colspan="2">Neurological Signs<br><span class="keyword"> and </span>Symptoms<span class="subclass"> SubClassOf </span>Symptom.<br></td>
            </tr>
            <tr class="removal">
               <td>1560</td>
               <td colspan="2">Obesity<span class="subclass"> SubClassOf </span>Symptom.<br></td>
            </tr>
            <tr class="removal">
               <td>1561</td>
               <td colspan="2">Overweight<span class="subclass"> SubClassOf </span>Other Finding.<br></td>
            </tr>
            <tr class="removal">
               <td>1562</td>
               <td colspan="2">PAX3/FOXO1 Fusion Protein<span class="subclass"> SubClassOf </span>Fusion Protein.<br></td>
            </tr>
            <tr class="removal">
               <td>1563</td>
               <td colspan="2">PAX3/FOXO1 Fusion Protein<span class="subclass"> SubClassOf </span>Gene_Product_Encoded_By_Gene<span class="some"> some </span>PAX3/FOXO1 Fusion Gene.<br></td>
            </tr>
            <tr class="removal">
               <td>1564</td>
               <td colspan="2">PAX3/FOXO1 Fusion Protein<span class="subclass"> SubClassOf </span>Gene_Product_Plays_Role_In_Biological_Process<span class="some"> some </span>Transcriptional Activation.<br></td>
            </tr>
            <tr class="removal">
               <td>1565</td>
               <td colspan="2">PD-168393<span class="subclass"> SubClassOf </span>Signal Transduction Inhibitor.<br></td>
            </tr>
            <tr class="removal">
               <td>1566</td>
               <td colspan="2">PML Gene<span class="subclass"> SubClassOf </span>Gene_Involved_In_Pathogenesis_Of_Disease<span class="some"> some </span>Acute Promyelocytic Leukemia with t(15;17)(q22;q12); PML-RARA.<br></td>
            </tr>
            <tr class="removal">
               <td>1568</td>
               <td colspan="2">Paranoia<span class="subclass"> SubClassOf </span>Other Finding.<br></td>
            </tr>
            <tr class="removal">
               <td>1569</td>
               <td colspan="2">Paraparesis<span class="subclass"> SubClassOf </span>Symptom.<br></td>
            </tr>
            <tr class="removal">
               <td>1570</td>
               <td colspan="2">Personality Change<span class="subclass"> SubClassOf </span>Symptom.<br></td>
            </tr>
            <tr class="removal">
               <td>1567</td>
               <td colspan="2">Phosphatidylinositol-3,4,5-Trisphosphate 3-Phosphatase<br><span class="keyword"> and </span>Dual-Specificity Protein Phosphatase PTEN<span class="subclass"> EquivalentTo </span>Signaling Protein<br><span class="keyword"> and </span>(Gene_Product_Encoded_By_Gene<span class="some"> some </span>PTEN Gene)<br><span class="keyword"> and </span>(Gene_Product_Has_Biochemical_Function<span class="some"> some </span>Protein Tyrosine Phosphatase)<br><span class="keyword"> and </span>(Gene_Product_Is_Element_In_Pathway<span class="some"> some </span>CTCF Pathway)<br><span class="keyword"> and </span>(Gene_Product_Is_Element_In_Pathway<span class="some"> some </span>Hepatocyte Growth Factor Receptor Signaling Pathway BioCarta)<br><span class="keyword"> and </span>(Gene_Product_Is_Element_In_Pathway<span class="some"> some </span>PTEN-Dependent Cell Cycle Arrest<br><span class="keyword"> and </span>Apoptosis Pathway)<br><span class="keyword"> and </span>(Gene_Product_Is_Element_In_Pathway<span class="some"> some </span>Phosphatidylinositol Signaling System Pathway)<br><span class="keyword"> and </span>(Gene_Product_Is_Element_In_Pathway<span class="some"> some </span>Skeletal Muscle Hypertrophy Pathway)<br><span class="keyword"> and </span>(Gene_Product_Is_Element_In_Pathway<span class="some"> some </span>eIF4 Regulation Pathway)<br><span class="keyword"> and </span>(Gene_Product_Is_Element_In_Pathway<span class="some"> some </span>mTOR Signaling Pathway BioCarta)<br><span class="keyword"> and </span>(Gene_Product_Malfunction_Associated_With_Disease<span class="some"> some </span>Cowden Syndrome)<br><span class="keyword"> and </span>(Gene_Product_Plays_Role_In_Biological_Process<span class="some"> some </span>Negative Regulation of G1 Phase)<br><span class="keyword"> and </span>(Gene_Product_Plays_Role_In_Biological_Process<span class="some"> some </span>Protein Dephosphorylation)<br><span class="keyword"> and </span>(Gene_Product_Plays_Role_In_Biological_Process<span class="some"> some </span>Signal Transduction)<br><span class="keyword"> and </span>(Gene_Product_Plays_Role_In_Biological_Process<span class="some"> some </span>Tumor Suppression).<br></td>
            </tr>
            <tr class="removal">
               <td>1571</td>
               <td colspan="2">Piscidia erythrina<span class="subclass"> SubClassOf </span>Piscidia piscipula.<br></td>
            </tr>
            <tr class="removal">
               <td>1572</td>
               <td colspan="2">Plethoric Face<span class="subclass"> SubClassOf </span>Other Finding.<br></td>
            </tr>
            <tr class="removal">
               <td>1573</td>
               <td colspan="2">Polydipsia<span class="subclass"> SubClassOf </span>Symptom.<br></td>
            </tr>
            <tr class="removal">
               <td>1574</td>
               <td colspan="2">Precocious Puberty<span class="subclass"> SubClassOf </span>Other Finding.<br></td>
            </tr>
            <tr class="removal">
               <td>1575</td>
               <td colspan="2">Prostration<span class="subclass"> SubClassOf </span>Symptom.<br></td>
            </tr>
            <tr class="removal">
               <td>1576</td>
               <td colspan="2">Pyrogenic Reaction<span class="subclass"> SubClassOf </span>Body Temperature Associated Symptom.<br></td>
            </tr>
            <tr class="removal">
               <td>1578</td>
               <td colspan="2">RET Gene<span class="subclass"> SubClassOf </span>Gene_Associated_With_Disease<span class="some"> some </span>Thyroid Gland Medullary Carcinoma.<br></td>
            </tr>
            <tr class="removal">
               <td>1579</td>
               <td colspan="2">RPN1 Gene<span class="subclass"> SubClassOf </span>Gene_Involved_In_Pathogenesis_Of_Disease<span class="some"> some </span>Acute Myeloid Leukemia with inv(3)(q21q26.2)<br><span class="keyword"> or </span>t(3;3)(q21;q26.2); RPN1-EVI1.<br></td>
            </tr>
            <tr class="removal">
               <td>1580</td>
               <td colspan="2">RUNX1 Gene<span class="subclass"> SubClassOf </span>Gene_Involved_In_Pathogenesis_Of_Disease<span class="some"> some </span>Acute Myeloid Leukemia with t(8;21)(q22;q22); RUNX1-RUNX1T1.<br></td>
            </tr>
            <tr class="removal">
               <td>1581</td>
               <td colspan="2">Rathyronine<span class="subclass"> SubClassOf </span>Thyroid Agent.<br></td>
            </tr>
            <tr class="removal">
               <td>1582</td>
               <td colspan="2">Regurgitation<span class="subclass"> SubClassOf </span>Other Finding.<br></td>
            </tr>
            <tr class="removal">
               <td>1583</td>
               <td colspan="2">Reptilase Time<span class="subclass"> SubClassOf </span>Coagulation Study.<br></td>
            </tr>
            <tr class="removal">
               <td>1584</td>
               <td colspan="2">Respiratory System Signs<br><span class="keyword"> and </span>Symptoms<span class="subclass"> SubClassOf </span>Symptom.<br></td>
            </tr>
            <tr class="removal">
               <td>1585</td>
               <td colspan="2">S-Adenosylmethionine<span class="subclass"> SubClassOf </span>Anti-Infective Agent.<br></td>
            </tr>
            <tr class="removal">
               <td>1586</td>
               <td colspan="2">SDHB Gene Mutation<span class="subclass"> SubClassOf </span>Gene Mutant.<br></td>
            </tr>
            <tr class="removal">
               <td>1587</td>
               <td colspan="2">SDHC Gene Mutation<span class="subclass"> SubClassOf </span>Gene Mutant.<br></td>
            </tr>
            <tr class="removal">
               <td>1588</td>
               <td colspan="2">SDHD Gene Mutation<span class="subclass"> SubClassOf </span>Gene Mutant.<br></td>
            </tr>
            <tr class="removal">
               <td>1589</td>
               <td colspan="2">STIL/TAL1 Fusion Gene<span class="subclass"> SubClassOf </span>Fusion Protein.<br></td>
            </tr>
            <tr class="removal">
               <td>1590</td>
               <td colspan="2">STIL/TAL1 Fusion Gene<span class="subclass"> SubClassOf </span>Oncoprotein.<br></td>
            </tr>
            <tr class="removal">
               <td>1591</td>
               <td colspan="2">Serine/Arginine-Rich Splicing Factor 3<span class="subclass"> EquivalentTo </span>Transport Protein<br><span class="keyword"> and </span>(Gene_Product_Encoded_By_Gene<span class="some"> some </span>SRSF3 Gene)<br><span class="keyword"> and </span>(Gene_Product_Has_Associated_Anatomy<span class="some"> some </span>Nucleus)<br><span class="keyword"> and </span>(Gene_Product_Has_Biochemical_Function<span class="some"> some </span>RNA Binding Protein)<br><span class="keyword"> and </span>(Gene_Product_Has_Structural_Domain_Or_Motif<span class="some"> some </span>RNA Recognition Motif)<br><span class="keyword"> and </span>(Gene_Product_Is_Element_In_Pathway<span class="some"> some </span>Spliceosome Pathway)<br><span class="keyword"> and </span>(Gene_Product_Plays_Role_In_Biological_Process<span class="some"> some </span>RNA Splicing)<br><span class="keyword"> and </span>(Gene_Product_Plays_Role_In_Biological_Process<span class="some"> some </span>Transcription Termination)<br><span class="keyword"> and </span>(Gene_Product_Plays_Role_In_Biological_Process<span class="some"> some </span>mRNA Export).<br></td>
            </tr>
            <tr class="removal">
               <td>1592</td>
               <td colspan="2">Shivering<span class="subclass"> SubClassOf </span>Symptom.<br></td>
            </tr>
            <tr class="removal">
               <td>1593</td>
               <td colspan="2">Sign<span class="subclass"> SubClassOf </span>Other Finding.<br></td>
            </tr>
            <tr class="removal">
               <td>1609</td>
               <td colspan="2">Sodium Phosphate, Tribasic<span class="subclass"> SubClassOf </span>Industrial Aid.<br></td>
            </tr>
            <tr class="removal">
               <td>1594</td>
               <td colspan="2">Sputum Excretion Difficulty<span class="subclass"> SubClassOf </span>Symptom.<br></td>
            </tr>
            <tr class="removal">
               <td>1595</td>
               <td colspan="2">Suffocation<span class="subclass"> SubClassOf </span>Other Finding.<br></td>
            </tr>
            <tr class="removal">
               <td>1596</td>
               <td colspan="2">Suicidal Ideation<span class="subclass"> SubClassOf </span>Symptom.<br></td>
            </tr>
            <tr class="removal">
               <td>1597</td>
               <td colspan="2">Sweating<span class="subclass"> SubClassOf </span>Body Temperature Associated Symptom.<br></td>
            </tr>
            <tr class="removal">
               <td>1598</td>
               <td colspan="2">Swelling<span class="subclass"> SubClassOf </span>Symptom.<br></td>
            </tr>
            <tr class="removal">
               <td>1599</td>
               <td colspan="2">Symptom<span class="subclass"> SubClassOf </span>Other Finding.<br></td>
            </tr>
            <tr class="removal">
               <td>1600</td>
               <td colspan="2">Syncope<span class="subclass"> SubClassOf </span>Symptom.<br></td>
            </tr>
            <tr class="removal">
               <td>1601</td>
               <td colspan="2">TCF3 Gene<span class="subclass"> SubClassOf </span>Gene_Involved_In_Pathogenesis_Of_Disease<span class="some"> some </span>B Acute Lymphoblastic Leukemia with t(1;19)(q23;p13.3); E2A-PBX1 (TCF3-PBX1).<br></td>
            </tr>
            <tr class="removal">
               <td>1602</td>
               <td colspan="2">TCF3 Gene<span class="subclass"> SubClassOf </span>Gene_Involved_In_Pathogenesis_Of_Disease<span class="some"> some </span>B Lymphoblastic Leukemia/Lymphoma with t(1;19)(q23;p13.3); E2A-PBX1 (TCF3-PBX1).<br></td>
            </tr>
            <tr class="removal">
               <td>1603</td>
               <td colspan="2">TOP1 Gene<span class="subclass"> SubClassOf </span>Regulatory Gene.<br></td>
            </tr>
            <tr class="removal">
               <td>1604</td>
               <td colspan="2">TOP2A Gene<span class="subclass"> SubClassOf </span>Regulatory Gene.<br></td>
            </tr>
            <tr class="removal">
               <td>1605</td>
               <td colspan="2">TOP2B Gene<span class="subclass"> SubClassOf </span>Regulatory Gene.<br></td>
            </tr>
            <tr class="removal">
               <td>1606</td>
               <td colspan="2">Tearing<span class="subclass"> SubClassOf </span>Symptom.<br></td>
            </tr>
            <tr class="removal">
               <td>1607</td>
               <td colspan="2">Tenderness<span class="subclass"> SubClassOf </span>Other Finding.<br></td>
            </tr>
            <tr class="removal">
               <td>1608</td>
               <td colspan="2">Thyroid Hormone Iodination Alteration<span class="subclass"> SubClassOf </span>Other Finding.<br></td>
            </tr>
            <tr class="removal">
               <td>1610</td>
               <td colspan="2">Unstable Personality<span class="subclass"> SubClassOf </span>Symptom.<br></td>
            </tr>
            <tr class="removal">
               <td>1612</td>
               <td colspan="2">Ventilation<br><span class="keyword"> or </span>Perfusion Signs<br><span class="keyword"> and </span>Symptoms<span class="subclass"> SubClassOf </span>Symptom.<br></td>
            </tr>
            <tr class="removal">
               <td>1494</td>
               <td colspan="2">Voice Alteration<span class="subclass"> SubClassOf </span>Symptom.<br></td>
            </tr>
            <tr class="removal">
               <td>1613</td>
               <td colspan="2">Weight Change<span class="subclass"> SubClassOf </span>Symptom.<br></td>
            </tr>
         </tbody>
         <tbody id="wkequiv" style="display:none">
            <tr class="withoutstyle">
               <td colspan="3"><a name="redef"></a><h4 style="display: inline-block;">Modified Definitions with Shared Terms (54)</h4> [<a href="#">back to top</a>]
               </td>
            </tr>
            <tr>
               <th class="removal">ID</th>
               <th class="removal">Target Definition in Ontology 1</th>
               <th class="normalrem">Source Definition in Ontology 2</th>
            </tr>
            <tr class="removal">
               <td>1615</td>
               <td>Acute Myeloid Leukemia (Megakaryoblastic) with t(1;22)(p13;q13); RBM15-MKL1<span class="subclass"> EquivalentTo </span>Acute Myeloid Leukemia with Recurrent Genetic Abnormalities<br><span class="keyword"> and </span>((Disease_Has_Cytogenetic_Abnormality<span class="some"> some </span>t(1;22)(p13;q13))<br><span class="keyword"> and </span>(Disease_Has_Molecular_Abnormality<span class="some"> some </span>RBM15-MKL1 Fusion Protein Expression))<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> some </span>Neoplastic Megakaryoblast)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>MKL1 Gene)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>RBM15 Gene). 
                  			
               </td>
               <td>Acute Myeloid Leukemia (Megakaryoblastic) with t(1;22)(p13;q13); RBM15-MKL1<span class="subclass"> EquivalentTo </span>Acute Myeloid Leukemia with Recurrent Genetic Abnormalities<br><span class="keyword"> and </span>((Disease_Has_Cytogenetic_Abnormality<span class="some"> some </span>t(1;22)(p13;q13))<br><span class="keyword"> and </span>(Disease_Has_Molecular_Abnormality<span class="some"> some </span>RBM15-MKL1 Fusion Protein Expression))<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> some </span>Neoplastic Megakaryoblast)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>MKL1 Gene)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>RBM15/MKL1 Fusion Gene)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>RBM15 Gene).<br></td>
            </tr>
            <tr class="removal">
               <td>1616</td>
               <td>Acute Myeloid Leukemia with Variant MLL Translocations<span class="subclass"> EquivalentTo </span>Acute Myeloid Leukemia with Recurrent Genetic Abnormalities<br><span class="keyword"> and </span>(((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(10;11)(p11;q23))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>MLL-AF10 Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(11;19)(q23;p13.1))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>MLL-EEN Fusion Protein Expression)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>MLL-ELL Fusion Protein Expression)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>MLL-ENL Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(4;11)(q21;q23))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>MLL-AF4 Fusion Protein Expression)))<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> some </span>Multipotent Bone Marrow Stem Cell)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>MLL Gene). 
                  			
               </td>
               <td>Acute Myeloid Leukemia with Variant MLL Translocations<span class="subclass"> EquivalentTo </span>Acute Myeloid Leukemia with Recurrent Genetic Abnormalities<br><span class="keyword"> and </span>(((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(10;11)(p11;q23))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>MLL-AF10 Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(11;19)(q23;p13.1))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>MLL-EEN Fusion Protein Expression)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>MLL-ELL Fusion Protein Expression)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>MLL-ENL Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(4;11)(q21;q23))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>MLL-AF4 Fusion Protein Expression)))<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> some </span>Multipotent Bone Marrow Stem Cell)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>MLL/AFF1 Fusion Gene)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>MLL/MLLT10 Fusion Gene)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>MLL/MLLT1 Fusion Gene)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>MLLT10/CLP1 Fusion Gene)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>MLL Gene).<br></td>
            </tr>
            <tr class="removal">
               <td>1617</td>
               <td>Acute Myeloid Leukemia with inv(16)(p13.1q22)<br><span class="keyword"> or </span>t(16;16)(p13.1;q22); CBFB-MYH11<span class="subclass"> EquivalentTo </span>Acute Myeloid Leukemia with Recurrent Genetic Abnormalities<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> some </span>Abnormal Eosinophil)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> some </span>Neoplastic Monoblast)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> some </span>Neoplastic Monocyte)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> some </span>Neoplastic Neutrophilic Precursor)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> some </span>Neoplastic Promonocyte)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> some </span>Abnormal Eosinophilic Granules Present)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> some </span>Blasts 20 Percent<br><span class="keyword"> or </span>More of Bone Marrow Nucleated Cells)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> some </span>Bone Marrow Eosinophilia)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> some </span>Neoplastic Granulocytes<br><span class="keyword"> and </span>Precursors 20 Percent<br><span class="keyword"> or </span>More of Bone Marrow Cells)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> some </span>Neoplastic Monocytes<br><span class="keyword"> and </span>Precursors 20 Percent<br><span class="keyword"> or </span>More of Bone Marrow Cells)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> some </span>Bone Marrow Stem Cell with Potential to Differentiate to Granulocytic<br><span class="keyword"> and </span>Monocytic Lineages)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>CBFB Gene)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>MYH11 Gene)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Auer Rods Present)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Favorable Clinical Outcome). 
                  			
               </td>
               <td>Acute Myeloid Leukemia with inv(16)(p13.1q22)<br><span class="keyword"> or </span>t(16;16)(p13.1;q22); CBFB-MYH11<span class="subclass"> EquivalentTo </span>Acute Myeloid Leukemia with Recurrent Genetic Abnormalities<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> some </span>Abnormal Eosinophil)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> some </span>Neoplastic Monoblast)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> some </span>Neoplastic Monocyte)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> some </span>Neoplastic Neutrophilic Precursor)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> some </span>Neoplastic Promonocyte)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> some </span>Abnormal Eosinophilic Granules Present)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> some </span>Blasts 20 Percent<br><span class="keyword"> or </span>More of Bone Marrow Nucleated Cells)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> some </span>Bone Marrow Eosinophilia)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> some </span>Neoplastic Granulocytes<br><span class="keyword"> and </span>Precursors 20 Percent<br><span class="keyword"> or </span>More of Bone Marrow Cells)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> some </span>Neoplastic Monocytes<br><span class="keyword"> and </span>Precursors 20 Percent<br><span class="keyword"> or </span>More of Bone Marrow Cells)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> some </span>Bone Marrow Stem Cell with Potential to Differentiate to Granulocytic<br><span class="keyword"> and </span>Monocytic Lineages)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>CBFB/MYH11 Fusion Gene)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>CBFB Gene)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>MYH11 Gene)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Auer Rods Present)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Favorable Clinical Outcome).<br></td>
            </tr>
            <tr class="removal">
               <td>1618</td>
               <td>Acute Myeloid Leukemia with t(11;17)(q13;q21)<span class="subclass"> EquivalentTo </span>Acute Myeloid Leukemia with a Variant RARA Translocation<br><span class="keyword"> and </span>((Disease_Has_Cytogenetic_Abnormality<span class="some"> some </span>t(11;17)(q13;q21))<br><span class="keyword"> and </span>(Disease_Has_Molecular_Abnormality<span class="some"> some </span>NUMA1-RARA Fusion Protein Expression)). 
                  			
               </td>
               <td>Acute Myeloid Leukemia with t(11;17)(q13;q21)<span class="subclass"> EquivalentTo </span>Acute Myeloid Leukemia with a Variant RARA Translocation<br><span class="keyword"> and </span>((Disease_Has_Cytogenetic_Abnormality<span class="some"> some </span>t(11;17)(q13;q21))<br><span class="keyword"> and </span>(Disease_Has_Molecular_Abnormality<span class="some"> some </span>NUMA1-RARA Fusion Protein Expression))<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>NUMA1/RARA Fusion Gene).<br></td>
            </tr>
            <tr class="removal">
               <td>1619</td>
               <td>Acute Myeloid Leukemia with t(11;17)(q23;q21)<span class="subclass"> EquivalentTo </span>Acute Myeloid Leukemia with a Variant RARA Translocation<br><span class="keyword"> and </span>((Disease_Has_Cytogenetic_Abnormality<span class="some"> some </span>t(11;17)(q23;q21))<br><span class="keyword"> and </span>(Disease_Has_Molecular_Abnormality<span class="some"> some </span>ZBTB16-RARA Fusion Protein Expression)). 
                  			
               </td>
               <td>Acute Myeloid Leukemia with t(11;17)(q23;q21)<span class="subclass"> EquivalentTo </span>Acute Myeloid Leukemia with a Variant RARA Translocation<br><span class="keyword"> and </span>((Disease_Has_Cytogenetic_Abnormality<span class="some"> some </span>t(11;17)(q23;q21))<br><span class="keyword"> and </span>(Disease_Has_Molecular_Abnormality<span class="some"> some </span>ZBTB16-RARA Fusion Protein Expression))<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>ZBTB16/RARA Fusion Gene).<br></td>
            </tr>
            <tr class="removal">
               <td>1620</td>
               <td>Acute Myeloid Leukemia with t(17;17)(q11;q11)<span class="subclass"> EquivalentTo </span>Acute Myeloid Leukemia with a Variant RARA Translocation<br><span class="keyword"> and </span>((Disease_Has_Cytogenetic_Abnormality<span class="some"> some </span>t(17;17)(q11;q11))<br><span class="keyword"> and </span>(Disease_Has_Molecular_Abnormality<span class="some"> some </span>STAT5B-RARA Fusion Protein Expression)). 
                  			
               </td>
               <td>Acute Myeloid Leukemia with t(17;17)(q11;q11)<span class="subclass"> EquivalentTo </span>Acute Myeloid Leukemia with a Variant RARA Translocation<br><span class="keyword"> and </span>((Disease_Has_Cytogenetic_Abnormality<span class="some"> some </span>t(17;17)(q11;q11))<br><span class="keyword"> and </span>(Disease_Has_Molecular_Abnormality<span class="some"> some </span>STAT5B-RARA Fusion Protein Expression))<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>STAT5B/RARA Fusion Gene).<br></td>
            </tr>
            <tr class="removal">
               <td>1621</td>
               <td>Acute Myeloid Leukemia with t(5;17)(q35;q12)<span class="subclass"> EquivalentTo </span>Acute Myeloid Leukemia with a Variant RARA Translocation<br><span class="keyword"> and </span>((Disease_Has_Cytogenetic_Abnormality<span class="some"> some </span>t(5;17)(q35;q12))<br><span class="keyword"> and </span>(Disease_Has_Molecular_Abnormality<span class="some"> some </span>NPM1-RARA Fusion Protein Expression)). 
                  			
               </td>
               <td>Acute Myeloid Leukemia with t(5;17)(q35;q12)<span class="subclass"> EquivalentTo </span>Acute Myeloid Leukemia with a Variant RARA Translocation<br><span class="keyword"> and </span>((Disease_Has_Cytogenetic_Abnormality<span class="some"> some </span>t(5;17)(q35;q12))<br><span class="keyword"> and </span>(Disease_Has_Molecular_Abnormality<span class="some"> some </span>NPM1-RARA Fusion Protein Expression))<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>NPM1/RARA Long Fusion Gene)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>NPM1/RARA Short Fusion Gene).<br></td>
            </tr>
            <tr class="removal">
               <td>1622</td>
               <td>Alveolar Rhabdomyosarcoma<span class="subclass"> EquivalentTo </span>Rhabdomyosarcoma<br><span class="keyword"> and </span>Sarcoma Differentiation Score 3<br><span class="keyword"> and </span>(((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(1;13)(q36;q14))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>PAX3-FOXO1 Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(2;13)(q35;q14))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>PAX7-FOXO1 Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(2;2)(q35;p23))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>PAX3-NCOA1 Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(X;2)(q13;q35))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>PAX3-FOXO4 Fusion Protein Expression)))<br><span class="keyword"> and </span>(Disease_Excludes_Finding<span class="some"> some </span>Well-Circumscribed Lesion)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> some </span>Round Cell with Primitive Myoblastic Differentiation)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>PAX3 Gene)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>PAX7 Gene). 
                  			
               </td>
               <td>Alveolar Rhabdomyosarcoma<span class="subclass"> EquivalentTo </span>Rhabdomyosarcoma<br><span class="keyword"> and </span>Sarcoma Differentiation Score 3<br><span class="keyword"> and </span>(((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(1;13)(q36;q14))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>PAX3-FOXO1 Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(2;13)(q35;q14))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>PAX7-FOXO1 Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(2;2)(q35;p23))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>PAX3-NCOA1 Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(X;2)(q13;q35))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>PAX3-FOXO4 Fusion Protein Expression)))<br><span class="keyword"> and </span>(Disease_Excludes_Finding<span class="some"> some </span>Well-Circumscribed Lesion)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> some </span>Round Cell with Primitive Myoblastic Differentiation)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>PAX3/FOXO1 Fusion Gene)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>PAX3 Gene)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>PAX7/FOXO1 Fusion Gene)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>PAX7 Gene).<br></td>
            </tr>
            <tr class="removal">
               <td>1623</td>
               <td>Alveolar Soft Part Sarcoma<span class="subclass"> EquivalentTo </span>Malignant Soft Tissue Neoplasm of Uncertain Differentiation<br><span class="keyword"> and </span>Sarcoma Differentiation Score 3<br><span class="keyword"> and </span>Sarcoma NCI Grade 3<br><span class="keyword"> and </span>Soft Tissue Sarcoma<br><span class="keyword"> and </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>ASPL-TFE3 Fusion Protein Expression)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Unbalanced Translocation)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(X;17)(p11.2;q25)))<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> some </span>Malignant Epithelioid Cell)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> some </span>Crystal Formation)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> some </span>Organoid Pattern)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> some </span>Pseudoalveolar Pattern)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hemorrhage)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Necrotic Change). 
                  			
               </td>
               <td>Alveolar Soft Part Sarcoma<span class="subclass"> EquivalentTo </span>Malignant Soft Tissue Neoplasm of Uncertain Differentiation<br><span class="keyword"> and </span>Sarcoma Differentiation Score 3<br><span class="keyword"> and </span>Sarcoma NCI Grade 3<br><span class="keyword"> and </span>Soft Tissue Sarcoma<br><span class="keyword"> and </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>ASPL-TFE3 Fusion Protein Expression)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Unbalanced Translocation)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(X;17)(p11.2;q25)))<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> some </span>Malignant Epithelioid Cell)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> some </span>Crystal Formation)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> some </span>Organoid Pattern)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> some </span>Pseudoalveolar Pattern)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>ASPSCR1/TFE3 Fusion Gene)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hemorrhage)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Necrotic Change).<br></td>
            </tr>
            <tr class="removal">
               <td>1614</td>
               <td>Anaplastic Large Cell Lymphoma, ALK-Positive<span class="subclass"> EquivalentTo </span>Anaplastic Large Cell Lymphoma<br><span class="keyword"> and </span>(((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>inv(2)(p23q35))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>ATIC-ALK Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(1;2)(q25;p23))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>TPM3-ALK Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(2;17)(p23;q23))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>CLTC-ALK Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(2;17)(p23;q35))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>ALO17-ALK Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(2;19)(p23;p13))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>TPM4-ALK Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(2;22)(p23;q11))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>MYH9-ALK Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(2;3)(p23;q21))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>TFG-ALK Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(2;5)(p23;q35))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>NPM-ALK Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(X;2)(q11-12;p23))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>MSN-ALK Fusion Protein Expression)))<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> some </span>Hallmark Cell)<br><span class="keyword"> and </span>(Disease_Has_Molecular_Abnormality<span class="some"> some </span>ALK Fusion Protein Expression)<br><span class="keyword"> and </span>(Disease_Has_Molecular_Abnormality<span class="some"> some </span>Rearrangement of 2p23)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> some </span>Activated Mature Cytotoxic T-Lymphocyte)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>ALK Gene)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Doughnut Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Hodgkin-Like Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Reed-Sternberg-Like Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Extranodal Disease)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Favorable Clinical Outcome)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Lymphadenopathy). 
                  			
               </td>
               <td>Anaplastic Large Cell Lymphoma, ALK-Positive<span class="subclass"> EquivalentTo </span>Anaplastic Large Cell Lymphoma<br><span class="keyword"> and </span>(((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>inv(2)(p23q35))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>ATIC-ALK Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(1;2)(q25;p23))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>TPM3-ALK Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(2;17)(p23;q23))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>CLTC-ALK Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(2;17)(p23;q35))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>ALO17-ALK Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(2;19)(p23;p13))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>TPM4-ALK Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(2;22)(p23;q11))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>MYH9-ALK Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(2;3)(p23;q21))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>TFG-ALK Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(2;5)(p23;q35))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>NPM-ALK Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(X;2)(q11-12;p23))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>MSN-ALK Fusion Protein Expression)))<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> some </span>Hallmark Cell)<br><span class="keyword"> and </span>(Disease_Has_Molecular_Abnormality<span class="some"> some </span>ALK Fusion Protein Expression)<br><span class="keyword"> and </span>(Disease_Has_Molecular_Abnormality<span class="some"> some </span>Rearrangement of 2p23)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> some </span>Activated Mature Cytotoxic T-Lymphocyte)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>ALK Gene)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>ATIC/ALK Fusion Gene)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>CLTC/ALK Fusion Gene)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>MSN/ALK Fusion Gene)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>NPM1/ALK Fusion Gene)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>RNF213/ALK Fusion Gene)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>TFG/ALK Fusion Gene)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>TPM3/ALK Fusion Gene)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>TPM4/ALK Fusion Gene)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Doughnut Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Hodgkin-Like Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Reed-Sternberg-Like Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Extranodal Disease)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Favorable Clinical Outcome)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Lymphadenopathy).<br></td>
            </tr>
            <tr class="removal">
               <td>1624</td>
               <td>Angiomatoid Fibrous Histiocytoma<span class="subclass"> EquivalentTo </span>Intermediate Soft Tissue Neoplasm<br><span class="keyword"> and </span>Soft Tissue Neoplasm of Uncertain Differentiation<br><span class="keyword"> and </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(12;16)(q13;p11))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>FUS-ATF1 Fusion Protein Expression))<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> some </span>Well-Circumscribed Lesion)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> some </span>Hemorrhagic Change)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> some </span>Hemosiderin Deposition)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> some </span>Pseudoangiomatoid Space Formation)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> some </span>Subcutaneous Involvement)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Neoplastic Epithelioid Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Neoplastic Spindle Cell). 
                  			
               </td>
               <td>Angiomatoid Fibrous Histiocytoma<span class="subclass"> EquivalentTo </span>Intermediate Soft Tissue Neoplasm<br><span class="keyword"> and </span>Soft Tissue Neoplasm of Uncertain Differentiation<br><span class="keyword"> and </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(12;16)(q13;p11))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>FUS-ATF1 Fusion Protein Expression))<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> some </span>Well-Circumscribed Lesion)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> some </span>Hemorrhagic Change)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> some </span>Hemosiderin Deposition)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> some </span>Pseudoangiomatoid Space Formation)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> some </span>Subcutaneous Involvement)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>FUS/ATF1 Fusion Gene)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Neoplastic Epithelioid Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Neoplastic Spindle Cell).<br></td>
            </tr>
            <tr class="removal">
               <td>1625</td>
               <td>Atypical Adenomatous Lung Hyperplasia<span class="subclass"> EquivalentTo </span>Atypical Hyperplasia<br><span class="keyword"> and </span>Lung Neoplasm<br><span class="keyword"> and </span>Pulmonary Precancerous Condition<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> some </span>Neoplastic Epithelial Cell)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> some </span>Multifocal Lesion)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> some </span>Alveolar Cell)<br><span class="keyword"> and </span>(Disease_Has_Normal_Tissue_Origin<span class="some"> some </span>Alveolar Epithelium)<br><span class="keyword"> and </span>(Disease_Has_Primary_Anatomic_Site<span class="some"> some </span>Alveolus)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 3p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 9)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>KRAS Gene Mutation). 
                  			
               </td>
               <td>Atypical Adenomatous Lung Hyperplasia<span class="subclass"> EquivalentTo </span>Atypical Hyperplasia<br><span class="keyword"> and </span>Lung Neoplasm<br><span class="keyword"> and </span>Pulmonary Precancerous Condition<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> some </span>Neoplastic Epithelial Cell)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> some </span>Multifocal Lesion)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> some </span>Alveolar Cell)<br><span class="keyword"> and </span>(Disease_Has_Normal_Tissue_Origin<span class="some"> some </span>Alveolar Epithelium)<br><span class="keyword"> and </span>(Disease_Has_Primary_Anatomic_Site<span class="some"> some </span>Alveolus)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>KRAS Gene)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 3p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 9)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>KRAS Gene Mutation).<br></td>
            </tr>
            <tr class="removal">
               <td>1626</td>
               <td>B Acute Lymphoblastic Leukemia with t(12;21)(p13;q22); TEL-AML1 (ETV6-RUNX1)<span class="subclass"> EquivalentTo </span>B Lymphoblastic Leukemia/Lymphoma with t(12;21)(p13;q22); TEL-AML1 (ETV6-RUNX1)<br><span class="keyword"> and </span>B Acute Lymphoblastic Leukemia<br><span class="keyword"> and </span>((Disease_Has_Cytogenetic_Abnormality<span class="some"> some </span>t(12;21)(p13;q22))<br><span class="keyword"> and </span>(Disease_Has_Molecular_Abnormality<span class="some"> some </span>TEL-AML1 Fusion Protein Expression))<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>ETV6 Gene)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>RUNX1 Gene)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Extensive Bone Marrow<br><span class="keyword"> and </span>Blood Involvement)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Favorable Clinical Outcome). 
                  			
               </td>
               <td>B Acute Lymphoblastic Leukemia with t(12;21)(p13;q22); TEL-AML1 (ETV6-RUNX1)<span class="subclass"> EquivalentTo </span>B Lymphoblastic Leukemia/Lymphoma with t(12;21)(p13;q22); TEL-AML1 (ETV6-RUNX1)<br><span class="keyword"> and </span>B Acute Lymphoblastic Leukemia<br><span class="keyword"> and </span>((Disease_Has_Cytogenetic_Abnormality<span class="some"> some </span>t(12;21)(p13;q22))<br><span class="keyword"> and </span>(Disease_Has_Molecular_Abnormality<span class="some"> some </span>TEL-AML1 Fusion Protein Expression))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Extensive Bone Marrow<br><span class="keyword"> and </span>Blood Involvement)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Favorable Clinical Outcome).<br></td>
            </tr>
            <tr class="removal">
               <td>1627</td>
               <td>B Lymphoblastic Leukemia/Lymphoma with t(v;11q23); MLL Rearranged<span class="subclass"> EquivalentTo </span>B Lymphoblastic Leukemia/Lymphoma with Recurrent Genetic Abnormalities<br><span class="keyword"> and </span>((Disease_Has_Cytogenetic_Abnormality<span class="some"> some </span>t(11;v)(q23;v))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>MLL-AF4 Fusion Protein Expression)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>MLLT3-MLL Fusion Protein Expression))<br><span class="keyword"> and </span>(Disease_Excludes_Finding<span class="some"> some </span>Blasts of Mixed Phenotype Present)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>MLL Gene)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Unfavorable Clinical Outcome). 
                  			
               </td>
               <td>B Lymphoblastic Leukemia/Lymphoma with t(v;11q23); MLL Rearranged<span class="subclass"> EquivalentTo </span>B Lymphoblastic Leukemia/Lymphoma with Recurrent Genetic Abnormalities<br><span class="keyword"> and </span>((Disease_Has_Cytogenetic_Abnormality<span class="some"> some </span>t(11;v)(q23;v))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>MLL-AF4 Fusion Protein Expression)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>MLLT3-MLL Fusion Protein Expression))<br><span class="keyword"> and </span>(Disease_Excludes_Finding<span class="some"> some </span>Blasts of Mixed Phenotype Present)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>MLL/AFF1 Fusion Gene)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>MLL Gene)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Unfavorable Clinical Outcome).<br></td>
            </tr>
            <tr class="removal">
               <td>1628</td>
               <td>Bronchial Mucosa-Associated Lymphoid Tissue Lymphoma<span class="subclass"> EquivalentTo </span>Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue<br><span class="keyword"> and </span>Lung Mature B-Cell Neoplasm<br><span class="keyword"> and </span>Lung Non-Hodgkin Lymphoma<br><span class="keyword"> and </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(11;18)(q21;q21))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>API2-MLT Fusion Protein Expression))<br><span class="keyword"> and </span>(Disease_Has_Normal_Tissue_Origin<span class="some"> some </span>Bronchus-Associated Lymphoid Tissue)<br><span class="keyword"> and </span>(Disease_Has_Primary_Anatomic_Site<span class="some"> some </span>Bronchus)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>MALT1 Gene)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(1;14)(p22;q32)). 
                  			
               </td>
               <td>Bronchial Mucosa-Associated Lymphoid Tissue Lymphoma<span class="subclass"> EquivalentTo </span>Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue<br><span class="keyword"> and </span>Lung Mature B-Cell Neoplasm<br><span class="keyword"> and </span>Lung Non-Hodgkin Lymphoma<br><span class="keyword"> and </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(11;18)(q21;q21))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>API2-MLT Fusion Protein Expression))<br><span class="keyword"> and </span>(Disease_Has_Normal_Tissue_Origin<span class="some"> some </span>Bronchus-Associated Lymphoid Tissue)<br><span class="keyword"> and </span>(Disease_Has_Primary_Anatomic_Site<span class="some"> some </span>Bronchus)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>BIRC3/MALT1 Fusion Gene)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>MALT1 Gene)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(1;14)(p22;q32)).<br></td>
            </tr>
            <tr class="removal">
               <td>1629</td>
               <td>CLC wt Allele<span class="subclass"> EquivalentTo </span>CLC Gene<br><span class="keyword"> and </span>(Gene_Found_In_Organism<span class="some"> some </span>Human)<br><span class="keyword"> and </span>(Gene_Has_Physical_Location<span class="some"> some </span>19: 44920508-44913736)<br><span class="keyword"> and </span>(Gene_In_Chromosomal_Location<span class="some"> some </span>19q13.1)<br><span class="keyword"> and </span>(Gene_Is_Element_In_Pathway<span class="some"> some </span>Phospholipid Degradation Pathway). 
                  			
               </td>
               <td>CLC wt Allele<span class="subclass"> EquivalentTo </span>CLC Gene<br><span class="keyword"> and </span>(Gene_Found_In_Organism<span class="some"> some </span>Human)<br><span class="keyword"> and </span>(Gene_Has_Physical_Location<span class="some"> some </span>19: 44920508-44913736)<br><span class="keyword"> and </span>(Gene_In_Chromosomal_Location<span class="some"> some </span>19q13.1).<br></td>
            </tr>
            <tr class="removal">
               <td>1632</td>
               <td>Cellular Congenital Mesoblastic Nephroma<span class="subclass"> EquivalentTo </span>Congenital Mesoblastic Nephroma<br><span class="keyword"> and </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Trisomy 11)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(12;15)(p13;q26))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>ETV6-NTRK3 Fusion Protein Expression))<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> some </span>High Mitotic Activity)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> some </span>Increased Cellularity Present)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>NTRK3 Gene)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Necrotic Change). 
                  			
               </td>
               <td>Cellular Congenital Mesoblastic Nephroma<span class="subclass"> EquivalentTo </span>Congenital Mesoblastic Nephroma<br><span class="keyword"> and </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Trisomy 11)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(12;15)(p13;q26))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>ETV6-NTRK3 Fusion Protein Expression))<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> some </span>High Mitotic Activity)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> some </span>Increased Cellularity Present)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>ETV6/NTRK3 Fusion Gene)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>NTRK3 Gene)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Necrotic Change).<br></td>
            </tr>
            <tr class="removal">
               <td>1631</td>
               <td>Central Nervous System Choriocarcinoma<span class="subclass"> EquivalentTo </span>Choriocarcinoma<br><span class="keyword"> and </span>Malignant Central Nervous System Germ Cell Tumor. 
                  			
               </td>
               <td>Central Nervous System Choriocarcinoma<span class="subclass"> EquivalentTo </span>Choriocarcinoma<br><span class="keyword"> and </span>Malignant Central Nervous System Germ Cell Tumor<br><span class="keyword"> and </span>Nongerminomatous Germ Cell Tumor.<br></td>
            </tr>
            <tr class="removal">
               <td>1637</td>
               <td>Central Nervous System Embryonal Carcinoma<span class="subclass"> EquivalentTo </span>Extragonadal Embryonal Carcinoma<br><span class="keyword"> and </span>Malignant Central Nervous System Germ Cell Tumor. 
                  			
               </td>
               <td>Central Nervous System Embryonal Carcinoma<span class="subclass"> EquivalentTo </span>Extragonadal Embryonal Carcinoma<br><span class="keyword"> and </span>Malignant Central Nervous System Germ Cell Tumor<br><span class="keyword"> and </span>Nongerminomatous Germ Cell Tumor.<br></td>
            </tr>
            <tr class="removal">
               <td>1667</td>
               <td>Central Nervous System Yolk Sac Tumor<span class="subclass"> EquivalentTo </span>Malignant Central Nervous System Germ Cell Tumor<br><span class="keyword"> and </span>Yolk Sac Tumor<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Honeycomb Pattern)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Sinusoidal Growth Pattern). 
                  			
               </td>
               <td>Central Nervous System Yolk Sac Tumor<span class="subclass"> EquivalentTo </span>Malignant Central Nervous System Germ Cell Tumor<br><span class="keyword"> and </span>Nongerminomatous Germ Cell Tumor<br><span class="keyword"> and </span>Yolk Sac Tumor<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Honeycomb Pattern)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Sinusoidal Growth Pattern).<br></td>
            </tr>
            <tr class="removal">
               <td>1634</td>
               <td>Clear Cell Sarcoma of Soft Tissue<span class="subclass"> EquivalentTo </span>Neoplasm of Uncertain Histogenesis<br><span class="keyword"> and </span>Soft Tissue Sarcoma<br><span class="keyword"> and </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(12;22)(q13;q12))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>EWSR1-ATF1 Fusion Protein Expression))<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> some </span>Malignant Polygonal Cell with Eosinophilic Cytoplasm)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> some </span>Fascicular Pattern)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> some </span>Nested Pattern)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Malignant Spindle Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Wreath-Like Multinucleated Giant Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 7)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 8)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Melanosomes Present)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Slow Growing Mass). 
                  			
               </td>
               <td>Clear Cell Sarcoma of Soft Tissue<span class="subclass"> EquivalentTo </span>Neoplasm of Uncertain Histogenesis<br><span class="keyword"> and </span>Soft Tissue Sarcoma<br><span class="keyword"> and </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(12;22)(q13;q12))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>EWSR1-ATF1 Fusion Protein Expression))<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> some </span>Malignant Polygonal Cell with Eosinophilic Cytoplasm)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> some </span>Fascicular Pattern)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> some </span>Nested Pattern)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>EWSR1/ATF1 Fusion Gene)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Malignant Spindle Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Wreath-Like Multinucleated Giant Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 7)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 8)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Melanosomes Present)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Slow Growing Mass).<br></td>
            </tr>
            <tr class="removal">
               <td>1633</td>
               <td>Conventional Lipoma<span class="subclass"> EquivalentTo </span>Lipoma<br><span class="keyword"> and </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(3;12)(q27-28;q13-15))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>HMGIC-LPP Fusion Protein Expression))<br><span class="keyword"> and </span>(Disease_Excludes_Abnormal_Cell<span class="some"> some </span>Neoplastic Lipoblast)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> some </span>Neoplastic Mature Adipocyte)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> some </span>Well-Circumscribed Lesion)<br><span class="keyword"> and </span>(Disease_Mapped_To_Chromosome<span class="some"> some </span>Chromosome 13)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>HMGA2 Gene)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 13q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(1;12)(p32-34;q13-15))<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(2;12)(p22-24;q13-15))<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(2;12)(q35-37;q13-15))<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(5;12)(q33;q13-15))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Painless Mass). 
                  			
               </td>
               <td>Conventional Lipoma<span class="subclass"> EquivalentTo </span>Lipoma<br><span class="keyword"> and </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(3;12)(q27-28;q13-15))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>HMGIC-LPP Fusion Protein Expression))<br><span class="keyword"> and </span>(Disease_Excludes_Abnormal_Cell<span class="some"> some </span>Neoplastic Lipoblast)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> some </span>Neoplastic Mature Adipocyte)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> some </span>Well-Circumscribed Lesion)<br><span class="keyword"> and </span>(Disease_Mapped_To_Chromosome<span class="some"> some </span>Chromosome 13)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>HMGA2/LPP Long Fusion Gene)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>HMGA2 Gene)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 13q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(1;12)(p32-34;q13-15))<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(2;12)(p22-24;q13-15))<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(2;12)(q35-37;q13-15))<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(5;12)(q33;q13-15))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Painless Mass).<br></td>
            </tr>
            <tr class="removal">
               <td>1635</td>
               <td>Dermatofibrosarcoma Protuberans<span class="subclass"> EquivalentTo </span>Cutaneous Fibrohistiocytic Neoplasm<br><span class="keyword"> and </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(17;22)(q22;q13))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>COL1A1-PDGFbeta Fusion Protein Expression))<br><span class="keyword"> and </span>(Disease_Excludes_Finding<span class="some"> some </span>Well-Circumscribed Lesion)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> some </span>Neoplastic Spindle-Shaped Fibrohistiocytic Cell)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> some </span>Invasive Lesion)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> some </span>Multinodular Mass)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> some </span>Storiform Growth Pattern)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Supernumerary Circular Chromosome). 
                  			
               </td>
               <td>Dermatofibrosarcoma Protuberans<span class="subclass"> EquivalentTo </span>Cutaneous Fibrohistiocytic Neoplasm<br><span class="keyword"> and </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(17;22)(q22;q13))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>COL1A1-PDGFbeta Fusion Protein Expression))<br><span class="keyword"> and </span>(Disease_Excludes_Finding<span class="some"> some </span>Well-Circumscribed Lesion)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> some </span>Neoplastic Spindle-Shaped Fibrohistiocytic Cell)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> some </span>Invasive Lesion)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> some </span>Multinodular Mass)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> some </span>Storiform Growth Pattern)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>COL1A1/PDGFB Fusion Gene)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Supernumerary Circular Chromosome).<br></td>
            </tr>
            <tr class="removal">
               <td>1636</td>
               <td>Desmoplastic Small Round Cell Tumor<span class="subclass"> EquivalentTo </span>Malignant Soft Tissue Neoplasm of Uncertain Differentiation<br><span class="keyword"> and </span>Small Cell Sarcoma<br><span class="keyword"> and </span>Soft Tissue Sarcoma<br><span class="keyword"> and </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(11;22)(p13;q12))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>EWSR1-WT1 Fusion Protein Expression))<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> some </span>Malignant Small Round Cell)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> some </span>Desmoplastic Stroma Formation)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>EWSR1 Gene)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Abdominal Mass)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Ascites)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>High Mitotic Activity)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Pain)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Tumor Cell Necrosis). 
                  			
               </td>
               <td>Desmoplastic Small Round Cell Tumor<span class="subclass"> EquivalentTo </span>Malignant Soft Tissue Neoplasm of Uncertain Differentiation<br><span class="keyword"> and </span>Small Cell Sarcoma<br><span class="keyword"> and </span>Soft Tissue Sarcoma<br><span class="keyword"> and </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(11;22)(p13;q12))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>EWSR1-WT1 Fusion Protein Expression))<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> some </span>Malignant Small Round Cell)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> some </span>Desmoplastic Stroma Formation)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>EWSR1/WT1 Fusion Gene)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>EWSR1 Gene)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Abdominal Mass)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Ascites)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>High Mitotic Activity)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Pain)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Tumor Cell Necrosis).<br></td>
            </tr>
            <tr class="removal">
               <td>1664</td>
               <td>ETV6/RUNX1 Fusion Gene<span class="subclass"> EquivalentTo </span>Fusion Gene<br><span class="keyword"> and </span>(Gene_Found_In_Organism<span class="some"> some </span>Human)<br><span class="keyword"> and </span>(Gene_Has_Abnormality<span class="some"> some </span>t(12;21)(p13;q22))<br><span class="keyword"> and </span>(Gene_Is_Biomarker_Of<span class="some"> some </span>Acute Myeloid Leukemia)<br><span class="keyword"> and </span>(Gene_Plays_Role_In_Process<span class="some"> some </span>Transcriptional Regulation)<br><span class="keyword"> and </span>(Gene_Plays_Role_In_Process<span class="some"> some </span>Tumorigenesis). 
                  			
               </td>
               <td>ETV6/RUNX1 Fusion Gene<span class="subclass"> EquivalentTo </span>Fusion Gene<br><span class="keyword"> and </span>(Gene_Found_In_Organism<span class="some"> some </span>Human)<br><span class="keyword"> and </span>(Gene_Has_Abnormality<span class="some"> some </span>t(12;21)(p13;q22))<br><span class="keyword"> and </span>(Gene_Involved_In_Pathogenesis_Of_Disease<span class="some"> some </span>B Lymphoblastic Leukemia/Lymphoma with t(12;21)(p13;q22); TEL-AML1 (ETV6-RUNX1))<br><span class="keyword"> and </span>(Gene_Is_Biomarker_Of<span class="some"> some </span>Acute Myeloid Leukemia)<br><span class="keyword"> and </span>(Gene_Plays_Role_In_Process<span class="some"> some </span>Transcriptional Regulation)<br><span class="keyword"> and </span>(Gene_Plays_Role_In_Process<span class="some"> some </span>Tumorigenesis).<br></td>
            </tr>
            <tr class="removal">
               <td>1639</td>
               <td>Gastric Mucosa-Associated Lymphoid Tissue Lymphoma<span class="subclass"> EquivalentTo </span>Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue<br><span class="keyword"> and </span>Gastric Non-Hodgkin Lymphoma<br><span class="keyword"> and </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(11;18)(q21;q21))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>API2-MLT Fusion Protein Expression))<br><span class="keyword"> and </span>(Disease_Has_Normal_Tissue_Origin<span class="some"> some </span>Gut-Associated Lymphoid Tissue)<br><span class="keyword"> and </span>(Disease_Has_Primary_Anatomic_Site<span class="some"> some </span>Stomach)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>MALT1 Gene)<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Hepatitis C Infection). 
                  			
               </td>
               <td>Gastric Mucosa-Associated Lymphoid Tissue Lymphoma<span class="subclass"> EquivalentTo </span>Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue<br><span class="keyword"> and </span>Gastric Non-Hodgkin Lymphoma<br><span class="keyword"> and </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(11;18)(q21;q21))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>API2-MLT Fusion Protein Expression))<br><span class="keyword"> and </span>(Disease_Has_Normal_Tissue_Origin<span class="some"> some </span>Gut-Associated Lymphoid Tissue)<br><span class="keyword"> and </span>(Disease_Has_Primary_Anatomic_Site<span class="some"> some </span>Stomach)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>BIRC3/MALT1 Fusion Gene)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>MALT1 Gene)<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Hepatitis C Infection).<br></td>
            </tr>
            <tr class="removal">
               <td>1640</td>
               <td>Growth Hormone-Producing Pituitary Gland Adenoma<span class="subclass"> EquivalentTo </span>Growth Hormone-Producing Pituitary Gland Neoplasm<br><span class="keyword"> and </span>Pituitary Gland Adenoma<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 17)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 19)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 22)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 5)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 9)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 1)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 11)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 18)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 2)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>CDKN2A Gene Inactivation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>GNAS Gene Mutation). 
                  			
               </td>
               <td>Growth Hormone-Producing Pituitary Gland Adenoma<span class="subclass"> EquivalentTo </span>Growth Hormone-Producing Pituitary Gland Neoplasm<br><span class="keyword"> and </span>Pituitary Gland Adenoma<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>GNAS Gene)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 17)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 19)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 22)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 5)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 9)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 1)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 11)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 18)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 2)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>CDKN2A Gene Inactivation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>GNAS Gene Mutation).<br></td>
            </tr>
            <tr class="removal">
               <td>1641</td>
               <td>Hereditary Paraganglioma<span class="subclass"> EquivalentTo </span>Extra-Adrenal Paraganglioma<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> some </span>Hereditary Lesion)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Multifocal Lesion)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Nesting (Zellballen) Growth Pattern)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Trabecular Pattern). 
                  			
               </td>
               <td>Hereditary Paraganglioma<span class="subclass"> EquivalentTo </span>Extra-Adrenal Paraganglioma<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> some </span>Hereditary Lesion)<br><span class="keyword"> and </span>(Disease_Has_Molecular_Abnormality<span class="some"> some </span>Mitochondrial Complex II Gene Mutation)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>SDHB Gene)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>SDHC Gene)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>SDHD Gene)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Multifocal Lesion)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Nesting (Zellballen) Growth Pattern)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Trabecular Pattern)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>SDHB Gene Mutation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>SDHC Gene Mutation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>SDHD Gene Mutation).<br></td>
            </tr>
            <tr class="removal">
               <td>1642</td>
               <td>Hereditary Paraganglioma-Pheochromocytoma Syndrome<span class="subclass"> EquivalentTo </span>Endocrine Syndrome<br><span class="keyword"> and </span>Hereditary Neoplastic Syndrome<br><span class="keyword"> and </span>((Disease_Has_Molecular_Abnormality<span class="some"> some </span>Mitochondrial Complex II Gene Mutation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>SDHB Gene Mutation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>SDHC Gene Mutation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>SDHD Gene Mutation))<br><span class="keyword"> and </span>(Disease_Has_Associated_Disease<span class="some"> some </span>Paraganglioma). 
                  			
               </td>
               <td>Hereditary Paraganglioma-Pheochromocytoma Syndrome<span class="subclass"> EquivalentTo </span>Endocrine Syndrome<br><span class="keyword"> and </span>Hereditary Neoplastic Syndrome<br><span class="keyword"> and </span>((Disease_Has_Molecular_Abnormality<span class="some"> some </span>Mitochondrial Complex II Gene Mutation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>SDHB Gene Mutation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>SDHC Gene Mutation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>SDHD Gene Mutation))<br><span class="keyword"> and </span>(Disease_Has_Associated_Disease<span class="some"> some </span>Paraganglioma)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>SDHB Gene)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>SDHC Gene)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>SDHD Gene).<br></td>
            </tr>
            <tr class="removal">
               <td>1643</td>
               <td>Hyperparathyroidism-Jaw Tumor Syndrome<span class="subclass"> EquivalentTo </span>Hereditary Neoplastic Syndrome<br><span class="keyword"> and </span>(Disease_Has_Associated_Disease<span class="some"> some </span>Primary Hyperparathyroidism)<br><span class="keyword"> and </span>(Disease_Has_Molecular_Abnormality<span class="some"> some </span>CDC73 Gene Mutation)<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Papillary Renal Cell Carcinoma)<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Parathyroid Gland Adenoma)<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Parathyroid Gland Carcinoma)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Renal Cyst). 
                  			
               </td>
               <td>Hyperparathyroidism-Jaw Tumor Syndrome<span class="subclass"> EquivalentTo </span>Hereditary Neoplastic Syndrome<br><span class="keyword"> and </span>(Disease_Has_Associated_Disease<span class="some"> some </span>Primary Hyperparathyroidism)<br><span class="keyword"> and </span>(Disease_Has_Molecular_Abnormality<span class="some"> some </span>CDC73 Gene Mutation)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>CDC73 Gene)<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Papillary Renal Cell Carcinoma)<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Parathyroid Gland Adenoma)<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Parathyroid Gland Carcinoma)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Renal Cyst).<br></td>
            </tr>
            <tr class="removal">
               <td>1644</td>
               <td>Infantile Fibrosarcoma<span class="subclass"> EquivalentTo </span>Childhood Fibrosarcoma<br><span class="keyword"> and </span>Conventional Fibrosarcoma<br><span class="keyword"> and </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(12;15)(p13;q26))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>ETV6-NTRK3 Fusion Protein Expression))<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>NTRK3 Gene)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Trisomy 11)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Trisomy 17)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Trisomy 20)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Trisomy 8)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Favorable Clinical Outcome). 
                  			
               </td>
               <td>Infantile Fibrosarcoma<span class="subclass"> EquivalentTo </span>Childhood Fibrosarcoma<br><span class="keyword"> and </span>Conventional Fibrosarcoma<br><span class="keyword"> and </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(12;15)(p13;q26))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>ETV6-NTRK3 Fusion Protein Expression))<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>ETV6/NTRK3 Fusion Gene)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>NTRK3 Gene)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Trisomy 11)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Trisomy 17)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Trisomy 20)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Trisomy 8)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Favorable Clinical Outcome).<br></td>
            </tr>
            <tr class="removal">
               <td>1645</td>
               <td>Inflammatory Myofibroblastic Tumor<span class="subclass"> EquivalentTo </span>Intermediate Fibrocytic Neoplasm<br><span class="keyword"> and </span>(((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(1;2)(q25;p23))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>TPM3-ALK Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(2;17)(p23;q23))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>CLTC-ALK Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(2;19)(p23;p13))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>TPM4-ALK Fusion Protein Expression)))<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> some </span>Neoplastic Spindle-Shaped Myofibroblast)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> some </span>Eosinophilic Infiltrate)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> some </span>Lymphocytic Infiltrate)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> some </span>Plasmacytic Infiltrate)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>ALK Gene)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>HMGA2 Gene)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Ganglion-Like Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Neoplastic Stellate Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Well-Circumscribed Lesion)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Fascicular Pattern)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Fever)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Multinodular Lesion)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Myxoid Background)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Pain). 
                  			
               </td>
               <td>Inflammatory Myofibroblastic Tumor<span class="subclass"> EquivalentTo </span>Intermediate Fibrocytic Neoplasm<br><span class="keyword"> and </span>(((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(1;2)(q25;p23))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>TPM3-ALK Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(2;17)(p23;q23))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>CLTC-ALK Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(2;19)(p23;p13))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>TPM4-ALK Fusion Protein Expression)))<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> some </span>Neoplastic Spindle-Shaped Myofibroblast)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> some </span>Eosinophilic Infiltrate)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> some </span>Lymphocytic Infiltrate)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> some </span>Plasmacytic Infiltrate)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>ALK Gene)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>CLTC/ALK Fusion Gene)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>HMGA2 Gene)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>TPM3/ALK Fusion Gene)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>TPM4/ALK Fusion Gene)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Ganglion-Like Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Neoplastic Stellate Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Well-Circumscribed Lesion)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Fascicular Pattern)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Fever)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Multinodular Lesion)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Myxoid Background)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Pain).<br></td>
            </tr>
            <tr class="removal">
               <td>1646</td>
               <td>Lipoblastoma<span class="subclass"> EquivalentTo </span>Benign Lipomatous Neoplasm<br><span class="keyword"> and </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Rearrangement of 8q11-13)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>COL1A2-PLAG1 Fusion Protein Expression)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>HAS2-PLAG1 Fusion Protein Expression))<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> some </span>Neoplastic Lipoblast)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> some </span>Neoplastic Mature Adipocyte)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> some </span>Well-Circumscribed Lesion)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> some </span>Localized Disease)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> some </span>Slow Growing Painless Mass)<br><span class="keyword"> and </span>(Disease_Mapped_To_Chromosome<span class="some"> some </span>Chromosome 8)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>PLAG1 Gene)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 8). 
                  			
               </td>
               <td>Lipoblastoma<span class="subclass"> EquivalentTo </span>Benign Lipomatous Neoplasm<br><span class="keyword"> and </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Rearrangement of 8q11-13)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>COL1A2-PLAG1 Fusion Protein Expression)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>HAS2-PLAG1 Fusion Protein Expression))<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> some </span>Neoplastic Lipoblast)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> some </span>Neoplastic Mature Adipocyte)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> some </span>Well-Circumscribed Lesion)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> some </span>Localized Disease)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> some </span>Slow Growing Painless Mass)<br><span class="keyword"> and </span>(Disease_Mapped_To_Chromosome<span class="some"> some </span>Chromosome 8)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>COL1A2/PLAG1 Fusion Gene)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>HAS2/PLAG1 Fusion Gene)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>PLAG1 Gene)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 8).<br></td>
            </tr>
            <tr class="removal">
               <td>1647</td>
               <td>Lipoblastomatosis<span class="subclass"> EquivalentTo </span>Benign Lipomatous Neoplasm<br><span class="keyword"> and </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Rearrangement of 8q11-13)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>COL1A2-PLAG1 Fusion Protein Expression)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>HAS2-PLAG1 Fusion Protein Expression))<br><span class="keyword"> and </span>(Disease_Excludes_Finding<span class="some"> some </span>Localized Disease)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> some </span>Neoplastic Lipoblast)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> some </span>Neoplastic Mature Adipocyte)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> some </span>Multifocal Lesion)<br><span class="keyword"> and </span>(Disease_Mapped_To_Chromosome<span class="some"> some </span>Chromosome 8)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>PLAG1 Gene)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 8). 
                  			
               </td>
               <td>Lipoblastomatosis<span class="subclass"> EquivalentTo </span>Benign Lipomatous Neoplasm<br><span class="keyword"> and </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Rearrangement of 8q11-13)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>COL1A2-PLAG1 Fusion Protein Expression)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>HAS2-PLAG1 Fusion Protein Expression))<br><span class="keyword"> and </span>(Disease_Excludes_Finding<span class="some"> some </span>Localized Disease)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> some </span>Neoplastic Lipoblast)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> some </span>Neoplastic Mature Adipocyte)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> some </span>Multifocal Lesion)<br><span class="keyword"> and </span>(Disease_Mapped_To_Chromosome<span class="some"> some </span>Chromosome 8)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>COL1A2/PLAG1 Fusion Gene)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>HAS2/PLAG1 Fusion Gene)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>PLAG1 Gene)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 8).<br></td>
            </tr>
            <tr class="removal">
               <td>1648</td>
               <td>Low Grade Fibromyxoid Sarcoma<span class="subclass"> EquivalentTo </span>Soft Tissue Fibrosarcoma<br><span class="keyword"> and </span>((Disease_Has_Cytogenetic_Abnormality<span class="some"> some </span>Balanced Chromosomal Translocation)<br><span class="keyword"> and </span>(Disease_Has_Cytogenetic_Abnormality<span class="some"> some </span>t(7;16)(q32-34;p11))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>FUS-CREB3L1 Fusion Protein Expression)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>FUS-CREB3L2 Fusion Protein Expression))<br><span class="keyword"> and </span>(Disease_Excludes_Finding<span class="some"> some </span>Nuclear Pleomorphism)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> some </span>Malignant Spindle-Shaped Fibroblast)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> some </span>Fibrotic Stroma Formation)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> some </span>Low Grade Lesion)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> some </span>Myxoid Stroma Formation)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> some </span>Whorling Growth Pattern)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>FUS Gene)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Favorable Clinical Outcome)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Mild Cytologic Atypia). 
                  			
               </td>
               <td>Low Grade Fibromyxoid Sarcoma<span class="subclass"> EquivalentTo </span>Soft Tissue Fibrosarcoma<br><span class="keyword"> and </span>((Disease_Has_Cytogenetic_Abnormality<span class="some"> some </span>Balanced Chromosomal Translocation)<br><span class="keyword"> and </span>(Disease_Has_Cytogenetic_Abnormality<span class="some"> some </span>t(7;16)(q32-34;p11))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>FUS-CREB3L1 Fusion Protein Expression)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>FUS-CREB3L2 Fusion Protein Expression))<br><span class="keyword"> and </span>(Disease_Excludes_Finding<span class="some"> some </span>Nuclear Pleomorphism)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> some </span>Malignant Spindle-Shaped Fibroblast)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> some </span>Fibrotic Stroma Formation)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> some </span>Low Grade Lesion)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> some </span>Myxoid Stroma Formation)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> some </span>Whorling Growth Pattern)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>FUS/CREB3L2 Fusion Gene)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>FUS Gene)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Favorable Clinical Outcome)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Mild Cytologic Atypia).<br></td>
            </tr>
            <tr class="removal">
               <td>1649</td>
               <td>Lung Adenocarcinoma<span class="subclass"> EquivalentTo </span>Non-Small Cell Adenocarcinoma<br><span class="keyword"> and </span>Non-Small Cell Lung Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 1q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 20q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 3q24-qter)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 5p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 8q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 13q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 4q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 6q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 8p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 9)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome Y)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>KRAS2 Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>LKB1 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Loss of Chromosome 5q). 
                  			
               </td>
               <td>Lung Adenocarcinoma<span class="subclass"> EquivalentTo </span>Non-Small Cell Adenocarcinoma<br><span class="keyword"> and </span>Non-Small Cell Lung Carcinoma<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>ALK Gene)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>EML4/ALK Fusion Gene)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>KRAS Gene)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 1q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 20q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 3q24-qter)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 5p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 8q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 13q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 4q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 6q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 8p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 9)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome Y)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>KRAS2 Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>LKB1 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Loss of Chromosome 5q).<br></td>
            </tr>
            <tr class="removal">
               <td>1650</td>
               <td>Lung Carcinoma<span class="subclass"> EquivalentTo </span>Carcinoma<br><span class="keyword"> and </span>Malignant Lung Neoplasm<br><span class="keyword"> and </span>(Disease_Has_Primary_Anatomic_Site<span class="some"> some </span>Lung). 
                  			
               </td>
               <td>Lung Carcinoma<span class="subclass"> EquivalentTo </span>Carcinoma<br><span class="keyword"> and </span>Malignant Lung Neoplasm<br><span class="keyword"> and </span>(Disease_Has_Primary_Anatomic_Site<span class="some"> some </span>Lung)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>TP53 Gene).<br></td>
            </tr>
            <tr class="removal">
               <td>1651</td>
               <td>Malignant Mesothelioma<span class="subclass"> EquivalentTo </span>Mesothelioma<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> some </span>Malignant Mesothelial Cell). 
                  			
               </td>
               <td>Malignant Mesothelioma<span class="subclass"> EquivalentTo </span>Mesothelioma<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> some </span>Malignant Mesothelial Cell)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>CDKN2A Gene).<br></td>
            </tr>
            <tr class="removal">
               <td>1630</td>
               <td>NUT Midline Carcinoma<span class="subclass"> EquivalentTo </span>Undifferentiated Carcinoma<br><span class="keyword"> and </span>(Disease_Has_Cytogenetic_Abnormality<span class="some"> some </span>t(15;19)(q13;p13.1))<br><span class="keyword"> and </span>(Disease_Has_Molecular_Abnormality<span class="some"> some </span>BRD4-NUT Fusion Protein Expression). 
                  			
               </td>
               <td>NUT Midline Carcinoma<span class="subclass"> EquivalentTo </span>Undifferentiated Carcinoma<br><span class="keyword"> and </span>(Disease_Has_Cytogenetic_Abnormality<span class="some"> some </span>t(15;19)(q13;p13.1))<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> some </span>Aggressive Clinical Course)<br><span class="keyword"> and </span>(Disease_Has_Molecular_Abnormality<span class="some"> some </span>BRD4-NUT Fusion Protein Expression)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>BRD4/C15orf55 Fusion Gene).<br></td>
            </tr>
            <tr class="removal">
               <td>1654</td>
               <td>Parathyroid Gland Adenoma<span class="subclass"> EquivalentTo </span>Adenoma<br><span class="keyword"> and </span>Benign Endocrine Neoplasm<br><span class="keyword"> and </span>Benign Parathyroid Gland Neoplasm<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> some </span>Neoplastic Parathyroid Gland Cell)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> some </span>Parathyroid Gland Parenchymal Cell)<br><span class="keyword"> and </span>(Disease_Has_Normal_Tissue_Origin<span class="some"> some </span>Parathyroid Gland Epithelial Tissue)<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Primary Hyperparathyroidism)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Acinar Pattern)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Encapsulated Mass)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Follicular Structures Present)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Solid Growth Pattern)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Trabecular Pattern)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Aneuploidy)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>MEN1 Gene Inactivation). 
                  			
               </td>
               <td>Parathyroid Gland Adenoma<span class="subclass"> EquivalentTo </span>Adenoma<br><span class="keyword"> and </span>Benign Endocrine Neoplasm<br><span class="keyword"> and </span>Benign Parathyroid Gland Neoplasm<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> some </span>Neoplastic Parathyroid Gland Cell)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> some </span>Parathyroid Gland Parenchymal Cell)<br><span class="keyword"> and </span>(Disease_Has_Normal_Tissue_Origin<span class="some"> some </span>Parathyroid Gland Epithelial Tissue)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>CCND1 Gene)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>MEN1 Gene)<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Primary Hyperparathyroidism)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Acinar Pattern)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Encapsulated Mass)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Follicular Structures Present)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Solid Growth Pattern)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Trabecular Pattern)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Aneuploidy)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>MEN1 Gene Inactivation).<br></td>
            </tr>
            <tr class="removal">
               <td>1655</td>
               <td>Parathyroid Gland Carcinoma<span class="subclass"> EquivalentTo </span>Adenocarcinoma<br><span class="keyword"> and </span>Malignant Endocrine Neoplasm<br><span class="keyword"> and </span>Malignant Parathyroid Gland Neoplasm<br><span class="keyword"> and </span>Neck Carcinoma<br><span class="keyword"> and </span>((Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>CCND1 Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Cyclin D1 Protein Overexpression))<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> some </span>Malignant Parathyroid Gland Cell)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> some </span>Parathyroid Gland Parenchymal Cell)<br><span class="keyword"> and </span>(Disease_Has_Normal_Tissue_Origin<span class="some"> some </span>Parathyroid Gland Epithelial Tissue)<br><span class="keyword"> and </span>(Disease_Has_Primary_Anatomic_Site<span class="some"> some </span>Parathyroid Gland)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Malignant Parathyroid Gland Chief Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Malignant Parathyroid Gland Clear Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Malignant Parathyroid Gland Oncocyte)<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Primary Hyperparathyroidism)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Broad Fibrous Bands Formation)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Capsular Invasion)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hemosiderin Deposition)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Mitotic Activity)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Neck Mass)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Perineural Invasion)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Solid Growth Pattern)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Trabecular Pattern)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Tumor Vascular Invasion)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Aneuploidy)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>CDC73 Gene Mutation). 
                  			
               </td>
               <td>Parathyroid Gland Carcinoma<span class="subclass"> EquivalentTo </span>Adenocarcinoma<br><span class="keyword"> and </span>Malignant Endocrine Neoplasm<br><span class="keyword"> and </span>Malignant Parathyroid Gland Neoplasm<br><span class="keyword"> and </span>Neck Carcinoma<br><span class="keyword"> and </span>((Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>CCND1 Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Cyclin D1 Protein Overexpression))<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> some </span>Malignant Parathyroid Gland Cell)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> some </span>Parathyroid Gland Parenchymal Cell)<br><span class="keyword"> and </span>(Disease_Has_Normal_Tissue_Origin<span class="some"> some </span>Parathyroid Gland Epithelial Tissue)<br><span class="keyword"> and </span>(Disease_Has_Primary_Anatomic_Site<span class="some"> some </span>Parathyroid Gland)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>CDC73 Gene)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Malignant Parathyroid Gland Chief Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Malignant Parathyroid Gland Clear Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Malignant Parathyroid Gland Oncocyte)<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Primary Hyperparathyroidism)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Broad Fibrous Bands Formation)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Capsular Invasion)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hemosiderin Deposition)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Mitotic Activity)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Neck Mass)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Perineural Invasion)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Solid Growth Pattern)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Trabecular Pattern)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Tumor Vascular Invasion)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Aneuploidy)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>CDC73 Gene Mutation).<br></td>
            </tr>
            <tr class="removal">
               <td>1656</td>
               <td>Prostate Carcinoma<span class="subclass"> EquivalentTo </span>Carcinoma<br><span class="keyword"> and </span>Malignant Prostate Neoplasm<br><span class="keyword"> and </span>((Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>ERG Gene Rearrangement)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>TMPRSS2-ERG Fusion Protein Expression))<br><span class="keyword"> and </span>(Disease_Has_Normal_Tissue_Origin<span class="some"> some </span>Prostatic Epithelium)<br><span class="keyword"> and </span>(Disease_Has_Primary_Anatomic_Site<span class="some"> some </span>Prostate Gland). 
                  			
               </td>
               <td>Prostate Carcinoma<span class="subclass"> EquivalentTo </span>Carcinoma<br><span class="keyword"> and </span>Malignant Prostate Neoplasm<br><span class="keyword"> and </span>((Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>ERG Gene Rearrangement)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>TMPRSS2-ERG Fusion Protein Expression))<br><span class="keyword"> and </span>(Disease_Has_Normal_Tissue_Origin<span class="some"> some </span>Prostatic Epithelium)<br><span class="keyword"> and </span>(Disease_Has_Primary_Anatomic_Site<span class="some"> some </span>Prostate Gland)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>ERG Gene)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>TMPRSS2/ERG Fusion Gene).<br></td>
            </tr>
            <tr class="removal">
               <td>1657</td>
               <td>Renal Cell Carcinoma Associated with inv(X)(p11;q12)<span class="subclass"> EquivalentTo </span>Renal Cell Carcinoma Associated with Xp11.2 Translocations/TFE3 Gene Fusions<br><span class="keyword"> and </span>((Disease_Has_Cytogenetic_Abnormality<span class="some"> some </span>inv(X)(p11;q12))<br><span class="keyword"> and </span>(Disease_Has_Molecular_Abnormality<span class="some"> some </span>NONO-TFE3 Fusion Protein Expression)). 
                  			
               </td>
               <td>Renal Cell Carcinoma Associated with inv(X)(p11;q12)<span class="subclass"> EquivalentTo </span>Renal Cell Carcinoma Associated with Xp11.2 Translocations/TFE3 Gene Fusions<br><span class="keyword"> and </span>((Disease_Has_Cytogenetic_Abnormality<span class="some"> some </span>inv(X)(p11;q12))<br><span class="keyword"> and </span>(Disease_Has_Molecular_Abnormality<span class="some"> some </span>NONO-TFE3 Fusion Protein Expression))<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>NONO/TFE3 Fusion Gene).<br></td>
            </tr>
            <tr class="removal">
               <td>1658</td>
               <td>Renal Cell Carcinoma Associated with t(X;1)(p11.2;p34)<span class="subclass"> EquivalentTo </span>Renal Cell Carcinoma Associated with Xp11.2 Translocations/TFE3 Gene Fusions<br><span class="keyword"> and </span>((Disease_Has_Cytogenetic_Abnormality<span class="some"> some </span>t(X;1)(p11.2;p34))<br><span class="keyword"> and </span>(Disease_Has_Molecular_Abnormality<span class="some"> some </span>PSF-TFE3 Fusion Protein Expression)). 
                  			
               </td>
               <td>Renal Cell Carcinoma Associated with t(X;1)(p11.2;p34)<span class="subclass"> EquivalentTo </span>Renal Cell Carcinoma Associated with Xp11.2 Translocations/TFE3 Gene Fusions<br><span class="keyword"> and </span>((Disease_Has_Cytogenetic_Abnormality<span class="some"> some </span>t(X;1)(p11.2;p34))<br><span class="keyword"> and </span>(Disease_Has_Molecular_Abnormality<span class="some"> some </span>PSF-TFE3 Fusion Protein Expression))<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>SFPQ/TFE3 Fusion Gene).<br></td>
            </tr>
            <tr class="removal">
               <td>1659</td>
               <td>Renal Cell Carcinoma Associated with t(X;1)(p11.2;q21)<span class="subclass"> EquivalentTo </span>Renal Cell Carcinoma Associated with Xp11.2 Translocations/TFE3 Gene Fusions<br><span class="keyword"> and </span>((Disease_Has_Cytogenetic_Abnormality<span class="some"> some </span>t(X;1)(p11.2;q21))<br><span class="keyword"> and </span>(Disease_Has_Molecular_Abnormality<span class="some"> some </span>PRCC-TFE3 Fusion Protein Expression))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Psammoma Body Formation). 
                  			
               </td>
               <td>Renal Cell Carcinoma Associated with t(X;1)(p11.2;q21)<span class="subclass"> EquivalentTo </span>Renal Cell Carcinoma Associated with Xp11.2 Translocations/TFE3 Gene Fusions<br><span class="keyword"> and </span>((Disease_Has_Cytogenetic_Abnormality<span class="some"> some </span>t(X;1)(p11.2;q21))<br><span class="keyword"> and </span>(Disease_Has_Molecular_Abnormality<span class="some"> some </span>PRCC-TFE3 Fusion Protein Expression))<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>PRCC/TFE3 Fusion Gene)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Psammoma Body Formation).<br></td>
            </tr>
            <tr class="removal">
               <td>1660</td>
               <td>Salivary Gland Mucoepidermoid Carcinoma<span class="subclass"> EquivalentTo </span>Mucoepidermoid Carcinoma<br><span class="keyword"> and </span>Salivary Gland Carcinoma<br><span class="keyword"> and </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(11;19)(q14-21;p12-13))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>MECT1-MAML2 Fusion Protein Expression)). 
                  			
               </td>
               <td>Salivary Gland Mucoepidermoid Carcinoma<span class="subclass"> EquivalentTo </span>Mucoepidermoid Carcinoma<br><span class="keyword"> and </span>Salivary Gland Carcinoma<br><span class="keyword"> and </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(11;19)(q14-21;p12-13))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>MECT1-MAML2 Fusion Protein Expression))<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>CRTC1/MAML2 Fusion Gene).<br></td>
            </tr>
            <tr class="removal">
               <td>1661</td>
               <td>Secretory Breast Carcinoma<span class="subclass"> EquivalentTo </span>Breast Adenocarcinoma<br><span class="keyword"> and </span>Invasive Breast Carcinoma<br><span class="keyword"> and </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(12;15)(p13;q26))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>ETV6-NTRK3 Fusion Protein Expression))<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> some </span>Adenocarcinoma Cell with Abundant Pale Staining Cytoplasm)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> some </span>Intracytoplasmic<br><span class="keyword"> and </span>Extracytoplasmic Eosinophilic Material Present)<br><span class="keyword"> and </span>(Disease_Is_Grade<span class="some"> some </span>Low Grade)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Well-Circumscribed Lesion)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Favorable Clinical Outcome). 
                  			
               </td>
               <td>Secretory Breast Carcinoma<span class="subclass"> EquivalentTo </span>Breast Adenocarcinoma<br><span class="keyword"> and </span>Invasive Breast Carcinoma<br><span class="keyword"> and </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(12;15)(p13;q26))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>ETV6-NTRK3 Fusion Protein Expression))<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> some </span>Adenocarcinoma Cell with Abundant Pale Staining Cytoplasm)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> some </span>Intracytoplasmic<br><span class="keyword"> and </span>Extracytoplasmic Eosinophilic Material Present)<br><span class="keyword"> and </span>(Disease_Is_Grade<span class="some"> some </span>Low Grade)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>ETV6/NTRK3 Fusion Gene)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Well-Circumscribed Lesion)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Favorable Clinical Outcome).<br></td>
            </tr>
            <tr class="removal">
               <td>1662</td>
               <td>Small Intestinal Mucosa-Associated Lymphoid Tissue Lymphoma<span class="subclass"> EquivalentTo </span>Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue<br><span class="keyword"> and </span>Small Intestinal B-Cell Non-Hodgkin Lymphoma<br><span class="keyword"> and </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(11;18)(q21;q21))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>API2-MLT Fusion Protein Expression))<br><span class="keyword"> and </span>(Disease_Has_Normal_Tissue_Origin<span class="some"> some </span>Gut-Associated Lymphoid Tissue)<br><span class="keyword"> and </span>(Disease_Has_Normal_Tissue_Origin<span class="some"> some </span>Small Intestinal Mucosa)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>MALT1 Gene)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(1;14)(p22;q32)). 
                  			
               </td>
               <td>Small Intestinal Mucosa-Associated Lymphoid Tissue Lymphoma<span class="subclass"> EquivalentTo </span>Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue<br><span class="keyword"> and </span>Small Intestinal B-Cell Non-Hodgkin Lymphoma<br><span class="keyword"> and </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(11;18)(q21;q21))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>API2-MLT Fusion Protein Expression))<br><span class="keyword"> and </span>(Disease_Has_Normal_Tissue_Origin<span class="some"> some </span>Gut-Associated Lymphoid Tissue)<br><span class="keyword"> and </span>(Disease_Has_Normal_Tissue_Origin<span class="some"> some </span>Small Intestinal Mucosa)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>BIRC3/MALT1 Fusion Gene)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>MALT1 Gene)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(1;14)(p22;q32)).<br></td>
            </tr>
            <tr class="removal">
               <td>1663</td>
               <td>Synovial Sarcoma<span class="subclass"> EquivalentTo </span>Malignant Soft Tissue Neoplasm of Uncertain Differentiation<br><span class="keyword"> and </span>Sarcoma NCI Grade 3<br><span class="keyword"> and </span>Soft Tissue Sarcoma<br><span class="keyword"> and </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(X;18)(p11;q11))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>SS18-SSX1 Fusion Protein Expression)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>SS18-SSX2 Fusion Protein Expression)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>SS18-SSX4 Fusion Protein Expression))<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>SS18 Gene). 
                  			
               </td>
               <td>Synovial Sarcoma<span class="subclass"> EquivalentTo </span>Malignant Soft Tissue Neoplasm of Uncertain Differentiation<br><span class="keyword"> and </span>Sarcoma NCI Grade 3<br><span class="keyword"> and </span>Soft Tissue Sarcoma<br><span class="keyword"> and </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(X;18)(p11;q11))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>SS18-SSX1 Fusion Protein Expression)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>SS18-SSX2 Fusion Protein Expression)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>SS18-SSX4 Fusion Protein Expression))<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>SS18/SSX1 Fusion Gene)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>SS18/SSX2 Fusion Gene)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>SS18/SSX4 Fusion Gene)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>SS18 Gene).<br></td>
            </tr>
            <tr class="removal">
               <td>1665</td>
               <td>Thyroid Gland Follicular Adenoma<span class="subclass"> EquivalentTo </span>Adenoma<br><span class="keyword"> and </span>Benign Endocrine Neoplasm<br><span class="keyword"> and </span>Benign Thyroid Gland Neoplasm<br><span class="keyword"> and </span>Thyroid Gland Nodule<br><span class="keyword"> and </span>(Disease_Excludes_Finding<span class="some"> some </span>Capsular Invasion)<br><span class="keyword"> and </span>(Disease_Excludes_Finding<span class="some"> some </span>Ground Glass Nuclear Inclusion)<br><span class="keyword"> and </span>(Disease_Excludes_Finding<span class="some"> some </span>Nuclear Clearing)<br><span class="keyword"> and </span>(Disease_Excludes_Finding<span class="some"> some </span>Nuclear Grooves)<br><span class="keyword"> and </span>(Disease_Excludes_Finding<span class="some"> some </span>Nuclear Pseudoinclusion)<br><span class="keyword"> and </span>(Disease_Excludes_Finding<span class="some"> some </span>Tumor Vascular Invasion)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> some </span>Neoplastic Thyroid Gland Follicular Cell)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> some </span>Monoclonal Cellular Population Present)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> some </span>Encapsulated Mass)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> some </span>Follicular Structures Present)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> some </span>Thyroglobulin Positive Neoplastic Cells Present)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> some </span>Thyroid Gland Follicular Cell)<br><span class="keyword"> and </span>(Disease_Has_Normal_Tissue_Origin<span class="some"> some </span>Thyroid Gland Follicle)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 10)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 13)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 19)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 3p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Trisomy 7)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Radiation Toxicity). 
                  			
               </td>
               <td>Thyroid Gland Follicular Adenoma<span class="subclass"> EquivalentTo </span>Adenoma<br><span class="keyword"> and </span>Benign Endocrine Neoplasm<br><span class="keyword"> and </span>Benign Thyroid Gland Neoplasm<br><span class="keyword"> and </span>Thyroid Gland Nodule<br><span class="keyword"> and </span>(Disease_Excludes_Finding<span class="some"> some </span>Capsular Invasion)<br><span class="keyword"> and </span>(Disease_Excludes_Finding<span class="some"> some </span>Ground Glass Nuclear Inclusion)<br><span class="keyword"> and </span>(Disease_Excludes_Finding<span class="some"> some </span>Nuclear Clearing)<br><span class="keyword"> and </span>(Disease_Excludes_Finding<span class="some"> some </span>Nuclear Grooves)<br><span class="keyword"> and </span>(Disease_Excludes_Finding<span class="some"> some </span>Nuclear Pseudoinclusion)<br><span class="keyword"> and </span>(Disease_Excludes_Finding<span class="some"> some </span>Tumor Vascular Invasion)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> some </span>Neoplastic Thyroid Gland Follicular Cell)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> some </span>Monoclonal Cellular Population Present)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> some </span>Encapsulated Mass)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> some </span>Follicular Structures Present)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> some </span>Thyroglobulin Positive Neoplastic Cells Present)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> some </span>Thyroid Gland Follicular Cell)<br><span class="keyword"> and </span>(Disease_Has_Normal_Tissue_Origin<span class="some"> some </span>Thyroid Gland Follicle)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>PAX8/PPARG Fusion Gene)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>PPARG Gene)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 10)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 13)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 19)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 3p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Trisomy 7)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Radiation Toxicity).<br></td>
            </tr>
            <tr class="removal">
               <td>1638</td>
               <td>Thyroid Gland Follicular Carcinoma<span class="subclass"> EquivalentTo </span>Differentiated Thyroid Gland Carcinoma<br><span class="keyword"> and </span>(Disease_Excludes_Finding<span class="some"> some </span>Ground Glass Nuclear Inclusion)<br><span class="keyword"> and </span>(Disease_Excludes_Finding<span class="some"> some </span>Nuclear Clearing)<br><span class="keyword"> and </span>(Disease_Excludes_Finding<span class="some"> some </span>Nuclear Grooves)<br><span class="keyword"> and </span>(Disease_Excludes_Finding<span class="some"> some </span>Nuclear Pseudoinclusion)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Encapsulated Mass)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Follicular Structures Present)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Solid Growth Pattern)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Trabecular Pattern)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>HRAS Gene Mutation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>NRAS Gene Mutation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>PPAR-gamma Rearrangement)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>PTEN Gene Inactivation). 
                  			
               </td>
               <td>Thyroid Gland Follicular Carcinoma<span class="subclass"> EquivalentTo </span>Differentiated Thyroid Gland Carcinoma<br><span class="keyword"> and </span>(Disease_Excludes_Finding<span class="some"> some </span>Ground Glass Nuclear Inclusion)<br><span class="keyword"> and </span>(Disease_Excludes_Finding<span class="some"> some </span>Nuclear Clearing)<br><span class="keyword"> and </span>(Disease_Excludes_Finding<span class="some"> some </span>Nuclear Grooves)<br><span class="keyword"> and </span>(Disease_Excludes_Finding<span class="some"> some </span>Nuclear Pseudoinclusion)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>PAX8/PPARG Fusion Gene)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>PPARG Gene)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Encapsulated Mass)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Follicular Structures Present)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Solid Growth Pattern)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Trabecular Pattern)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>HRAS Gene Mutation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>NRAS Gene Mutation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>PPAR-gamma Rearrangement)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>PTEN Gene Inactivation).<br></td>
            </tr>
            <tr class="removal">
               <td>1652</td>
               <td>Thyroid Gland Medullary Carcinoma<span class="subclass"> EquivalentTo </span>Neuroendocrine Carcinoma<br><span class="keyword"> and </span>Thyroid Gland Carcinoma<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> some </span>Calcitonin Positive Neoplastic Cells Present)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> some </span>Well-Circumscribed Lesion)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> some </span>Serum Calcitonin Level Increased)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> some </span>C-Cell)<br><span class="keyword"> and </span>(Disease_Has_Normal_Tissue_Origin<span class="some"> some </span>Thyroid Gland Follicle)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Malignant Neuroendocrine Polygonal Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Malignant Neuroendocrine Small Round Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Malignant Neuroendocrine Spindle Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Paraneoplastic Syndrome)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Cold Nodule)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Metastatic Malignant Neoplasm to the Lymph Node)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Organoid Pattern)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Trabecular Pattern). 
                  			
               </td>
               <td>Thyroid Gland Medullary Carcinoma<span class="subclass"> EquivalentTo </span>Neuroendocrine Carcinoma<br><span class="keyword"> and </span>Thyroid Gland Carcinoma<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> some </span>Calcitonin Positive Neoplastic Cells Present)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> some </span>Well-Circumscribed Lesion)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> some </span>Serum Calcitonin Level Increased)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> some </span>C-Cell)<br><span class="keyword"> and </span>(Disease_Has_Normal_Tissue_Origin<span class="some"> some </span>Thyroid Gland Follicle)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>RET Gene)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Malignant Neuroendocrine Polygonal Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Malignant Neuroendocrine Small Round Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Malignant Neuroendocrine Spindle Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Paraneoplastic Syndrome)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Cold Nodule)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Metastatic Malignant Neoplasm to the Lymph Node)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Organoid Pattern)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Trabecular Pattern).<br></td>
            </tr>
            <tr class="removal">
               <td>1653</td>
               <td>Thyroid Gland Papillary Carcinoma<span class="subclass"> EquivalentTo </span>Papillary Adenocarcinoma<br><span class="keyword"> and </span>Differentiated Thyroid Gland Carcinoma<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> some </span>Ground Glass Nuclear Inclusion)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> some </span>Nuclear Grooves)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> some </span>Nuclear Pseudoinclusion)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Cystic Change)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Indolent Clinical Course)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Psammoma Body Formation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>BRAF Gene Mutation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>HRAS Gene Mutation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>KRAS Gene Mutation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>NRAS Gene Mutation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>RET/PTC Rearrangement)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>TRK Rearrangement). 
                  			
               </td>
               <td>Thyroid Gland Papillary Carcinoma<span class="subclass"> EquivalentTo </span>Papillary Adenocarcinoma<br><span class="keyword"> and </span>Differentiated Thyroid Gland Carcinoma<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> some </span>Ground Glass Nuclear Inclusion)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> some </span>Nuclear Grooves)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> some </span>Nuclear Pseudoinclusion)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>ERC1/RET Fusion Gene)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>GOLGA5/RET Fusion Gene)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>NCOA4/RET Fusion Gene)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>PCM1/RET Fusion Gene)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>PRKAR1A/RET Fusion Gene)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>CCDC6/RET Fusion Gene)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>RET Gene)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>TPM3/NTRK1 Fusion Gene)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>TRIM24/RET Fusion Gene)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>TRIM33/RET Fusion Gene)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Cystic Change)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Indolent Clinical Course)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Psammoma Body Formation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>BRAF Gene Mutation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>HRAS Gene Mutation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>KRAS Gene Mutation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>NRAS Gene Mutation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>RET/PTC Rearrangement)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>TRK Rearrangement).<br></td>
            </tr>
            <tr class="removal">
               <td>1666</td>
               <td>Uterine Corpus Endometrial Stromal Neoplasm<span class="subclass"> EquivalentTo </span>Endometrial Stromal Neoplasm<br><span class="keyword"> and </span>Uterine Corpus Soft Tissue Neoplasm<br><span class="keyword"> and </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(7;17)(p15;q21))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>JAZF1-JJAZ1 Fusion Protein Expression))<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> some </span>Endometrial Stromal Cell). 
                  			
               </td>
               <td>Uterine Corpus Endometrial Stromal Neoplasm<span class="subclass"> EquivalentTo </span>Endometrial Stromal Neoplasm<br><span class="keyword"> and </span>Uterine Corpus Soft Tissue Neoplasm<br><span class="keyword"> and </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(7;17)(p15;q21))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>JAZF1-JJAZ1 Fusion Protein Expression))<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> some </span>Endometrial Stromal Cell)<br><span class="keyword"> and </span>(Disease_Mapped_To_Gene<span class="some"> some </span>JAZF1/SUZ12 Fusion Gene).<br></td>
            </tr>
         </tbody>
         <tbody id="rst" style="display:none">
            <tr class="withoutstyle">
               <td colspan="3">
                  <h4 style="display: inline-block;">Prospective Novel Redundant (15)</h4> [<a href="#">back to top</a>]
               </td>
            </tr>
            <tr>
               <th class="removal">ID</th>
               <th class="removal">Axiom in Ontology 1</th>
               <th class="normalrem">Justifications in Ontology 2</th>
            </tr>
            <tr class="removal">
               <td rowspan="1">1668</td>
               <td rowspan="1">Baptisia tinctoria Leaf<span class="subclass"> SubClassOf </span>Natural Product. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Plant Part<span class="subclass"> SubClassOf </span>Natural Product. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(2)</i>&nbsp; Leaf<span class="subclass"> SubClassOf </span>Plant Part. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(3)</i>&nbsp; Baptisia tinctoria Leaf<span class="subclass"> SubClassOf </span>Leaf. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td rowspan="1">1669</td>
               <td rowspan="1">Belladonna Leaf<span class="subclass"> SubClassOf </span>Natural Product. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Plant Part<span class="subclass"> SubClassOf </span>Natural Product. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(2)</i>&nbsp; Leaf<span class="subclass"> SubClassOf </span>Plant Part. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(3)</i>&nbsp; Belladonna Leaf<span class="subclass"> SubClassOf </span>Leaf. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td rowspan="1">1670</td>
               <td rowspan="1">CDK2/TRKA Inhibitor PHA-848125 AC<span class="subclass"> SubClassOf </span>Protein Kinase Inhibitor. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; CDK2/TRKA Inhibitor PHA-848125 AC<span class="subclass"> SubClassOf </span>Cyclin-Dependent Kinase Inhibitor. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Cyclin-Dependent Kinase Inhibitor<span class="subclass"> SubClassOf </span>Protein Kinase Inhibitor. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td rowspan="1">1671</td>
               <td rowspan="1">Calendula officinalis Flowering Top<span class="subclass"> SubClassOf </span>Natural Product. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Flower<span class="subclass"> SubClassOf </span>Plant Part. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(2)</i>&nbsp; Plant Part<span class="subclass"> SubClassOf </span>Natural Product. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(3)</i>&nbsp; Calendula officinalis Flowering Top<span class="subclass"> SubClassOf </span>Flower. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td rowspan="1">1675</td>
               <td rowspan="1">Calluna vulgaris Flowering Top<span class="subclass"> SubClassOf </span>Natural Product. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Flower<span class="subclass"> SubClassOf </span>Plant Part. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(2)</i>&nbsp; Plant Part<span class="subclass"> SubClassOf </span>Natural Product. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(3)</i>&nbsp; Calluna vulgaris Flowering Top<span class="subclass"> SubClassOf </span>Flower. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td rowspan="1">1672</td>
               <td rowspan="1">Central Nervous System Teratoma<span class="subclass"> EquivalentTo </span>Central Nervous System Germ Cell Tumor<br><span class="keyword"> and </span>Teratoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Nongerminomatous Germ Cell Tumor<span class="subclass"> EquivalentTo </span>Central Nervous System Germ Cell Tumor<br><span class="keyword"> and </span>(Disease_Excludes_Abnormal_Cell<span class="some"> some </span>Malignant Primitive Germ Cell). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Malignant Large Germ Cell with Abundant Cytoplasm<span class="subclass"> SubClassOf </span>Malignant Primitive Germ Cell. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(3)</i>&nbsp; Central Nervous System Teratoma<span class="subclass"> EquivalentTo </span>Nongerminomatous Germ Cell Tumor<br><span class="keyword"> and </span>Teratoma. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(4)</i>&nbsp; Teratoma<span class="subclass"> EquivalentTo </span>Germ Cell Tumor<br><span class="keyword"> and </span>(Disease_Excludes_Abnormal_Cell<span class="some"> some </span>Malignant Large Germ Cell with Abundant Cytoplasm)<br><span class="keyword"> and </span>(Disease_Excludes_Finding<span class="some"> some </span>Seminomatous Component Present)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Ectodermal Differentiation)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Endodermal Differentiation)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Mesodermal Differentiation). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td rowspan="1">1673</td>
               <td rowspan="1">Digitalis lanata Leaf<span class="subclass"> SubClassOf </span>Natural Product. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Digitalis lanata Leaf<span class="subclass"> SubClassOf </span>Leaf. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Plant Part<span class="subclass"> SubClassOf </span>Natural Product. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(3)</i>&nbsp; Leaf<span class="subclass"> SubClassOf </span>Plant Part. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td rowspan="1">1674</td>
               <td rowspan="1">Foeniculum vulgare Leaf<span class="subclass"> SubClassOf </span>Natural Product. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Plant Part<span class="subclass"> SubClassOf </span>Natural Product. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(2)</i>&nbsp; Foeniculum vulgare Leaf<span class="subclass"> SubClassOf </span>Leaf. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(3)</i>&nbsp; Leaf<span class="subclass"> SubClassOf </span>Plant Part. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td rowspan="1">1676</td>
               <td rowspan="1">Hydrangea serrata Leaf<span class="subclass"> SubClassOf </span>Natural Product. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Plant Part<span class="subclass"> SubClassOf </span>Natural Product. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(2)</i>&nbsp; Leaf<span class="subclass"> SubClassOf </span>Plant Part. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(3)</i>&nbsp; Hydrangea serrata Leaf<span class="subclass"> SubClassOf </span>Leaf. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td rowspan="1">1677</td>
               <td rowspan="1">Lasinavir<span class="subclass"> SubClassOf </span>Protease Inhibitor. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; HIV Protease Inhibitor<span class="subclass"> SubClassOf </span>Protease Inhibitor. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(2)</i>&nbsp; Lasinavir<span class="subclass"> SubClassOf </span>HIV Protease Inhibitor. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td rowspan="1">1678</td>
               <td rowspan="1">Neonatal Research Network Terminology<span class="subclass"> SubClassOf </span>Terminology Subset. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Neonatal Research Network Terminology<span class="subclass"> SubClassOf </span>NICHD Terminology. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; NICHD Terminology<span class="subclass"> SubClassOf </span>Terminology Subset. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td rowspan="1">1679</td>
               <td rowspan="1">PSA Failure<span class="subclass"> SubClassOf </span>Clinical Test Result. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Laboratory Test Result<span class="subclass"> SubClassOf </span>Clinical Test Result. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(2)</i>&nbsp; PSA Failure<span class="subclass"> SubClassOf </span>Laboratory Test Result. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td rowspan="1">1681</td>
               <td rowspan="1">Reptilase Time Measurement<span class="subclass"> SubClassOf </span>Hematology Test. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Coagulation Study<span class="subclass"> SubClassOf </span>Hematology Test. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(2)</i>&nbsp; Reptilase Time Measurement<span class="subclass"> SubClassOf </span>Coagulation Study. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td rowspan="1">1682</td>
               <td rowspan="1">Telinavir<span class="subclass"> SubClassOf </span>Protease Inhibitor. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Telinavir<span class="subclass"> SubClassOf </span>HIV Protease Inhibitor. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; HIV Protease Inhibitor<span class="subclass"> SubClassOf </span>Protease Inhibitor. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td rowspan="1">1680</td>
               <td rowspan="1">Toxicodendron vernix Leafy Twig<span class="subclass"> SubClassOf </span>Natural Product. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Plant Part<span class="subclass"> SubClassOf </span>Natural Product. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(2)</i>&nbsp; Toxicodendron vernix Leafy Twig<span class="subclass"> SubClassOf </span>Twig. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(3)</i>&nbsp; Twig<span class="subclass"> SubClassOf </span>Plant Part. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br></td>
            </tr>
         </tbody>
         <tbody id="rpsnovred" style="display:none">
            <tr class="withoutstyle">
               <td colspan="3">
                  <h4 style="display: inline-block;">Prospective Pseudo Novel Redundant (3)</h4> [<a href="#">back to top</a>]
               </td>
            </tr>
            <tr>
               <th class="removal">ID</th>
               <th class="removal">Axiom in Ontology 1</th>
               <th class="normalrem">Justifications in Ontology 2</th>
            </tr>
            <tr class="removal">
               <td rowspan="1">1683</td>
               <td rowspan="1">CLCF1 wt Allele<span class="subclass"> SubClassOf </span>CLCF1 Gene. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; CLCF1 wt Allele<span class="subclass"> EquivalentTo </span>CLCF1 Gene<br><span class="keyword"> and </span>(Gene_Found_In_Organism<span class="some"> some </span>Human)<br><span class="keyword"> and </span>(Gene_In_Chromosomal_Location<span class="some"> some </span>11q13.3)<br><span class="keyword"> and </span>(Gene_Is_Element_In_Pathway<span class="some"> some </span>Cytokine-Cytokine Receptor Signaling Pathway)<br><span class="keyword"> and </span>(Gene_Is_Element_In_Pathway<span class="some"> some </span>Jak-STAT Signaling Pathway). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">1684</td>
               <td rowspan="1">CLCF1 wt Allele<span class="subclass"> SubClassOf </span>Gene_Found_In_Organism<span class="some"> some </span>Human. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; CLCF1 wt Allele<span class="subclass"> EquivalentTo </span>CLCF1 Gene<br><span class="keyword"> and </span>(Gene_Found_In_Organism<span class="some"> some </span>Human)<br><span class="keyword"> and </span>(Gene_In_Chromosomal_Location<span class="some"> some </span>11q13.3)<br><span class="keyword"> and </span>(Gene_Is_Element_In_Pathway<span class="some"> some </span>Cytokine-Cytokine Receptor Signaling Pathway)<br><span class="keyword"> and </span>(Gene_Is_Element_In_Pathway<span class="some"> some </span>Jak-STAT Signaling Pathway). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">1685</td>
               <td rowspan="1">CLCF1 wt Allele<span class="subclass"> SubClassOf </span>Gene_In_Chromosomal_Location<span class="some"> some </span>11q13.3. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; CLCF1 wt Allele<span class="subclass"> EquivalentTo </span>CLCF1 Gene<br><span class="keyword"> and </span>(Gene_Found_In_Organism<span class="some"> some </span>Human)<br><span class="keyword"> and </span>(Gene_In_Chromosomal_Location<span class="some"> some </span>11q13.3)<br><span class="keyword"> and </span>(Gene_Is_Element_In_Pathway<span class="some"> some </span>Cytokine-Cytokine Receptor Signaling Pathway)<br><span class="keyword"> and </span>(Gene_Is_Element_In_Pathway<span class="some"> some </span>Jak-STAT Signaling Pathway). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
         </tbody>
         <tr class="withoutstyle">
            <td>&nbsp;</td>
         </tr>
      </table>
      <div id="shared" style="display:none" class="footnote">Shared axiom between Ontology 1 and 2.</div>
   </body>
</html>